key: cord-0071951-rer5j7q6
authors: nan
title: 62nd Annual Conference of Indian Society of Hematology & Blood Transfusion (ISHBT)
date: 2021-12-18
journal: Indian J Hematol Blood Transfus
DOI: 10.1007/s12288-021-01510-0
sha: def8d08ffcdeed3495eadc5a5944bb1916459f20
doc_id: 71951
cord_uid: rer5j7q6

nan

Thromboembolism at a Tertiary Care Hospital in Western Rajasthan S. Veena, Abhishek Purohit, Naresh Kumar Midha, Mahendra Kumar Garg Introduction: Venous thromboembolism, comprising of deep venous thrombosis and pulmonary embolism, is a multifactorial condition that is associated with significant morbidity and mortality. Only few Indian studies have been conducted to determine its prevalence and risk factors. Aims & Objectives: The objectives of our study were to determine the prevalence, risk factors and complications of VTE in adult patients visiting our tertiary hospital in Jodhpur.

Adult patients with VTE who presented between July 2019 and June 2021 were recruited in the study. Along with clinical data, blood samples were collected for Protein C and S, antithrombin, lupus anticoagulant, activated protein C resistance, antinuclear antibody, fibrinogen, vitamin B12, homocysteine, and Factors VIII and IX. Patients were followed up for 6 months and assessed for any complications of VTE-chronic venous insufficiency, recurrence or death. Result: The prevalence of VTE was 6.28 per 10,000 patients. Mean age was 47.37 ± 18.032 years and 135 (56.25%) were male of the 243 patients. DVT alone was the initial presentation in 58.75%, PE alone in 15.83% and both in 8.33%. The most common risk factor was malignancy (13.75%) followed by recent trauma (within 1 month) (8.33%). Protein C deficiency was seen in 87 (66.41%) patients and Protein S deficiency in 70 (53.44%) patients (N = 131), andantithrombin deficiency in 19 (15.7%) patients (N = 121). Lupus anticoagulant was positive in 23 (21.70%) patients (N = 107). APCR was detected in 27 (24.55%) patients (N = 110). Elevated serum homocysteine level ([ 15 lmol/L) was seen in 54 (48.21%) patients. Vitamin B12 level less than 200 pg/mL was seen in 19 (17.43%) patients. A positive ANA titre was seen in 14 (15.56%) patients (N = 90). Factor VIII (N = 104) and Factor IX (N = 107) were elevated in 29 (27.88%) and 33 (30.84%) patients. Twenty-four (10%) of the 240 patients had recurrent VTE and 46 (24.08%) patients expired within 6 months. Conclusions: VTE is a prevalent condition in this part of the country with multifactorial etiology and significant morbidity and mortality.

Introduction: Hematopoietic stem cell transplantation is the curative option for life threatening blood disorders. However, graft failure and graft versus host disease are the major hurdles in providing an optimal outcome. We present data on primary and secondary graft failure in children who underwent HSCT at our center. Aims & Objectives: We aimed to analyse the outcome of the children who had graft failure post HSCT. Materials & Methods: Our retrospective study included children who had primary and secondary graft failure between April 2007 and October 2020 and analyzed both the patient and donor characteristics. Primary graft failure is defined as no evidence of hematological recovery of donor cells, within the first month after transplant and secondary graft failure refers to the loss of a previously functioning graft.

Result: A total of 950 children underwent HSCT of which seventytwo children had graft failure (7.5%). Primary graft failure occurred in 34 children (48%) and secondary graft failure in 38 children (52%). Table 1 represents the patient and donor characteristics of children with graft failure. The incidence of primary graft failure was higher in benign 74% versus 26% in malignant conditions. Children with marrow failure (32%), primary immune deficiency (PID) (27%) and JMML (44%) had a higher incidence of primary graft failure. Similarly children with hemoglobinopathy (47%) and PID (32%) had increased incidence of secondary graft failure. Incidence of primary graft failure was seen increased in haploidentical HSCT (47%). Graft failure resulted in increased risk of mortality (54%) and it was high in children with marrow failure and primary immune deficiency who had primary and secondary graft failure (p-0.45 and p-0.0001) respectively and also who underwent alternate donor HSCT with primary graft failure (p-0.013). Conclusions: The incidence of graft failure was increased in children with marrow failure, PID, JMML and also in children who underwent haploidentical HSCT. Mortality in this cohort of children when they had graft failure was high at 54%. Hence, effective strategies while planning HSCT for these children is of paramount importance for optimal outcome.

Introduction: Refractory acute myeloid leukemia (AML), defined as failure of 2 cycles of induction therapy at diagnosis or of 1 cycle at relapse, represents a subgroup with poor outcomes. In our transplant cohort, the long-term survival in this subgroup was 16%. Haploidentical natural killer cell (NK) therapy is a strategy that is being explored in refractory malignancies. Our in-vitro and animal model data suggest that exposure to arsenic trioxide (ATO) results in enhanced NK cytotoxicity.

Aims & Objectives: To evaluate the role of addition of NK cell therapy in a sequential transplant for refractory AML.

Materials & Methods: At our center, patients with refractory AML have been treated with cytoreductive therapy followed by 1-week rest and a reduced-intensity transplant. We used the same strategy for this trial (CTRI/2019/02/017505) with addition of CD56 positive cells from a haploidentical family donor infused 1-day after chemotherapy ( Fig. 1a and 1b) . CD56 selection was done using CliniMACS prodigy followed by overnight incubation in autologous plasma ? 2 lMATO ? 500U/mL IL-2. Result: From February 2019, 14 patients with a median age of 29 years (IQR: 16. 5-38.5) were enrolled. Six were females. Six had primaryrefractory AML while 8 had relapsed-refractory AML. Cytoreductive chemotherapy was FLAG ± idarubicin (n = 7), Mitoxantrone ? Etoposide (n = 6) and GCLAC (n = 1). Median blast percentage before NK infusion was 15.9% (IQR: 9.1%-54.5%) (n = 11). Pre-defined release criteria, including sterile cultures, and endotoxin negativity were met in all cases. There was no infusion related toxicity. Median blast percentage following NK cell infusion was 11.9% (IQR: 4.9%-47.6%) (n = 8). One patient withdrew consent after NK cell infusion and did not undergo transplant. For the remaining 13 patients, the stem cell donor was HLA matched (n = 4), HLA 9/10 matched (n = 1) or HLA haplomatched (n = 8). Five (38.5%) patients died of immediate post-transplant complications before engraftment while 2(15.4%) did not engraft and died following a second transplant. Of the remaining 6(46.2%) patients who engrafted, the day 28 posttransplant MRD was negative for 5 patients. On follow up, 2(15.4%) patients developed disease relapse (on days 54 and 218 respectively) and died. The remaining 4(30.8%) patients are alive and relapse free at last follow up (mean follow up of surviving patients is 16 months). The estimated 1-year EFS was 28.8% ± 13.1% (Fig. 1d) . Conclusions: Thus, haploidentical NK cell therapy as an adjunct to transplant is safe and merits further evaluation in patients with AML.

from January 2015 to May 2020 using concurrent ATO, ATRA, and minimal anthracyclines in a risk-stratified manner. Result: During the study period, 167 patients were diagnosed to have APL in our hospital. Of these, we excluded patients presenting at relapse, those opting for treatment elsewhere, and those treated with single-agent ATO. The remaining 134 patients with newly diagnosed APL treated with uniform concurrent ATO and ATRA treatment were included in the analysis. The median age was 35 years (IQR: 23.25 to 44.75 years). Forty-eight (35.8%) were females. Prior to admission, the median duration of symptoms was 14 days (IQR: 7 to 28 days). Seventy (52.2%) had high-risk APL. Twelve (9%) patients died during induction. Nineteen (14.2%) patients developed differentiation syndrome. At a median follow-up of 854 days, there were 2 (1.6%) hematologic relapses and no deaths beyond induction. The 2-year OS and EFS for the intention-to-treat analysis was 91% ± 2.5% and 89.3% ± 2.7%, respectively. The total direct hospital costs incurred during 1 year of treatment per patient (for 123 patients who received the treatment protocol) was USD 6400 (IQR: 5000 to 8300). Conclusions: Even in a real-world setting, concurrently administered ATO and ATRA with minimal anthracycline use results in excellent long-term survival in APL, including in the high-risk group. Early deaths due to delayed presentation with infections and life-threatening bleeding remain an unmet need for future research.

Thiopurine Methyltransferase (TPMT), Nudix Hydrolase 15 (NUDT-15) and Methylene Tetrahydrofolate Reductase (MTHFR) Polymorphisms in Children with Acute Lymphoblastic Leukaemia Srikanth Marda, Sirisha Rani Introduction: Methotrexate (MTX) and 6-Mercaptopurine (6 MP) have been among the major chemotherapy drugs used in ALL treatment and toxicity due to 6-MP and MTX has always been a concern. Studies analysing the incidence of gene polymorphisms regulating 6-MP metabolising enzymes viz NUDT15, TPMT and also MTX metabolising enzymes i.e. MTHFR genes and their effect on toxicity are lacking, especially in India.

• To assess polymorphism of TPMT, NUDT15 and MTHFR genes in children with ALL and their effect on toxicity.

The study was conducted in Paediatric Haemato-Oncology Department, Rainbow Children's Hospital, Hyderabad.

• All children diagnosed with ALL from 1 to 16yrs age who underwent mutation analysis in our centre were included in the study.

Result: The total sample size was 71, out of which 36 were male and 35 were female with mean age being 4.9 years. Mutation in TPMT gene was noticed in 5 subjects i.e. 7.1%, NUDT-15 mutation was seen in 16.6% of subjects and MTHFR mutation in 77.5%. Overall severe reduction in 6-MP dose ([ 40%) secondary to toxicity was noted in 31.4% of cases & MTX toxicity in 25.7% of cases.

Out of 10 cases who had mutation for NUDT-15 gene, 9 were found to have 6MP toxicity, 7 had febrile neutropenia and relation was statistically significant.

Statistically significant relation seen between presence of TPMT mutation and febrile neutropenia episodes in the subjects. No statistically significant correlation was found between presence of MTHFR mutation and MTX toxicity. Conclusions: Gene polymorphisms in TPMT and NUDT15 were low (7 and 16%), where as it was high (77%) in MTHFR.However correlation between polymorphisms and toxicity was statistically significant in TPMT and NUDT-15, whereas it was not statistically significant in patients with MTHFR polymorphisms.

A Tertiary Care Centre Observational Study Sandhya Vaddadi, Sirisha Rani S, VarshiniB, Srikanth M Introduction: Acute lymphoblastic leukemia (ALL) is the most common malignancy of childhood. Though cure rate of ALL has improved significantly, relapse remains of concern. Minimal/Measurable Residual disease (MRD) is a highly sensitive marker for presence of residual leukemic cells in bone marrow post treatment. But, given current cost of MRD, it is not yet being done routinely in every center in a developing country. Aims & Objectives: To assess relevance of testing MRD in children undergoing chemotherapy for ALL in developing countries and to look for correlation between MRD and other established prognostic factors in ALL.

Materials & Methods: Observational study. In our study, MRD tested in Bone marrow on Day 33 (post induction); if positive ([ 0.01%) repeated on Day 78 (Post consolidation). Period: April 2015 to September 2020. Result: Included total 203 cases with male to female ratio of 1.4:1. Out of 203, 173 (85%) were B cell, 20 (9.8%) T cell, 7 (3.4%) Infant and 4 (2%) mixed phenotype ALL. High count disease ([ 50,000/ mm3 initial WBC count) seen in 53 (26%). High risk cytogenetics positivity BCR ABL-7 (3.5%) & MLL-10 (5%). Intermediate risk cytogenetic E2A positive-6 (3%). Good risk Tel AML positive-37(18.5%). Hyperdiploidy-34(17.4%), .MRD done in 193 cases; Day 33 MRD positive-21 (10.8%). Day 78 MRD done 20 (in those with Day 33 MRD positive), was negative 18 and positive for 2. A statistically significant correlation was found with risk of relapse and death and D33 MRD positivity. Also, significant correlation found between high WBC count and Day33 MRD positivity. Conclusions: MRD evaluation on Day 33 in all cases of ALL is useful to predict the risk of relapse and guide further treatment, though confirmation requires further follow-up.

of Bortezomib and Vincristine were separated by 3 days to reduce neurotoxicity. Remission was assessed at the end of 4 weeks. The data was collected from hospital records and institutional database. Result: A total of 37 patients with relapsed ALL who received at least 3 doses of the regimen were included in this analysis. The median age was 23.9 years [range: and included 14 children [38%] . 32 patients had B cell ALL while 4 had T cell ALL and 1 had a mixed phenotypic leukemia. This included 17 patients with very early relapse, 13 patients with early relapse and 7 with late relapse. The remission rates were assessed at the end of 4 weeks of treatment. Remission was achieved in 11 [29.7%] of patients but MRD remained positive in 8/11 patients. Responses in patients with B cell ALL was 34.3% while no patients with T cell ALL or MPAL responded. Some of the patients received further cycles of chemotherapy to achieve further remission. No major toxicity was seen in all these patients and the chemotherapy was administered on an out-patient basis for most patients. Conclusions: The use of a Bortezomib based salvage chemotherapy results in 35% remission rates in patients with relapsed B cell ALL with minimal toxicity and can be easily administered on an out-patient basis.

Nihar Desai, Vinita Paswan, Akhilesh Sharma, Manish K Singh, Dinesh Chandra, Sanjeev, Anshul Gupta, Khaliqur Rahman, Ruchi Gupta, Rajesh Kashyap Introduction: The management of early phase CML (Chronic Myeloid Leukemia) has been revolutionized with the introduction of TKIs (Tyrosine kinase inhibitors) but the treatment of blast crisis remains an unmet need.

Aims & Objectives: To study the prevalence, clinicopathological features and treatment outcomes in patients with CML in blast crisis. Materials & Methods: This was a retrospective study of patients with CML-BC diagnosed at our centre between January 2015 and September 2021. Clinical and laboratory data were retrieved from the electronic medical records supplanted by telephonic follow-up. Data was analyzed using Graph Pad Prism v8.4.2 and expressed as median and interquartile range. Result: Blast crisis was noted in 6.1% [44/723] [2/44] cases to have a T lymphoid, and 6.8% [3/44] to have a mixed [B & Myeloid] phenotype. Concomitant CNS involvement was noted in 3 [6.8%] cases. All patients were treated with imatinib during the chronic phase. TKD mutation was present in seven of 11 analyzed patients [T315I in 6] . Compliance data were available for 25 patients, 14 [56%] were noncompliant with TKI therapy during the chronic phase. The commonest reason for non-compliance was the cost of therapy.

A total of 22 patients were treated for blast crisis [11 myeloid, 11 lymphoid] . Dasatinib with acute leukemia like induction therapy was the commonest treatment modality. 1 patient with myeloid phenotype underwent an allogenic stem cell transplant. The overall survival was 27% with a median survival of 6 months.

Age, gender, EUTOS score, de novo blast crisis were not significant factors in predicting mortality. Non-compliance during the chronic phase had a significant bearing on mortality (p 0.003, OR 16). Conclusions: Blast crisis remains a dreaded complication of chronic myeloid leukemia with a dismal prognosis. Compliance with TKI therapy during chronic phase may prevent the development of blast crisis. Hb (g/dl) 7.8 [6.7-9.5] 8.5 [7-9.5] 0.5 TLC (9 10 9 /L) 67. 5 [21.3-87] 73 [33.9-198] 0.2 Platelets (9 10 9 /L) 101 116 Introduction: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of the BCR-ABL fusion gene. Typically, the transcript type observed in cases of CML is e13a2 (b2a2) or e14a2 (b3a2). Some atypical transcripts like e6a2, e19a2, etc. are also noted. Having the knowledge of which is important for TKI response monitoring.

Aims & Objectives: The objective of this study was to observe the prevalence of various transcript subtypes in our cohort and to evaluate its impact on the patient demographic and hematological profile. Additionally, we evaluated the impact of the transcript in the achievement of optimal response to TKI.

This was a retrospective as well as prospective study over a period of 4 years. BCR-ABL1 fusion transcript analysis was done using RT PCR followed by gel electrophoresis using Biomed Consortium I recommendation. Demographic profile and haematological parameters like HB, TLC, PLT, Peripheral blood blast and basophil counts were noted from electronic medical records. Optimal response to TKI was evaluated by looking at the presence of major molecular response at 12 months of TKI treatment.

Result: In total 233 CML cases, 158 males and 74 females (M: F * 2.1:1) with a median age of 42 yrs. (7 yr to 82 yrs.). There were 11(4.7%) paediatric cases (age \ 18 yrs.), 207 (88.8%) adult cases (18-60 yrs.) and 15 (6.4%) elderly cases ([ 60yrs) . The different transcript noted were: e13a2 in 69 cases (29.6%), e14a2 in 156 cases (66.9%), both e13a2 & e14a2 in 2 cases (0.8%) e19a2 in 4 cases (1.7%), e6a2 and e14a3 in one case each (0.4%). All the paediatric cases (11/11) expressed e14a2 transcript. All the paediatric cases had e14a2 transcripts. Patients with e13a2 transcript had a slightly higher median age as compared to that of e14a2 transcript. (42 vs 38 yrs; p = 0.051). Though statistically not significant, a higher proportion of patients with e14a2 transcript achieved MMR at 12 months (50.7% vs 40%; p = 0.236). No association was found between transcript type and other haematological parameters.

Conclusions: To conclude, e14a2 is the commonest fusion transcript type being almost twice as common as e13a2. The transcript type doesn't have any effect on the presenting hematological parameter.

The e14a2 transcript has a higher MMR rate as compared to e13a2 transcript. Introduction: Patients with hematological disorders often require long-term venous access. Central venous access devices (CVAD) are preferred considering their longevity. However, they are associated with the inherent risk of venous thrombosis, central line-associated bloodstream infection (CLABSI), and displacement warranting their removal. These risks are directly proportional to diligent VAD care. The literature on life and outcomes of CVAD in resource-constrained settings is sparse and has led to this study.

Aims & Objectives: We intended to study the life of CVADs, incidence, and microbiological profile of CLABSI in a tertiary care center and the reasons for their removal.

Materials & Methods: This prospective observational study was conducted from 01 January 2020 to 31 July 2021. All patients requiring CVAD in the Department of Hematology were enrolled in the study after informed consent. All adverse and serious adverse events were serially recorded. JMP 15.0 was used for statistical analysis.

Result: A total of 101 CVADs were inserted during the study period commonest being peripherally inserted central catheters (PICC: 62.4%), followed by Hickman catheters (15.8%). Of these, 89.1% (n-90) had a hematological malignancy and rest, benign hematological disorder. The mean number of attempts was 1.44 ± 0.55. The mean life of the line was 40.22 days (0-133). Complications occurred in 38.6% of patients, the commonest being CLABSI-29.7%, and thrombus-8.9%. The main reasons for removal were the completion of the intended purpose (35.6%), death of the patient (22.7%), thrombus (8.9%), CLABSI (19.8%), and fracture of the catheter (2.9%). Gramnegative bacilli were the primary reason for CLABSI in 73.3% of positive cases, the microbiological profile of infections is shown in table 1. The line was still patent and being used in 26% (n-10) patients at the time of submission.

Conclusions: This real-world data shows that the average life of the line was far lower than that expected for CVAD. Most of the lines (41.7%) were removed prematurely, of which the majority were due to complications (38.6%). Vigilant protocols increased sensitization to VAD care and dedicated VAD care nurses might improve the life of CVADs in resource-constrained settings.

neoplasm by WHO based on presenting WBC count, absolute low and middle income countries where access to targeted therapy is limited.

Shekhar, Shubhangini Kumar, Vighnesh Shailesh Rane, Rahul Radhakrishnan, Vidya Sanjay Nagar Introduction: HLH is a fatal hyperinflammatory state caused by highly stimulated but ineffective immune system. This could be primary or secondary in response to triggers like-infections, malignancy or autoimmune conditions; resulting in a syndrome of fever, cytopenia, hepatosplenomegaly and hypercytokinemia associated multiorgan dysfunction syndrome (MODS). Secondary HLH in tropical infections often remains unrecognized due to overlapping features (symptoms, signs and lab). Also, more common -sepsis associated MODS tends to mimic HLH. This makes suspicion important as early recognition and treatment may prevent mortality.

Aims & Objectives: To understand clinical, laboratory profile, treatment and response in HLH encountered with tropical infections.

We report the clinical features, laboratory data, treatment and outcome of 6 cases of HLH in tropical infections identified using Modified 2009 HLH criteria. Result:

1. Total 6 cases were identified-2 females and 4 males. The mean, median age at diagnosis were 30 and 26.5 years respectively (with range of 16 to 52 years). All patients had persistent fever, hepatomegaly or/and splenomegaly, a bi or trilineagecytopenia, elevated liver enzymes, hyperferritinemia and hypertrygliceridemia. 4 out of 6 patients had hypofibrinogenemia while 5 had hemophagocytosis in bone marrow. 2. The cause of HLH in our series included pulmonary tuberculosis*-1, malaria-2, enteric fever-1, worm infestation*-1, cholangitis with sepsis*-1. 3* of these patients had HIV infection as well. 3. Patients received treatment for underlying cause, immunosuppression with steroids and supportive treatment. 5 out of 6 patients recovered, 1 died.

Conclusions: Due to overlapping clinical and lab features with tropical infections like malaria, viral hemorrhagic fevers, enteric fever etc. and mimics which are commoner like sepsis with MODS, diagnosis of HLH in the setting of tropical infections may go unrecognized. Therefore, there should be suspicion of HLH in complicated/severe tropical infection that is deteriorating despite disease specific treatment. Early immunosuppression is the difference between life and death.

Sarjana, Jasmita, Ganesh, Mukul, Rishi Dhawan, Pradeep kumar, Tulika Seth, Seema Tyagi, Manoranjan Mahapatra

Introduction: Cytogenetics and molecular analysis for diagnosis of Chronic Myeloid Leukemia (CML) are costly and require several days to be processed. In some cases, it may be difficult to differentiate CML from other myeloproliferative or myelodysplastic syndromes. CD26 is a highly specific marker expressed in CML stem cells, which is not present on normal BM stem cells or on LSCs of other myeloid neoplasms. It may prove to be an optimal biomarker during the diagnosis and management of CML.

Aims & Objectives:

1. Assessment of CD 26 expression, its specificity and sensitivity in suspected cases of CML. 2. Correlation of CD 26 ? stem cells with clinico-pathological parameters at baseline and its kinetics on TKI treatment in patients on follow-up at 12 months.

In peripheral blood samples (n = 75), CD26 expression was evaluated by a standardized multiparametricflowcytometry analysis on CD45?/CD34?/CD38-population using a fourcolour staining protocol with stain-lyse-wash procedure. To reach a sensitivity of 10-5, acquisition and analysis of at least 1.0 9 106 cells was performed in all samples by FACSCanto II flow cytometer using a DIVA 8 software (BD, Biosciences). CML patients were evaluated for peripheral blood BCR-ABL1 transcript levels by standard qRT-PCR analysis, according to European Leukemia Net (ELN) criteria.

Patients with blood disorders other than CML, and normal HSCs donors treated with granulocyte-colony stimulating factors (G-CSF), were included as negative controls.

Introduction: Therapy related myeloid neoplasms (t-MNs) are long term consequences of chemotherapy and radiotherapy for an antecedent disorder. They are characterised into therapy related acute myeloid leukemia (t-AML), myelodysplastic syndrome (t-MDS) and myelodysplastic/myeloproliferative neoplasm (t-MDS/MPN). The evolution pattern toward t-MNs is a complex process depending upon the type of cancer therapy, the aging process and individual exposures.

Aims & Objectives: To define the cytogenetic and molecular profile of t-MNs.

Materials & Methods: Retrospective data was analysed from August 2011-August 2021. The latency interval was defined as the time period between the first cytotoxic therapy and first bone marrow examination exhibiting t-MN. Cytogenetic analysis was performed on bone marrow aspirate samples using the standard protocols. Mutation and fusion profiling were performed using Oncomine Myeloid Research AssayÒ (Thermo Fisher Scientific) on Ion PGM and S5 sequencers and analyzed using Torrent Suite, Torrent Variant Caller, and Alamut software.

Result: The patient demographics, clinical, cytogenetic and molecular genetic data is summarised in Table 1 . Of the total 26 patients, 16 received a combination of alkylating agents with or without topoisomerase II inhibitors and radiotherapy. The most frequent cytogenetic abnormality in these cases were t (8;21) [n = 3] followed by inv(16)[n = 2] . MLL gene rearrangements and complex karyotype were seen in 3 patients each. NUP98 rearrangement, deletion 7q, trisomy 8 and normal karyotype was seen in one patient each. Out of 10 patients who received alkylating agents and or radiotherapy alone unbalanced structural abnormalities were seen in 6 patients. Two patients who received topoisomerase ll inhibitors alone developed recurrent balanced translocations. Oncomine myeloid research assay was performed in 13/26 patients. Eight patients showed pathogenic mutations. PTPN11 was seen in 2 patients each. TP53 mutation, TET2, BCOR, NRAS, BRAF, RUNX1 and FLT3 mutations were seen in 1 patient each. Germ line mutation testing was done in 2 patients and both showed BRCA 1 gene mutation.

Conclusions: As described before patients treated with alkylating agents showed unbalanced structural abnormalities and those with topoisomerase II inhibitors showed balanced translocations. Germline mutation testing is essential to identify increased predisposition to develop-MNs. Acknowledgement: Partially funded by ALTITUDE Study.

Arathi K, Neha Singh, Arvind Kumar Gupta, Nilotpal Chowdhury, Uttam Kumar Nath, Harish Chandra

Introduction: CLL is the most common hematological malignancy in the western world but is relatively uncommon in India. The prognosis of CLL is determined by well-established prognostic markers.

Recently, CD49d has been emerging as a promising prognostic marker in CLL. It has been reported that cases of CLL with CD49d expression in more than 30% tumour cells follow an aggressive clinical course, shorter time to first treatment and poorer prognosis.

Aims & Objectives: To analyse the flowcytometric expression of CD49d in newly diagnosed patients of CLL, and to correlate its expression with the clinico-hematological parameters.

Materials & Methods: Twenty-five consecutive patients of CLL, diagnosed on flow cytometry were included in the study. Patients on treatment, or those with relapse were excluded. The panel for flow cytometry included the routine markers used for CLL diagnosis along with CD49d. CD49d was considered positive if immunoexpression was present in more than 30% tumour cells. Expression of CD49d was correlated with the clinico-hematological parameters in all patients.

Result: Mean age of the patients was 62.6 ± 12.5 years, and 80% were symptomatic at diagnosis. 88.

The results of our study are in concordance with the published data on CD49d in CLL. CD49d expression in the present study correlated with a higher prolymphocyte percentage, lymphadenopathy, splenomegaly, and higher Rai and Binet stages. CD49d expression on flowcytometry was reproducible and easy to interpret.

of [ 1.5 was taken as significant. Target genes of these miRNAs were evaluated by qRT-PCR using SYBR-green. The relative fold change expression was calculated using 2 -DDCt method. Data were normalized using GAPDH as an endogenous control.

Result: Bone marrow samples of 15 diagnosed cases of AA were included in the study. Median age of the patients was 27 years (15-60 years), with a M:F ratio of 4:1. As per Cammitta criteria, there were 9(60%) cases of NSAA, 4 (27%) SAA, and 2 (13%) of VSAA. Upregulation of hsa-miR-155 (FC-3.50; P-value-0.0067) was noted in all the samples. Subsequently target prediction was performed using two highly cited prediction tools and six targets of miR-155, which have shown to be critical for T cell activation were evaluated. The expression of all the target genes viz T-Bet (FC-4.51 ± 0.85, 0.0009), SHIP-1 (FC-1.52 ± 0.15, p value-0.005), IFNGR1 (FC-1.91 ± 0.34, p value-0.024), TNF-a (FC-2.54 ± 0.46 p value-0.007), IFN-c (FC-4.22 ± 0.74, p value 0.002), IL-6 (FC-7.53 ± 1.96, p value 0.011) and IL-8 (FC-7.71 ± 2.80, p value -0.043) was increased.

Conclusions: miR-155 levels are significantly upregulated in aAA. The interplay of the target genes and miR-155 is complex and apparently, miR-155 up-regulates the expression of cytokines and vice-versa, thereby, favouring a proinflammatorymileu in aAA. miRNA knockdown/silencing studies are required to delineate the exact relation of miR-155 and its target genes.

Gaurav Joshi, Phaneendra Datari, PrasanthS, Uday Kulkarni, Biju George, RVShaji

Introduction: Fanconi anaemia (FA) is a rare recessive disease resulting from mutations in at least one of the 22 FA genes. Mutation types and phenotypic manifestations of FA are highly heterogeneous and may influence the clinical management of the disease.

Aims & Objectives: Detection of single to multi-exon deletions in Fanconi anaemia pathway genes.

Materials & Methods: Exome sequencing was performed for 127 FA patients on the Illumina HiSeq X system and the data was analyzed by Sentieon (v201808.01) to identify germline variants. Copy number variants (CNVs) were detected from targeted sequence data using ExomeDepth (v1.1.10). CNVs common in 10 or more samples were filtered out, and those with Bayes factors of more than 15, or 10% of the expected read counts were collected. The deletions identified in the FANCA gene by ExomeDepth were confirmed by Multiplex ligation-dependent probe amplification (MLPA) using SALSA MLPA P031 and P032 Probe Mixes (MRC Holland), and coffalyser software. Gene dosage analysis was performed for the deletion identified by WES in the FANCT/UBE2T gene. Result: Out of 127 patients, 27 had no mutations and 12 had heterozygous mutations. They were analyzed for copy number variations (CNVs) to identify potential deletions in FA pathway genes.

The read counts of each patient's exome data was compared with those of other patients that were sequenced together. CNV analysis could detect deletions in 21 patients, 7 with heterozygous and 13 with homozygous deletions in FANCA, and one with a homozygous deletion in FANCT (UBE2T). MLPA analysis was performed to confirm the deletions and their zygosity in the 20 patients with defective FANCA gene. The homozygous deletion of exon 7 in the FANCT gene was confirmed by a fluorescent PCR based gene dosage analysis. Deletion in the FANCA gene was found at an extremely high frequency (15.7%), of which exon 27 deletion was quite common (25%). Conclusions: We used ExomeDepth for CNV analysis and applied filters to discard the false positives to obtain 100?curacy in detecting deletions in our patients. Our results confirmed that the improved bioinformatics methods detect CNVs efficiently, and their application can improve the current diagnostic strategy for FA. Introduction: Flow cytometry serves as a rapid tool to determine the proportion of various leukocyte populations mainly lymphocytes and the proteins expressed, which are essential for diagnosing Inborn Errors of Immunity (IEI). These patients can present from infancy to late adulthood with recurrent infections or immune dysregulation. In India, the existing reference values for rare lymphocyte subsets are based on data originated in other countries. There is limited information on normal variation for these rare-subset parameters in Indian children.

Aims & Objectives: To establish reference values for Indian paediatric lymphocyte subsets using extended immunophenotyping.

In this study, using the dual-platform method, we present pediatric age-matched reference values of a total of 148 healthy children aged 0 to 16 years for rare lymphocyte subsets. Immunophenotyping was performed by 10-color Navios Ex or 13-colorDxflex (Beckman Coulter) Flowcytometer. Dataanalysis was done using Kaluza V2.1. Differences between age groups were assessed by the Kruskal-Wallis test by Dunn's multivariate comparison. We compared the lymphocyte subset reference ranges with available literature.

Result: The median along with 10th-90th percentiles of the absolute and relative size of more than 34 distinct immunological parameters using flow cytometry, for different age groups was calculated. Data analysis showed that the total lymphocyte and T lymphocyte absolute counts are proportionately high in early infancy and decrease with age, but the relative frequency of T cells remains stable. Naive and recent thymic emigrants (T helper and T cytotoxic) decrease gradually with age whereas central memory and effector memory cells increase in the later year of life. It is observed that absolute B cells decrease and class-switched memory B cells increase with age. NK cell counts are relatively stable. We also for the first time report reference ranges for some rare parameters like NKT cell, activated NK expression, RTE, HLADR and CD45RA co-expression on DNT cell ranges for healthy Indian. Data analysis showed majority of subsets compared to international group were similar to Indian data.

Conclusions: This is the first comprehensively performed immuneprofiling study from India reporting normal reference ranges in different age groups. These values can be used by clinicians to interpret the immunological status in IEI, infectious and autoimmune diseases.

Shobhita Katiyar, ArunimShah1, Khaliquer Rehman2, Naresh Tripathy2, Chandra Prakash Chaturvedi1

Introduction: Erythropoiesis is a process by which RBCs are generated from hematopoietic stem cells. At cellular level it can be characterized by studying temporal changes in cell surface markers by FACS. However, the detailed characterization of erythroid differentiation using FACS has not been done till date.

Aims & Objectives:

1. To establish an efficient protocol for ex vivo erythroid differentiation. 2. To study the kinetics of ex-vivo erythroid differentiation progression using a set of marker panels by FACS.

Materials & Methods: HSPCs from GCSF mobilized peripheral blood were purified using magnetic CD34 microbeads. The CD34 ? cells were cultured for 26 days in presence of cytokines SCF, EPO and IL-3 in IMDM medium containing 20% BIT. Quantitative analysis of uncommitted progenitors (UCPs), committed progenitors (CPs) and terminally differentiated erythroid progenitors (EPs) was done from day zero to day 26 on every alternate day using panel of markers by FACS.

Introduction: Sepsis is a life threatening disease being a major cause of morbidity and mortality in ICU setting, however the pathogenesis of sepsis is still poorly understood. The gold standard for sepsis still remains blood culture which is time consuming and even the sensitivity is low which further delays the diagnosis and treatment resulting in adverse prognosis for the patient. Hence there is an urgent need of identifying a reliable marker for sepsis. Although ample amount of literature is present for serological markers like CRP and Procalcitonin and newer hematological markers like Neut-X, Neut-Y and Neut-Z are still being evaluated, Flow cytometry markers also form the potential for being the reliable markers for sepsis.

Aims & Objectives: We are presenting this study to highlight the significance of flow cytometry markers like CD-64, CD-25 and HLA-DR in diagnosis of sepsis.

In this cross sectional observational study, 79 cases were blood culture proven sepsis and 161 cases were healthy cases (study subjects). MFI value of markers CD 64, CD 25 AND HLA-DR was analyzed using Beckman coulter. The analysis of CD64 was done on neutrophils, CD 25 on lymphocytes and HLA-DR on monocytes. The normal reference range for the same was calculated from the control samples.

Result: HLA-DR has better sensitivity (87.6%) and specificity (91.1%) as compared to CD64 (87.3%, 72%) and CD25 (79.7%, 0.87.6%). Conclusions: Although sepsis is a major cause of morbidity and mortality in ICU setting there still remains a dire need for a reliable marker for sepsis diagnosis. We want to conclude that flow cytometry markers will help for early diagnosis of sepsis and hence timely management reducing the morbidity and mortality of sepsis.

worked up for immunotherapy. However, larger sample size is required for validation of results.

Rachana Ravindra Lakhe, Amit Nisal, Preeti Doshi, Ravindra Nimbargi

Introduction: Coagulation tests performed in laboratory are prothrombin time, activated partial thromboplastin time (APTT), thrombin time help in understanding of pathways involved in coagulation, yet they lack information on the complexity of haemostasis. Global coagulation assays like Thromboelastogram, Thrombin Generation Test and Clot waveform analysis (CWA) are point of care tests which provide rapid approach to a clinical condition. Clot wave is an optical waveform which measures changes in transmittance or absorbance of light beam through sample. Various applications of CWA have been extensively studied in last few years.

Aims & Objectives: To analyze clot wave form characteristics like morphology, first and second derivative values in cases with abnormal APTT.

Materials & Methods: APTT and curves generated by ACL TOP 300 analyzer of total 125 patients and 20 controls were included. Parameters studied were first derivative (maximum velocity of clot formation), second derivatives (maximum acceleration and deceleration), morphology of curve: sigmoid, biphasic, prolonged pre coagulation phase, second derivative morphology like early and late shoulder, biphasic peak, delayed deceleration were noted. Mann Whitney U test was performed and p value was determined.

Result: The APTT waveforms were analyzed in 125 patients (M: F-2.2:1, mean age: 46.9 ± 20 years). A spectrum of clinical conditions showed covid (20%), liver disease (23%), polytrauma (10.4%), cardiac (8.8%), sepsis/DIC (7.2%), thromboembolism (7.2%), renal (6.4%), bacterial infections (4%), dengue (4%), snake bite (1.6%), factor deficiency (1.6%). There was significant difference in acceleration and deceleration peaks in cases of liver and heart disease, sepsis, dengue, polytrauma and sepsis/DIC cases. Deceleration peak was additionally prolonged in patients of covid (p \ 0.05). First derivative peak was prolonged in only sepsis and liver diseases (p \ 0.05). The pre coagulation phase was prolonged in 75 cases (60%) cases and predominantly covid patients along with second derivative showing delayed deceleration, early and late shoulder. Conclusions: CWA is readily available on automated coagulation analyzers being inexpensive with fast turn round time. It provides both quantitative information on coagulation like velocity, acceleration of clot formation and qualitative details of wave pattern. There was significant association of second derivative with the disease in our study. Our study highlights importance to probe into quantitative and qualitative CWA parameters acquired by performing a simple APTT test.

The Silent Thalassemia: The Sound of Silence Sucheta Bansal, Sujata Raychaudhuri, Shilpi More, Tathagata Chatterjee

Introduction: The Silent Thalassemia: The Sound of Silence.

Aims & Objectives:

1. To revisit the standard HbA2 values defined for B thalassemia carriers and to establish the existence of silent and almost silent thalassemia with normal HbA2 levels.

2. To identify silent and almost silent thalassemia in our population and subject these patients for family studies, prenatal counseling and molecular profile if needed. 3. To design and formulate an approachable molecular panel based on the vast genetic mutations associated with these thalassemia in our population.and formulate an approachable molecular panel based on the vast genetic mutations associated with these thalassemia in our population.

A cross sectional study was conducted on 150 patients over a period of 6 months using D-10TMHemoglobin Testing System (Bio-RadHigh Performance Liquid Chromatography). 5 ml of EDTA blood was collected and HPLC performed for various hemoglobins.D10 analyzer defines HbA2 levels between 3.6-4% as borderline or carriers. These were categorized into Silent thalassemia and almost silent thalassemia based on HbA2 levels and RBC indices.

Result: Out of the 120 samples for thalassemia workup, 21.6% percent were thalassemia trait and 15.8% (19) cases were found to have borderline HbA2 levels of which 26.3% (05/19) were categorized as silent and 73.68% (14/19) as almost silent thalassemia.

Conclusions: To unravel and analyze these so called silent Thalassemia's in a resource poor country like India an approachable and cost effective algorithm including the molecular diagnosis will help prevent birth of thalassemia child which is the ultimate goal of the National Thalassemia program.

Targeted N.G.S.-Based Haplotyping and TAG-SNP Determination Among Genotypically Similar North Indian Transfusion-Dependent? ETA-Thalassemia Patients block 1 was most frequent (Table 1 ). The 12 Tag-SNPs included rs368698783, a known SNP at the LYAR antibody-binding site in the 5'UTR of the HBG1 gene, that strongly influences HbF levels.

Conclusions: Haploview TM analysis using targeted-NGS across the beta-globin cluster permitted identification of multiple LD-patterns in TDbT patients of north Indian ancestry with similar pathogenic HBB variants. This database should help future comparisons of the north Indian TDbT cohort with patients from other regions, or with divergent phenotypes. It is also likely to prove useful in genome-wide association studies aiming at uncovering novel genotypic determinants of severity in symptomatic b-thalassemia.

Sukrita Bhattacharjee, Maitreyee Bhattacharyya

Introduction: Thalassemia patients require regular blood transfusion for their survival. Fetal haemoglobin HbF has been known to reduce the severity and phenotype of the disease by decreasing ineffective erythropoiesis. Hydroxyurea (HU) and thalidomide have been used separately as effective HbF inducers.

Aims & Objectives: To study the effect of HU and thalidomide combination on transfusion dependent thalassemia (TDT) patients with respect to increment in haemoglobin and HbF levels, reduction in transfusion requirements and ferritin levels.

Materials & Methods: This prospective interventional study conducted at IHTM, MCH, Kolkata included 41 TDT patients (26 Beta thalassemia major and 15 E Beta thalassemia patients), [ 12 years of age, attending Thalassemia clinic and OPD, having failed a reasonable trial of hydroxyurea. These patients were started on a combination of low dose thalidomide (50 mg OD) and hydroxyurea (500 mg OD) and followed up for 6 months. Complete response (CR) was defined as transfusion independence and partial response (PR) denoted at least 50% reduction in transfusion burden. Patients with less than 50% reduction in transfusion burden after 6 months of therapy were defined as non-responders (NR), and treatment was discontinued thereafter. All statistical analysis was done using the SPSS ver.23. Result: The mean age of the cohort was 20.78 years (range 12-45 years). There were 13 males and 28 females. Nineteen (46.3%), 7 (17.1%) and 15 (36.6%) patients achieved CR, PR and no response respectively. The overall response rate (CR ? PR) at the end of study period was 63.4%. The mean increase in Hb over 6 months was 2.7 g/dl in the patients achieving response (CR or PR), which was statistically significant (p \ 0.000). Mean transfusion requirement in the entire cohort was 1.97 units/month which reduced to 0.9 units/month after treatment (p \ 0.000). The decrease in mean ferritin level (1958 ng/ml to 1301 ng/ml) was found to be statistically significant (p \ 0.000). There were no significant adverse reactions to therapy. No significant predictors of response, viz. age, gender, pre-trial clinical parameters like liver and spleen size, type of thalassemia (EB vs BM), baseline Hb or HbF were found. Conclusions: The combination of thalidomide and hydroxyurea appear safe and effective in the reduction in transfusion requirement of TDT patients. The judicious use of these drugs can improve the quality of life and reduce the morbidity of thalassemia patients in India. Introduction: Sickle cell disease (SCD) is a common monogenic disorder characterized by phenotypic variation. It has been shown that phenotypic expression is associated with complex genetic and environmental interactions as well as some genetic modifiers. A major genetic modifier is the fetal haemoglobin (HbF). High HbF level is associated with reduced morbidity and mortality. From various studies it has been shown that almost 45% of variations in Hb F levels are associated with the Single nucleotide polymorphism (SNPs) in three different genes or gene loci i.e. Xmn1-HBG2, HBS1L-MYB and BCL11A.

Aims & Objectives: In the present study, we have attempted to correlate the association Hb F level with haematological parameters and morbidity of SCD cases. The genetic association between SNPs (Xmn1, HBS1L-MYB and BCL11A) and HbF level was also investigated.

Materials & Methods: This is a prospective study. Laboratory investigation was done for haematology and SNPs analysis. Statistical analysis was carried out in SPSS version 20.

Result: A total of 134 sickle cell patients with mean age of 20.62 ± 11.67 years were recruited in this study. The patients were grouped into two categories on the basis of Hb F level. Group I had Hb F less than 10% and remaining were in Groups II. Out of 134 cases 11.36% were in group I and 88.63?longed to group II. From the association study it was observed that individuals belonging to the group I had higher level of Hb A0%, Hb S%, White blood cell, Platelet as compared to group II. Clinical severity was more in the patients who had Hb F level less than 10%.It has been also found that age of onset of symptom (in year), age of First transfusion (in year), was less and Frequency of transfusion /year, average no. Of Hospitalization/year was more in Group I. The genetic association study did not show any statistically significant association between Hb F level and the four SNPs studied (rs11886868, rs 9,399,137, rs766432, rs7482144) .

Conclusions: The present study shows that high level of Hb F in SCD patients is protective, as it is with less severe clinical symptom and better hematological profile.

neutrophils and monocytes. This study was conducted with the aim to assess neutrophil oxidative burst activity by flow cytometry based DHR assay.

Aims & Objectives: AIM: Effect of iron deficiency on neutrophil oxidative burst activity in children less than 5 years of age. OBJECTIVE: (1) To estimate neutrophil oxidative burst activity in children with iron deficiency anemia by dihydrorhodamine (DHR) assay and compare it with control group. (2) To correlate DHR assay with severity of anemia.

Materials & Methods: 72 subjects aged between 6 months to 5 years were included, out of which 36 were cases with moderate to severe iron deficiency anemia and 36 were age matched healthy non anemic controls. We excluded Mild anemia, blood transfusion and iron supplementation. Baseline investigations were CBC by automated analyser (MINDRAY 1800), peripheral blood smear microscopy and DHR assay by Flowcytometry (BECKMAN COULTER CYTOMICS FC 500). IDA was confirmed by iron studies. In DHR assay, phorbolmyristate acetate (PMA) is used to stimulate neutrophils and these activated neutrophils convert dihydrorhodamine to fluorescent rhodamine, which is detected and measured by flow cytometry.

Result: Out of 72 participants, 36 were boys and 36 were girls. Both groups had similar gender distribution. The mean (SD) MFI index was significantly higher in healthy controls [422(165) ] as compared to cases [181(110) ]; p = 0.00. The mean (SD) MFI index in moderately anemic children [212 (107)] was significantly higher than severely anemic children [103 (87)]; p = 0.005. There was significant correlation between MFI index and hemoglobin levels in children with iron deficiency anemia(r = 0.529, p = 0.001).

Conclusions: Neutrophils oxidative burst is significantly reduced in children with iron deficiency anemia as compared to healthy non anemic children. Also, there is more reduction in neutrophil oxidative burst in children with severe anemia as compare to children with moderate anemia. Reduced neutrophil oxidative burst activity may contribute to increased susceptibility of these children to infection.

Introduction: Inadequate 6-Mercaptopurine (6-MP) mediated myelosuppression during maintenance therapy for acute lymphoblastic leukemia (ALL) is associated with an increased risk of relapse. 6-MP is metabolized in a complex pathway involving plethora of enzymes to metabolites including pharmacologically active 6-thioguanine (6-TGN) & hepatotoxic 6-methylmercaptopurine .

Aims & Objectives: We aimed in evaluating the clinical impact of erythrocyte 6-TGN & 6-MMPN levels in patients with ALL, in predicting relapse and toxicities during 6-MP therapy. Materials & Methods: All patients with ALL who underwent 6-MP maintenance therapy were included in this study. Genomic DNA isolated from peripheral blood was used for screening NUDT15, MRP4, ITPA & TPMT variants prior to maintenance. Blood sample was at collected at every routine visit or at adverse events, and erythrocyte thiopurine nucleotide (6-TGN & 6-MMPN) levels were measured using HPLC. The levels were correlated with genotypes, dose, hepatotoxicity and relapse status. Result: A total 73 patients with ALL were included in this study [median 2 sample per patient (range 2-11 measurements/patient]. Average 6-MP dosing was low in patients with NUDT15 c.415C [ T variant [35.5 (18-100) vs 69.12 (20-100), p = 0.008). No associations were observed between genotypes and 6-TGN/6-MMPN levels or clinical outcomes. We observed positive correlation between 6-TGN/ 6-MMPN levels and 6-MP dose (r = 0.245, p \ 0 r = 0.577, [ 12,000 pmol/8*10 8 RBC) and higher MMPN/TGN ratio ([ 40) [Therapeutic ranges proposed by Cohen et al., 2020] had significantly higher ALT levels compared to their counterparts [34 (9-110) vs. 79 (34-169) , p = 0. 002 & 27 (9-110) vs. 52 (16-169) , p = 0.0004]. Strikingly, MMPN & TGN levels were significantly lower in the patients who relapsed compared to those who did not (776 vs. 2824 pmol/8*10 8 RBC, p = 0.01 & 362 vs. 711 pmol/ 8*10 8 RBC, p = 0.01, Figure) . Conclusions: Our data suggests that low TGN & MMPN levels results in inadequate myelosuppression thereby increasing the probability of relapse in patients with ALL. Serial thiopurine metabolite level assessments and dose adjustment aiming to maintain therapeutic 6-TGN/6-MMPN levels may be helpful in improving treatment outcome of maintenance therapy in ALL.

Association of Various HLA-B Polymorphisms in Acute Lymphoblastic Leukemia in Children in Indian Population Akansha Gautam, Leelavathi Dawson, Mukul Singh, Rani Gera, Sunil Ranga Introduction: Acute Lymphoblastic Leukemia is the most common cancer in childhood with a prevalence of up to 25% of cancers in children who are under the age of 15 years. Several HLA types are associated with an increased risk of various immunologically mediated diseases. There is also evidence that the HLA gene complex may mediate susceptibility to or protection from malignancies. Various studies have been conducted worldwide but there is a paucity of literature in India regarding the association of HLA-B alleles in Acute Lymphoblastic Leukemia in children.

To study the association of HLA-B alleles in cases of Acute Lymphoblastic Leukemia in children.

Materials & Methods: HLA-B alleles were determined in 40 patients with Acute Lymphoblastic Leukemia. DNA was extracted with Innotrain Kit and HLA typing was performed with Fluogene. Data was analyzed using SPSS software version 21.0. Quantitative data was analyzed by t-test while qualitative data was analyzed by Pearson's chi-square test/Fischer's exact. Result: HLA-B subtypes were evaluated in cases of Acute Lymphoblastic Leukemia in children and the data was compared with that of controls. Statistical analysis showed a higher frequency of HLA-B*40 allele in cases than in controls and was found to be a susceptible allele whereas HLA-B*35 allele was expressed more frequently in controls and was found to be a protective allele. Conclusions: The present study helped us to identify the susceptible population in the Indian setting. Future studies with a larger sample size and with further subtyping of HLA-B alleles will be required for a definitive conclusion.

Barun Kumar Chakrabarty, Aaishwarya Dhabe, Ashish Gorantla, Arun SR, Sipra Rani Patel, Arijit Nag, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Deepak Kumar Mishra, Reena Nair, Mammen Chandy, Mayur Parihar Introduction: Cytogenetic characterisation of leukaemia cells is a standard component of modern risk-adapted therapy in B Cell Precursor Acute Lymphoblastic Leukaemia (BCP-ALL) in both paediatric and adult patients. There are sparse data on the cytogenetic profile of adult BCP-ALL patients from India. We present a systematic cytogenetic strategy based on karyotyping, flow ploidy, and fluorescent in situ hybridisation (FISH) and describe the spectrum of cytogenetic abnormalities in adult BCP-ALL. Aims & Objectives: To describe the cytogenetic profile of adult BCP-ALL using a systematic cytogenetic strategy. Materials & Methods: The data of newly diagnosed adult BCP-ALL patients (2011-2019) was retrospectively analyzed. Karyotyping and FISH were done on bone marrow aspirate samples as per standard cytogenetic protocols. A 4 probe FISH strategy, with ETV6/RUNX1, BCR/ABL1 fusion probes, and a KMT2A and TCF3 breakapart probe, was used along with karyotyping to reliably identify major prognostic cytogenetic subtypes. Patients with additional ABL1 signals were tested using ABL1 break apart probes to identify ABL1 rearrangements. Additional FISH probes were used based on immunophenotyping results including CRLF2 overexpression and DNA index. Patients with dim/negative CD10 and aberrant CD13 and CD33 were tested for ZNF384 gene rearrangements and those with CD138 for MEF2D gene rearrangements. Result: Of the 286 ALL patients 228 patients were diagnosed as BCP-ALL. The mean age of the patients was 38.8 ± 14 years with male predominance (64%). Successful karyotype was obtained in 204 patients (89.5%), of whom 151(74%) had an abnormal karyotype. FISH was not possible in 4 patients who also had a failed karyotype. Therefore, a total of 224 out of 286 patients had informative cytogenetics. The incidence of most chromosomal abnormalities varied significantly with age. The distribution of cytogenetics abnormalities is described in Fig. 1 . are as follows: Conclusions: Ph positive ALL was the most frequent abnormality. The Cytogenetic strategy identified Ph-like ALL patients, MEF2D and ZNF384 rearranged patients as well.

Correlation of Thromboelastography Parameters with Bleeding Risk in Newly Diagnosed 'Treatment Naive' Cases of Acute Leukemia Rama Hariharan, Seema Tyagi, M Mahapatra, Jasmita Introduction: Acute leukemias present with bleeding and thrombotic manifestations due to thrombocytopenia and coagulation abnormalities. Screening coagulation tests are used to monitor and predict risk of bleeding in patients with bleeding in acute leukemia. However, these are not the best indicators of hemostatic function as these are based on a static end point with no measure of cellular/plasma interactions. Thromboelastography (TEG) provides integrated information between the various components of coagulation-coagulation, thrombosis and clot lysis thereby measuring the dynamic coagulation process from initial clot formation to clot strength and clot lysis. Aims & Objectives: To study the correlation of TEG parameters with bleeding symptoms in newly diagnosed cases of Acuteleukemia excluding patients having prior bleeding tendencies not related to acute leukemia. Materials & Methods: Using TEM-A automated thromboelastometer (FramarBiomedica, Rome, Italy), TEG was performed on citrated peripheral blood samples of newly diagnosed leukemia cases (n = 60). Patients were divided into bleeding and non-bleeding groups based on clinical signs and symptoms and severity grade assessed as per World Health Organisation bleeding scale. This was correlated with TEG parameters and compared with the screening coagulogram parameters. Result: Out of the 60 acute leukemia cases, 39 patients were in the bleeding group and 21 patients in the non-bleeding group. The leukemia subgroups were AML-30, APML-13, B-ALL 12 and T-ALL-05. WHO grade 3-4 bleeding was seen in 10/39 (25.6%) and grade 1-2 bleeding in 29/39 (74.3%) bleeding patients. Multiple deranged TEG parameters with reduced MA and reduced MA with alpha angle were seen in the bleeding group which also correlated with deranged screening coagulogram parameters. Conclusions: TEG combined with conventional coagulation tests can guide evaluation of hemostatic function. A proper interpretation of TEG parameters can help the physicians regarding severity of bleeding risk and guide appropriate transfusions thereby reducing the risk of over transfusions or under transfusions.

Karthik Dhandapani, Biren Parikh, Sunitha S Introduction: Recent WHO classification (2017) has included Acute Myeloid Leukemia (AML) with mutations in NPM1, Biallelic CEBPA and RUNX1 as separate entities along with AML with cytogenetic abnormalities in AML with recurrent genetic abnormalities. Even-though C-kit and FLT3 mutations in AML have no diagnostic importance, prognostic significance in different subtypes of AML for the presence of these mutations are not the same. Aims & Objectives: To assess the correlation between French American British (FAB) AML classification, specific cytogenetic abnormalities with C-kit and FLT3 mutation in AML. To evaluate the prognosis and survival of AML patients with respect to cytogenetic abnormalities and C-kit and FLT3 mutation status. Materials & Methods: Retrospectively, all AML cases in which C-kit and FLT3 mutation status was assessed were retrieved; C-kit D816V mutation status had been assessed by Real time PCR; For FLT3 mutation, both Internal tandem duplication (ITD) and D835V mutation status had been assessed using PCR and gel electrophoresis; The data regarding morphological with immunophenotypic diagnosis, conventional karyotyping, FISH for translocation 8;21 (t (8;21) ) and inversion16/translocation16; 16 (t (16;16) were also retrieved in all these cases along with follow-up from hospital records. Result: Total 75 cases were included; Male/ Female ratio was 1.21 (41/34); Median age was 31 (Range: 2-64); 18 cases had t (8;21); 3 cases showed inversion16/t (16;16); Out of the 18 cases which showed t (8;21) , 10 cases had associated loss of sex chromosome. Eight cases had C-kit D816V mutation; three of which had t (8;21) while two had inversion 16.

12 cases had FLT3 mutations among which nine were ITD while three had D835V mutation. On karyotyping one of these cases showed hyper diploidy while majority had normal karyotype.

A single case had both C-kit D816V mutation and FLT3 D835V mutation with inversion 16 on karyotyping. Conclusions: Most common type of AML in both cases with FLT3 mutation and C-kit mutation was AML-M2 (FAB). Commonest karyotyping abnormality for cases with C-kit mutation was t (8;21) ; while for FLT3 mutation, majority had normal karyotype. The single case which had both C-kit D816V mutation and FLT3 D835V mutation was alive event free at three year follow-up. Even though multiple studies have shown contradictory prognosis and survival results for AML cases with C-kit mutation, our study did not show significant difference in survival in AML cases with C-kit and FLT 3 mutation.

Poster Abstracts 1. Acute Leukemia (Laboratory) Bone Marrow Fibrosis in B-Cell Acute Lymphoblastic Leukemia Anurag Gupta, Sonali Dixit, Neha Garg, Mrinalini Kotru, Sunil Gomber, Pooja Dewan, Richa Gupta Introduction: Bone Marrow fibrosis occurs in various hematological malignancies such as acute myeloid leukemia, chronic myeloid leukemia (CML) and lymphoid malignancies. However, there is paucity of literature showing association of Acute Lymphoblastic Leukemia (ALL) with bone marrow fibrosis. ALL is a hematological disorder characterized by proliferation of immature lymphoid cells which predominantly presents in younger age group. Despite great improvements in treatment results of childhood acute lymphoblastic leukemia (ALL), approximately 15-20% of the children die from the disease or its treatment complications. Therefore, evaluation of different prognostic factors is very important to assess the disease outcome. Bone marrow fibrosis is associated with poor prognosis in cases of CML. Very few studies have described bone marrow fibrosis as prognostic marker in ALL.

Aims & Objectives: To study frequency of bone marrow fibrosis in acute lymphoblastic lymphoma of B-cell origin. Materials & Methods: All cases of B-Cell ALL were retrieved from the archives of hematopathology section of UCMS and GTB Hospital, reported in years 2016-2019. Clinical features, demographic data, CBC, flowcytometry, MRD findings and other relevant data were documented. Bone marrow biopsy sections were reviewed and paraffin embedded blocks were retrieved from the records. Hematoxylin-eosin and reticulin stain were performed as per laboratory protocol. Bone marrow fibrosis was graded by semi quantitative method as per WHO criteria using reticulin stain sections. Statistical analysis is performed. Result: A total of 27 patients were included in the study. Mean age of patient is 6.3 years ranged from 2 to 21 years. Male: Female ratio was 1.2:1. Immunophenotyping showed blasts having lineage marker of B-cell origin. Amongst 27 cases, 70.3% (19/27) have total leukocyte count (TLC) of more than 50,000 per cubic mm, while 29.6% (8/27) cases had TLC of less than 50,000 per cubic mm. We found marrow fibrosis in 16 out of 27 (59.3%) cases of B-ALL while 11(40.7%) cases showed no fibrosis. There was a significant correlation between presence of bone marrow fibrosis in B-ALL and TLC count of patient (p-0.033). Conclusions: Marrow fibrosis is found in 59.3% (16/27) cases of ALL of B-cell origin and significantly correlated with total leukocyte count. However, long term study for follow-up of these cases and correlation with cytogenetics might be needed for prognosis of patients. coagulopathy along with hemorrhagic complications at time of hospital admission leading to mortality. Aims & Objectives: APL is a usually associated with a life-threatening coagulopathy. Herein, we report a case of acute promyelocytic leukemia (APL) that was identified by APL criteria of automated hematology analyzer (Siemens ADVIA 2120i) which can aid in early diagnosis of APL in emergency setting. APL criteria was given by Vincenzo Rocco et al. and includes 6 parameters based on automated hematology analyzer values: 1-platelet count \ 150 9 109 /L, 2.monocyte: \ 10%,3-Large undifferentiated cells (LUC) \ 4%,4-hyperchromic cells [ 2%, 5-Peroxidase saturated cells C 1%, 6-blasts [ 4%. Materials & Methods: A 33 yrs male presented to emergency with acute onset of altered sensorium.CT scan of head revealed acute subdural hematoma (SDH) with subarachnoid hemorrhage (SAH) over left tempo-parietal region. Patients samples were send to laboratory for routine investigations. Result: On analysis automated hematology analyzer (Siemens ADVIA 2120i) displayed anemia (6.7 g/dL), leucocytosis (104.210 9 109/L), thrombocytopenia (23 9 109/L), blast count: 26.5%. and DLC ( Neutrophil:87.%, lymphocyte:0.8%, monocyte:0.1%, eosinophil:11.1%, basophil:2.8% and LUC: 0.2%). As per APL criteria, critical alert for APL was generated. Peripheral blood smear examination showed marked leukocytosis with 90% blasts morphologically consistent with abnormal promyelocytes along with dimorphic anemia and severe thrombocytopenia. Coagulation profile was deranged with PT: 19.7 s, INR: 1.6, and D-Dimer of 5778 ng/m L. According to International Society of Thrombosis and Haemostasis (ISTH) Criteria for disseminated intravascular coagulation (DIC), case was consistent with overt DIC. So, a prompt diagnosis of APL with DIC was made and informed to clinician for further management of patient. The final diagnosis was further confirmed by RT-PCR revealing PML-RARA fusion transcript. Conclusions: APL criteria given by hematology analyzer and ISTH Criteria for Disseminated Intravascular Coagulation (DIC) can alert the pathologists of the possible diagnosis of APL which can help in timely management of patients. Furthermore it may reduce turnaround time of APL diagnosis with further reduction in early death.

Interesting Contrast from the Expected Archi Sharma, U K Nath Introduction: COVID19 can be considered as one of the worst pandemics humans have faced. There haven't been many cases reported, specifically looking at its severity and outcome in patients with hematological malignancies. Aims & Objectives: Presenting a diagnosed case of AML, on Azacytidine therapy, manifesting with COVID19 disease. Materials & Methods: On 13th July 2021, a 43 year old female, diagnosed with AML came to the OPD with history of cough, fever and running nose from last 7 days. She was receiving antimicrobial prophylaxis with levofloxacin and fluconazole. Her temperature was 38°C, BP 110/60 mm Hg, heart rate 88 bpm, and SpO2 was 97% in room air. She tested positive for COVID19 the same day. She was started on Azithromycin, Ivermectin and vitamin supplements. Her stay in COVID ward was uneventful, except for the significant changes in her laboratory data [ Table 1 ]. Result: The patient's cell lineages went down after the chemotherapy. During COVID19 infection, she developed leukocytosis with 60% blast cells while still having neutropenia. Despite persistent neutropenia, she didn't develop any major respiratory symptoms or complications. Chest X-ray was normal. Her KFT, RBS, electrolytes, LFT and PT-INR were in normal range. CRP and D-Dimer were raised. On day 10, after testing negative for COVID 19, third cycle of chemotherapy was started, and she was discharged on day 17. Conclusions: Typical Covid19 presentation is neutrophilia and lymphopenia, which is in contrast to our result depicting increased total leucocyte count (lymphocytosis and blasts), with consistent neutropenia. This difference could be attributed to underlying AML and treatment received. Although there are few published reports indicating patients with myeloid malignancies and COVID19 having higher mortality, our patient with active AML and no other comorbidities, made a full recovery without any antiviral therapy, and had mild respiratory symptoms only. This also calls for the need of additional studies to further delineate risk factors contributing to mortality in this subgroup of patients.

Jumping Translocation OF 3Q in a Patient with Acute Myeloid Leukemia-A Rare Cytogenetic Event Bibhas Kar, Mamta Belnekar, Shital Virulkar, Anjali Patil, Sameer Tulpule, Kiran Ghodke, Nikhil Rabade, Varsha Vadera Introduction: Jumping translocations (JT) are rare cytogenetic alterations consisting of the nonreciprocal translocation of a segment from a single donor chromosome onto two or more recipient chromosomes. This results in the gains of donor chromosomal segment and possible loss of segments of the recipient chromosomes. There can be multiple factors leading to JT like chromosomal instability, shortening of telomeres, viral infections, pericentromeric heterochromatin decondensation, or recombination between repeated telomere sequences and interstitial telomeric sequences, or pathogenic variants of the TP53 gene. JTs are recurrently observed in solid and hematologic cancers, including myeloid malignancies. Aims & Objectives: To present a case of acute myeloid leukemia (AML) with rare chromosomal abnormalities.

We present a case of 75 years-old-female presented with shortness of breath, fever with cough, a known case of hypertension, diabetes mellitus Type 2 and chronic kidney disease. The CBC was indicative of bicytopenia (Hb 6.8 g/dL, WBC 13.23 9 10 3 /ul, and platelet 18 9 10 3 /ul) with 65% blasts on peripheral smear examination. Flow cytometry confirmed the diagnosis of AML with monocytic differentiation (cells expressed CD4, CD11c, CD64, HLADR, CD45, CD13, CD15, CD36, CD38, CD33and CD117).Conventional cytogenetics was performed from unstimulated cell cultures (direct, overnight, 24 h and 48 h) followed by GTG banding. Sequential fluorescence in-situ hybridization (FISH) on G-banded metaphases was performed using GATA2(3q21.3)/MECOM(3q26.2) probe to confirm the chromosomal breakpoint region. Result: In cytogenetic study, a JT was seen involving 3q21 as a donor chromosome segment onto 12 different recipient chromosomes viz. 1p36. 3, 3p26, 4p16, 4q35, 5q35, 8p22, 9p24, 9q34, 10q26, 12q24.3, 15q26.3, 17p13, 20p13, 20q13.3 and 21q22 . In addition, monosomy 7 and trisomy 8 was observed in all the abnormal clones eventually developing a complex karyotype. Conclusions: JT have poor prognosis with high risk of disease progression as seen in our patient and also in the existing data that is available. Our study concludes that conventional cytogenetics has an advantage over other techniques in providing a complete picture of all chromosomal changes at diagnosis, within its limit of detection. Introduction: Flow cytometry plays a central role in the diagnosis of acute leukemia. The incorporation of baseline minimal residual disease (MRD) markers and markers of therapeutic relevance such as CD22 increases the number of tubes in the 8 colour panels which in turn increases the cost. Further, rare entities such as gamma delta T ALL, blastic plasmacytoid dendritic cell neoplasm can be missed in a panel with limited markers. Aims & Objectives: To evaluate the use of a 12 colour flow cytometry panel for the diagnosis of acute leukemia with a sequential strategy. Materials & Methods: Between March 2021 and August 2021, 184 bone marrow or peripheral blood samples from adolescent and adult patients (14 years or older) with an increase in the blast count identified by morphology or CD45 screening were evaluated with the 12 colour acute leukemia panel. The markers were selected based on our previous experience, availability, signal intensity, spill over and compensation. A minimum of 50,000 events were acquired per tube in BD FACSLyric TM and the data was analyzed with BD FACSuite TM software. Result: The results from the 184 samples are shown in the table. Following CD45 screening the first two tubes which had the lineage and blast specific markers (tube 1) and markers for myeloid, monocytic and dendritic cell lineage (tube 2) were processed for all the samples. No further tubes were processed for acute myeloid leukemia (except in rare cases such as mast cell leukemia, AML M7) while an additional tube ( B or T lineage specific) is processed for acute lymphoid leukemia which also serves as the panel for MRD assessment. By moving from 8 to 12 colour panel, we could reduce the number of antibodies, tubes processed, and the consumables used per sample, thereby reducing the cost and the need to process additional tubes for baseline MRD data. Conclusions: A 12 colour panel is cost effective, provides more information which helps in diagnosis of rare or atypical cases and in follow up MRD assessment. However, the associated technical challenges must be carefully addressed before making the transition to 12 colour diagnostic panels.

Abhinav Bhardwaj, Preeti Tripathi, Deep Kumar Raman, Manoj Pant, Lakshmi Nair G, Siva Chaitanya S,Shruti Nagrath Introduction: Extramedullary acute myeloid leukemia or myeloid sarcoma (MS) also termed as granulocytic sarcoma or chloroma, characterized by one or more myeloid precursor cells at an extramedullary site, is a rare manifestation. We present a case of Acute myelomonocytic Leukaemia where soft tissue infiltration of leukemic cells preceded any blood or bone marrow evidence of leukemia. Aims & Objectives: A 05-year-old male child, with progressive periorbital swelling of 10 days duration with a single episode of lowgrade fever 5 days back was initially suspected to be a local inflammatory pathology, with differentials of inflammatory pseudotumor, IgG4 related disease, or lymphoma. Materials & Methods: Case Report. Result: Case Summary Examination showed swelling of bilateral upper eyelids. On evaluation found to have leukocytosis (TLC 15,800/cumm), anemia (6.5gm/dl) , and thrombocytopenia (plt 50,000/cumm). PBS showed 35% blasts with no Auer rods & thrombocytopenia. Bone marrow aspirate revealed 51% blasts & equivalents suggestive of acute myeloid leukemia & the presence of abnormal eosinophils indicating acute myelomonocytic leukemia, supported by bone marrow biopsy. Flow cytometry (Fig. 1) of BMA showed Dim CD33 and CD45 positivity with 26% blast window events. CD34, CD64, CD117, HLA-DR, CD13, CD11C & CyMPO turned out to be positive suggesting Acute myelomonocytic leukemia M4. Karyotyping (Fig. 2 ) revealed reciprocal translocation between long arms of chromosome 8 and chromosome 21 involving the region q22 & q22 respectively, presence of an additional copy of chromosome 4. He was started on induction and subsequent consolidation chemotherapy with complete BM remission and shrinkage of the orbital tumor confirming that the orbital lesion was a myeloid sarcoma. Conclusions: Myeloid sarcoma can present as the first clinical sign of AML, like in our case, often appearing months to years before detectable atypical malignant cells or as a manifestation of relapsed AML. Combined modalities of immunohistochemistry, immunophenotyping, cytogenetic and molecular studies besides imaging studies are essential for the diagnosis. Treatment is almost always with AML induction regimen.

Adult Acute Myeloid Leukemia: Experience of a Tertiary Care Center from Eastern India Neha Singh, Avinash Gupta, Sujeet Kumar, Nilesh Dhole, Rohit Kori, Gojiri Mawalankar, Bhumika Gupta, Anil Singh, Nikhil Patkar, Dhanlaxmi Shetty Introduction: Acute myeloid leukemia (AML) is a biologically heterogeneous disease. As per the revised ELN-2017 guidelines, the use of gene mutations for risk stratification is no longer restricted to patients with normal cytogenetics, reflecting the growing prognostic relevance of gene mutations in AML. In addition to cytogenetics and molecular risk stratification, early response to chemotherapy is an important variable. Importantly, detectable minimal residual disease (MRD) is a measure of impending relapse and offers a therapeutic window to modify treatment to prevent overt relapse or de-intensify treatment. Except for AML with recurrent cytogenetic abnormalities as well as NPM1 gene mutations, multi-parametric immunophenotyping is the most accepted and established technique to detect MRD. Aims & Objectives: The primary aim was to find out the clinicohematologic and molecular characteristics of newly-diagnosed adult AML patients and to evaluate the initial response to therapy in terms of flow cytometric MRD status post-induction (PI-MRD).

This retrospective observational study included only those AML patients who had undergone complete diagnostic workup, including immunophenotyping, conventional cytogenetics and molecular analysis at presentation, during the period from August 2020 to July 2021. All patients were risk stratified in accordance with the revised European Leukemia Network (ELN) guidelines. Response to treatment was assessed using post-induction flow cytometric MRD testing. Result: Out of a total of eighty-seven such patients, thirty-six had abnormal karyotype. t (8;21) was the commonest cytogenetic abnormality followed by 11q23 rearrangements. RAS mutations was observed in 30.5% of such patients followed by KIT and WT-1 mutations respectively. 30.5% (11/36) patients belonged to ELN good-risk category. Interestingly, all of them were post-induction MRD negative. Among patients with normal karyotype (51/ 87 = 58.6%), C 3 mutations were detected in 64.7% patients (n = 33/ 51). MRD was positive in 43.5% of these patients overall and 70% of patients with C 3 mutations. On the contrary, only 53.8% of patients Indian J Hematol Blood Transfus with MRD negative status had C 3 mutations. Out of all the MRD positive cases, IDH1/2 mutations were the commonest mutations followed by NPM1, DNMT3 and FLT3-ITD mutations, in concordance with the recent studies showing encouraging response with use of targeted therapies in AML. Conclusions: PI-MRD status concords well with the cytogenetic and molecular stratification of AML patients. However, longer follow up period is required for making any definite conclusions regarding the overall impact on survival of patients.

Journey of CMML to AML on the Wheels of High-Risk Mutation Halted by Venetoclax & Azacytidine Shalaka Khade, Richa Juneja, Rahul Arora, Nishad Dhakate, Rasika Gadkari Introduction: CMML (Chronic myelomonocytic leukemia) is characterized by peripheral blood monocytosis, dysplasia in one or more hematopoietic lineages and propensity to transform into acute myeloid leukemia (AML) in 15-20?ses. Percentage of blasts, age, cytogenetics and mutation profile plays a role in determining prognosis. NPM1 mutation in CMML is very rare (\ 5%). It increases the risk of leukemic transformation with grim prognosis. We hereby present an unusual case of CMML-1 with NPM1 mutation transformed to AML and treated with newer therapies. Case Report:

71-year-old female with chronic anemia for 2 years not responding to hematinics therapy. There was no organo megaly or lymphadenopathy. Laboratory evaluation revealed Hb of 8.7 g/dL, platelet count of 114 9 103/ll and WBC count of 12.31 9 103/ll with absolute monocyte count of 1599/mm 3 . Bone marrow (BM) aspirate revealed erythroid hyperplasia with significant multilineage dysplasia and 8% blast. In view of persistent monocytosis and BM findings, a diagnosis of MDS/MPN neoplasm-chronic myelomonocytic leukemia (CMML-1) was given. Her karyotyping revealed trisomy 17 and del (9)(q22). NGS for myeloid panel detected variants in DNMT3A, NRAS, NPM1, WT1.

Patient was counselled for the need for hypomethylating agent but the family opted for growth factors (erythropoietin weekly) with poor response. On routine evaluation at 3 months, she presented with severe anemia and 40% blast in blood. Flow cytometry confirmed myeloid immunophenotype. She was then started on azacytidine 75 mg/m 2 (D1 to D7) and venetoclax 100 mg once daily. On day 24 she had severe pancytopenia with hypocellular marrow and recovered with growth factors. Till date patient is continued on same therapy with reduced dose venetoclax for 7 cycles. She is currently doing well and has ECOG PS of 2 and has a decent quality of life. Result: NA, it is a case report. Conclusions: In conclusion, we report a rare case of CMML with NPM1 mutation with sudden transformation into AML but managed well with venetoclax and azacytidine. This case reemphasizes importance of genomic profile in predicting course and outcome. Newer therapies offer hope to patients not fit for toxic chemotherapies and BMT.

Tonushree Purohit, R.K Nigam Introduction: Acute promyelocytic leukemia (APML) is an uncommon subtype of acute myeloid leukemia (AML). M3 phenotype is a less common presentation of APML and these patients usually present with leukocytosis and abnormal promyelocytes that are characterized by sparse granulation and are less likely to have faggot cells with multiple Auer rods. Distinguishing M3 phenotype from acute febrile illness can be challenging as the diagnosis relies on examination of peripheral smear. Case Report: A 65-year-old male with complaint of weakness, breathlessness, easy fatigue and bleeding from gums and heamorrhoids which was resulting in severe blood loss.CBC revealed severe anemia, leucocytosis and severe thrombocytopenia. For establishing diagnosis, bone marrow aspiration was done. Bone marrow smear showed hypercellular marrow with 68% hypergranular promyelocytes. Peripheral smear and bone marrow aspiration finding were in support of Acute Promyelocytic Leukemia with hypergranular promyelocytes along with faggot cells having abundant auer rods for which ATRA treatment was given and resulting in significant improvement.

Crisis of CML from AML Dhaval N. Bamania, Mandakini M. Patel Introduction: CML is a type of clonal BM stem cell disorder in which proliferation of mature granulocytes and its precursors are found. It has 3 phases: (1) Chronic, (2) Accelerated and (3) Introduction: Acute myeloid leukemia (AML) is characterized by clonal expansion of myeloid blasts leading to impaired production of normal blood cells. With the advent of new AML classification based on recurrent genetic abnormalities in 2008, emphasis on diagnostic modalities have shifted from morphology to karyotyping and molecular genomic analysis. However, due to unavailability of this advanced genomic tools widely in India, morphology still plays a pivotal role in making a primary diagnosis. In absence of molecular genetic tools, proper discrimination is a matter of diagnostic dilemma. Due to its morphological heterogeneity, AML with t(8;21) can masquerade as MDS, AML with myelodysplasia related changes, AML-NOS. However, prognostically it is more favourable than all of them. Aims & Objectives: Comparative study of different morphometric parameters in AML cases to assess the predictability for presence of t(8;21)/ RUNX1-RUNX1T1 fusion.

Materials & Methods: All cases of AML diagnosed in our department of Hematology, AIIMS between May 2020-September 2021 have been included. Bone marrow aspirate slides of all AML cases have been reviewed by two hematopathologists. Morphological details of blasts, Auer rods, dysmyelopoiesis, eobasophils, mast cells etc. have been noted. Result: A total 165 cases of AML were reported, among which t(8;21) was positive in 32 cases. On statistical comparison, the presence of thin slender Auer rods in the blasts had a high positive predictive value (PPV) of 93.75% and negative predictive value (NPV) of 97.87%. Though the finding of mast cells had 100% specificity as well as PPV, the sensitivity was only 50%. The morphological feature of dysplasia had a sensitivity of 87.5% and NPV of 92%, however the specificity and PPV were significantly low (48.93% and 36.84% respectively). On the other hand, presence of eobasophils was associated with low sensitivity (12.5%). We found two cases of cytogenetically proven AML with t(8;21) with blast count \ 20% & primarily diagnosed as MDS with excess blast 2 & 2 cases showing monocytic differentiation which are an infrequent finding. Conclusions: Though cytogenetic study is an indispensable tool for diagnosis of AML with t(8;21) cases, its characteristic morphological features are useful in early as well as accurate prediction and can be followed in low resource set ups.

Nitish Kumar, Aditya Kumar Sangwan Introduction: Tumor lysis syndrome (TLS) is an oncological emergency resulting from massive lysis of malignant cells. This lysis of malignant cells may occur spontaneously before treatment or after induction of chemotherapy. Aims & Objectives: Tumor lysis syndrome (TLS) is a life-threatening oncological emergency with high morbidity and mortality. The objective of this study was to determine the frequency of TLS in children with ALL and various biochemical abnormalities in children (age 18 years or below) with TLS. Materials & Methods: This Prospective observational study was conducted on 34 children (age 18 years or below) with ALL and 12 children's (age 18 years or below) of lymphoma who were managed in the Department of Pediatrics, ABVIMS & Dr. RML Hospital, New Delhi from November 2018 to November 2020 Operational Definition defined According to Cairo and Bishop criteria. Patients already received chemotherapy were excluded. Data including risk categories, immunophenotyping, laboratory parameters like complete blood picture, serum creatinine (SCr), potassium (K), calcium (Ca), phosphorus (P) and uric acid (UA) on days 0,3 and 7 after chemotherapy were collected. These levels were monitored from the day of admission till completion of 4 weeks of induction for acute leukemia patients and on day 1 and day 2 of each cycle of chemotherapy in lymphoma patients. All patients received standard adequate hydration and allopurinol. Data were analyzed and the following results were obtained. Result: Out of 34 patients with acute leukemia 7 fulfilled the criteria for TLS of which 6 patients developed spontaneous tumor lysis syndrome (STLS), 6 developed laboratory tumor lysis syndrome whereas 1 patient developed clinical tumor lysis syndrome. Out of 12 patients with lymphoma 2 fulfilled the criteria, TLS and all of them had laboratory tumor lysis syndrome. Overall, 1 patient died because of TLS. Hyperuricaemia was the most prominent findings in patients with TLS in both groups. All cases of TLS occurred during the first cycle of chemotherapy and recovered by day 9. Conclusions: It is concluded that 20.5% of the patients with acute leukemia and 16.6% of patients with lymphoma developed TLS (including both laboratory and clinical TLS) despite all measures of prevention, it can occur and result in mortality. Early recognition and treatment are essential to avoid morbidity and mortality. 50% (18/36) were ALLs and 11.1% (4/36) were of Mixed phenotype or Bi-lineage ALs. Most common aberrancy in AMLs was T-cell markers with 22.2% (8/36) cases, such as CD3, CD4 etc. This was followed by B-cell markers i.e. CD79a in 13.8% (5/36) cases. One case of AML expressed CD56 (NK cells marker). Most common aberrant expression in ALLs was Myeloid marker CD33 in 22.2% (8/ 36) cases, followed by CD13 and Co-expressions of CD33-CD13 i.e. 5.5% (2/36) cases each. These cases were predominantly B-ALLs. 16.6% (6/36) of ALLs expressed counterpart Lymphoid antigens (T-ALL expressed B-cell markers and vice versa). One T-ALL case expressed CD117. Mixed phenotypic ALs or Bi-phenotypic ALLs expressed CD19, CD20, CD79a, CD3, CD5, CD13 and CD33 in various combinations and permutations. Conclusions: AMLs express aberration of T-cell antigens more commonly than B-cell antigens. Aberrant antigens are more frequent in B-ALLs than T-ALLs. ALLs aberrancy is predominantly shared by T-cells expressing B-ALLs markers. CD79a, CD56 and CD117 are rare aberrant expression in ALs. Favorable and unfavorable prognostic significance of these aberrant expressions is still under contrivance.

Isolated Extramedullary Relapse in Gastric Mucosa of a Patient with T Cell Acute Lymphoid Leukaemia (ALL) Rukmini Bezbaruah, Dhaval Jetly, Karthik Dhandapani Introduction: Extramedullary relapse of acute lymphoblastic leukaemia (ALL) is rare. The most frequent sites are sanctuary sites of the central nervous system and testis. Aims & Objectives: We reported an unusual case of ALL, in which the patient showed isolated extramedullary relapse in gastric mucosa without bone marrow recurrence whilst on BFM (Berlin Frankfurt Munster)-90 maintenance.

A 24-year-old girl, diagnosed case of T Cell ALL had completed BFM 90 consolidation and was on maintenance when she presented with epigastric pain of 1 month's duration. Result: She was started on BFM 90 ALL protocol, she completed the consolidation, treatment so far stayed uneventful. In August 2021 she presented with severe abdominal discomfort and altered bowel pattern. Blood counts at this juncture showed no aberration on further screening both CSF and bone marrow showed no evidence of relapse.

Upper GI endoscopy revealed flat crescentic elevated ulcers with central umbilication in the lesser curvature of the gastric body, samples for histopathological examination were taken.

Histopathologic study revealed infiltration in gastric mucosa by T cell acute lymphoid leukaemia. Conclusions: Extramedullary relapse in Acute lymphoblastic leukemia is uncommon with isolated involvement of gastric mucosa being extremely rare.Further research is needed to improve the treatment of extramedullary disease with ALL.

A Case Report and Review of the Literature Vanitha. R. Swamy, Divya. V, Archana, Jayashree Kulkarni, Sulakshna, Nataraj, Rekha. V. Kumar

Introduction: Leukaemia initially presenting as a breast mass is very rare, with fewer than 200 cases reported in the literature. Acute myeloid leukaemia (AML) and lymphocytic leukaemia (ALL) involving the breast have both been described, with acute myeloid leukaemia being the more common.

Aims & Objectives: This case report aims to inform the clinicians of the range in differential diagnosis at the level of morphology and the methods implemented to achieve the diagnosis and differentiate primary breast cancer versus involvement by leukemia. Materials & Methods: In summary, we report a case of a 74 year old female patient who presented with bilateral breast masses biopsied and reported elsewhere as invasive lobular carcinoma. Result: Review of slides and immunohistochemistry with a panel of markers suggested involvement with acute leukemia. Following this, bone marrow aspiration and biopsy, conventional cytogenetics and flow cytometry studies led to the diagnosis of B-ALL. A unique finding was the concurrent myeloperoxidase staining on immunohistochemistry, throwing up the differential diagnostic consideration of mixed phenotype acute leukemia, which was excluded. Conclusions: Leukemic involvement of the breast may be seen in isolation or in the setting of widespread disease. The patient may present with unilateral or bilateral breast masses, with or without enlarged axillary lymphadenopathy. Mammographic and sonographic features of breast involvement in leukaemia are non-specific and indistinguishable from other breast malignancies. Therefore, a specific diagnosis cannot be made solely on the basis of imaging. A prior history of haematological malignancy is helpful in diagnosing secondary breast lesions. Meanwhile, the diagnosis is more challenging if breast leukemic infiltration is the initial presentation, as in the present case. Core needle biopsy with a panel of IHC markers would be required. Haematological malignancies with breast involvement will benefit most from appropriate treatment of leukaemia. It is therefore important to differentiate primary breast cancer from leukemic involvement of the breast.

Keywords: ALL, flow cytometry, cytogenetics. By the time, MasterB completed his induction phase of chemotherapy, MasterA also presented to our institution with relapse. He was again evaluated and was found to have relapsed B-ALL. Result: Bone marrow findings of both siblings showed the presence of blasts ([ 80%) which appeared as lymphoblasts morphologically. The flow cytometry revealed these Lymphoblasts to belong to the B-lineage with these markers (CD34, CD45, HLA-DR, CD19, CD10, CD20, CD22, TdT-dim) positive in both brothers, which was interpreted as B-ALL (CALLA-positive). Subsequently, Molecular analysis was performed in both cases by RT-PCR for the commonly occurring recurrent genetic abnormalities t(1;19), t(4;11), t(9;11), t(9;22), t (11;19), t(12;21) all of which were found to be negative. This is an unusual situation where both siblings developed the disease in the absence of any previous family history of malignancy or any inherited genetic defects. The lymphoblasts showing similar immunophenotypic & molecular characteristics point towards an uncharacterized germline mutation that may have occurred in both siblings. Conclusions: Acute Lymphoblastic Leukemia is a disease studied for decades with the advent & application of Molecular analysis. It still remains a condition that needs our focus and attention further to decode the genetics and reasoning behind its causation, as briefly highlighted by our present case. in 14 genes -NR3C2, NT5C2, PMS2, MSH2,  MSH6, TP53, NSD2, KMT2D, ETV6, KRAS, NRAS, TET2 , UHRF1, TENM3 in 10/11 (91%) cases. A total of 45 CNV events were noted in 22 samples, of which, CDKN2A del was most common event noted in 10/22 (45%) cases. On clonal evolution analysis, 4 cases (36%) acquired a mutation under chemotherapy pressure, 3 (27%) shared major clones at diagnosis and relapse, 2 (18%) had a minor clone at diagnosis that evolved at relapse and 1 (9%), a mixed pattern. Conclusions: The relapse enriched gene signature was noted in 14 genes related with epigenetic, mismatch repair, chemotherapy metabolism and cell signalling pathways. Clonal evolution highlighted higher percentages of our relapse cases (36%) evolving from a mutation under chemotherapy pressure compared to literature (25%).

Ravi Shankar, Savitri Singh, Nita Radhakrishnan, Manideepa Maji Introduction: Identification of blue-green cytoplasmic inclusions in neutrophils on peripheral blood smear are rarely reported in critically ill patients with liver failure. As these inclusions usually herald very bad prognosis and death shortly after identification, they are referred to as: critical green inclusions'' or ''death crystals''. We report the presence of these crystals in the CSF of a child with acute myeloid leukemia. Case Report:

A 4-year old boy presented with fever, pallor and bleeding was evaluated and diagnosed to have acute myeloid leukaemia and started on treatment for the same. He completed induction and was documented to be in remission. After the third HiDAC cycle, he developed fever on Day ? 14 which was managed as per febrile neutropenia protocol. Clinically there was evidence of neck stiffness and distension of abdomen with absent bowel sounds. He continued to receive meningitic dose of antibiotics, antifungals and other supportive care measures. Blood culture and CSF culture grew Klebsiella pneumoniae ss. pneumoniae (Carbapenem resistant Enterobacteriaceae). CSF examination done showed the presence of 1100 cells/micL with 78% neutrophils. The polymorphs showed prominent cytoplasmic granulations with occasional vacuolations. Dark blue green round inclusions were noted in few polymorphs. He has evidence of multiorgan dysfunction with transaminitis and conjugated hyperbilirubinemia. The child succumbed to the illness the next day despite best efforts. Conclusions: Blue green inclusions in neutrophils have been reported in peripheral smear in patients who deteriorate rapidly. Although originally thought to represent hepatic injury, they have been reported also in patients with tissue injury with normal liver function. The inclusions are thought to contain lipofuscin like deposits representing lysosomal degradation products. They are postulated to be found more in neutrophils than monocytes due to the phagocytic efficiency of neutrophils. We observed the presence of these ''death crystals'' in cerebrospinal fluid neutrophils and report a similarly grave prognosis. Introduction: Disseminated intravascular coagulation (DIC) is a frequent presentation of Acute Promyelocytic Leukemia (APL). Mixed Phenotype Acute Leukemia (MPAL) are rare leukemias, characterized by blasts that express antigens of more than one lineage and are associated with poor prognosis. These patients on rare occasions may present with DIC similar to APL, which is associated with a favorable prognosis. This unusual observation has been infrequently reported in medical literature.

Aims & Objectives: To study Immunophenotyping on Flowcytometry in MPAL.

A 34 year old male presented with history of generalized body ache and intermittent fever for 2 month followed by sudden bilateral painless vision impairment. Hemogram revealed normal TLC of 9940/ul with Hb-4.9 g/dL and platelet count of 8000/ul. PT/INR/APTT was 20 s/3/60 s with S.Fibrinogen-50 mg/dL and D-Dimer [ 5200. Bone marrow aspiration (BMA) smears and bone marrow sample for immunophenotyping was also received. Result: 87% and 91% Blast were seen on peripheral smear and BMA smears respectively. These Blasts had high N/C ratio with hypergranular cytoplasm obscuring nucleus in most of the cells. Few Auer Rods and occasional Faggot cells were seen. Blasts were positive for MPO on cytochemistry. Hence, based on morphology, provisional diagnosis of Acute Myeloid Leukemia with possibility of APL was offered. Flowcytometry revealed a tear drop shaped single population of Blast showing moderate CD45 expression and high side scatter along with expression of CD33, CD13, CD117, cMPO, cCD3, Tdt, CD3, CD5 and CD79a. These Blasts were negative for HLA DR, CD34, CD19 and CD10. Thus, a differential diagnosis of T/Myeloid MPAL and APL with aberrant T cell expression was considered. Cytogenetic study was advised. However, the patient died shortly thereafter of massive intracranial bleed. Conclusions: MPAL can sometime present with DIC, having poor prognosis. They can be misdiagnosed as APL, which carries a better prognosis. Thus, ensuring correct diagnosis by cytogenetics is needed for better prognostication and guiding appropriate therapy in these patients.

Neonatal Acute Leukemia or Transient Abnormal Myelopoiesis (TAM): A Case Report with Review Literature Sandhya Biswal, Gaurav Chhabra, Krushna Kumari Sahoo, Pankaj Kumar Mohanty, Tapas Kumar Som Introduction: Neonatal Leukemia is defined as the development of leukemia within the first 30 days after birth. The exact incidence is not known. It accounts for \ 1% of all childhood leukemia. The most common presentation is hepatomegaly, splenomegaly, and skin lesions (leukemia cutis). Aims & Objectives: We report a case of neonatal acute myeloid leukemia (AML) presenting with respiratory distress. Materials & Methods: A 3-week-old female neonate born to a G3 P2 A0 L1 mother, presented to the emergency department with complaint of low birth weight and respiratory distress. The baby was delivered at 38 weeks through normal vaginal delivery, with birth weight of 1.8 kg. The perinatal period was uneventful. The clinical examination revealed hepatomegaly along with downs like dysmorphic facies. Therefore, clinically Down's syndrome was suspected. The blood sample for complete hemogram and peripheral smear examination was collected and sent to the hematology laboratory. Result: The hemogram showed leukocytosis with 75% blasts, anemia, and thrombocytopenia. The blasts are of larger size than mature small lymphocytes, round to irregular indented nuclear membrane, fine chromatin, 2-3 prominent nucleoli, slightly granular basophilic cytoplasm. Few cells show cytoplasmic blebs. With these features, a provisional diagnosis of transient abnormal myelopoiesis or acute myeloid leukemia with megakaryoblastic differentiation was considered. This diagnosis was confirmed by flow cytometry. Immunophenotype shows expression of CD34 (dim to negative), CD7, CD 33, CD 117, CD58, CD71, CD41A and CD56. The parents have been counseled for starting chemotherapy and the response to treatment is awaited. Conclusions: Neonatal Leukemias are extremely rare. Down syndrome with transient abnormal myelopoiesis is the most common differential diagnosis. The morphological changes in children with TAM usually resolve on their own in some time. However, in our case, the child presented at 3 weeks and the blood picture is consistent with AML in repeated samples over weeks. The findings of the case emphasize the importance of the peripheral blood examination in a child presenting with Down's like features. These children need to be closely followed up with flow cytometric immunophenotyping and cytogenetic analysis to confirm the diagnosis of myeloid proliferation.

Are Concomitant Deletions of BTG Anti-proliferation Factor 1 (BTG1) and IKZF1 Worse than IKZF1 Deletions Alone in B-Cell Acute Lymphoblastic leukemia?

Sanjeev Kumar Gupta, Sameer Bakhshi, Ritu Gupta, Preity Sharma, Smeeta Gajendra, Anita Roy, Deepam Pushpam, Ranjit Kumar Sahoo Introduction: Recently, BTG anti-proliferation factor 1 (BTG1) deletions in childhood B-ALL have been reported to have a much worse outcome when present concomitantly with IKAROS family zinc finger 1 (IKZF1) deletions, compared to IKZF1 deletions alone, a known poor prognostic marker in B-ALL. Aims & Objectives: To establish the prevalence of BTG1 deletions, its co-existence with IKZF1 deletions and clinical correlation in our pediatric B-ALL cohort. Materials & Methods: We retrospectively analyzed the baseline genetic work-up data from untreated B-ALL cases for BTG1 and IKZF1 deletions. In addition to the standard morphological, cytochemical, immunophenotypic and cytogenetic/molecular work-up, multiplex ligation-dependent probe amplification (MLPA) was done using SALSA MLPA kits P335 and P202 (MRC-Holland) for BTG1 and IKZF1 deletions. The patients received ICICLE protocol. Event free survival (EFS) and overall survival (OS) were noted. Result: The study included 320 pediatric BCR-ABL1 negative B-ALL patients with median age 6 years (1-18); M:F ratio:: 1.8:1. Twenty-one out of 320 (6.6%) cases had BTG1 deletions (BTG1del The aim of the present study was to evaluate the association of individual HLA alleles in either predisposing or protecting the individual from myeloid and lymphoid leukemias.

Here we analyzed HLA class I and II alleles and haplotypes in 611 unrelated healthy donors and 251 leukemic patients (48 CML, 95 AML and 108 ALL). EDTA blood samples were collected after obtaining informed consent. DNA extraction was performed using the column method (Qiagen, GmBh). High resolution HLA typing was performed by Sequence based typing using the GenDx Sequence based typing kits. Result: A total of 273 different HLA alleles were observed in the study cohort. Out of the 273 alleles, 47 were for HLA A, 69 for HLA B, 41 for HLA C, 56 for HLA DRB1, 28 for HLA DQB1 and 32 for HLA DPB1. No significant positive association with the disease was found for any of the alleles with all the three patient cohorts. A*68:01:01:01G was found to be significantly decreased in AML and CML patients, whereas DPB1*13:01:01G was significantly decreased in ALL patients as compared to controls. No significant association was found between case and controls with respect to HLA haplotypes. Conclusions: It can be concurred that A*68:01:01:01G and DPB1*13:01:01G alleles are suggested as protective genetic factors against myeloid and lymphoid leukemias respectively. Larger studies are needed to confirm and establish the role of these associations.

Shilpa Anupurba, Smeeta Gajendra,Ritu Gupta1, Sanjeev Kumar Gupta, Deepshi Thakral, Ranjit Kumar Sahoo, Sameer Bakhshi, Atul Sharma, Lalit Kumar Introduction: RAM phenotype acute myeloid leukemia (AML) is a newly described subgroup of AML with unique morphological and immunophenotypic features. It is characterised by strong CD56 expression with dim to negative CD45 and CD38, and negative HLA-DR, and is associated with presence of CBFA2T3-GLIS2 fusion gene. There is a high incidence of acute megakaryoblastic leukemia among RAM phenotype. It shows an extreme poor response with resistance to treatment and high relapse rate. Aims & Objectives: To critically analyse various pathological characteristics including peripheral blood, bone marrow, flowcytometric immunophenotyping (FCMI), cytogenetics and molecular findings of RAM phenotype AML. Materials & Methods: All the pediatric AML cases from January 2019 to July 2021 were studied retrospectively and cases with the characteristic RAM AML phenotype was identified. We analysed detailed pathological profile including morphology, cytochemistry, FCMI, cytogenetic and molecular features. Result: Six cases with distinct RAM AML phenotype was identified, out of which 3 were males and 3 are females, with age ranging from 1 to 4 years. The hemoglobin ranged from 4.9 to 12.9 g/dL, total leukocyte counts 2.87 to 30.21 9 109/L and platelets 9 to 350 9 109/ L. Peripheral blood and bone marrow showed variable percentage of blasts ranging from 2 to 30% and 25 to 98%, respectively. Blasts showed unusual cohesiveness and clumping with nuclear molding, mimicking non hematologic malignancies. On FCMI, all cases showed positivity for CD34, CD117, CD33 and negativity for CD36, CD7, CD41 and CD61. Cytogenetic analysis did not reveal any recurrent abnormality. Molecular studies for NPM1, FLT3-ITD, FLT3-TKD, CEBPA, PML-RARa, AML-ETO and CBFB-MYH11 were negative in all cases. Two of these cases were secondary AML.None of the cases showed megakaryoblastic differentiation. Conclusions: RAM AML phenotype is a rare subgroup of AML with distinct morphological and phenotypic profile. Unusual morphological features may pose diagnostic challenge. It is not associated with any specific cytogenetic or molecular subgroup. Identification of this phenotype along with additional genotypic marker is essential for better understanding of clinical implications.

Smeeta Gajendra, Nupur Das,Ritu Gupta, Sanjeev kumar Gupta, Sandeep Rai,Saroj Singh,Vijay kumar Prajapati, Ranjit Kumar Sahoo,Ajay Gogia, Sameer Bakhshi, Atul Sharma, Lalit Kumar Introduction: The central nervous system (CNS) is involved in about 3-5% at initial diagnosis and 30-40% at relapse in patients of Acute Lymphoblastic Leukemia (ALL). Isolated CNS relapse occurs in 2-5% in ALL. Flowcytometric immunophenotyping (FCMI) offers a specific and sensitive tool for detection of CNS involvement even in samples with low volumes/counts or in cases with minimal involvement. Aims & Objectives: In this study the various parameters including the peripheral blood, bone marrow and FCMI findings of B-ALL cases with isolated CNS relapse were studied. Materials & Methods: B-ALL follow up CSF samples were evaluated for CNS involvement using FCMI. Bone marrow aspirate from baseline and follow-up time points were assessed for diagnostic and minimal residual disease (MRD) work-up. Radiological and systemic assessment was done at follow-up to rule out systemic relapse. Result: A total of 118 cerebrospinal fluid (CSF) samples of B-ALL were evaluated at follow up time point and 17 cases had CSF infiltration. Out of which, seven B-ALL cases were found to have isolated CNS relapse. Age of the patients ranged from 6 to 37 years including 4 pediatric and 3 adult patients. There were 6 males and one female. At diagnosis, the hemoglobin ranged from 5.7 to 9.9 g/dL. Total leukocyte count ranged from 0.34 to 133.7 9 10 9 /L and platelets ranged from 8 to 306 9 10 9 /L. At diagnosis, peripheral blood and bone marrow showed variable percentage of blasts ranging from 0 to 90% and 30 to 100%, respectively. Four patients achieved complete remission on post induction, one was not in morphological remission and two showed MRD positivity. Duration of remission till isolated CNS relapse ranged from 4 to 50 months. The FCMI of CSF showed 6 CALLA positive and one CALLA negative B-ALL phenotype. One adult B-ALL case had second isolated CNS relapse in 6 months from second remission. Conclusions: CNS relapse may occur alone or with systemic relapse. CNS relapse in B-ALL may occur during treatment or even after treatment completion and may occur multiple time. It is associated with inferior prognosis. So, it is essential to maintain a high degree of suspicion of isolated CNS relapse for early diagnosis and management.

Mixed Phenotypic Acute Leukaemia with Megakaryocytic Dysplasia-A Rare Case Study Sumon Betal, P L Jyotsna, V Singh Introduction: Mixed phenotypic Acute Leukaemia are rare leukaemia's accounting for \ 4%of total cases. They occur in both children and adults, but are seen more in adult population and are mostly associated with poor prognosis. Here we present a rare case of Acute Biphenotypic Leukemia with Megakaryocytic dysplasia in a 11 year old child. Aims & Objectives: A 11-year-old male presented with history of fever and cough since 2 months. On examination, pallor was present along with cervical lymphadenopathy. Liver was 1.5 cm palpable below left coastal margin, no splenomegaly was present. Materials & Methods: On CBC analysis, Hb-9.5 g/dl, TLC-2.47 9 103 /ll, Platelets-36 9 103 /ll. Peripheral Smear examination revealed 32% blasts which were 2-4 times the size of small mature lymphocyte, with high N:C ratio, scant to moderate agranular cytoplasm, few showing granules, round nucleus with fine chromatin, 0-2 nucleoli. Occasional blast showed Auer rods. Bone Marrow aspirate showed 68% blast of similar morphology. Erythroid and Myeloid series showed marked suppression. However, increase in Megakaryocytes were seen showing dysplastic features with mono and bi-lobated forms. Blast showed MPO positivity on cytochemistry.

On flow cytometry, 74.6% blast gated showed moderate to bright expression of CD19, cCD79a, cMPO, CD33, HLA-DR, CD34, CD117 and Moderate expression of Tdt. T-Cell markers (CD3, CD5, CD7) were negative. Result: Acute Biphenotypic Leukaemia (B-Lymphoid/Myeloid) with Megakaryocytic Dysplasia. Progression to MPALs have been reported as rare cases mostly in elderly patients with denovo myelodysplastic syndrome with multilineage dysplasia.

Present case did not meet the criteria for childhood MDS and therefore suggested to have no additional features explaining the dysplastic changes associated with the diagnosis.

Also, dysplasia was seen in Megakaryocytic lineage only. History suggestive of nutritional deficiency, toxin exposure, drug intake was not obtained.

Genetic analysis required to corroborate our diagnosis could not be done as patient was lost to follow up. Conclusions: In conclusion, broader understanding of leukemia's associated with dysplasia is required with emphasis on its therapeutic implications.

Aberrant Marker Expression in Acute Leukemia's: Effect on Clinico-Hematological Profile and Induction Outcome Dawrika Tiwari, Kanwaljeet Singh, Ankur Ahuja, Venkatesan Somasundarum, Tathagat Chatterjee Introduction: Aberrant phenotype is a phenomenon of abnormal expression or loss of expression of cell specific lineage marker not associated with specific cell type. As per literature, there is mixed opinion regarding effect of aberrant phenotype expression on induction outcome. Aims & Objectives: The purpose of the study was to find out the occurrence of aberrant phenotypes in leukemia patients and its relation to clinico-hematological profile and induction outcome. Materials & Methods: Prospective and retrospective study at Army Hospital (Referral and Research) New Delhi. All age and sex groups were included in this study. We analyzed a total of 200 acute leukemia cases by multiparametric flow cytometry using an acute leukemia panel. Result: Among the total 100 cases of acute leukemia enrolled in this study, the most common aberrant CD marker in AML cases were CD7 and in B-ALL cases it was CD7, Cd13 and CD4. In T-ALL, the most common aberrant CD marker was CD33, CD117. These aberrant CD markers association was correlate with clinical (age and sex) and hematological profile like hemoglobin, WBC count and platelet count. It was found significant correlation between aberrant markers expression in B-ALL and hemoglobin level (p \ 0.05). But other hematological parameters did not show any significant association with aberrant markers in acute leukemias. After following up the cases it was demonstrated that there is no significant association between aberrant expression of CD markers in acute leukemia cases and day 28 post induction bone marrow aspirate. Conclusions: The incidence of aberrant antigens expression in acute leukemia, correlation with hematological parameters and post induction status was comparable with the other published national and international data and it may open the gateway for further prognostication of acute leukemia cases when follow up of the patient for longer duration as literature search shows poor prognostication among acute leukemia patients with certain aberrant CD marker expression such as CD56 in AML, CD19 in ALL. To augment findings of our study, further studies in larger subset of patients are suggested to confirm the correlation of aberrant phenotypes in diagnosis, prognosis and therapeutic response of acute leukemia.

Anju Khairwa, Mrinalini Kotru, Diva Khatana Introduction: Chromosomal instability (CI) or genetic instability due to chromosome structure and number changes is an essential factor in oncogenesis.

Aims & Objectives: Aim of the present study is to analyze various morphological markers of CI, including chromatin bridges, multipolar mitosis, nuclear budding, micronuclei, nuclear heterogeneity, laggards and chromatin strings in bone marrow aspirate (BMA) and biopsy of acute leukaemia (AL) and myelodysplastic syndrome (MDS Although the awareness regarding the disease has increased manifold since its inception in December 2019, the treatment of patients with already suppressed immune status owing to hematological malignancies and other comorbidities is a challenge. Patients with leukemias and COVID-19 show a higher fatality rate of 37%.The time-lapse between disease presentation and diagnosis is also increased due to COVID-19 as many symptoms are overshadowed due to the typical presentation of COVID-19.

The aim is to diagnose the patients with leukemias at the very onset of disease during this pandemic as the outcome is very poor so that the management and follow-up of the patients begin at the earliest.

We are presenting case series of four patients of COVID-19 with coexistent AML. The diagnosis was established with the correlation of flow cytometry, bone marrow examination, and radiology. Interestingly all the patients diagnosed with AML were not having any clinical abnormality before the COVID-19 infection so we feel that this is a de-novo presentation of AML with COVID-19 and can only speculate about the coronavirus per se causing the hematological malignancy. However, more data is required to confirm this association, particularly the role of IL-6 and its direct effect in the causation of hematological malignancy. Result: One of the patients was in the intensive care unit for a week however patient's condition deteriorated and he could not survive. Rest of them are under follow-up. Conclusions: Concurrent presentation of AML and COVID-19 is challenging from a diagnostic and management point of view. There have been few case reports in patients with leukemia getting infected with COVID-19 but to the best of our knowledge, these are possibly the first few cases of AML occurring in concurrence with COVID-19 infection detected incidentally without any prior history of any significant disease. These cases highlight the association of hematological malignancies with the current pandemic and also difficulty in their management.

Malvika Gaur, Tushar Sehgal, Ganesh Kumar V Introduction: Abnormal chromatin clumping (ACC) can be observed in myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), BCR-ABL1 negative atypical chronic myelogenous leukemia (aCML), drug effect with mycophenolate mofetil or in acute leukemias with trilineage dysplasia. Aims & Objectives: To study the peripheral smear findings of a case of ACC, correlate them with flow cytometry, and with clinical history. Materials & Methods: CBC was analysed in Sysmex XN9000, peripheral blood smear was examined. Correlation with flow cytometry to confirm the diagnosis. Result: 95 year male presented with fatigue & dyspnea to the emergency department. Complete blood count showed hemoglobin of 6.3 g/ dL, platelet count of 27 9 109/L, white blood cell count of 177 9 109/ L. He had mild hepatosplenomegaly and no lymphadenopathy. Peripheral blood film revealed 95% atypical cells with abnormal nuclear chromatin clumping (ACC) (large blocks of chromatin separated by clear zones) and inconspicuous nucleolus mimicking chronic lymphocytic leukemia (CLL) Occasional dysplastic polymorphs were also seen. The scatterplots obtained by Sysmex XN 1000 hematology analyzer misclassified these atypical cellsas immature granulocytes and monocytes. Flow cytometry on peripheral blood was positive for CD13, CD33, CD34, cMPO, HLA-DR and CD117 confirming the diagnosis of Acute myeloid leukemia. Cytogenetic analysis could not be performed as the patient succumbed to his illness. Discussion: ACC in leucocytes is a distinct morphological entity, characterized by extremely exaggerated clumping of heterochromatin into large blocks separated by clear zones of euchromatin and is also associated with hyposegmentation of neutrophils. Felman et al. suggested that this clumping is probably related to an abnormal distribution within the nucleus and is due to modification of the heterochromatin: euchromatin ratio. No karyotypic abnormality was found in his study. Presence of ACC imparts a poorer prognosis. Most of the patients die of complications such as infection or haemorrhage. Conclusions: The atypical morphology due to ACC is a diagnostic pitfall and led us to initial suspicion of CLL. Flow cytometry immunophenotyping helped us confirming AML and preventing misdiagnosis.

Correlation of NK Cell and T Cell Subpopulations with Chemotherapeutic Response (8th Day Blast Count and MRD Day33) in Newly Diagnosed Pediatric B-All Patients Nikita, Richa Gupta, Mrinalini Kotru, Sunil Gomber Introduction: ALL is common malignancy in children and is treated with multiagent chemotherapy which is tailored individually according to risk stratification. It is associated with relapse and complication. Targeted immunotherapy can improve effectiveness of treatment as well as prevent relapse. NK cells-part of innate immune system. Preliminary work on NK cells showed its antileukemic effect, better treatment outcome and survival. Tregs-maintains self-tolerance and in hematological malignancies exert immunosuppressive effect, thus play critical role in tumor cell growth, proliferation. Therapeutic interventions targeting intratumoral Treg infiltrates can kill tumor cells. Therefore role of Tregs, NK cells in prognosis is area of interest.

Their manipulations can open therapeutic options and may be used to enhance effect of chemotherapy. Aims & Objectives: AIM: Study correlation of baseline NK cell and T cell subpopulations (Tregs, with chemotherapeutic response (8th day blast count and MRD day 33). Objectives:

Primary-Correlate NK cell percentage with chemotherapeutic response.

Secondary-Correlate Tregs percentage with chemotherapeutic response.

Materials & Methods: 25 newly diagnosed B-ALL untreated children (0-14 years) evaluated. Children on treatment and immunosuppressed were excluded. 3 ml EDTA sample was collected. CBC was done using MindrayBC-6800 and peripheral smear was drawn for blast count. Day 8th blast count was done and [ 5% were taken as positive. Flowcytometric analysis using BC FC-500 was done. Two tubes containing-CD45, CD127, CD4, CD25 and CD 45,CD 4, CD8,CD 3,CD 56 used to evaluate T cell and NK cell population respectively. MRD was conducted on day33. Result: 25 patients (19-males, 6-females) showed significant correlation (correlation coefficient-0.585, P value-0.002) between day 8thblast count ([ 5%) and MRD day33. NK cell percentage showed negative correlation with day8 blast count (P value-0.02) and MRD (P value-0.012). CD 4/CD8 ratio showed positive correlation (P value-0.04) with MRD day 33. No correlation of Tregs with any prognostic parameters was found. Conclusions: Increased NK cell and low CD4/CD8 count was found to be good prognostic parameter because it correlated with negative MRD. Introduction: Acute Myeloid Leukemia (AML) is characterized by clonal expansion of myeloid blasts leading to impaired production of normal blood cells. With the advent of new AML classification based on recurrent genetic abnormalities in 2008, emphasis on diagnostic modalities have shifted from morphology to karyotyping and molecular genomic analysis. However, due to unavailability of this advanced genomic tools widely in India, morphology still plays a pivotal role in making a primary diagnosis. In absence of molecular genetic tools, proper discrimination is a matter of diagnostic dilemma. Due to its morphological heterogeneity, AML with t(8;21) can masquerade as MDS, AML with myelodysplasia related changes, AML-NOS. However, prognostically it is more favourable than all of them. Aims & Objectives: Comparative study of different morphometric parameters in AML cases to assess the predictability for presence of t(8;21)/ RUNX1-RUNX1T1 fusion. Materials & Methods: All cases of AML diagnosed in department of Hematology, AIIMS between May 2020-September 2021 have been included. Bone marrow aspirate slides of all cases have been reviewed by two hematopathologists. Morphological details of blasts, Auer rods, dysmyelopoiesis, eobasophils, mast cells etc. have been noted. Result: A total 165 cases of AML were reported, among which t(8;21) was positive in 32 cases. On statistical comparison, the presence of thin slender Auer rods in the blasts had a high positive predictive value (PPV) of 93.75% and negative predictive value (NPV) of 97.87%. Though the finding of mast cells had 100% specificity as well as PPV, the sensitivity was only 50%. The morphological feature of dysplasia had a sensitivity of 87.5% and NPV of 92%, however the specificity and PPV were significantly low (48.93% and 36.84% respectively). On the other hand, presence of eobasophils was associated with low sensitivity (12.5%). We found two cases of cytogenetically proven AML with t(8;21) with blast count \ 20% & primarily diagnosed as MDS with excess blast 2 & 2 cases showing monocytic differentiation which are infrequent findings. Conclusions: Though cytogenetic study is an indispensable tool for diagnosis of AML with t(8;21) cases, its characteristic morphological features are useful in early as well as accurate prediction and can be followed in low resource set ups. Introduction: Blood disorders usually range from anaemias to advanced hematological malignancies among different age groups. Developing countries bear more than half of global cancer burden because 70% of worlds population lives in these countries. In India, leukemias constitute 3.5% of all malignancies. Here, an attempt has been made to get an idea about the pattern of hematological malignancies in an institution based study. Aims & Objectives: To evaluate the most common hematological malignancies presenting at our institution, their male: female ratio and gender distribution. Materials & Methods: This is a 6 month study conducted in the department of pathology GMC Aurangabad and Government Cancer Hospital, Aurangabad. A total of 50 cases of hematological malignancies were diagnosed on peripheral blood smear and whenever needed cytochemistry and cytogenetic studies were done for confirmation of diagnosis and included in our study. The data obtained was analysed to evaluate various types of hematological malignancies by percentage analysis. Result: During the study period (January 2021 to July 21), we received 50 cases of hematological malignancies and were appropriately diagnosed as follows. Among a total of 50 cases of malignancy, 27 were diagnosed as Acute Leukemia out of which 5 were diagnosed as Acute Myeloid leukemia. Among 16 cases of Chronic leukemia, 9 were diagnosed as Chronic Myeloid Leukemia and 7 were diagnosed as Chronic Lymphoid Leukemia. Males were affected more commonly than females (2.33:1) . Overall, adults outnumbered the children and the commonest leukemia in children was Acute lymphoblastic leukemia followed by Acute Myeloid Leukemia. Conclusions: In our study, Acute Leukemia was the most common subtype of leukemia in all age groups. Of all leukemia cases, majority were of AML whereas ALL was found to be the the least common as is also observed in other studies from India. The study has highlightend the burden and epidemiological pattern of hematological malignancies in our institution and would serve as a term of reference for further studies on the topic and a tool for raising awareness on the disease burden. (Fig. 1) for four days. On examination there was moderate pallor, periorbital edema, bilateral subconjunctival hemorrhages and petechial hemorrhages over right forearm. Complete blood count revealed hemoglobin of 6.5 g/dl, total leucocyte count of 122.4 9 109 /L and platelet count of 13 9 109/L. Peripheral blood findings revealed 95% normal promyelocytes (blast equivalents) with irregular nuclear membrane, bilobed nucleus and granular cytoplasm with multiple Auer rods (faggot cells) (Fig. 2 ) suspicious for APL. Coagulation studies showed prothrombin time of 20.5 s, activated partial thromboplastin time of 92.9 s, fibrinogen of 157.024 mg/dl and D-Dimer was [ 5250 ng/ml DDU. Flow cytometry on peripheral blood showed 97% blasts on CD45/SSC plot with a high side scatter. Blasts showed bright positivity for cMPO, CD13 and CD33 with negative CD 34 and HLA DR. Final diagnosis was APL with features of disseminated intravascular coagulation (DIC). He was started on All Trans Retinoic Acid. Molecular studies could not be done. Patient succumbed to his illness soon after due to DIC. Result: Discussion: APL accounts for 5-8% of AML cases in younger patients. It presents with bleeding manifestation like epistaxis, menorrhagia, gingival bleeding, ecchymosis and CNS bleeding. Incidence of gum hypertrophy in APL is 5.7% and 20% from two retrospective studies in India. APL is also associated with DIC and increased fibrinolysis. Two morphological variants include hypergranular and hypogranular. Cytochemically MPO is strongly positive and nonspecific esterase is weakly positive. Immunophenotypically hypergranular variant shows homogenously positive for CD33 and heterogeneously for CD 13. Hypogranular variant shows expression of CD34 and CD2. Diagnosis is confirmed by molecular detection of PML-RARA fusion.

Conclusions: To conclude we present an interesting case of young male with gingival bleeding and gum hypertrophy who initially presented to the dental OPD. Clinicians and laboratory physicians should be well versed with varied presentation of APL so that a treatable disorder is appropriately managed in timely fashion.

Jyoti Mishra, Vijay Kumar, Taruna Bansal Introduction: Acute lymphoblastic leukemia (ALL) with an incidence of 25-40%, ranks first among the cancers almost similar to a worldwide incidence.Commonly, the peripheral blood in ALL show lymphoblasts, but at many instances, they go undetected as their population is very minimal, as in cases of pancytopenia or leukopenia. In this study, we describe a group of patients in whom pancytopenia was the initial hematological finding and with various evaluation methods, the diagnosis of ALL had been made. Aims & Objectives: To compare the clinicopathologic and immunophenotyping data of ALLpatients presenting with and without pancytopenia. Materials & Methods: A retrospective study was conducted on patients over a period of 5 years in the Department of Pathology, ABVIMS and RML hospital, Delhi from November 2017 to July 2021. A total number of 110 patients included in the study out of which 28 presented with pancytopenia and 82 without pancytopenia. The pancytopenic group of ALL patients was compared with ALL without pancytopenia. Analysis of peripheral blood, bone marrow, immunophenotyping, were made to find out the importance of each parameter and have a global approach for prompt diagnosis. Result: In the present study the patients included were in the age range of 1 year to 67 years. Details of the cases will be discussed. Conclusions: The present study highlights the importance of comprehensive evaluation of hemogram, peripheral blood, bone marrow findings and immunophenotyping findings in ALL cases presenting with pancytopenia. Introduction: B-lymphocyte progenitors, namely the haematogones may pose problems in morphological assessment of bone marrow, not only during diagnostic work-up but also while evaluating bone marrow for remission status following chemotherapy. Aims & Objectives: Here we describe a series of 12 cases of Precursor B-lymphoblastic leukemia (B-ALL) and T-ALL when evaluated for remission status revealed blastoid cells in bone marrow in range of 6-27%, which on immunophenotypic analysis turned out to be haematogones. Materials & Methods: This is a case series of 12 ALL cases, who were undergoing treatment at Army Hospital (Referral and Research) New Delhi. All these cases were under work up for post induction status and to check for suspected ALL relapse. Bone marrow aspirate, biopsy and immunophenotyping were performed. Multicolored Flow cytometry was performed using CD10, CD20, CD22, CD34, CD19, and CD38 antibodies panel.

Result: Bone marrow on morphological assessment of all 12 cases revealed that maximum 27% blastoid cells and minimum upto 6%, raising the suspicion of hematological relapse. However on clinical assessment, these patient was well preserved, with preserved peripheral counts. Hence the marrow aspirate were subjected to flow cytometry using the CD markers panel as discussed above, which revealed haematogones These cases were followed by MRD analysis which revealed MRD negative status, further confirming our findings. Conclusions: This case series highlights the importance of morphology and then immunophenotyping in unveiling the diagnostic dilemma in ALL patients. Introduction: Leukemia associated Aberrant immunophenotypic expression is an important finding in the patients with acute lymphoblastic leukemia (ALL). The clinical and the prognostic significance of this aberrant immunophenotypic expression at diagnosis and its association with MRD expression and the outcome is debatable.

Aims & Objectives: To study the association of aberrant immunophenotypic expression and MRD status at day 35 in patients with B cell-acute lymphoblastic leukemia. Materials & Methods: All the consecutively diagnosed patients of pediatric B cell ALL between 2018 to 2020 were included in the study. The flowcytometric immunophenotypic analysis was done and the patients were categorized accordingly. All the data pertaining to clinico-hematological parameters at the time of diagnosis and MRD status at day 35 was collected and studied for association, if any between the two groups. All the cases were followed up every six monthly for any relapse or outcome in terms of death or alive for the next two years. Result: Out of the total 74 patients enrolled in the study 26% patients had aberrant immunophenotypic expression on the diagnostic flow cytometry. Out of the total patients 66 achieved complete remission and six patients relapsed during the study period. Of these six patients two patients expressed aberrant expression at the diagnosis. The MRD positivity at day 35 was found to be significantly associated with expression of aberrant markers at the diagnosis. Conclusions: We conclude that aberrant immunophenotypic expression is frequently seen in patients with B cell ALL and correlates with Indian J Hematol Blood Transfus MRD status at day 35 and may help in risk stratification at the time of the diagnosis.

Significance of Expression of CD38, CD58, CD49D AND CD66C in Acute Lymphoblastic Leukemia Lity Dhar, Sarika Singh, Parul Tanwar, Bembem Khuraijam, Kirti Balhara, Shubhra Signal Introduction: ALL constitutes a family of genetically heterogeneous lymphoid neoplasms derived from B-and T-lymphoid progenitors. CD38 expression in blasts is dimmer than hematogones and hence can be used as Leukemia associated immunophenotype (LAIP) aiding in detection of Minimal residual disease (MRD). CD38 expression is also useful for deciding anti-CD38 targeted therapy. CD58 a.k.a Leucocyte function associated antigen 3 has higher expression in B cell precursor ALL and hence can be used for MRD. CD49d plays an important role in many autoimmune diseases as well as CLL in which it is a negative prognostic marker. In ALL, targeted therapy using antibodies against CD49d has shown promising. CD66c is a myeloid marker with aberrant expression in pre-B cell ALL and also has a strong correlation with BCR/ABL rearrangement. Hence, it plays important role in MRD and is also predictive of poor prognosis.

Aims & Objectives: To study the diagnostic and prognostic significance of CD38, CD58, CD49d and CD66c in newly diagnosed cases of acute lymphoblastic leukemias. Materials & Methods: 29 diagnosed cases of ALL were retrospectively studied from September 2019-September 2021 in the department of Pathology, Maulana Azad Medical College, New Delhi. The age group ranged between 2 months-50 years with male: female ratio of 2.2: 1.

Peripheral blood was processed, and smear was stained using giemsa. The TLC ranged from 2430 to 5,66,400/mm 3 with blast percentage ranging between 18-99%. Flow cytometry was done using primary diagnostic panels for ALL and prognostic markers namely CD38, CD58, CD49d, CD66c, CD25 and NG2. Result: CD38 was put in 20/29 (68.9%) cases, out of which 19/20 were dim to moderately positive. CD49d was put in 16/29 (55.2%) cases, all of which showed heterogenous positivity. CD66c was put in 14/29 (48.3%) cases, of which 7/14 were positive with almost 95% dim to moderate positivity in all. CD58 was put in 19/29 (65.5%) cases, out of which 18/19 were heterogeneously positive. Conclusions: Incorporating prognostic markers such as CD38, CD58, CD49d and CD66c at the time of diagnosis helps provide valuable information on disease progression, MRD analysis at later date for disease monitoring and therapy and thus should be be routinely incorporated in ALL workup. Introduction: FIP1L1-PDGFRA rearrangement in patients with eosinophilia-associated myeloproliferative disorders have a broad clinical and pathologic spectrum. There are rare cases of mutations leading to primary or secondary resistance to tyrosine kinase inhibitors despite in vitro activity. We report a hitherto undescribed case of FIP1L1-PDGFRA rearrangement associated myeloproliferative neoplasm with hypereosinophilia and subsequent progression to AML. Targeted sequencing revealed an emergence a D842V mutation with variant allele frequency of 39.5% in PDGFRA kinase domain, a pan-resistant mutant after treatment with Imatinib. Materials & Methods: A 23 years old male referred to our centre with complaints of skin rashes, fever, dyspnoea on exertion. Initial evaluation was suggestive of eosinophilia and 2D-ECHO demonstrated severe MR with pericardial effusion. He underwent mitral valve repair and referred to our department owing to history of hypereosinophilia. Result: Bone marrow aspirate smear and biopsy review showed hypercellular bone marrow with prominence of eosinophils and precursors with 1% blasts. There were no cytologically atypical lymphocytes, mast cells and abnormal eosinophils. Fluorescence-in-situ hybridisation showed deletion involving the CHIC2 gene locus resulting in fusion of FIP1L1 and PDGFRA gene in 80?lls. He was started on imatinib 100 mg OD and achieved complete hematological response for three months however after five months, he presented with low grade fever and leucocytosis. Peripheral smear revealed blasts. Flow cytometric immunophenotyping on the bone marrow aspirate revealed AML with monocytic differentiation along with grade 2 reticulin fibrosis in bone marrow. Breakapart FISH was negative for CBFB gene rearrangement. Cytogenetics revealed a normal male karyotype (46, XY[20] ).The patient consequently received 3 ? 7 Induction therapy and Imatinib therapy (100 mg daily). Targeted sequencing panel for myeloid genes revealed an emergence of an acquired D842V mutation, a pan-resistant mutant with 39.5% mutant allele percentage after treatment with Imatinib. Conclusions: All eosinophilia-associated hematological malignancies should be screened for the presence of the FIP1L1-PDGFRA fusion gene by RT-PCR and/or FISH analysis. This rare presentation of an unusual disease emphasise the importance of an integrated pathologic, cytogenetic and molecular approach to precisely diagnose and treat a hematologic neoplasm with hypereosinophilia and subsequent development of an Imatinib-resistant mutation.

Identification of a Novel Fusion Transcript IKZF1-CIITA USING Targeted Next Generation Sequencing in Case of Relapsed B-cell Acute Lymphoblastic Leukemia Preity Sharma, Sanjeev Kumar, Gupta,Ritu, Gupta,Lata, Rani,Smeeta, Gajendra,Anita Roy, Deepam, Pushpam,Ranjit Kumar Sahoo, Sameer Bakhshi Introduction: Class II major histocompatibility complex transactivator (CIITA) participates in adaptive immune response and its genetic alterations downregulate expression of MHC-II molecules like HLA-DR. This contributes to tumor immune escape and immune dysregulation. The IKZF1 alterations affect B-lymphoid differentiation and contribute to leukemogenesis. Aims & Objectives: To report a novel fusion transcript involving IKZF1 and CIITA in a case of relapsed B-cell acute lymphoblastic leukemia (B-ALL). Materials & Methods: Genomic DNA and total RNA was obtained from peripheral blood at the time of B-ALL relapse. Multiplex PCR was done for recurrent translocations. RNA based targeted NGS analysis were done using Archer FusionPlex ALL kit covering 81genes and Archer analysis v6.2.7 Software (ArcherDx, USA). A fusion was considered strong candidate with at least 5 unique reads detected for valid structural variation. Multiplex ligation-dependent probe amplification (MLPA) was performed using P335 kit (MRC, Holland). MRD was assessed using 10-color flow cytometry. Result: The patient was diagnosed with BCR-ABL1 negative B-ALL at the baseline. The patient received treatment as per the BFM-95 protocol for 2 years and was treatment free for around 7 years, after which there was a late isolated bone marrow relapse of B-ALL. The bone marrow was replaced by blasts and peripheral blood had 58% blasts. The patient was then started on UK-ALL protocol. The post-induction MRD analysis by flow cytometry was positive with 0.12% B-lineage blasts, which were HLA-DR negative, whereas the blasts were HLA-DR positive at baseline. Data from multiplex PCR showed absence of any recurrent translocation. The targeted sequencing data revealed a unique fusion read IKZF1-CIITA, with strong fusion call. The fusion was in-frame, with exon 3 of IKZF1 on chromosome 7 (chr7:50,367,353; hg19/GRCh37) joining to exon 9 of CIITA on chromosome 16 (chr16:10,997,588; hg19/GRCh37). MLPA analysis showed no copy number variation of IKZF1. The patient is alive and has suffered an episode of Herpes Zoster infection, multiple episodes of diarrhoea and UTI during the ongoing maintenance chemotherapy. Conclusions: IKZF1-CIITA is a novel fusion transcript not described in the literature so-far. The fusion may have contributed to the relapse of the disease and a likely immunocompromised state in our patient.

Introduction: Leukaemia is a highly malignant neoplastic proliferation of immature/ blast cells in the bone marrow replacing normal marrow elements. Acute Lymphoblastic leukaemia (ALL) is a malignancy of childhood commonly seen in 1-5 years age accounting for [ 25% of all paediatric cancers. Acute myeloid leukaemia (AML) is the most common type of leukaemia in adults with lowest survival rate of all leukaemias.

Neuron-glial antigen 2 (NG2/CSPG4) is a transmembrane proteoglycan barely expressed in normal haematopoietic cells and detects a 220-240 kDa cell surface chondroitin sulphate homologue. NG2 is specifically expressed in 90% of 11q23/MLL rearranged (MLLr) leukaemias and is used in their immunophenotyping because of its high predictive value. NG2 is strongly associated with M4-M5 AML subtypes. Aims & Objectives: Primary objective of this study was to detect NG2 expression in acute leukaemia (AL) by Flow cytometric immunophenotyping (FCI), to correlate with leukaemia subtypes and assess the performance status by minimal residual disease analysis. Materials & Methods: A cross-sectional study was conducted on 27 newly diagnosed patients of ALs for a period of 1 year. The FCI was performed on FC500 Beckman and Coulter triple laser five colour instrument, on a freshly collected Ethylene diamine tetra acetic acid peripheral blood sample or bone marrow (BM) sample. The cut off for surface and cytoplasmic markers was taken as [ / = 10% & for NG2 [ 5%.

Result: Out of the 27 cases analysed, positivity was seen in 1 case of T-ALL and one case of Early T cell lymphoblastic leukaemia(ETPLL) of 10.1% & 5.2% respectively while 3 cases showed dim NG2 positivity, out of which one was a case of AML-M2 & others were AML-M3v & Pre B-ALL respectively. Thus a strong correlation between T-ALL & NG2 was seen.

Conclusions: Present study showed that NG2 is a potential tumor marker for lymphoblastic leukaemias especially of the T-cell subtype. Since this marker is not found in healthy BM samples, thus it can be used as a sensitive tumor marker to monitor further course & to detect minimal residual disease.

Optimization of a Ten-Colour Antibody Panel for Measurable Residual Disease Detection in B Cell Precursor Acute Lymphoblastic Leukemia Based on Leukemia Associated Immunophenotype at Diagnosis Sujaya Mazumder, Prabhu Manivannan, Rakhee Kar, Smita Kayal, Debdatta Basu

Introduction: The understanding of the importance of measurable residual disease (MRD) detection in acute lymphoblastic leukemias, has led to constant efforts in identifying ways to increase the sensitivity of detecting residual disease by flow cytometry and distinguishing it from the normal counter parts or hematogones. While the application of commonly used markers in flowcytometry is limited by the lack of demonstrable leukemia associated immunophenotype (LAIP) and antigenic modulation post therapy, the inclusion of too many markers in the panel poses cost constraints and drawback of non-informative markers. Hence an optimised panel for LAIP detection and MRD tracking by flow cytometry is necessary. Aims & Objectives:

1. To study the immuno-profile of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) and to study the expression of seven newer LAIP markers-CD9, CD44, CD58, CD73, CD81, CD86, CD123 at diagnosis. 2. To propose an optimized 10-color panel for MRD detection based on the LAIP expression at diagnosis.

This was a retrospective, cross-sectional study. All newly diagnosed cases of BCP-ALL which were diagnosed based on morphology, cytochemistry and immunophenotyping by flow cytometry from the period of October 2019 to April 2021 were included (n = 82). The expression pattern of the markers at diagnosis were studied in comparison to that of normal pattern of maturation of hematogones.

Result: Overexpression of CD73 (82.92%) and CD86 (76.92%) were the most effective markers in establishing LAIP at diagnosis. Underexpression of CD81 was the next most frequent LAIP in 70.73?ses. CD44 and CD58 were similar to each other in terms of LAIP expression and hence any one of them could be used. It was noted that CD9 though positive in 94.28% of the cases showed significant overlap with the marker expression of hematogones (overexpression in only 37.14%) and CD123 was overexpressed in only 36.20%. We studied a virtual combination of the markers to analyse the ten best marker combinations in terms of highest LAIP expression shown intable 1.

We propose a single ten-color tube comprising CD45, CD19, CD34, CD10, CD20, CD38, CD73, CD86, CD81 and CD44/ CD58 for diagnosis as well as for MRD in the post-therapy samples of BCP-ALL. Introduction: Diagnosis of acute leukemias by convention requires the evaluation of blood smears and confirmation by Flow cytometry. However, PBS examination has a lot of pitfalls, even by a trained and experienced pathologist, and flow cytometry, in a resource crunched country, is available at only very selected laboratories. Automated hematology analyzers which are present ubiquitously, generate scattergrams that can be used for preliminary screening of acute leukemias which can be confirmed by flow cytometry at higher centres.

To determine the accuracy of diagnosis of acute leukemias by scattergrams generated by automated hematology analyzer.

Materials & Methods: Thirty seven cases diagnosed as acute leukemias in a period of six months (01/03/21-31/08/21) by evaluating the scattergram patterns generated by the automated hematology analyzer installed in Department of Pathology, M.K.C.G. Medical College, Brahmapur were included in the study, and all the cases were evaluated by flow cytometry for confirmation of diagnosis and classification.

Result: Of the 39 cases, there were 30 (77%) cases of ALL and 09 cases of AML. 37 of the cases were confirmed to be acute leukemia by immunophenotyping (specificity of 95%). The two discordant cases were of-one case of chronic lymphocytic leukemia erroneously diagnosed as a case of acute lymphoblastic leukemia; and one case of neutrophilic leukemoid reaction diagnosed as acute myeloid leukemia.

Conclusions: Flow cytometry is the gold standard for diagnosing cases of acute leukemia, but in resource crunch setting, the patterns on automated hematology analyzer scattergrams can be a valuable aid for suspecting acute leukemia cases which can be sent for confirmation and typing by immunophenotyping in higher centres.

Orbital Chloroma in a Child with Acute Myeloid Leukemia: A Case Report Rasmi Sasha Viegas, Ranjit Kangle, Vivek Tripathi

Introduction: Chloroma (Myeloid Sarcoma) is a rare extra-myeloid tumor composed of leukemia cells derived from granulomatous myeloid precursors. It occurs in only 2-8% of acute myeloid leukemia and rarely occurs in the orbital area. In pediatric population, orbit is one of the most common sites of occurrence. Focal masses of immature myeloid cells from the granulocytic lineage infiltrate bone and soft tissue. It is most common in the pediatric population and may present at any time in the course of the disease, either concurrently with the onset of leukemia or during a remission or relapse. Occasionally, it may precede the clinical onset of acute myeloid leukemia (AML), presenting a diagnostic challenge.

Aims & Objectives: Myeloid sarcoma (MS) of the orbit is an uncommon condition in occurring in children, generally coupled to myeloproliferative neoplasms.

We report a case of a 4 year old male child who presented to the Department of Ophthalmology with painless progressive unilateral exophthalmos in left eye that developed over 14 days and was diagnosed with acute myeloid leukemia AML M4 on peripheral smear and bone marrow. Was later shifted to Department of PediatricOncology. The patient was put on chemotherapy protocol. The patient passed away a week later due to sepsis. Result: A comprehensive revision of the literature on isolated orbital MS was carried out for emphasizing differential diagnosis and treatment.

Conclusions: MS generally occurs in patients with AML, but it can also occasionally precede myeloproliferative disorders within a matter of months in patients with no evidence of hematological disease at the time of bone marrow aspiration and biopsy at the initial diagnosis (isolated, primary or non-leukemic MS). Particularly in these patients, a prompt diagnosis of MS is essential to the most effective clinical management, because conventional AML-type chemotherapy and or allogeneic hematopoitic cell transplantation improves overall free survival options and stressing the need to consider MS even in the absence of sign and symptoms of an underlying myeloproliferative disorders. immunophenotyping, karyotyping, molecular analysis, CSF analysis, Ultrasonography of scrotum, testicular biopsy & immunohistochemistry were done at the time of presentation. Result: The mean age and male/female ratio of relapsed patients were 17 years (range: 1 year to 36 year) and 2:1, respectively. The incidence of relapse was higher in B-ALL (n = 22, 91.6%) compared to T-ALL (n = 2, 8.3%). Bone marrow was the most common (n = 18, 75%) site of relapse, followed by CNS (n = 10, 41.6%) and the testes (n = 2, 8.3%). Isolated relapse in the bone marrow, CNS, and testes was documented in 12 (50%), 6 (25%), and zero cases, respectively. Combine medullary and extra medullary relapse involving CNS and testes were documented in 4 (16.6%), 2 (8.3%) respectively. The incidence of very early, early and late relapse was 4 (16.6%), 16 (66.6%), 4 (16.6%) respectively. The incidence of early relapse was higher in CNS relapse (n = 8, 50%) and testicular relapse (n = 2, 12.5%). High risk features such as TLC greater than 50 9 109/L and high-risk cytogenetics (MLL gene rearrangements, t (9,22), t (1,19) was significantly more frequent in early relapse (n = 6, 40%).

Conclusions: The higher incidence of early relapse, extra medullary relapse indicates the need for reappraisal of treatment protocol. There is a need of identifying risk factors and high-risk groups and riskstratified intensification of chemotherapy in them. De novo AML patients in complete induction remission, who have received HIDAC consolidation chemotherapy at a dose of 3 g/m 2 twice on days 1,3,5 in hematology ward of NRS hospital between January 2020 to October 2021 were randomised either to receive a single dose subcutaneous pegfilgrastim (6 mg in adults,100 l/kg in children) or daily filgrastim 5 l/kg starting on day 6 of HIDAC chemotherapy.

Result: A total of 58 cycles of HIDAC were given to AML patients. The mean duration of neutropenia in pegfilgrastim arm (n = 29) was 9.8 days (range 7-17 days) and in filgrastim arm (n = 29) was 8.8 days (range 6-12 days). The incidence of febrile neutropenia in pegfilgrastim arm was 55.1% and in filgrastim arm was 482%. Febrile neutropenia occurred at a mean of 11.8 days (range 10-13 days) from start of-chemotherapy and lasted 8.5 days (range 5-15 days) in pegfilgrastim arm and at 12.4 days (range 11-14 days) from start of chemotherapy and lasted 7.4 days (range 5-10 days) in filgrastim arm. The incidence of positive microbiological cultures in pegfilgrastim arm was 55.1% and in filgrastim arm was 41.3%. Conclusions: Results from our study connotes no clinically significant difference between a single dose pegfilgrastim and daily filgrastim in ameliorating the duration of neutropenia following HIDAC consolidation chemotherapy in AML patients. Introduction: In children AML accounting for 15%-20% of leukemia in children present commonly as extramedullary mass commonly known as myeloid sarcoma (MS) which is also known as myelosarcoma, extra-myeloid tumor, or chloroma. CNS although rare but usually presents with seizure or raised ICP due to intra cranial bleed or leukostasis but it's presentation as acute flaccid paralysis with involvement of brain and spine is rarely reported in children (3). Here we reporting a pediatric case of AML who presented to us as acute flaccid paralysis along with facial nerve deficit.

Aims & Objectives: Highlighting the suspicion of hematological malignancy should be kept in a child with acute flaccid paralysis before reaching a diagnosis.

Materials & Methods: A 3-year-old male child presented to us with history of bilateral eyelid swelling, vomiting, poor urinary stream, progressive weakness, quadriperesis (LL [ UL) with left sided UMN type 7th cranial palsy progressed in last 20 days. On examination child also had pallor, sensory level below the clavicles, absent DTR in bilateral lower and upper limb. Initial possibility of compressive myelopathy, GBS were kept.

His complete blood count suggestive of normocytic normochromic anaemia along with thrombocytopenia and monocytosis. His peripheral smear was showing 32% blast cell suggestive of AML. MRI brain with spine was done which was suggestive of compressive lesion (? Leukemic cell infiltration ??bleed) involving brain stem and spinal cord. Child was started on rescue chemotherapy considering neurological emergency (compressive myelopathy) after sending necessary samples. Currently child is in follow-up.

Result: MS in AML is found to be more commonly associated with pediatric patients (up to 30%) as compared to adult patients (2-5%). GBS is the common clinical condition occurring in pediatric population but AML presenting like features of GBS is though a rare presentation. This case highlights that high suspicion of haematological malignancy should be kept in a child with acute flaccid paralysis before reaching a diagnosis. Conclusions: Although AML involving CNS at presentation is a rare scenario but early suspicion and peripheral blood smear examination by an expert haematopathologist always need to be considered in every unexplained multisystem clinical condition for timely diagnosis and treatment plan. Introduction: Early thymic precursor acute lymphoblastic leukemia (ETP-ALL) is a recently identified subgroup of T-lymphoblastic leukemia/lymphoma, which is associated with poor outcomes. However, pediatric ETP-ALL has been thought to have a distinct biology and to have improved outcomes as compared to adult ETP-ALL. We looked at the outcomes of patients treated in our center between the years 2015-2019 with ETP ALL.

Aims & Objectives:

1. To look at the outcomes of patients with ETP ALL treated at our centre. 2. To identify any difference in outcomes between the paediatric and adult population treated for ETP ALL.

Materials & Methods: Retrospective data analysis was done of the treatment details of patients with ETP-ALL between the years 2015-2019. Pediatric age group was defined as less than 15 years of age.

Result: 64 patients were diagnosed to have ETP ALL during the study period. 11(17%) of these were in the pediatric age group. 47(3%) of the patients were male. 5(8%) had CNS involvement, 6(9%) had mediastinal mass/pericardial effusion at diagnosis. There were 4 induction deaths. Of the 31 who completed induction, 17 were in complete remission at the end of phase 1 induction. MRD was available for 6 patients, of which 4 were MRD positive. 16 patients underwent allogeneic hematopoietic cell transplantation (allo-HCT) in remission. The 3 year overall survival (OS) for the entire cohort was 52.4 ± 9.8%. The 3 year OS among the adult and pediatric cohorts was 45.8 ± 11.2% and 80 ± 17.9% (p = 0.233) respectively. The 3 year event free survival for the entire cohort was 43.6 ± 10%, while the 3 year EFS in the adult and pediatric population was 34.9 ± 10.9% and 80 ± 17.9% (p = 0.140) respectively. The 3 year EFS among those who had undergone allo-HCT was 54.2 ± 12.8%, as compared to 32.4 ± 174% (p = 0.145) among those that did not have an allo-HCT.

Conclusions: Patients treated for pediatric ETP-ALL appeared to do better as compared to adults treated for ETP ALL as evidenced by a 3 year EFS which has a trend to a statistically significant difference. However, this study is limited by small numbers and being limited to a single center. Larger multi-center studies are required to validate these observations.

Lekshmon K S, Alka Khadwal, Aditya Jandial, Prashant Sharma, Diksha Dev Yadav, Pankaj Malhotra, Harpreet Virk

Introduction: Acute lymphoblastic leukemia in adults represent a major therapeutic challenge even in modern era. Constantly evolving genomics has led to a better risk stratification and prognostication.

Aims & Objectives: Here we present a novel mutation in calreticulin gene in a patient with Precursor B lineage Acute lymphoblastic leukemia.

A 19 year old boy presented with fever, jaundice and pancytopenia. Initial investigation revealed a hemoglobin of 5.8 g/dl with a total leukocyte count of 700 cells/mm 3 and platelet count of 11,000/mm 3 . Differential count showed 95% lymphocytes and 5% neutrophils and no blasts with mild anisopoikilocytosis on PBF. Bone marrow biopsy demonstarted reduction granulocytic and erythroid lineage with adequate megakaryocytes and occasional collections of immature appearing cells, whose charcter was not able to be definitely ascertained. PET CT showed FDG avid lymph nodes on both sides of diaphragm, with PET guided biopsy was suggestive of non specific lymphocytic inflammatory infiltrate. • Retrospective study over a period of 19 months that is from 1st January 2020 to 31st July 2021 • Bone marrow aspiration and biopsy reports from the Pathology department of IGMC. • Clinical and investigative records from the oncology department of IGMC, Shimla.

Result: Out of the 523 patients who underwent bone marrow procedures 75 (15%) were diagnosed with leukemia of which 22 patients were from pediatric age group (B 18yrs) and 53 were adults. Male to female ratio was 0.9:1. Among pediatric patients: 13 were male and 09 were female (M: F-1.4:1). Acute lymphoblastic leukemia (ALL) was the most common diagnosis in children 90.9% (20/22). One of the patients was diagnosed with AML (18 yr/male) and one with CML (16 yr/male). Maximum patients were within the age group of 2 to 10 yrs.

Among adult patients: 23 were male and 30 were female (M: F-0.7:1).

Chronic myeloid leukemia (CML) was the most common diagnosis in adults 22% (17/75). Maximum patients were [ 60 yrs of age. Conclusions: 15% of the bone marrow investigation done during the above-mentioned period of 19 months were diagnosed as leukemia. It was overall more common among women with a male to female ratio of 0.9:1. However, among the pediatric age group leukemia was more common in males (M: F-1.4:1) in contrast to adults where it was more among females (M: F-0.7:1). The most common diagnosed leukemia among adults was CML and among pediatric age group was ALL. Most of the patients in the adult population were above 60 years of age and in pediatric population most were within the age group of 2-10 yrs.

Dual Malignancy Association of Plasma Cell Neoplasm and APML: A Rare Coexistence Nidhi Rathi, Kanwaljeet Singh, Venkatesan Somasundarum, Ankur Ahuja, Tathagata Chatterjee Introduction: Multiple myeloma (MM) is clonal expansion of neoplastic plasma cells in the bone marrow and the secretion of high amounts of monoclonal immunoglobulins. Characteristically, the neoplastic bone marrow plasma cells in multiple myeloma have undergone recombination, and most patients secrete IgG or IgA. The goals of treatment in MM include eradicating all evidence of disease, controlling disease to prevent damage to target organs, preserving normal function and quality of life, relieving pain, and managing myeloma that is in remission. Intermittent melphalan and prednisone have for many years been the recommended treatment for patients with MM. Acute leukemia has been described as a late complication of chemotherapy with alkylating agents in patients treated for hematological malignancies. Therapy-related AML constitutes approximately 5%-10% of all cases of AML.

Aims & Objectives: To study the profile of a rare case of APL arising from Plasma cell myeloma with review of the literature. Materials & Methods: Peripheral blood findings and Flowcytometry studies of the patient showed Abnormal promyelocytes in 'tear drop pattern' s/o APML. Result: The patient already a diagnosed case of multiple myeloma was lost to follow up and treatment. Patient developed therapy related Acutepromyelocyticleukemia. Despite of timely and accurate diagnosis, patient suffered intracranial hemorrhage and succumbed to her illness. Conclusions: This case report is to highlight the importance of knowledge of coexistence of such rare hematological malignancies. So that timely suspicion and diagnosis of such cases using multicentric approach in terms of clinicopathologic al correlation, PBS/ BMA and use of ancillary techniques such as multicolouredflowcytometry can be done. To reduce patients mortality.

Priscilla Nethala, Rohith Chitrapur, Shreyas Hanmantgad Introduction: Acute Myeloid Leukemia constitutes about 3% of all cancers in India and 80-90% of acute leukemias in adults. Socioeconomic inequalities in AML influence survival and outcome. There is limited real world data on the subject. Aims & Objectives: To study the profile of AML patients in a tertiary hospital and the clinical, biological, and social factors which influence the treatment and outcome. Materials & Methods: A retrospective, cross-sectional study of all newly diagnosed cases of AML from 2019 to 2021 was conducted with data collected from patient medical records. Karnofsky Performance Status was used to assess the functional status at presentation.

Modified Kuppuswamy scale 2021 was used for measuring socioeconomic status. ELN guidelines were used for AML risk stratification. Severe infection was defined as neutropenic sepsis, MDR bacterial infections and fungal infections. Outcome was measured as all-cause mortality at the time of data collection. Descriptive statistics were calculated for all variables. Result: 35 cases of AML were diagnosed during the study period. 27 (77%) proceeded with treatment. The mean age at presentation was 47 years (range SD 18.96 [47.0571 ± 6 .282 (± 13.35%)] 95% CI). 16 (45%) had comorbidities and 5(14.2%) had Karnofsky performance status of 40 and below. 20 (57%) belonged to lower SES. Cytogenetics risk stratification showed 21(60%) with adverse, 9 (25.7%) with intermediate, and 5 (14.2%) with favourable risk. Among the 27 patients treated in our hospital, 12(44.4%) were fit for standard intensive chemotherapy out of which 8 chose the standard option, while 4 opted for low-intensity chemotherapy. 10 (37%) patients who were unfit for intensive therapy received hypomethylating agent. 3 (11.1%) patients chose best supportive care and 2 (7.4%) preferred alternative medicine. 2 patients underwent allogeneic HSCT post-induction. All treated patients had febrile neutropenia, and 20 (74%) patients had severe infections. 6(22.2%) patients are alive, and 21(77.8%) are deceased. Conclusions: Age, poor performance status, severe infections, and lower SES were constraints for treatment. Collaborative studies involving major treatment centres are required for better resolution of factors influencing outcomes.

Rajan Yadav, Sonia K Parikh, Harsha Panchal, Apurva Patel, Akanksha Garg, Kajal Shah, Poulami Basu, Vivek Patel, Seshagiri Rao, Srikanth Ravichandran, Debanti Banerjee, MBMinu Chandra Introduction: Treatment related acute myeloid leukaemia (t-AML) is well documented after chemotherapy (0.8-6.3% at 20 years). In this subgroup of patients acute promyelocytic leukaemia (APML) due to delayed complication of using anthracycline is rare.We report a rare occurrence of t-APML in breast cancer patient treated with adjuvant anthracycline, taxane and radiation. A 40-year-old woman presented to us after she had sudden onset bilateral loss of vision and altered sensorium. Fundus examination pointed towards transfusion related retinopathy. The blood works from referring centre were as follows haemoglobin 3.7, total leucocyte count (TLC) 27,350, platelets 27,000. Peripheral smear from the same centre suggested; acute myeloid leukaemia.

On evaluation at our centre NCCT Scan of her brain showed frontal subarachnoid haemorrhage, her D-Dimer was 12,500.Bone marrow aspiration revealed acute promyelocytic leukaemia (APL) with promyelocytes and 92% blasts. In lieu of her bone marrow findings she was started on differentiating agents.Immunophenotyping showed CD15, CD13, CD96 and MPO moderate positive.Subsequently on FISH (Fluorescence in situ hybridization) there was chromosomal abnormality of t (15; 17), normal chromosome 16 and negative ETV6-AML1 fusion.

Previously she had undergone left modified radical mastectomy in April 2020, staged T4bN1M0 (infiltrating ductal carcinoma), positive ER/PR and negative her2/neu. She received 4 cycles of adjuvant chemotherapy with AC (cyclophosphamide, adriamycin), 4 cycles of 3 weekly docetaxel followed by adjuvant radiotherapy and tamoxifen for nine months. On routine blood examinations that she was found to have bi-cytopenia with incremental increase in TLC.

The patient in lieu of treatment history and bone marrow findings was diagnosed as APL, probably secondary to adjuvant therapy for breast cancer.

Alkylating agents, anthracyclines and taxanes may cause secondary malignancy including acute myeloblastic leukaemia (AML) and/or MDS. Signs of hematologic disease and/or unexpected change in haematological parameters should prompt workup for a possible secondary hematologic malignancy. The series of secondary APL are mostly clustered in patients with breast cancer in the literature. In our case the latent period between chemotherapy and appearance of symptoms is 9 months making it rarest among rare. Conclusions: A correlation between the BRCA2 mutation and the risk of hematologic malignancy can be hypothesized, as the break point on chromosome 17 in the t (15; 17) translocation is at or near the location of BRCA2.This needs further validation. Materials & Methods: All cases of AML diagnosed by bone marrow aspiration, biopsy and flowcytometry at our centre in past 3 years after approval from ethics committee. Karyotyping and AML-PCR panel were done in all patients. NPM1 and FLT3-ITD allelic ratio was done by PCR followed by fragment analysis. Result: A total of 95 AML patients with median age 54 years (18-88) were studied, comprising 61.5% males and 38.5?males. Normal Cytogenetics AML were 48/84 (57.2%) and of these, 27/48 (56.3%) had mutations on molecular analysis. Of all the 95 cases, 53/95 (55.8%) had mutations; 21/95 (17.5%) were NPM1 mutated and 13/95 (10.9%) FLT3-ITD mutated. 2/95 (2.1%) cases had both NPM1 and FLT3-ITD mutation with low AR were shifted from Intermediate to Favourable risk group of ELN2017. 7/95 (7.4%) cases with FLT3-ITD high AR or genetic variants defined in high risk group in ELN2017, were shifted from either Intermediate I or II of ELN2010 to adverse risk of ELN 2017. All the patients were treated as per the standard of care protocols based on risk stratification as per ELN2017. Conclusions: The ELN 2017 risk stratification of AML is relevant in day-to-day practice by classifying the patients and helpful in taking therapeutic decision about continuing consolidation or upfront AlloHSCT as per the risk group. The incorporation of AR in FLT3-ITD mutated patients is pivotal in shifting the patients from intermediate to favourable group, obviating the need of upfront AlloHSCT in them.

Leukemia (ETP ALL) in a Tertiatry Care Hospital in Eastern India; Study Over One Year Roy S1,BAUL S N2,MITRA S3,DOLAI T K4,DE R5,MANDAL P K6,BHATTACHARYA Shipla Roy, S N Baul,SMitra, T K Dolai, RDe, P K Mandal, SBhattacharya, AChattopadhyay, S Dutta Introduction: Early precursor T cell acute lymphoblastic leukemia (ETP ALL) is a recently recognised relatively rare acutyeleukemia with poor prognosis characterised by chemoresistance as well as limited data regarding optimal management. It's clinical characteristics, treatment and prognosis are significantly heterogenous. Here we have presented seven cases of ETP ALL admitted in our department in last 1 year. Aims & Objectives: To observe the clinical behaviour among ETP ALL treated with induction phase of BFM 2002 protocol. Materials & Methods: In this study we have observed the outcome of patients with ETP ALL who have received frontline BFM 2002 induction therapy. Out of all acute leukemia patients only seven ETP ALL patients were included. They were of 5-40 years age group who were diagnosed by bone marrow aspiration and immunophenotyping (CD1a -0, CD8-, CD5 dim and positivity for 1 or more stem cell or myeloid antigens). They have received induction therapy as per BFM 2002 ALL protocol because of poor performance status. Result: Median age was 13 years (range 5-40 years) with three female and four male patients. One patient had day 8 good prednisolone response but M3 marrow on day 15. Rest six patients had day 8 poor prednisolone response, three had M3 marrow and three had M2 marrow on day 15. Three patients achieved complete hematological remission after induction phase A. Four patients expired during induction phase. In all cases septic shock was the cause of death. Presently two patients are in consolidation phase and one patient had unnatural death during mid consolidation phase unrelated to disease. Conclusions: Our data is a largest compilation data in ETP ALL from a tertiary care hospital of eastern India. However more than 50% patients failed to complete induction. Due to rarity of ETP ALL till now no definitive chemotherapy protocol is well established. Hence BFM 2002 has not given satisfactory results for this subset of ALL. However a largest study is needed to analyse the proper therapy suitable for these patients.

Vineeta Singh, Vineeta Gupta, Priyanka Aggarwal Introduction: Acute Leukemia contributes 25-30% of all childhood cancers and among them AML comprises 20% of childhood leukemias. Although bone manifestations are common in lymphoid leukemias they are seldom seen in myeloid leukemia. We present a case of a 13 year old male with Acute myeloid leukemia (AML) with multiple bony lytic lesions with tumour lysis syndrome, acute Kidney injury, hypertension and hypercalcemia. Aims & Objectives: Our case is a humble attempt to report a rare case of Acute myeloid leukemia with bony manifestations and showcases the diagnostic as well as therapeutic challenges in managing such case. Materials & Methods: A 13 years male presented with complaints of pain at multiple joints and fever for 3 months associated with progressive paleness of the body and significant weight loss. On examination he had anemia, hypertension, bilateral knee joint swelling with hepatosplenomegaly. His lab investigations were suggestive of hyperuricemia (serum uric acid: 15 mg/dl), hyperphosphatemia (serum phosphate: 6.5 mg/dl), non-oliguric acute kidney injury (creatinine: 2.1 mg/dl) which were managed with intravenous hydration fluids, oral allopurinol and furosemide. Child also had persistent hypercalcemia (serum calcium: [ 10.5 mg/dl) which was managed with zolendronic acid and calcitonin. The skeletal survey showed multiple osteolytic lesions in both axial and appendicular skeleton. Later on diagnosed with Acute myeloid leukemia on bone marrow biopsy and managed with chemotherapy at Division of PediatricHematology Oncology Department of Pediatrics. Result: The child was managed conservatively on admission and showed clinical, hematological and radiological improvement following chemotherapy. Conclusions: Osteolytic lesions in AML is an extremely rare phenomenon but they do not confer worse outcome compared to those without bone involvement.

Inotuzumab Ozagomicin in Combination with Minihyper CVD Regimen with or Without Rituximab in Two Children with Relapsed Refractory Acute Lymphoblastic Leukemia Nivedita Dhingra, Esha Kaul, Silky Jain, Ankit Malhotra, Sachin Jain Introduction: Inotuzumabozagomicin (Ino), an antibody-drug conjugate targeting CD22 is currently approved as monotherapy for relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) above 18 years. Standard dose is 1.8 mg/m 2 for first cycle and 1.5 mg/m 2 once patient achieves complete remission (CR). Inotuzumab with modified HyperCVD (Ino-miniHyperCVD) regimen has shown high response rates in adults with R/R ALL and elderly with de novo ALL. Data on apllication of Ino in children is limited. Aims & Objectives: To report outcomes of 2 children with R/R ALL treated with Ino-miniHyperCVD regimen. Materials & Methods: Retrospective review of medical records. Result: Mini-HyperCVD (alternating cycles of Part A and B) previously described in adults was administered. Part A comprising of fractionated cyclophosphamide (150 mg/m 2 q 12 hourly for 6 doses), vincristine (1.4 mg/m 2 on day 1 and 8) and dexamethasone (20 mg/ m 2 from days 1 to 4 and days 8 to 11). Inotuzumab was given in a reduced dose of 0.6 mg/m 2 on day 2 and 0.3 mg/m 2 on day 8. Part B comprised of methotrexate 250 mg/m 2 as continuous infusion over 24 h, cytarabine 500 mg/m 2 12 hourly for 4 doses. Inotuzumab given as single infusion of 1.3 mg/m 2 on day 3. Rituximab (375 mg/m 2 ) was given for CD20 positive leukemia on days 1 and 7 in part A and days 2 and 8 in Part B. Intrathecal chemotherapy was given twice in each block. Baseline characteristics of both patients are summarised in Table- 1. P1 had primary induction failure. She became MRD negative after Part A and subsequently underwent matched-sibling donor HSCT. She remains in CR 6 months post HSCT. P2 had previously received UKALL-R3 protocol followed by rituximab and 2 cycles of blinatumomab. He had partial response after Part A and achieved MRD negative CR after Part B. Currently undergoing HSCT. None of the patients developed veno-occlusive disease (VOD). P2 developed neutropenic sepsis which resolved with count recovery. Conclusions: Ino-miniHyperCVD regimen was safe and efficacious even in a heavily pre-treated child with prior exposure to blinatumomab. The reduced dose of inotuzumab makes it cost-effective in resource-constraint settings and possibly decreases the risk of VOD.

Clinical Profile and the Outcome of Induction in Acute Proyelocytic Leukemia: A Single Center Experience Santosh Govind Rathod, Afaq Ahmad Khan, Reshmaroshan, Sajadahmed Geelani, Javid Rasoolbhat Introduction: Acute PromyelocyticLeukemia is a curable malignancy, but it carries a high early mortality rate of around 10-20% in various studies. Here we are reporting clinical profile and outcome of induction in acute promyelocyticleukemia in our center. Aims & Objectives: Here we are reporting clinical profile and outcome of induction in acute promyelocyticleukemia in our center. Materials & Methods: This was an observational, retrospective study conducted in the department of clinical hematology at Shere-i-Kashmir institute of medical sciences, Sringar. All patients with confirmed APL from January 2018 to August 2021included. Patients were treated as per protocol with ATRA along with arsenic trioxide in low risk and anthracycline in high-risk patients.

Result: A total of 43 patients were included, of which 39 patients were adults and 4 were paediatric. Median age of presentation was 29 years (range 2-58 years). Male to female ratio was 1:2. Fever was the most common presenting symptom seen in 22(51%) patients followed by bleeding gums in 16(37.2%), ecchymosis in 13(30.23%), generalised weakness in 14(32.3%), epistaxis in 8(18.60%) and type 1 respiratory failure in 1(2.35%) patient. Mean duration of presentation from onset of symptoms to hospital was 11 days. (Range 3-30 days) Coagulopathy observed in 26(60.46%) patients. There were 7(16.27%) patients in high-risk group and 36(83.72%) patients were in low-risk group. Complete blood count showed Mean Hb 6.8 gm% (Range 2-11.2), Mean TLC 6.02 9 109/l (Range 0.6-30), Mean platelet 48 9 109/l (Range 02-163). There were 3(6.97%) deaths during induction. Central nervous system bleeding was cause of death in 2(4.65%) (n = 2) and septic shock in 1 (2.35%) patient. All three deaths were in low-risk group. Differentiation syndrome observed in 20 (46.51%) patients with median duration 8 days (range 6-12 days). Median duration of induction was 44 days (range 42-56 days). Overall, 40(93.02%) patients were in remission at the end of induction.

Conclusions: In this present study over all induction mortality is 3(6.97%). Early suspicion on the basis of clinical sign and symptomology along with use of arsenic trioxide, ATRA and aggressive blood support in acute promyelocyticleukemia prevents the induction related mortality.

Occult B12 Deficiency in Indians Aman Setiya, Anil Kem, Subhash Jha, Yatish Introduction: Over the past decades many advances have taken place in diagnosis and management of anemias. B12 deficiency is a common type of anemia in strict vegetarians however it is not uncommon in non-vegetarians. Aims & Objectives: The present study was conducted with the objective of assessing the status of B12 deficiency in Indian population in western UP and evaluate the progression of symptoms. Materials & Methods: A cross-sectional study was carried out among 100 patients with anemia with MCV [ 100 aged 25-45 year old presenting at Saraswathi institute of medical sciences, Hapur. Result: It was observed that out of 100 patients (60 vegetarian, 40 non-vegetarian), whose MCV values were beyond 100FL-Vegetarians-Total 60 patients (40 were asymptomatic, 20 with mild to moderate symptoms like fatigue, weakness, numbness, claudication, etc.) Non vegetarians-Total 40 patients (35 were asymptomatic, 5 with mild to moderate symptoms). Conclusions: Vitamin B12 deficiency is a common cause of anemia in India especially in vegetarians however it is also not uncommon in non vegetarians, although many patients are asymptomatic, however there are patients with mild to moderate symptoms. So early warning signs of deficiency should be monitored carefully. Periodic monitoring and early introduction of B12 supplements can prevent many complications.

Compound Introduction: The beta thalassemia intermedia represents a clinically heterogenous disorder characterized by moderate to severe degree of anemia that doesn't require regular blood transfusion. Genetically the clinical features are the result of either one or two abnormal beta genes presenting in homozygous or compound heterozygous states with some other co-inherited beta gene mutation or other genetic modifiers that increase the synthesis of gamma globin chain.

We present a case of beta thalassemia intermedia resulting from a rare mutation in the beta globin gene and its combination with a mutation in the gamma globin gene. Materials & Methods: A 2-year-old male child presented to the outpatient department with feeding difficulties, vomiting and increasing pallor since last 8-10 months. The previous history of the child revealed repeated upper respiratory tract infections, loss of appetite and failure to thrive since the age of 4-5 months. He had been on hematinic with a suspicion of nutritional anemia following advise by a local doctor and has received one unit of blood transfusion recently. The blood sample was taken and sent for evaluation of underlying cause of anemia with hemoglobin HPLC. Result: The CBC and peripheral smear examination of the child revealed severe anemia with marked anisopoikilocytosis showing tear drop cells, target cells, numerous polychromatophils with microcytic hypochromic blood picture and nucleated RBC40-50/100 WBC and raised Hb F on HPLC. The work up of the mother showed Hb-10.7 g/ dl, RBC-5.43 million/cumm, MCV-64.3 fl, MCH-19.7 pg, Hb-HPLCrevealed HbA-83.5%, HbA2-5.4%. The work up of the father showed Hb-13.3 g/dl, RBC-5.43 million/cumm, MCV-76.6 fl, MCH-24.5 pg Hb-HPLC-HbA-70.6%, HbA2-2.7%, HbF-15.5%. The mutation analysis of the child revealed a compound heterozygous for c.46delT Codon 15[-T] in the beta globin gene and Gy Ay ????b thalassemia mutation. Conclusions: The compound heterozygosity of beta thalassemia with deletional hereditary persistence of fetal hemoglobin present with a thalassemia intermedia type phenotype and could pose a diagnostic challenge in absence of proper family screening and molecular screening.

Children with Beta Thalassemia Major: Should We Screen for Peripheral Neuropathy?

have been done on peripheral neuropathy in children with BTM.However Indian data is sparse.

Aims & Objectives: This study was conducted to determine prevalence of Peripheral Neuropathy (Clinical and Subclinical) in children with BTM and its association with factors like levels of hemoglobin, ferritin, vitamin B12 and folate, in addition to annual transfusion requirement (ATR) and iron chelators. Materials & Methods: This cross-sectional study was conducted on children admitted in Thalassemia Ward of a tertiary care teaching hospital in New Delhi, India. After a detailed history, a neurological examination focusing on peripheral neuropathy was done, then NCS (Nerve Conduction Studies) were performed on all the patients. Relevant investigations done and data from case records were noted. The correlation of peripheral neuropathy with factors like chronic anemia, ferritin levels, chelation status, ATR, deficiency of Vitamin B12 and Folate levels was studied.Age-wise cutoff values outside of 2.5 SD of normal were taken as abnormal.

Result: Hundred eligible children participated in the study out of which none had clinical features of peripheral neuropathy although 77% had abnormalities in NCS. Out of these 41% had sensory nerve changes, 40% had motor nerve changes and 7% had abnormal F responses (FIGURE 1). Significant correlation was found with chronic anemia. These children were on single or multiple iron chelators, there was significant correlation of duration of chelation with abnormal NCS, but no correlation was seen with dose of chelators.The association of abnormal NCS with ferritin level, annual transfusion requirement, deficiency of Vitamin B12 and Folate was not statistically significant. Conclusions: High prevalence of abnormalities of nerve conduction in children with BTM may suggest need for screening for peripheral neuropathy. Its association with chronic anemia warrant further research on need for more strict control on hemoglobin values to prevent peripheral neuropathy. Role of individual chelators in these nerve conduction changes require further studies.

Archita Makharia, Pradeep Lalwani, Manoj Lakhotia, Kishan Gopal Introduction: In patients presenting with microcytic anemia, bone marrow is often required for differentiation between iron deficiency anemia from anemia of chronic disease. We explored the value of reticulocyte hemoglobin (Ret Hb) and percentage microcytic RBCs (%Micro R) in the differentiation of both these conditions with bone marrow iron studies being the gold standard.

Aims & Objectives: To study correlation between RET HB, %MICRO R and bone marrow iron store in patients of iron deficiency anemia and anemia of chronic disease/ Functional iron deficiency anemia.

Overall 130 patients with iron deficiency anemia and anemia of chronic disease were recruited and they underwent detailed evaluation including RBC indices, Ret Hb, %Micro R, serum iron studies, bone marrow examination including estimation of bone marrow iron. The diagnostic accuracy of Ret Hb and %Micro in differentiation between the two conditions was determined. Result: At a cut-off value of RET HB of 27 pg/mL, the diagnosis of IDA could be made at a sensitivity of 93.4% and a specificity of 95.83%. RET HB was found to have best diagnostic efficiency (area under the curve 0.96 on ROC analysis) in the differentiation of these two conditions. MICRO R was found to be inferior to other parameters (AUC of 0.39) in the differentiation of these two conditions. A positive correlation was observed between serum ferritin level and Ret Hb.

In conclusion, Ret Hb is a non-invasive test predicts bone marrow iron store with high accuracy. Ret Hb differentiates iron deficiency anemia from anemia of chronic disease with a high accuracy rate of 96%.

Arun Mukesh R, Bharat Paliwal, Manoj Kamal, Sadik Mohammad Introduction: In India, the prevalence of anemia in general population is very common. Major researches regarding the influence of preoperative anemia on major surgeries and its postoperative outcomes were performed in western population while very few studies were done in the Indian population. Here, we evaluate the effect of preoperative anemia and the postoperative outcomes total joint replacement surgeries done in AIIMS, Jodhpur. Aims & Objectives: To find the effect of preoperative anemia on postoperative outcomes such as length of hospital stay (LOS), requirement of allogeneic blood transfusion, vasopressor requirements, oxygen therapy, surgical site infection (SSI), sepsis, thrombo-embolic events, and hospital mortality, following elective total joint arthroplasties. Materials & Methods: This prospective observational study was conducted on 116 patients of either sex, aged [ 18 years, belonging to ASA (American Society of Anesthesiologists) grades 1 and 2, who underwent elective total joint arthroplasty during a period of 1 year. Anemia was classified according to WHO definition. Demographic data and patient variables, length of hospital stay, postoperative parameters and complications were documented. Prolonged length of hospital stay was defined as more than 7 days. Patients were followed up till discharge from hospital. Result: The prevalence of anemia was 46.55% (n = 54). 38 patients (32.75%) had mild anemia and 16 patients (13.79%) had moderate anemia prior to surgery. Overall mean LOS was 7.05 ± 0.8 days. On performing univariate regression, anemia was found to be a significant risk factor of prolonged hospital stay. Anemic patients had significantly high risk of prolonged hospital stay with odds ratio of 2.399 (1.056 to 5.449). Patients with preoperative anemia had increased chance of intraoperative blood transfusion (p = 0.002), and postoperative blood transfusion (p = 0.045), required vasopressor support (p = 0.024) and oxygen supplements (p = 0.024) during perioperative periods. Conclusions: Anemia is an independent risk factor which has shown to prolong the duration of hospital stay and also predispose these patients to postoperative complications such as the requirement for allogenic blood transfusion, oxygen requirement, vasopressor support. We suggest measures to correct anemia prior to surgery.

Ashwanth SP, Jhasaketan Meher, Md Sabah Siddiqui, Vinay R. Pandit Introduction: Food adulteration is an emerging problem of concern, posing a serious public health hazard. Metanil yellow, a highly toxic non permitted, banned substance, is used widely in spices, pulses, sweets as adulterants. It causes life-threatening adverse effects in humans.

Aims & Objectives: Here we report a case of toxin (Metanil Yellow) induced hemolysis, acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI) in a healthy young male.

A 25 year old male with no comorbidity was referred to our emergency as a case of hemolytic anemia under evaluation. He had a history of sudden onset shortness of breath, one Indian J Hematol Blood Transfus episode of fever, sweating, passing cola-color urine. He was drowsy, tachypneic (RR-32/min), hypoxemic (SPO2-80% on room air). On systemic examination, he had crepitation over both lungs. Laboratory investigation showed haemoglobin-3.3 gm/dl, leukocyte count-45900/ lL, indirect hyperbilirubinemia (Total bilirubin-7.05 mg/dl, indirect bilirubin-6.35 mg/dl), serum creatinine-2.54 mg/dl, high serum lactate dehydrogenase (5436 U/L). Peripheral blood smear showed anisocytosis, fragmented red cells. Serology for malaria, dengue, and other infective pathology, was negative. Blood and urine culture was sterile. He tested negative for the sickling and ANA. G6PD test was normal. Chest X-ray showed bilateral diffuse opacities. Ultrasonography of the whole abdomen was normal. On further enquiry, he revealed consumption of food (Manchurian) adulterated with Kamdhenu (an industrial colouring agent containing Metanil Yellow) to impart colour to food in the previous night. Result: He was diagnosed as a case of toxin-induced hemolytic anemia and managed with antioxidants (Vitamin C), antibiotics, oxygen support, and other supportive measures. He recovered drastically over few days and was discharged in a stable condition. Conclusions: Nowadays, adulterating food products to improve the appearance/colour, flavour, and texture has become a malpractice to earn profit. In our case, the hemolytic crisis with multiorgan dysfunction (MODS) was probably caused by Metanil yellow, which was unintentionally used as a colouring agent. Metanil yellow interferes with cellular metabolic processes, disrupts the indigenous antioxidant system, induces free radicals, and can cause hemolysis, organ dysfunction. So detailed history and high index of suspicion are needed to identify a rare cause of hemolysis with MODS for timely.

Uma Doddabudihal, Aarti Kinikar, Naresh Sonkawade Introduction: A 11-year-old developmentally normal female child borne to non-consanguineous marriage with normal birth &family history was presented with progressive paleness for 15-20 days, intermittent jaundice 3-4 episodes since 6 months each lasting for a week,1-2 months apart, with melena, abdominal distension and cola coloured urine for 7 days. On examination child had mild icterus, pallor and massive hepatomegaly (span 17 cm) with splenomegaly (5 cm below left costal margin). Routine labs & anemia workup was done. Hemogram: Hemoglobin 6gm/dl, MCV (95 fl) higher, MCH and MCHC're normal. Peripheral blood smear: spherocytic hemolysis, anisopoikilocytosis, polychromatic cells, teardrop cells & few fragmented cells. Direct coomb's test-positive with Indirect coomb'snegative; Retic count-5%; Coagulation profile-Normal; sickling & osmotic fragility were negative with normal Hb-electrophoresis. LFTS-raised liver transaminases (2 times above normal) with normal Alkaline phosphatase; total Bilirubin levels-5 mg/dl. Serum Ceruloplasmin was normal. Ophthalmic evaluation was normal. Hepatic viral markers negative (HepB, D, E, C HIV). An autoimmune etiology was suspected. Serum IgGs elevated with strong positive ANA. Autoantibodies to liver i.e. ASMA (smooth muscle antibodies were positive) with LKM antibodies negative which was fitting into Autoimmune hepatitis type I which was confirmed by Liver biopsy suggesting effaced architecture of hepatocytes with preserved morphology, mild portal fibrosis with piecemeal necrosis with infiltration by monocytes with bile plate malformation & dilated venous radicals. She was started on steroids with Azathioprine according to standard dose resulted in clinical and laboratory remission & fallowed up every 6 monthly doing well. Autoimmune hemolytic anemia (AIHA) is very rare in childhood (incidence: 0.9-2 per 105/year), where it's primary in 37% and associated with immune disorders in 53%. Although AIHA occurs in association with various immunological disorders, an association with autoimmune hepatitis (AIH) is rarely reported. We report a rare case of AIHA associated with AHA. Conclusions: Autoimmune hepatitis is a rare disorder with unspecified cause. Undiagnosed disease has very poor outcomes; it's readily treatable with timely immunosuppressive therapy. Important positive features include female gender, primary elevation of transaminases, normal ALP, elevated IgGs; presence of autoantibodies (antinuclear, anti-smooth muscle) with characteristic histologic findings supported the diagnosis.

A Rare Cause of Anemia in Infancy Aakash Chozakade, Reashma Roshan, Afaq Khan, Syed Sajad Geelani, Javid Rasool Introduction: Anemia in infancy has multitude of causes. Consideration is given to heritable cause for anemia in the evaluation. Most of these are practically difficult to treat or require haematopoietic transplantation for cure. Transcobalamine deficiency is a very rare disorder and considering it in the differential of anemia of infancy is important.

Aims & Objectives: A male baby, born to third degree consanguineous marriage presented for the first time at 22 months of age with refusal of feeds and on investigation was found to have bicytopenia-severe anemia with thrombocytopenia. Infections were ruled out. Hb electrophoresis and iron profile were normal. Bone marrow examination done, which showed megaloblastoid erythroid hyperplasia. Treated with transfusion support and dual deficiency treatment and discharged. Patient would present every 4-5 months with similar complaints with investigation showing macrocytic anemia and thrombocytopenia. Materials & Methods: Fanconi's anemia, pediatric MDS, celiac disease and other auto immune work up was normal. Genetic testing revealed a homozygous mutation at exon 7 of TCN2 gene, which is associated with transcobalamine II deficiency. Result: Patient was treated with monthly vitamin b 12 supplementation with improvement in lab parameters and clinical profile. Patient is being followed up for the past 1 year and doing well. Key words-infantile anemia, trasncobalamine deficiency Conclusions: Even though transcobalamine deficiency is a rare autosomal recessive disease (\ 1:1,000,000), considering this entity in the evaluation of infantile macrocytic anemia is highlighted since a simple treatment results in complete resolution of anemia, which is important for the normal neurodevelopment and growth in the infant. Introduction: India has a huge burden of b thalassemia patients with an estimated 100,000 patients. Of the 10,000 to 12,000 thalassemia babies born each year in India, very few are adequately managed even in urban areas. Aims & Objectives: To conduct a cross-sectional audit of Thalassemia Major patients from seven centers in North India by collecting information about blood transfusion, iron chelation, T2* MRI, and hematopoietic stem cell transplantation practices. Materials & Methods: A total of 129 Thalassemia Major patients above 9 years of age from seven centers in North India were included.113 patients were from 5 government hospitals (GH1-5) and 16 patients were from 2 private hospitals (PH1-2). The study was conducted on 4th & 5th May 2019 as part of the Fast MR study conducted in the Cardiac-Radiology department of AIIMS, Delhi. Patients completed a pre-set questionnaire regarding practices concerning blood transfusion, iron chelation therapy, T2 * MRI, and HSCT. Result: None of the patients at any of the centers had pre-transfusion hemoglobin between 9.5-10.5 g/dl. Access to leucodepletion at source was available at GH1, GH5, PH1. At other centers, 51% used leukodepletion filters. To 15% of the patients, leukodepletion was not available. Free chelation therapy was available to 74 (57.4%) patients and was available at GH1-4. DFP (Deferiprone) with DFX was the preferred combination chelation therapy being used in 37.5% versus DFP with DFO (Desferrioxamine) being used in 3.9% of patients. Only GH5 had availability of T2 * MRI scan and the rest were dependent on private diagnostics for the same. 102 (79.1%) had normal cardiac T2* MRI, 27(20.9%) had values less than 20 ms. Liver R2* MRI was normal in 2 (1.6%), moderate to severe iron loading (\ 4.5 ms) was present in 82.1%. HSCT services are not available at GH1-4 & PH2. A total of 57 (44.2%) were not counseled regarding HSCT. In 52 patients, HLA matching could not be done. Conclusions: Developing an integrated closed referral system among centers and strict implementation of subsidized rates for tests is crucial to overcome disparities in Thalassemia patient care.

Subhah Chandra Jha, Bibhuti Bhusan Prasad Introduction: Sickle cell disease are inherited disorders characterized by an abnormality in the structure of haemoglobin. It is the most common hemoglobinopathy, accounting for about 70% of the world's major haemoglobinopathies. It comprises sickle cell anaemia and other compound heterozygous state such as haemoglobin SC disease, Sb-thalassaemia, and SDPunjab. About 5% of the world's populations are carriers of genes responsible for haemoglobinopathies and about 300,000 children are born annually with haemoglobin disorders. Due to the high prevalence of sickle cell trait at 20-30%, the frequency of sickle cell anaemia in Nigeria is about 20 per 1000 births resulting in about 150,000 babies being born each year with the disorder. This makes Nigeria the country with the largest burden of sickle cell disease globally with 4.1% of the population being affected.The prevalence of heterozygotes in India varies from 1 to 40% [7, 8] . Current methods used by laboratories are high performance liquid chromatography (HPLC), capillary electrophoresis, globin chain electrophoresis and DNA analysis/protein analysis. Evaluation of the peripheral blood smear, as well as correlation with the results of a complete blood count (CBC) are very important as many of the clinically significant haemoglobin disorders show characteristic peripheral blood findings, and are often co-inherited. This present study evaluated the high performance liquid chromatographic patterns and red cell indices of sickle cell disease patients to determine the coinheritance of other haemoglobin (Hb) variants and b-thalassaemia traits in SCD patients in Bihar. Aims & Objectives: Sickle cell disease is commonly seen in rural population of western part of India. It is one of the common causes of recurrent hospitalization, morbidity and mortality in paediatric population. As there are limited studies addressing the pattern of sickle cell disease amongst paediatric population in Bihar, This study was taken up to evaluate the clinic-haematological prole of paediatric population with sickle cell in tertiary health centres.s Materials & Methods: It was a retrospective observational study. Data were retrieved from haemato-pathology departments of tertiary care centres of Bihar. Data of children diagnosed with sickle cell disease from January 2019 to January 2021 were collected and analyzed to assess the clinical, haematological and HPLC profile at the time of diagnosis. Result: Male and female ratio was 2:1 and average age was 10.6 year, minimum age was 7 year and maximum age was 20 year. Cases with low MCV, MCH were subjected to HPLC to conrm different types of hemoglobinopathies. Majority of total 10 cases were noted carrying Sb?/Sb0 (45.71%) trait and HbAS (20%). Tables 1 and 2 represented the HPLC and haematological values in 10 samples. General clinical symptoms and signs noted in the patients with various forms of hemoglobinopathies were pallor, weakness, fatigue, abdominal pain, joint pain, fever, jaundice, poor appetite and chest pain [ Table 3 ]. Microcytosis, hypochromia and nucleated RBC's were detected in various haemoglobinopathies but in present study microcytosis seen maximum in S/b0, where as hyperchromasia and nucleated RBC's maximum in SS, S/b? and S/b0 [ Fig. 10 ]. Hemoglobin HPLC of these cases revealed presence of the average HbS values 87.46% in SS followed by 70.45% in S/HPFH, 57.17% in S/b?, 49% in S/b0 and 23.4% in S/a. Similarly average HbF values were highest in S/HPFH (24.63%) and lowest in S/a (0.6%). Average value of HbA was highest in S/a (69.2%) and lowest in S/HPFH (1.56%). The value of HbA2 was highest in S/b? (4.19%) followed by AS (3.32%), S/a (2.73%), S/b0 (2.6%) and SS (1.26%) respectively [Tables 1 & 2] . In two patients,HPLC ndings were affected due to post transfusion sampling.The clinical symptoms were moderate to severe in SS, S/HPFH and S/b0 followed by mild to moderate in S/a and S/b?. The common clinical features were pallor, pain, splenomegaly and one patie. Conclusions: At the time of diagnosis vasoocclusive crisis and generalized bodyache were the most common manifestations in patients with sickle cell disease while haematological picture was suggestive of microcytic hypochromic moderate anemia. All cases were conrmed with HPLC.There was a positive correlation between age at presentation and severity of anemia at the time of diagnosis.

Patients with Megaloblastic Anemia Sweety Kumari, Kaniyappan, Richa Gupta, Ashish Goel, Mrinalini Kotru Introduction: Increasing elderly population has lead to rise in various haematological conditions among them. HSCs have been implicated in many of these disorders, however exact changes in HSCs with age is largely unknown. Most of what is known about HSCs is based on murine studies. Changes in human HSCs with age is incompletely characterised, with very little literature available. Megaloblastic anemia is nutritional anemia with maturation defect instead of stem cell defect. Hence changes in HSCs with aging can be studied in megaloblastic background to homogenise both elderly and adult population as well as minimise confounding factors. Aims & Objectives: To study and compare Cd34 ? HSCs in bone marrow biopsy by immunohistochemistry in elderly ([ 60 yr) with megaloblastic anemia with younger (18-40 yr) adult with megaloblastic anemia. Materials & Methods: Bone marrow biopsy slides of elderly & younger patients with megaloblastic anemia were stained with H&E and CD34 immunostain. The Percentage of CD34 ? HSCs was calculated by counting minimum 500 nucleated cells in the cellular area and expressed in percentage.

The study included 30 young and 31 elderly patients. The mean age among the young patients was 25.8 years (range, 18-40 years). The M:F ratio was 2:1. There were 21 hypercellular marrows and the rest were normocellular. The mean age among the elderly patients was 66.6 years (Range, 60-86 years). The M:F ratio was 2.3:1. There were 26 hypercellular marrows and the rest were normocellular. The overall mean percentage of CD34 positive HSCs was 1.09 ± 0.64% (range, 0-3.61%) in young patients, whereas it was 0.78 ± 0.52% (range, 0-2.4%) in elderly patients. The CD34 expression in young and elderly showed significant difference (p = 0.008) on performing Mann-Whitney test. Conclusions: Our Results revealed that aging might significantly alter the proportion of CD34 ? HSCs in the bone marrow of megaloblastic anemia. This indirectly indicates that the quantitative stem cell defect might contribute to the hematological conditions in the elderly.

Alka Yadav, Jyoti Thakur Introduction: Background: Pulmonary dysfunction is one of the least understood complications in b thalassemia.

Aims & Objectives: This study was aimed to identify the pattern of lung functions in repeatedly transfused thalassemia major children from North India and correlation of their pulmonary function tests (PFTs) with serum ferritin. Materials & Methods: Materials and Methods: A hospital-based cross-sectional descriptive study done from Jan 2020 to June 2021. Inclusion criteria: Children with confirmed diagnosis of beta-thalassemia major in the age group of 5-15 years were included in the study. Exclusion criteria: Already diagnosed cases of pulmonary dysfunctions, congenital or acquired heart diseases were excluded from the study. Demographic details, pre-transfusion hemoglobin value, serum ferritin levels, chelation details and transfusion requirement were analyzed for all enrolled children. PFT was done within 24 h of BT using spirometer (Helios-401). Statistical analysis was done using SPSS (Version22). Result: Results: Among the 60 subjects studied, 40 were boys, and 20 were girls. Mean serum ferritin levels of the group was 2610.82 ± 679.51 ng/mL. The pulmonary dysfunction was present in 33(55.5%), but none had clinical symptoms. The pulmonary dysfunction observed was restrictive 31(51.7%), obstructive 1(1.7%), and combined 1(1.7%). The PFT abnormalities observed were mild in 16(51.6%), moderate in 10(32.3%), moderate-severe in 1(3.2%) and severe in 4(12.9%) patients in terms of reduced forced vital capacity (FVC) % of predicted, a reduced forced expiratory volume in the 1st second (FEV1%), FEV1/FVC and a reduced FEF 25-75%. Risk factors such as, age, height, pre-transfusion hemoglobin and duration of chelation ([ 5 years) were significantly associated with pulmonary dysfunction (P \ 0 [ 2500 ng/ml). Conclusions: Restrictive pattern was the most common abnormality, and it did not correlate with serum ferritin. Pulmonary function monitoring would help in identifying children with significant morbidity and help in initiating an early intervention to improve the quality of life. Keywords: Ferritin, Pulmonary function, Thalassemia.

Ismetara Begam, Deepika Gupta, Ambar Khalwadekar, Abhishek Purohit, Manish Chaturvedy Introduction: Renal osteodystrophy assimilates to the histopathological changes of bone lesions commonly seen in patients with chronic kidney disease due to mineral and bone metabolism disorder. Three different histological forms have been described (1) High turnover-predominant hyperparathyroid (osteitis fibrosa cystica), (2) low-turnover uremic osteodystrophy with low or normal PTH levels (osteomalacic and adynamic renal bone disease) and (3) (11.7-61 .1 pg/mL), Uric acid: 7.7 mg/ dL(2.6-6.0 mg/dL), Alkaline Phosphatase: 1203 IU/L(30-120 IU/L). Serum iron studies and serum ferritin were within normal limits. Ultrasound abdomen revealed bilateral renal parenchymal disease. In view of persistent pancytopenia, bone marrow examination was done. Result: Complete hemogram revealed pancytopenia (Haemoglobin: 3.5 g/dL, total leucocyte count: 3430/lL and platelet count: 47,000/ lL) suggestive of bone marrow failure. Bone marrow aspirate smears were grossly haemodiluted and aparticulate. Bone marrow biopsy revealed marked thickening of bony trabeculae with extensive bone formation and remodeling. Scalloping of trabeculae and osteoblasts lining the trabecular borders were noted. Intertrabecular marrow spaces were narrowed and were replaced by areas of fibrosis in few spaces. Rest of the spaces revealed cellular marrow with normal marrow components. Reticulin stained revealed diffuse and dense increase in reticulin fibers with many intersections. The overall features were consistent with renal osteodystrophy, high turnover type. Conclusions: Anaemia commonly occurs in CKD patients, but pancytopenia is relatively rare. Also bone disease occurs as a consequence of CKD, which becomes more severe as the disease progresses. Both abnormalities can be detected easily by bone marrow biopsy which helps in guiding the proper management.

Pappu Kumar, Kailash Kumar Gupta, Nilesh Kumar, Farid Alam, Shivam Sharma, Nomulla Gowtham Reddy Introduction: Auto immune haemolytic anemia (AIHA) is characterise by destruction of Rbcs by immune mediate mechanisms which manifest as positive Coombs test. AIHA is classified as warm (65%), cold (30%) and mixed (5%) type on the basis of thermal amplitude of autoantibody. Mix type is usually associated with sle or lymphoma. Aims & Objectives: Here we present a rare case of mixed type AIHA related to Epstein bar virus (EBV).

A 26 year old female presented with fever and genralised weakness from 15 days. There is no history of cough, burning micturation, joint pain, rash, any bleeding manisfestation and drug intake.

On clinical examination there was severe pallor with icterus with hepatosplenomegaly. On investigation hemoglobin was 5 gm/dl and general blood picture showed spherocytes and agglutination with corrected retic count of 6%. serum LDH was 2600. Total bilirubin was 5 mg/dl and indirect 3.5 mg/dl. Direct and indirect Coombs test were positive and DCT profile showed high titers of warm and cold antibody. Serum ANA was negative, S.IGM was positive for EBV so diagnosis was made. After giving methylprednisolon patient improved. Result: Mixed type AIHA associated with EBV infection is a rare presentation. It shows good response to steroids. Conclusions: Epstein-Bar virus infection should be consider as a differential diagnosis of any haemolytic anemia. Treatment with intravenous steroid is beneficial.

Sanjay Kumar Pandey, Sweta Pandey,.Sudhakar Dwivedi, Naresh Bajaj,.Vinit Shah, Dinesh Pandey Introduction: The genetic forms of iron deficiency anemia (IDA) are associated with deficient iron absorption. The TMPRSS6 gene that interferes with hepcidin production led to the discovery of a severe form of iron deficiency anaemia due to mutations in TMPRSS6 genes. SLC40A1 gene mutation may play the useful clinical outcomes in the severity of the disease due to their varied role in the iron metabolism. Aims & Objectives: Aim of the study is to investigate the gene mutation of TMPRSS6 and SLC40A1 gene and their pathophysiological effect on the phenotype of iron deficiency anemias. Our objective was to identify TMPRSS6 & SLC40A1 gene mutation in iron deficiency anemia patients and relate genotypes to various clinical and laboratory variables of iron deficiency anemia patients. Materials & Methods: All IDA patients were diagnosed by iron profiling and hemogram analysis. Serum ferritin and CRP analysis were done by ELISA method while ESR analysis was done according to Wintrobe method. Hemogram analysis was done by an autoanalyzer machine. Molecular analysis of DMT1, SLC40A1, and TMPRSS6 gene was done by PCR-RFLP Method. A t-test was applied to compare the mean of values and p value [. Result: A total 50 IDA patient samples were collected from SGMH hospital, Shyam Shah Medical College, Rewa, Madhya Pradesh. Out of them 15 were male (mean age = 19.4 ± 8.1Yrs) and 35 were female (mean age of 21.5 ± 9.7). Total 50 healthy age & sex-matched control samples (15 male and 35 female with a mean age of 18.3 ± 6.4 and 19.2 ± 7.9 Yrs respectively) were collected and compared with the investigation value of patients. Among the patients, 7 were heterozygous and 2 were homozygous while controls were presented 2 heterozygous while none of homozygous identified in control for TMPRSS6 (rs855791C [ T) genotype. Five heterozygous and 01 homozygous were identified in the case while 1 control was presented heterozygous and none homozygous condition for SLC40A1 (R178G) genotype. We reported the significant elevation of serum ferritin and hemoglobin level in TMPRSS6 (rs855791C [ T) and SLC40A1 (R178G) genotype while the decreased level of ESR and CRP was observed in both mutant genotypes. TIBC Level and % transferrin saturation level was increased in both mutant genotype and p values were statistically significant. Conclusions: Data of this research showed the TMPRSS6 (rs855791C [ T) & SLC40A1(R178G) mutation genotype plays a key role as predators of IDA. It can be used in baseline investigation and treatment decisions. It may act as the predator of disease severity. The presence of modifier genes that modulate the disease severity, can be used as diagnostic tools of Iron deficiency anemia and suggested that the iron homeostasis abnormalities are caused by functional loss due to the above mutations.

Gopinathan Mathiyazhagan, Archit Pandaripande, Faheema Hasan, Anshul Gupta, Rajesh Kashyap Introduction: Spondyloenchondrodyplasia with immune dysregulation (SPENCDI) is an immuno-osseous dysplasia with distinctive skeletal abnormalities, variable immune and neurological manifestations commonly in the form of autoimmune cytopenias, seizures and spasticity. It is caused by biallelic mutations of ACP-5 gene which encodes for tartrate resistant acid phosphatase (TRAP) protein.

Aims & Objectives: We hereby report the course of a 7 year old male child of SPENCDI with novel mutation in ACP-5 and distinctive clinical features.

The index case was born to non-consanguineous parents as term, appropriate for gestational age with insignificant natal history. He was noted to have global developmental delay with gradually increasing tone of bilateral lower limbs and varus deformity of both feet noted by parents since 2 years. There was no dysmorphism, neurocutaneous markers, audio-visual abnormalities or occult spinal dysraphism. He seeked attention of a hematologist since 3 years of age in view of repeated episodes of autoimmune hemolytic anemia (AIHA) due to mixed type antibodies and remained refractory to steroids, mycophenolate, azathioprine and rituximab therapy. He also started to have generalised tonic-clonic seizures since 6 years of age which was responsive to dual anti-epileptics. Result: In view of early onset hemolysis viral screen, immunoglobulin profile, T cell subset analysis, ANA and ds-DNA was done which was negative. TORCH screen and thyroid profile was normal. MRI brain revealed 14 mm defect in cribriform plate of ethmoid with CSF herniation though parenchyma and myelination pattern was normal. Skeletal survey platyspondyly of dorsolumbar vertebra with enchancing soft tissue enchondromal lesions and stippling calcification in metaphysis of forearm bones reflecting abnormal calcification. Considering the constellation of symptoms, genetic analysis was sent which revealed a novel homozygous deleterious mutation in exon-6 of ACP-5 gene (c.608C [ A). The resultant deficiency of TRAP leads to osteopontin hyperphosphorylation disturbing balance of osteoclast differentiation, type-1 interferon regulation by dendritic cells. His AIHA finally responded to addition of sirolimus at 5 years of age and remains transfusion independent for past 1 year 8 months. He was encouraged to continue active limb mobilisation and occupational therapy. Conclusions: Early onset AIHA along with distinctive skeletal/neurological abnormalities warrants immunological and genetic workup. Sirolimus can be a promising option in such early onset refractory AIHA in children and needs to be validated in larger cohorts.

Kusha Sharma, Priti Chatterjee, Nupur Parakh, Sunita Sharma, Varinder Singh

Introduction: Anaemia coexisting with Gaucher disease (GD) is often associated with non-haemolytic processes. Few cases of GD with autoimmune haemolytic anaemia have been reported. However, literature on GD with concomitant non-immune haemolytic anaemia is very scarce.

To study the clinico-haematological features of Glucose-6-phosphate dehydrogenase (G6PD) deficiency with co-inheritance of Gaucher disease.

Materials & Methods: A 1.5 year old male child presented in 2018 with complaints of palpable mass in left upper abdomen, fever, cough and vomiting. There was no history of bleeding manifestation. On examination, he had pallor, hepatosplenomegaly of 2 cm & 8 cm below costal margin respectively. A clinical diagnosis of haemolytic anaemia was suspected. Result: Complete blood count revealed Hb-6.7 g/dl, TLC-8.9 9 10 3 / ll, Platelet count-180 9 10 3 /ll. Peripheral smear showed predominantly microcytic hypochromic anaemia with moderate degree of anisocytosis, many nucleated red blood cells, few schistocytes, occasional bite cells, polychromatophils and corrected reticulocyte count 7.89%. S. Bilirubin was 1.1 mg/dl. Haematological work up revealed negative results for direct Coombs'test, osmotic fragility test and sickling test. Hb High Performance Liquid Chromatography (HPLC) of the child and his parents was within normal limit. Glucose-6-phosphate dehydrogenase was deficient with level of 39 units/trillion RBC, normal 146-376. A diagnosis of G6PD deficiency was made and he was transfused intermittently. He was on regular follow up during which his blood counts revealed persistent anaemia, thrombocytopenia and increasing splenic size. In view of this, bone marrow was performed to exclude myelofibrosis. Aspirate smears were cellular and showed normoblastic erythroid hyperplasia. Numerous large histiocytes with basophilic fibrillary cytoplasm exhibiting ''crumpled tissue paper'' appearance were seen. Similar findings were seen on bone marrow trephine biopsy. Genetic testing revealed pathogenic variations in the GBA gene. Beta glucosidase enzyme levels were low while chitotriosidase was raised (1109.19 nmol/hr/ml). A final diagnosis of G6PD deficiency with GD was made. Conclusions: The present case emphasizes the importance of investigating other conditions which remain unexplained by the primary pathology like in our case persistent thrombocytopenia prompted work up for GD. This knowledge can be invaluable for clinicians to help guide their treatment plan and manage these patients effectively.

Lenin Thomas, Sasidharan P K Introduction: Vitamin B12 deficiency is very common in the general population of India. Subclinical B12 deficiency could be easily missed in clinical practice, as the symptoms are vague and numerous and are often overlooked or ignored due to lack of awareness. Early B12 deficiency can be identified by studying the dietary habits of the patients, because the root cause of nutritional deficiencies lies in their poor dietary habits, about which they are not aware of. It will be a good clinical practice to identify the deficiency early and advice on balanced diet which in the long run would bring about a social change.

Aims & Objectives: To identify the common presentations of B12 deficiency, to make a strong clinical suspicion of B12 deficiency based on the pitfalls in dietary habits, to initiate early treatment, to assess the response to treatment in patients with established B12 deficiency and to prevent recurrence. Materials & Methods: This was a prospective study of 203 patients with clinical and hematological evidence of B12 deficiency who attended the outpatient department of PVS Hospital Calicut. The patients were evaluated for their symptoms, dietary practices, physical signs and laboratory tests including Vitamin B12 levels.

Result: Fatigue was the most common symptom, seen in 65% of patient's and was apparently due to anemia suggesting that most common clinical presentation can still be hematological. Anorexia was the next common and was seen in 57% of patients, which could have been multifactorial including gastric mucosal atrophy. Skin hyperpigmentation was seen in 40% of patients. Pallor was present in 70% of patients and Romberg's sign was present in 71% of patients. Evidence suggestive of peripheral neuropathy was seen in 25% and psychiatric manifestations including irritability, depression, memory disturbances were seen in 23% of patients. Neuropsychiatric manifestations were seen independent of any hematological manifestations in B12 deficiency. B12 assay showed low levels in 65% of patients only. Majority (67%) of the study group with B12 deficiency had poor intake of fruits and vegetables too and 52% of them had deficient meat or other protein intake. Conclusions: B12 deficiency can present with any of the numerous manifestations affecting hematopoiesis, skin & mucosa and the entire nervous system, including mental functions. Overt B12 deficiency with classical signs and symptoms can be picked up easily, but subclinical cases are easily missed. All patients will not present with classical hematological or neurological manifestations. The key is to suspect the deficiency by remembering the most common symptoms and their correlation with the dietary habits. Since the awareness and practice of a balanced diet is very poor in our society, B12 deficiency can be seen very commonly in clinical practice but is easily overlooked unless we look for it. We miss them because the 'eyes will not see what the mind doesn't know'.

Ratneev Kaur, Neetu Rani, Jasbir Kaur Hira, Sanjeev Chhabra, Pankaj Malhotra, Amita Trehan, Prashant Sharma, Reena Das Introduction: Thalassemias comprise different forms which include b-, aand db-thalassemia. Inappropriately higher levels of fetal hemoglobin in adult life can be encountered in the conditions such as Hereditary persistence of fetal hemoglobin (HPFH) and db-thalassemia. The db-thalassemia and HPFH are consequence of the large deletions engaging part or complete dand b-genes deletion and other regions of b-globin gene cluster. In addition, variants in Krupple like Factor 1 (KLF1) have been known to have an indirect role in causing high HbF levels in adults. Aims & Objectives: To analyse the molecular spectrum of eight common large deletions of b-globin gene cluster and genetic variants of KLF1 in HPFH and db-thalassemia cases.

The present retro-prospective study comprised a total of 88 cases from the year 1996 to 2020 with dbthalassemia and HPFH which were mined from the data repository of the Department of Hematology, PGIMER, Chandigarh. The hematological indices along with hemoglobin profiles were determined for all the cases. The molecular screening for detecting the eight common large deletions/rearrangements (HPFH-3, HPFH-9 GcAc(db)0, HPFH-10 Gc(Acdb)0, 32.6 kb deletion GcAc(db)0, Asian-Indian inversion deletion Gc(Acdb)0, Corfu deletion (d0b?), Chinese deletion Gc(Acdb)0 and 49.3 kb deletion) was done by the GAP-PCR. The cases that were negative for above mentioned deletions were analysed for presence of genetic variants in KLF1 by Sanger sequencing. Result: The hematological data including HbF% for the cases are illustrated in Table 1 . The most prevalent heterozygous deletion detected was the Asian-Indian inversion deletion found in 50% (n = 44) of the cases, followed by HPFH-3 deletion found in 11.3% (n = 10) cases. The 32.6 kb deletion was found in two members of the family and other two unrelated cases (4.5%). The 49.3 kb deletion was observed in four individuals (4.5%). The HPFH-9 deletion was determined in four members of the family. The KLF1 screening revealed probably damaging heterozygous variant, c.901C [ T (p.Arg301Cys) in two family members and two unrelated individuals. After screening, 20.4% (n = 18) of the cases remained uncharacterized. Conclusions: The study highlights the molecular spectrum of cases showing high HbF. This strategy could determine molecular characterization of 79.6% of the cases. Additional deletions may likely be present among the unsolved cases. Table 1 : Hematological data (mean ± standard deviation) representation of cases and statistical analysis of distribution using one-way ANOVA in different groups. Introduction: Patients who undergo surgical resection often are anaemic and requires a blood transfusion. The main reason for anaemia seen in a patient with colorectal cancer is mainly due to the blood loss from the bowel or bleeding per rectum leading to deficiency in iron. The anaemia could be one of the signs of colorectal cancer or maybe the side effect due to the regime of FOLFOX treatment.

Aims & Objectives: The study aims to investigate the relationship between histological findings and haematological parameters in colorectal cancer patients of the M.P. population, India.

The Haematological and histopathological profiles were determined of colorectal cancer patients admitted to the Department of Surgery and Cancer ward of Sanjay Gandhi Hospital Rewa, M.P., India. The patients were followed up to correlate the symptoms of bowel cancer, blood transfusion, and preoperative anemia.

Result: A study on 22 patients with colorectal cancer, among which 15 were male of the mean age (age ± SD) 51.66 ± 15.94 years and 7 females of 62.42 ± 9.25 years. The haemoglobin level, mean corpuscular volume (MCV), mean cell haemoglobin concentration (MCHC) and tumour site, and side were determined. A haemoglobin level less than 10 g/dl was the considered criterion for anaemia, among these 31% of the men and 13% of women met this cut-off with a mean of (10.64 ± 1.66) and (10.67 ± 1.57) respectively. The anaemia type was considered according to erythrocyte MCV values, where 27% of patients with microcytic anaemia were found followed by normocytic 68% and only a single case of macrocytic anaemia. Of which the mean MCV was (82.05 ± 7.81). However, the deficiency of iron is the main cause of anaemia and hence, MCHC of 45% have shown iron deficiency indicating hypochromic microcytic anaemia. Microcytic anaemia is also found to be associated with the right-sided proximal colon, comprising ascending colon and caecum. Moreover, the older patients presented low haemoglobin content and proximal location of the tumour. Conclusions: It is common to see colorectal cancer patients be anaemic and needs a blood transfusion. Microcytic anaemia is commonly found in proximal colon cancer patients. The anaemia in colorectal cancer patients is most recurrently normocytic followed by microcytic and less of macrocytic.

Introduction: Evan's syndrome is an autoimmune entity comprising of autoimmune haemolytic anemia and immune thrombocytopenia, with or without neutropenia. The autoimmune haemolytic anemia component is warm AIHA, in which IgG antibodies react with red blood cell surface antigens at body temperature. Aims & Objectives: A case report of a 40 year old diagnosed as Evan's syndrome.

A 40 year old female, with no comorbidities, presented with complaints of exertional breathlessness for 2 months, which was associated with pedal edema and palpitations. On examination, patient was pale, icteric with bilateral pitting pedal edema. Patient gave history of blood transfusion reaction 2 weeks back. Hb-6.6, MCV-126.9, Total count-6,270, Platelets 0.72, Peripheral Smearmacrocytes, hypersegmented neutrophils, Reticulocyte count-6%, Vit B12 levels were high as patient was treated at outside hospital. LDH-419, Direct Coomb's test-positive, ANA positive 1:100, speckled pattern. Ds DNA-negative, LIA was done-positive for RP 11, . Red cell agglutination seen, and diagnosis of Evan's syndrome was made. Rheumatology opinion was sought and APLA profile done-lupus anticoagulant antibodies -negative, anti cardiolipin antibodies IgG and IgM-negative. Hematology opinion was sought. Result: Inj Methylprednisolone 1 g IV was given for 5 days. At the time of discharge, Hb was 8.8 and discharged with oral steroids. Conclusions: Diagnosis and management of Evan's syndrome is a challenge, as many conditions mimic the same. Management involves steroids, immunoglobulins and immunomodulators. Course of the illness is grave, and has worse prognosis in comparison to AIHA and Conclusions: We found that serum hepcidin levels were lower in Children with iron deficiency anemia which increased following treatment with iron but it was insignificant thus serum hepcidin levels is not useful for estimating response to oral iron therapy.

Age Group?

Yasmeen Singh, Siyaram Didel, Abhishek Purohit

Introduction: Megaloblastic transformation of erythroid precursors in the bone marrow is the morphological hallmark of megaloblastic anaemia. Deranged cellular DNA synthesis results in characteristic finely stippled lacy pattern of nuclear chromatin. The term masked megaloblastosis is reserved for conditions in which true cobalamin or folate deficiency with anaemia is not accompanied by classic findings of megaloblastosis in the peripheral blood and bone marrow. Vitamin B12 and folic acid deficiency remain the leading cause of megaloblastic anaemia. However, other causes of megaloblastosis include drugs (antineoplastic drugs such as hydroxyurea or immunosuppressants) that interfere with DNA synthesis and rare metabolic disorders such as hereditary orotic aciduria.

Aims & Objectives: The aim of present study is to know the prevalence as well as the causes of megaloblastosis in paediatric age group.

Materials & Methods: This retrospective study was conducted over a period of three and a half years (Jan 2018-June 2021) in the department of Pathology at AIIMS, Jodhpur. Inclusion criteria considered were paediatric age group (age less than and equal to 18 years) with mean corpuscular volume (MCV) of 90 fl and/or bone marrow showing evidence of megaloblastosis. A total of 64 cases were selected for the study and demographic as well as clinical details were retrieved from the hospital information system. Result: Majority of the cases showed MCV values between 91-100 fl (59.3%), followed by [ 100 fl in 18 cases (28.12%) and 7 cases (10.9%) each having MCV between 81-90 fl and \ 80 fl respectively. The most common cause of megaloblastosis was malignancy (48.4%), of which hematolymphoid malignancies were the commonest followed by solid organ malignancies. Other causes include pancytopenia, infections, anaemia with easy fatigability, haemolytic anemia, aplastic anaemia, haemophagocytosis, Langerhans cell histiocytosis and nutritional deficiency. No significant clinical details were available in five cases but erythroid prominence was noted on bone marrow examination.

Conclusions: Megaloblastosis doesn't always mean vitamin B12 and folic acid deficiency, it can also be seen in several other conditions. Hence, other causes should always be kept in mind while interpreting bone marrow findings of megaloblastosis.

Dibyajyoti Sahoo, Anuragaa S Introduction: Autoimmune hemolytic anemia (AIHA) is the clinical condition in which antibodies of immunoglobulin G (IgG) and/or immunoglobulin M (IgM) bind to red cell surface antigens and initiate red cell destruction via the complement system and the reticuloendothelial system. These auto antibodies sometimes create blood group discrepancies and incompatibility in cross matching. In AIHA there is decreased survival of RBC due to increased destruction by the patient's autoantibodies. When the destruction is severe and the patient's marrow cannot compensate for the loss, anemia develops. With increasing anemia patient becomes clinically symptomatic with cardiopulmonary symptoms because of decreased oxygen-carrying symptoms by the RBC. In these conditions patient need RBC transfusion.

The aim of the present study is to asses transfusion support and serological difficulties in AIHA patients. . Findings at presentation: Anemia (29%), jaundice (13%), hemolytic facies (13%), hepatomegaly (68%), splenomegaly (87%) with mean spleen size -5.33 ± 4.38cms, short stature (40%) were found at initial presentation. The mean age at which first transfusion was-was 2.75 ± 3 years. Mean Hb and mean serum ferritin were 6.7 ± 1.36 g/dl and 511.09 ± 587 ng/ml respectively. On the basis of HPLC, patients were divided into-Eb Thalassemia (31), homozygous b thalassemia (10), compound heterozygous for b thalassemia (5), compound heterozygous for b thalassemia & silent mutation (6), compound heterozygous for db & b thalassemia (2), homozygous for db thalassemia, heterozygous for Lepore & thal trait (3), HbH disease (2).Three patients had associated alpha deletion. The mutational analysis could be performed for 33/69 patients. Most frequent single genotype encountered was compound heterozygous

, and homozygous for IVS1-5. During mean follow up period of 3.5 ± 2.4 years: Fourteen patients required short term regular transfusion-commonest reason being growth faltering and splenomegaly. Two patients developed thrombotic complications whereas amongst patients more than 10 years of age (n = 20), subclinical hypothyroidism was detected in 30%, and impaired glucose tolerance in 5%.

In management of patients with NTDT strict monitoring with detailed clinico-hematological evaluation, growth assessment and search for complications is prudent. It not only prevents unnecessary transfusions & iron overload but helps in prevention, early detection and timely management of NTDT related complications.

Introduction: Diamond black fan anemia is a rare congenital disorder. The condition name for pediatrician Louis K Diamond and Kenneth black fan who described congenital hypoplasia anemia in 1938. Incidence is 5-7 million people live birth per year but in US 4-million live births per year then there are 25-35 new patients born per year. there are 5000 cases worldwide sex ratio is equal for male and female.

Aims & Objectives: To rule out various disease associated with diamond black fan anemia and treatment. The disease present in 1st yrs-5yrs of life as severe anemia with macrocytosis, reticulocytopenia. It associated with congenital anomalies microcephaly, micrognathia ptosis low set of ears.ASD, VSD Urogenital anomalies hypospadias, tri-phalangeal thumb, cataract, glaucoma. Diamond black fan anemia associated with cancer & sarcoma. The pathogenesis is raised erythroid adenosine deaminase activity and fetal hemoglobin, fetal Hb indicator of stress erythropoiesis. Genetic testing can identify a mutation in approximately 80-85% of patient with diamond black fan anemia, erythro-blastpenia is a major characteristic of disease which is due to ribosomal disease related to heterozygous allelic variation of ribosomal protein genes of either that small or large ribosomal unit. There is mutation of RPL5, RPL11 RPL35A, RPS10, RPS17, RPS19, RPS24 and RPS24 gene. Introduction: Reticulocytes are the youngest erythrocytes released from the bone marrow into the blood and they circulate for 1-2 days before becoming mature erythrocytes. It is used in basic diagnostic workup in all types of anaemias, analysis of which provides an indirect measurement of functional iron available for RBC production.

Aims & Objectives: To check the clinical utility of manual reticulocyte count and reticulocyte production index in differential diagnosis of iron deficiency anaemia, vitamin B12 deficiency anaemia and b thalassemia minor cases in comparison with routine haematological parameters.

Materials & Methods: The study was performed by retrieving records (laboratory parameters) of 50 cases of anaemia, comprising of 26 iron deficiency anaemia, 19 Vitamin B12 deficiency anaemia and 5 b thalassemia trait cases.

Result: In our study, male gender predilection was observed. Mean age distribution ranged mostly in 41-50 years in all the cases of anaemia. The ROC curve indicates 100% sensitivity and 87% specificity for manual reticulocyte count and reticulocyte production index. Other routine haematological parameters like MCV, MCH and MCHC were also found to be significant in differentiating iron deficiency anaemia from vitamin B12 deficiency anaemia.

Conclusions: The significance of red cell parameters and limitations of the same have a significant effect in the diagnosis of anaemia in haematology. This study showed a statistical significance in manual reticulocyte count and reticulocyte production index, along with routine haematological parameters for iron deficiency anaemia in comparison to vitamin B12 deficiency anaemia.

Introduction: Hemolytic disease of the fetus and newborn (HDFN) occurs when maternal antibodies, aiming against Rhesus (Rh) or other blood group antigens, enter the fetal circulation during pregnancy and destroy the baby's red blood cells. It is associated with wide range of consequences, ranging from mild anemia and hyperbilirubinemia to lifethreatening complications. Despite the fact that Rh HDN is one of the preventable causes of newborn morbidity and mortality, cases continue to be seen in Indian hospitals. Hence, the present study is undertaken.

(1) To study the various causes for the persistence of Hemolytic disease of newborn due to Rh isoimmunization. (2) To assess hematological/laboratory findings in babies with Hemolytic disease of newborn due to Rh isoimmunization.

This cross-sectional descriptive study spanning from June 2019 to May 2021 was conducted in a tertiary care centre of southern Assam. In this study, anemic and/or hyperbilirubinemic newborns of Rh negative mothers with suspected Rh isoimmunization were taken as cases. Cord blood was collected to assess CBC, Reticulocyte count, PBF, ABO & Rh grouping, direct Coomb's test and serum bilirubin. Maternal history was taken. Statistical analysis was done using SPSS (Version 25.0, Armonk) and Microsoft Excel 2013.

Result: A total of 78 cases were studied. Most of these babies were born to mothers of age group 18-30 years and multiparous women. It was observed that 47% mothers were of blood group O negative. History of anti-D administration was available in only 36?ses. Incidence of HDN due to Rh incompatibility in our set-up was found to be 4.34/1000 live births. 32?bies developed significant jaundice and had total serum bilirubin level of [ 15 mg/dl. Conclusions: The decline in the global incidence of Hemolytic disease of newborn due to Rh isoimmunization since the 1960s has reasons like increase in precautionary antenatal testing, widespread use of injection Anti-D immunoglobulin and population control. Though this also holds true for India, but due to comparatively poorer health services, education level and financial status, our country still suffers from this disease. Dimorphic anemia was seen in 08%. Macrocytic anemia in 05% and Normocytic anemia constitutes 42%. In Patients with Decreased MCV (N = 45), 2 patients (4.4%) were found to be having hemolytic Anemia in peripheral smear examination.

Patients with normal MCV (N = 42) showing Microcytic, hypochromic anemia were 26.19% (11 cases), Dimorphic anemia were 7.14% (03 cases) and Normocytic, Normochromic anemia were 66.6% (28 cases) on peripheral smear examination.

Microcytic, Hypochromic anemia showing left shift in curve, Normocytic, Normochromic anemia showing Bell shaped curve and of Dimorphic anemia showed bimodal peak. Conclusions: Histogram & RBC indices are useful aids in diagnosis of Microcytic, Hypochromic and Normocytic, Normochromic anemias but Dimorphic and Hemolytic anemias show different Histogram patterns. Therefore, Peripheral smear findings are useful for identifying Red Blood Cell changes which remain as gold standard in diagnosis of anemia.

Jiss Joy, Dr. Maria Ann Vasnaik, Dr. Seetharam Anandram, Dr. Arun George Introduction: Spontaneous extradural hemorrhage in a patient with sickle cell disease is an uncommon complication of sickle cell hemoglobinopathy and is rarely seen in clinical practice. Aims & Objectives: We discuss a case of spontaneous non-traumatic EDH in a patient who presented with a sickling bony crisis.

Materials & Methods: A 20-year-old male sickle cell anemia patient presented to the emergency department with suspected sickling bone crises and was admitted for further management. The next day he developed sudden onset right-sided headache, paucity of right sided limb movements, projectile vomiting, altered sensorium. He had a Glasgow coma score of 8; right upgoing plantar, reduced power (3/5) of the right upper and lower limb. Blood tests revealed a drop in hemoglobin (9.8 g/dL to 6.0 g/dL) and platelet count (213,000/mm 3 to 83,000/mm 3 ). MRI brain revealed left-sided large parieto-temporal epidural hematoma with midline shift [ 10 mm and mass effect.

Emergency left parieto-craniotomy was performed, and the hematoma, evacuated. He received multiple red blood cell and platelet transfusions. Repeat CT brain showed no further worsening. Patient improved with no residual neurological deficits. Result: Possible mechanisms of EDH in sickle cell disease include skull bone infarction, insufficient venous drainage due to sludging of sickle cells in the diploic veins or abnormal anatomy of the skull bones resulting from chronic extramedullary hematopoiesis. Coagulopathy due to a fall in platelet count could be a precipitating event for spontaneous EDH. In our patient, there was a fall in hemoglobin and hematocrit levels, precipitating the development of the EDH. Neuroimaging showed no evidence of bone infarction, however it showed features of anatomical changes seen in chronic extramedullary hematopoiesis. Contusion was noted in the left high parietal region; our patient had become agitated and may have sustained trauma from the bed railings. Images were reviewed with Radiology, it was noted the degree of injury sustained from the contusion is unlikely to be a causative factor for the EDH. Conclusions: Early identification of EDH and aggressive management is crucial to survival and good prognosis in patients with sickle cell disease.

Hematological Indices and Formulae as Screening Test for Beta Thalassemia Trait: An Observational Study in a Tertiary Care Centre Pummi kumara, Ruchi Sinha, Surabhi, Punam Prasad, Tarun Kumar,

Introduction: Anemia is one of the most prevalent health issue in India. Majority of cases presents with microcytic hyphochromic RBC morphology are diagnosed as iron deficiency anemia and given emperical treatment with iron supplements. But, one of the most important differential is beta thalassemia trait that has entirely different pathophysiology. Overall reported frequency ranges from \ 1 to 17% in different population. So, this necessitates an easy and reliable screening tool. Aims & Objectives: To evaluate and compare role of various hematological indices and formulas in the diagnosis of beta thalassemia trait.

This was an observational hospital based study done retrospectively from September 2020 to August 2021 in the department of Pathology, AIIMS, Patna. All the cases diagnosed as beta thalassemia trait using Bio rad D10 hemoglobin testing system were analysed excluding those cases with co-existing iron deficiency anemia (ruled out by low serum ferritin level). Complete hemogram reports were collected of the same blood sample on which HPLC was done. All these cases were then evaluated for 6 hematological indices and formulae (RBC count, Mentzer index (MI), Srivastav index (SI), Shine & Lal index (SLI), Ricerca index (RI), Red cell distribution width index (RDWI)).

Result: In total, 59 cases were diagnosed as beta thalassemia trait and 14 cases had co-existing iron deficiency anemia. The sensitivity of RBC count, MI, SI, SLI, RI, RDWI analysed were 44%, 64%, 57%, 80%, 77% and 64% respectively. Conclusions: In our study, we obtained highest sensitivity of Shine & Lal index followed by Ricerca index for detecting beta thalassemia trait. Although no parameter has 100% sensitivity, but it can be used as simple and easily available screening tool for detecting carriers in all cases presenting with microcytic hypochromic anemia cases, further confirmed by HPLC studies.

A Study to Evaluate the Effect of Anemia in Type 2 Diabetic Patients Radhika Maheshwari, Monika Sisodia, Divya J., R. Muthukrishnan, Sahayaraj J Introduction: As the tribulation of diabetes escalates, developing countries like India is expected to be the Diabetic capital in the world in coming years. Diabetes Mellitus progressively results in various complications including both microvascular and macrovascular disorders. The nephropathy undermines the renal production of erythropoietin, positively contributing to an increased anaemic framework. However, anaemia in type 2 diabetic patients is often untended.

1. To correlate the levels of haemoglobin with the degree of glycaemic control (HbA1c [ 6.5% vs HbA1c \ 6.5%). 2. To determine the morphology and severity of anaemia in type 2 diabetic patients. 3. To know prevalence of other comorbidities as a result of anaemia and diabetes.

A prospective observational study was conducted in 100 type 2 diabetic patients visiting the Out Patient Department in ACS Medical College and Hospital, Chennai.

1. Haemoglobin and Red cell indices were estimated. 2. Comorbidities like Hypertension, Chronic Kidney Disease, Arthritis and Retinopathy were recorded. 3. Peripheral blood smear examination was done using Leishman's stain. 4. Ion exchange chromatography was used to measure the HbA1c levels.

Result: In the poor glycaemic control group, a significant decrease in the haemoglobin levels was noted especially in females and elderly population. Microcytic Hypochromic Anaemia was the most prevalent which was of mild to moderate severity. Predominantly reduced iron stores in Microcytic Hypochromic Anaemia were attributed to increased HbA1c levels. The poor control of diabetes when associated with anaemia, were also found to have comorbidities like Hypertension, Chronic Kidney Disease, Arthritis and Retinopathy. Conclusions: To conclude, though anaemia is significantly prevalent in diabetic patients, it is often neglected. In accordance with the study, poor glycaemic control is the result of increased glycation of haemoglobin A1c (HbA1c) due to reduced iron stores. Hence in diabetic patients, it would be beneficial to assess haemoglobin levels often, for better quality of life.

Harika Varla, Satish kumar meena, Rumesh chander

Introduction: Pure red cell aplasia (PRCA) is a rare haematological condition which affects the red cell lineage specifically presenting as normocytic normochromic anemia with reticulocytopenia Congenital sideroblastic anemia (CSA) affects the red cell lineage secondary to pathological deposition of iron in the mitochondria of erythroid precursors (sideroblasts). Congenital erythropoietic porphyria (CEA) is associated with a defect in the synthesis of heme. For transfusion dependant PRCA, CSA and CEA, allogenic haematopoietic stem cell transplantation is the only curative option.

Aims & Objectives: We present outcome data of HSCT in the above conditions and the variables that affect outcome.

We performed a retrospective study in the department of pediatric Blood and Marrow transplantation in children upto 18 years of age diagnosed to have PRCA, CSA and CEA who underwent transplantation.

Result: A total number of 16 children were included with male to female ratio of 0.7:1 with 4 children with CSA and 11 children with PRCA and 1 child with CEP. 10(61%) children underwent Allogenic transplantation from family donor, 3 underwent haploidentical transplant, 3 unrelated HSCT. All children had MAC conditioning regimen with FLU/TREO/THITEPA and for all unrelated and haploidentical HSCT, ATG was added. 94% of children engrafted. 7(43%) developed acute GVHD, of which 5(31%) developed grade 1-2 GVHD and 1(06%) had grade 3 and 1(06%) had grade 4 GVHD. 6(37%) developed chronic GVHD (3PRCA, 2CSA, 1 CEP). 4 children among chronic GVHD required prolonged low dose steroids for 2 years. The overall survival with median follow up of 120 months was 13(81%).

Conclusions: Transfusion dependant Pure red cell aplasia, Congenital sideroblastic anaemia and Congenital erythropoeitic porphyria are curable with HSCT with overall survival of over 80%. Alternative donor HSCT is a feasible option where no matched family donor is available. Treosulphan based myeloablative conditioning is safe and effective. Follow up for GVHD, immune cytopenia and chronic steroid related effects help reduce mortality. Graft rejection rates were low, however, GVHD remains a significant challenge.

Karthikeyan Mohan, Sarit Chatterjee, Vishaka Mittal

Introduction: Thalassemia is an autosomal recessive disorder and it is characterized by absent or reduced synthesis of either alpha or beta globin chains of haemoglobin. In Beta thalassemia major the production of beta-globin chains doesn't occur at all and it manifests as severe anaemia in infancy or childhood, requiring regular blood transfusion for survival. With improvement in blood transfusion and effective use of iron chelation therapy, the average life expectancy has increased from 25 years to over 55 years of age. Hence, complications related to repeated blood transfusion are likely to develop such as transfusion-related infections and iron-related endocrine complications.

Aims & Objectives: The main aim was to study the clinical profile of transfusion-dependent adult ([ 18 years of age) thalassemia patients.

We included 30 adult thalassemia patients who were on regular monthly blood transfusions. It was a crosssectional observational study conducted at the tertiary care centre in New Delhi.

Result: Among study subjects, there were 23 males and 7 females. The median age was 21.5 years with a range of 18-49 years. Only 20% of patients had a splenectomy. All 30 patients were on chelation therapy and 80% were on single chelation therapy mainly on deferasirox. 1 patient had hepatitis B and 4 patients had hepatitis C infection. 63.3% of patients were underweight and 43.33% were stunted. Among 30 patients, 40% of the patients had pre-transfusion haemoglobin below 9 g/dl and patients who had undergone splenectomy had maintained higher pre-transfusion haemoglobin. 80% of the patients had higher serum ferritin ([ 1000 ng/ml) suggesting a state of iron overload. Iron related endocrine complications were higher with 10% of patients had hypothyroidism, 13.33% had subclinical hypothyroidism and 16.67% had impaired fasting glucose tolerance while none of them had over diabetes mellitus.

Conclusions: The present study was designed to find the transfusion adequacy, complications of ineffective erythropoiesis and blood transfusions, in adult thalassemia patients. It was observed that even in Delhi, patients were inadequately transfused and had complications of ineffective erythropoiesis. There was a significant number of patients who were not on adequate chelation therapy and developed iron-related endocrine complications. Introduction: Pure red cell aplasia (PRCA) is a rare entity, characterized by normocytic normochromic anemia and reticulocytopenia in peripheral blood, and reduction of erythroblasts from the bone marrow. It is classified as congenital and acquired type based on pathogenesis. Congenital PRCA (cPRCA), also known as Diamond-Blackfan anemia (DBA), has been associated with mutations involving ribosomal proteins. Acquired PRCA (aPRCA) can be a primary disease, or secondary to other diseases, such as lymphoproliferative diseases, autoimmune diseases, thymoma, infection, or drugs. There are only few clinical studies on PRCA mostly focussing on therapy.

Aims & Objectives: To study the clinico-biological features of patients with PRCA and correlate it with treatment outcomes. Materials & Methods: 84 patients diagnosed as PRCA in Department of Hematology from January 2017 to January 2021 were included. Their biological and demographic data was recorded with baseline investigations. This was correlated with available bone marrow findings, therapy and outcome.

Result: Patients were between the age group of 1 month to 75 years with M:F -1.04:1. Most common presentation was symptomatic anemia (95.2%). Concomitant neutropenia and thrombocytopenia was seen in 10(11.9%) and 14(16.7%) patients respectively. Bone marrow examination revealed erythroid precursors constituting 0-8% of total nucleated cells. 20 patients had cPRCA. Among the aPRCA (n = 64), 31 (48.4%) had primary PRCA. Cause of secondary PRCA (n = 33) was MDS, CLPD, infections other than parvovirus, parvovirus infection, autoimmune disorder and chronic kidney disease in 9 (27.3%), 8 (24.24%), 7 (21.2%), 5 (15.2%), 3 (9.09%) and 1 (3.03%) respectively. Therapy and follow up details were available for 52 patients which are described in table 1.

Conclusions: PRCA should be suspected in a case of anemia with reticulocytopenia. Diagnosis requires complete patient evaluation including complete history and clinical examination with long list of laboratory investigations to determine its cause which may reduce morbidity and mortality. Systematic long-term follow-up studies need to be performed. 

Lenin Thomas, Sasidharan P K Vitamin B12 deficiency is very common in the general population of India. Subclinical B12 deficiency could be easily missed in clinical practice, as the symptoms are vague and numerous and are often overlooked or ignored due to lack of awareness. Early B12 deficiency can be identified by studying the dietary habits of the patients, because the root cause of nutritional deficiencies lies in their poor dietary habits, about which they are not aware of. It will be a good clinical practice to identify the deficiency early and advice on balanced diet which in the long run would bring about a social change.

Aims & Objectives: To identify the common presentations of B12 deficiency, to make a strong clinical suspicion of B12 deficiency based on the pitfalls in dietary habits, to initiate early treatment, to assess the response to treatment in patients with established B12 deficiency and to prevent recurrence.

This was a prospective study of 203 patients with clinical and hematological evidence of B12 deficiency who attended the outpatient department of PVS Hospital Calicut. The patients were evaluated for their symptoms, dietary practices, physical signs and laboratory tests including Vitamin B12 levels.

Result: Fatigue was the most common symptom, seen in 65% of patient's and was apparently due to anemia suggesting that most common clinical presentation can still be hematological. Anorexia was the next common and was seen in 57% of patients, which could have been multifactorial including gastric mucosal atrophy. Skin hyperpigmentation was seen in 40% of patients. Pallor was present in 70% of patients and Romberg's sign was present in 71% of patients. Evidence suggestive of peripheral neuropathy was seen in 25% and psychiatric manifestations including irritability, depression, memory disturbances were seen in 23% of patients. Neuropsychiatric manifestations were seen independent of any hematological manifestations in B12 deficiency. B12 assay showed low levels in 65% of patients only. Majority (67%) of the study group with B12 deficiency had poor intake of fruits and vegetables too and 52% of them had deficient meat or other protein intake.

Conclusions: B12 deficiency can present with any of the numerous manifestations affecting hematopoiesis, skin & mucosa and the entire nervous system, including mental functions. Overt B12 deficiency with classical signs and symptoms can be picked up easily, but subclinical cases are easily missed. All patients will not present with classical hematological or neurological manifestations. The key is to suspect the deficiency by remembering the most common symptoms and their correlation with the dietary habits. Since the awareness and practice of a balanced diet is very poor in our society, B12 deficiency can be seen very commonly in clinical practice but is easily overlooked unless we look for it. We miss them because the 'eyes will not see what the mind doesn't know'. Since the clinical improvement during the hospital stay was suboptimal, he was evaluated further as he also had severe anemia (hemoglobin: 4.4 gm/dL), leukocytosis (total leukocyte count: 64,440) and developed thrombocytopenia (platelet count: 84,000). So a bone marrow aspiration was done which was suggestive of hemolytic anemia. Thus, an HPLC was done which revealed homozygous sickle cell anemia which was confirmed with mutation analysis (c.20 A [ T) both parents being sickle cell trait.

Conclusions: Sickle cell Anemia presenting as fulminant hepatic failure with encephalopathy at initial presentation is rare. We must have a high index of suspicion of such a presentation in specific population and regions. Hereby we also reiterate the importance of parental studies for diagnosing a case of hemolytic anemia.

Paruvathavarthini Thambiraj, Rakhee Kar, Nivedita Nanda, Debdatta Basu

Introduction: Microcytic hypochromic anemia due to varied causes is an important cause for poor performance in daily life. Evaluation of red cell indices and markers of iron homeostasis will help to narrow down cases needing sophisticated investigations like HPLC/capillary electrophoresis.

Aims & Objectives: To assess the utility of derived red cell indices and indices of iron homeostasis in the evaluation of microcytosis without anemia or with mild anemia.

A single institutional hospital-based study from January 2019 to October 2020. Patients without anemia or with mild anemia (Hb: 10-10.9 g/dL) as per ICMR criteria with MCV \ 80 fL were included. The study was approved by Institute Introduction: Anaemia is a very commonly seen health problem in Indian setting, iron deficiency being the most common cause. The pink colour of palpebral conjunctiva during general examination helps in giving a rough estimate of a patient's haemoglobin status.

Another important ocular examination with findings in anaemic patients is the fundus examination. Retina requires regular oxygen supply to maintain its functional integrity. Inner retinal layers receive their blood supply from superficial and deep capillary plexus formed by the central retinal artery and are more susceptible to hypoxic changes. Retinal ischemia leads to many other visual disorders like diminution of vision or inflammatory infiltrates over the retina and retinal haemorrhage. Roth spots are seen in the centre of retinal haemorrhage. Roth spots are caused due to focal areas of ischaemia. Therefore, fundus examination is done to diagnose as well as to observe the progression of anaemia.

Aims & Objectives:

1. To study ocular findings in cases of anaemia. 2. To demonstrate fundus changes in anaemic patients.

MATERIALS & METHODS This is a hospital based retrospective cross-sectional study which included patients from all the bedside/OPD references done for Department of Medicine from 01 October 2020 to 01 April 2020. Personal details and diagnosis for each patient was harvested from the out-patient register maintained by the Department. Result: RESULTS Conjunctival pallor was the commonest ocular manifestation of anaemia seen. Retinal haemorrhage (with Roth spots at their centre) was the second commonest ocular manifestation closely followed by diminution of vision. Other ocular finding which were also observed were subconjunctival haemorrhage, disc pallor, and vascular changes. Conclusions: CONCLUSION: The fundus gives a picture of the state of vessels and thus can give important diagnostic aid in cases of anaemia. Therefore, fundus examination should be a part of essential routine examination in all cases of suspected as well as confirmed anaemia. Introduction: Unstable hemoglobins are characterized by an abnormal propensity to post-translational structural alterations, leading to the loss of their normal tertiary and/or quaternary structures. Clinically, these present as autosomal dominant disorders with evidence of hemolysis and often, Heinz body formation.

We describe a child with severe chronic hemolytic anemia who was found to have a rare unstable hemoglobin variant, Hb Alesha on next-generation sequencing.

A 1-year-old boy presented with pallor and severe transfusion-dependent anemia, since the age of 6-months. There was no significant family history. On examination, spleen was palpable. Investigations revealed Hb 67 g/L, corrected reticulocyte count 14% and Heinz body formation. Peripheral smear showed moderate anisocytosis with macrocytes, polychromatophils, and many spherocytes. Direct antiglobulin test, incubated osmotic fragility, and G6PD-deficiency screening, were all within normal limits. Hb highperformance liquid chromatography revealed 13.6% HbF (reference range for age 1 year: 1.3-5.0%), but was considered inconclusive due to a recent transfusion, as well as the possibility of stress erythropoiesis. Further routine work-up was unfeasible as the child continued to require multiple transfusions. Hence, whole-exome sequencing (WES) was done using Nextera Rapid Capture Enrichment kit (Illumina). FASTQ files were generated after WES, and quality assurance/ quality control of the sequence data was performed by FASTQC (Brabaham Bioinformatics). Sequence reads were mapped to the hg19 genome, and data analysis was done using in-silico bioinformatics tools. Introduction: NFHS-4 shows the prevalence of anaemia to be about 50% among women including pregnant women. Anaemia in pregnancy may be associated with an incidence risk of preterm birth, lowbirth-weight and small for gestational age infants, preeclampsia, placental abruption, poor maternal thyroid status, poor wound healing, cardiac failure, and even maternal death.

Aims & Objectives: We conducted a study to examine the prescription practices of residents and interns to prevent, and manage anaemia in pregnancy at tertiary care centers in Mumbai.

Materials & Methods: An audit of prescriptions from the antenatal participants attending the Obstetrics out-patient department (OPD) of two tertiary care hospitals in Mumbai was conducted between June and September 2021. Prescription screenshots were captured from consenting participants. Data analysis was performed according to WHO core prescribing indicators.

Result: A total of 691 prescriptions were captured and analysed, with the gestational age of participants ranging from 7 to 39 weeks. 99% of the participants attending the obstetric OPD were screened for anaemia, with an overall prevalence of anaemia being 74% (n = 506). 38/691(5.5%) women who presented for antenatal care were screened for hemoglobinopathies and only 1.3% (n = 9) were investigated for the cause of anaemia. A total of 518 participants were prescribed oral iron and one participant received IM iron. About 18% of the prescriptions from 2nd and 3rd trimester participants had no prescription of iron among whom 41% were moderately and 3% were severely anaemic. Of the remaining 82% prescriptions which had iron prescribed, 32.5% were not according to Hb estimation. 75.4% of iron preparations were prescribed by generic name and comprised of ferrous sulphate, ferrous fumarate and ferrous ascorbate. Only 3.3% (n = 23) of the prescriptions were found to be complete. Omissions among the incomplete prescriptions (n = 668) comprised of missing formulation (22.8%), missing dose (53.6%), missing frequency (60.6%), missing duration (100%) and lack of written/verbal instructions (100%).

Conclusions: Adverse feto-maternal outcomes due to anaemia in pregnancy are preventable, and local hospital guidelines for the prevention, detection and management of the same should ensure that they align the local guidance with the latest standard treatment guidelines.

Sindhushree N, Bharathi M Introduction: Hemoglobinopathies are the most common group of inherited genetic disorders of hemoglobin in which there is an abnormal production or abnormal structure of the hemoglobin molecule. They include Thalassemias and abnormal variant hemoglobins such as Hemoglobin S, Hemoglobin E, Hemoglobin D etc. As the exact data pertaining to the prevalence of these hemoglobinopathies in Mysuru region, Karnataka is scarce, we considered it important to find out the extent of burden of hemoglobinopathies in this population. A total of 39 patients were randomized into three arms: Arm 1 (Hydroxyurea 500 mg/day), Arm 2 (thalidomide 50 mg/day), and Control Arm (Standard of care). The primary outcome was rise in haemoglobin at 12 and 24-weeks from the baseline levels.

Result: The mean age of the cohort was 26.9 ± 4.7 years, with 15 females (38.5%) and 24 males (61.5%). Total 13 patients (33.3%) were splenectomised. The mean rise of haemoglobin at the end of 12 weeks was 0.37 ± 0.825 g/dl, 0.64 ± 1.403 g/dl, and 0.20 ± 0.861 g/dl in the hydroxyurea, thalidomide, and control arm, respectively, p = 0.626. The mean rise of haemoglobin at the end of 24 weeks was 0.31 ± 0.652 g/dl, 0.56 ± 1.343 g/dl, and -0.31 ± 0.942 g/dl in the hydroxyurea, thalidomide and control arms, respectively, p = 0.138. The mean volume of blood transfused per unit body weight in 24 weeks was significantly less in the thalidomide arm compared with the other two arms (p = 0.033). Only 2 patients (20%) in hydroxyurea and 2 (22.2%) in low dose thalidomide group had sustained rise in haemoglobin (p = 0.355). Abdominal pain (Grade 1-2, 23.1%) and pruritus (Grade 1, 15.4%) were the main adverse events in hydroxyurea arm, whereas somnolence was noted in the thalidomide arm (Grade 1-2, 78.3%). A total of 21.4% of patients discontinued thalidomide, and another 21.4% of patients required dose interruption for adverse events. Conclusions: Single agent hydroxyurea or thalidomide are ineffective in increasing haemoglobin and decreasing transfusion burden among majority of the adult transfusion dependent thalassemia patients.

Vibha Sinha, Sapnita Shinde1, Vinit Singh Baghel1, Naveen Kumar Vishavakarma1, Atul Kumar Tiwar2, Saurabh Saxena3, Sanjay Kumar Pandey4, Vinit Shah4, Sudhakar Dwivedi4, Mahendra Tilkar5, Dhananjay Shukla1

Introduction: Anemia and obesity both are global epidemics that affect billions of people, with regional disparities. Obesity is a socioeconomic burden in developed countries over the last century, but its prevalence is now increasing in developing countries because of a high-fat diet and low physical activity. It's become clear that anemia and obesity are not simply coincidental conditions, but are molecularly linked and mutually affect each other. Anemia can be affected by an individual's body mass index because increasing weight can lead to lower systemic inflammation and elevation of hepcidin, which ultimately results in iron sequestration inside a variety of cells such as macrophages, hepatocytes, and enterocytes, leading to the progression of anemia of inflammation. Aims & Objectives: To identify the effect of obesity on blood parameters and establish a correlation between obesity and various type of anemia.

To evaluate the effects of body mass index on complete blood parameters and to identify the type of anemia present in the obese population, the piolet study was conducted in Rewa, Madhya Pradesh in adults of both genders, male and female, aged 10-65 years. 5 ml blood samples were collected from all the obese population. Anthropometric data were calculated and hematological profiling was done by Sysmex auto analyzer.

Result: A total of 52 obese patient samples were collected from SGMH hospital, Shyam Shah Medical College, Rewa, Madhya Pradesh. Out of them, 23 were female (mean age-37.68 ± 15.64) and 29 were male (mean age-28.65 ± 15.03). The BMI of male patients was 29.86 ± 4.31, female patients were 31.68 ± 7.73, and the overall BMI of 52 obese populations was 30.12 ± 5.96. By the calculation and comparison of MCV and MCHC values, we found that 67.32% of the population have normocytic normochromic anemia, and 30.76% have macrocytic normochromic anemia. Only 1.92% population has microcytic hypochromic anemia. As a result, normocytic normochromic anemia has a high prevalence in the obese population. Conclusions: From this piolet study, we conclude that weight gain and adiposity can affect the blood parameters. They are responsible for causing various types of anemia in the obese population. Future studies are needed to clarify the effect of obesity on blood parameters.

Vikash Kumar Maurya, Kailash Kumar Gupta, Nilesh Kumar, Jitendra Singh, Pappu Kumar, Ranjan Kumar Introduction: Delta/beta-thalassemia is a heterogeneous group of disorder characterized by elevated HbF concentration persisting into adult life. Delta /beta thalassemia results from a deletion in both the delta and beta genes on chromosome 11. Heterozygous variant clinically show characteristics of thalassemia minor. However, homozygous variant may give a clinical picture of thalassemia intermedia with a mild anemia. Aims & Objectives: The aim of this study is to highlight the rare Delta/beta thalassemia presenting as a case of massive splenomegaly. In this report we can also differentiate the Delta/beta thalassemia from hereditary persistence of fetal hemoglobin without genetic analysis.

A 30 years male presented to the hematology OPD for evaluation of heaviness in LUQ of abdomen and generalized weakness and easy fatigability for 5 months. Family history was insignificant for congenital anemia. No history of blood transfusion in past. Physical examination revealed mild pallor and palpable spleen 8 cm below the left costal margin. Other examination findings were unremarkable. A complete blood count revealed a Hemoglobin level of 10.8 g/dl, (MCV-68 fl, MCH-19.7 pg, MCHC-31 g/dl), RBC 5.49 million/ml; WBC count of 10 9 109/L, and platelet count of 155 9 109/L. A peripheral blood smear revealed anisocytosis with hypochromic microcytic red cells. The corrected reticulocyte count was 2.56%. LFT showed raised levels of serum total bilirubin (2.6 mg/dl) and indirect bilirubin (0.7 mg/dl). Serum LDH was raised (726 U/L). Osmotic fragility was normal and Coomb's test was negative. HPLC showed 21.90% HbF, 76.5% HbA and 1.6% HbA2. The Kleihauer-Betke test revealed a heterogenous pattern of HbF cell distribution. Unfortunately, mutational analysis could not be performed because the patient was lost to follow-up. Result: After getting Mentzer index of 12.3. HPLC was done which showed raised HbF (21.9%). Possibility of Delta/beta thalassemia and HPFH was considered, but the diagnosis of delta/beta thalassemia was made by getting microcytic hypochromic RBCs on GBP and heterogenous pattern of HbF cell distribution on Kleihauer-Bekte test. Conclusions: Delta/beta thalassemia is a benign condition which are usually incidental finding. Sometimes it can present with features of mild anemia and splenomegaly. Its close differential Hereditary persistence of fetal hemoglobin can be differentiated from even without molecular analysis. Introduction: FVII deficiency is a rare (1:5000,000), bleeding disorder caused by mutations in FVII gene. Molecular defects in FVII gene show molecular heterogeneity and their correlation with clinical phenotypes are uncertain. Aims & Objectives: In the current study we screened the FVII gene for mutations and find out their association with phenotype. Materials & Methods: 10 patients (mean age 26 years, age of onset of bleeding 18.5 years) with FVII deficiency (activities: \ 1%-45%) 6 females and 4 males were recruited. Mutations were detected by direct DNA sequencing and In-Silico analysis was performed for their potential structural and functional consequences. Result: We found 10 cases (34.4%) of FVII deficiency out of a total 29 cases of rare bleeding disorders. The commonest bleeding symptom was menorrhagia observed in 40?ses followed by epistaxis (30%) and easy bruisability (20%). Three patients with FVII levels \ 1% had mild bleeding while 1 had severe bleeding. 2 patients with FVII levels above 20% had mild bleeding, 2 had severe bleeding symptoms while 1 was asymptomatic. Total 4 missense mutations (D302N, R413Q, G425S and C370F) and 2 silent mutations (Z95Z and H175H) were detected. C370F mutation was observed in severe bleeders whereas Arg302Asn an R413Q were observed in severe and mild bleeders respectively. The C370F mutation causes ablation of critical disulphide bond and disruption of several side chain and backbone hydrogen bonds resulting in a major impact on protein stability. Conclusions: Like previous studies, we did not observe precise correlation between FVII levels and bleeding severity. The deleterious effect of C370F mutation on protein structure and stability gives more emphasis on its causative role in disease development.

Prevalence of Activated Protein C Resistance on Thrombophilia Testing from a Tertiary Care Centre of Western Rajasthan Apurva Arora, Manali satiza, Abhishek Purohit Introduction: Thrombophilia is an abnormal predisposition for arterial and/or venous thrombosis and can be acquired or inherited. Activated Protein C resistance (APCR) is laboratory test which screens individuals for factor V gene mutation (factor V leiden).

The aim of this retrospective study was to audit APCR testing pattern at our institute and to look for the frequency of APCR in our patient population.

This cross-sectional study was conducted at AIIMS, Jodhpur over a period of four years. Laboratory and clinical details were extracted from hospital information system. The blood taken in sodium citrate 3.2% in 9:1 blood to citrate ratio was centrifuged at 3000 rpm for 15 min to separate plasma. Resistance to APC was determined by functional test for APC resistance, ProC global test kit. All the reagents are kept refrigerated between 2 to 8°C. The test was performed in semi automated coagulation analyzer (Sysmex CA-1500). Result was expressed by determining Protein C activity dependent clotting time (PCAT). Result: In the study duration, a total of 380 cases were tested for APCR. Out of these, 176 were females and 204 were males. Of all, 94 cases revealed resistance to Activated Protein C. In our laboratory, thrombophilia testing also included testing for protein C, protein S, anti-thrombin and lupus anticoagulant. We noted that requisitions for APCR testing are much less than other thrombophilia markers. Conclusions: APCR assay is highly sensitive and specific for factor V Leiden gene mutation. There are certain pre-analytical factors (Heparin administration, ongoing haemolysis) for APCR testing which should be taken care of. Atleast 90% of cases with APCR are explained by point mutation in gene for factor. We may not know the exact percentage of F V Leiden in our cases with APCR as we have not followed these cases with molecular testing. Still, APCR has been utilized for risk stratification of cases of thrombosis.

Mixing Study-To Do or Not to Do; in the Era of Integrated Testing for Lupus Anticoagulant Debadrita Ray, Debadrita Ray, Narender Kumar, Jasmina Ahluwalia, Chander Hans, Anita Kler Introduction: Guidelines acknowledge that no single assay system is sufficient for detecting lupus anticoagulant (LA). Tests based on two different principles are recommended. Although, the use of mixing studies is supported by all guidelines, the relative importance and position of mixing studies in the sequence of tests for LA identification remains controversial. The role of mixing studies needs to be further explored in today's era of integrated LA tests. Aims & Objectives: We aimed to evaluate the impact of mixing studies on the LA detection in the two automated integrated LA tests.

We retrospectively reviewed the data of 124 consecutive patients who were referred to our laboratory for testing of LA. LA was tested by screen and confirm of diluted Russel's viper venom time (dRVVT) and silica clotting time (SCT). Both these integrated tests were performed on fully automated coagulation analyser (ACL-TOP 500). The presence of LA was where the normalised ratio was elevated (dRVVT C 1.2or SCT C 1.16) or where the screen result was prolonged than 2 SD from local cut off. Result: Mean age of our patients was 28.7 ± 11.5 years and majority were females (80.6%). Abnormal normalised ratio of dRVVT and SCT were seen in 94 and 25 patients, respectively. After mixing studies 35?ses with DRVVT and 68?ses with SCT finally turned out positive. Additionally, screening test of dRVVT and SCT were prolonged in 22 and 21 patients, respectively however normalised ratio was with in normal range. None of the case with prolong screening time in SCT was positive after mixing study while 4.5% (n = 1) cases with DRVVT finally turned positive. Conclusions: Normalised ratios of integrated dRVVT and SCT have substantial false positive rates for LA detection. Hence, confirmation of these findings by further mixing studies as a routine practice appears prudent. Laboratory studies and coagulation profile along with factor assay were done for all patients. Result: A total of 102 patients with suspected bleeding disorder attended the centre in a period of 3 years. Out of these 101 (99%) had inherited bleeding disorders. Haemophilia A was the most common diagnosed in 79 patients (77%), while there were 19 (18.6%) patients with haemophilia B and other rare disorders were 3(2.9%)-1 with factor X deficiency, 1 with VWD, 1 with Factor V deficiency. Age range in Haemophilia A was from 2 months to 63 years with mean age of 14 years. In Haemophilia B patients age range was from 1 year 10 months to 34 years with mean age of 16 years. Mean age at first bleed was 6 years for Haemophilia A and 5 years for Haemophilia B. The mean no of bleeds per year for Haemophilia A was 50 and 20 for Haemophilia B. Hemarthrosis and hematoma was much more frequent in Haemophilia A and B than mucosal bleeding. Hemarthrosis was seen in 74% of severe Haemophilia A and 88% of severe Haemophilia B. Hematoma was seen in 90% of severe Haemophilia A and 96% of severe Haemophilia B. I5 year old girl presented with prolonged bleeding to minor cuts and ecchymotic patches diagnosed as VWD. 13 year old boy diagnosed case of Factor V deficiency our Hemophilia clinic for dental extraction clearance and he was allowed to undergo the procedure under FFP coverage. 41 year old female patient planned for a dental procedure with c/o prolonged bleeding, referred to our Hemophilia clinics, found to have prolonged PT and APTT, mixing study prolonged, factor assay ordered,diagnosed to have factor X deficiency. 3 of our patient have developed inhibitors (1 haemophilia B (age-7 year), 2 haemophilia A (age 20 year and 22 year respectively). Conclusions: Among all the inherited bleeding disorders, Hemophilia A is the commonest, and in hemophilia patients, severe form is the commonest.

Autoimmune Heparin Induced Thrombocytopenia: First Confirmed Case from India Chetan Agarwal, Jyoti Kotwal, Anurag Gupta, Sabina Langer, D.S. Rana

Introduction: Autoimmune heparin-induced thrombocytopenia (aHIT) is a rare phenomenon and has been recognized recently. It shows presence in patients of anti-plate-let factor 4 (PF4)-polyanion antibodies that are able to activate platelets strongly even in the absence of heparin (heparin-independent platelet activation). Here we report a case of 54-year-old male, known case of chronic kidney disease post renal transplant 3 years back who presented with fever, gram negative septicemia with Klebsiella, thrombocytopenia, deranged Liver and renal function tests, raised d-Dimer, CRP and Ferrtin. There was no exposure to heparin. He was diagnosed as a confirmed case of Autoimmune heparin-induced thrombocytopenia (aHIT) by platelet aggregation based functional assay which is a gold standard functional assay.

To bring awareness about Autoimmune heparininduced thrombocytopenia (aHIT), which is a new and rare entity.

Patient's serum was tested using Gel card test for Anti-H PF4 IgG and platelet aggregation testing. Result: The Gel card test for Anti-HPF4 IgG antibody was positive and the heparin induced platelet aggregation based functional assay showed activation of donor platelets in presence of low dose heparin as well as in the absence of heparin; thereby indicating autoimmune HIT (aHIT) where anti PF4 antibodies activate platelets by a heparin independent mechanism. Conclusions: Autoimmune heparin-induced thrombocytopenia (aHIT) is a rare and new entity. A high degree of suspicion is needed for its workup, diagnosis and start of early treatment. Our case emphasizes the need of more awareness regarding this entity.

Moreover, in developing countries like India where high quality laboratories are not readily available, awareness is the only tool that will expedite the diagnosis and save patients. There has not been any official case of aHIT in India. Therefore, the index case may be the first case of aHIT confirmed by a gold standard functional assay.

Acquired Hemophilia-Treated with Rituximab and Emicizumab-A Case Report Karthick R G, Shilpa Prabhu,Bharath Ram, Monisha H,.Chaitanya, Tejaswini, Sharat Damodar Introduction: Acquired haemophilia A is a rare bleeding disorder caused due to autoantibodies against Factor VIII. As this is a rare entity, there are no randomized prospective trials to guide therapy. Aims & Objectives: We are herewith presenting a case report of an elderly gentleman diagnosed with Acquired haemophilia A and treated with Rituximab and Emicizumab. Materials & Methods: 84 years old male, presented with extensive ecchymotic patches over his extremities associated with swelling of bilateral lower limbs and left upper limb in April 2021. His arterial and venous Doppler showed subcutaneous edema without any thrombus. He had severe anemia with isolated prolonged aPTT (68.3; INR 0.9) with no previous history of bleeding disorder. Patient was a known hypertensive on treatment for 7 years. Mixing studies done showed correction-(aPTT-82 s; post 1:1 mix with pooled normal plasma aPTT-34.7 s). Factor VIII and IX levels sent showed severe factor VIII deficiency (levels \ 1%)%. Factor VIII inhibitor level-1.8 BU/ml(low titre). PETCT, Von willebrand antigen,ANA profile-normal. Hence, he was diagnosed with Acquired haemophilia A and was treated with FFP, rfVIIa along with Azathioprine and Rituximab. He also developed hematoma in the tongue and new onset swelling into the right upper limb-he was given FEIBA 2000 units for 2 days. Result: He received 3 cycles of Rituximab (375 mg/m 2 ) and one dose of Emicizumab (210 mg). After 2 doses of Rituximab, repeat inhibitor titres sent was 5.2 BU and F VIII levels -4%.After one dose of Emicizumab, aPTT normalized to 24 s.Few days later, he developed fever, altered sensorium and hypotension; he was found to be COVID positive. His condition deteriorated in spite of mechanical ventilation and he died of cardiac arrest after 6 days of COVID treatment. Conclusions: As most of the Acquired haemophilia patients are elderly, their comorbidities and medications, influence the initial clinical presentation. The current management is based on rFVIIa, APCC, recombinant porcine FVIII and immunosuppressive therapy. Emicizumab (approved for congenital haemophilia) has been used effectively in acquired haemophilia A as per few case reports. However, effectiveness of Emicizumab in our patient could not be determined as he unfortunately succumbed to COVID infection.

Suryaprakash Yadav, Rupal Dosi, Dr.Himanshu Ranam.Aniruddh Ambaliya,Harikrishna Prajapati, Dr.Neha Sharma Introduction: Immune thrombocytopenia is a syndrome in which platelets becomes coated with auto antibodies to platelet membrane antigen resulting in splenic sequestration and phagocytosis by mononuclear macrophages. Incidence of ITP among adults in the USA is estimated to be 3.3. per 100,000 adults/year.The prevalence is 9.5 cases per 100,000. Incidence of ITP peaks in children aged 1-6 years, adults may be affected at any age but most common in women aged 30-40 years. 

Introduction: The development of inhibitor is the main complication of hemophilia treatment in patients receiving factor replacement as management. The mainstay of therapy in patients who develop inhibitor is to eliminate the inhibitor antibody entirely. This can be achieved by immune tolerance induction therapy which comprises regular F8/F9 infusions in high dose. There are only a few studies on ITI from India and hardly any from Eastern India. Aims & Objectives: To evaluate the outcome and clinical profile of hemophilia patients receiving ITI therapy. Materials & Methods: It is a retrospective analysis of data. The study describes the clinical profile and outcome of ten severe hemophilia patients who had developed inhibitor antibody after few years of factor replacement therapy and thereafter started on ITI therapy. Result: Of those 10 patients all of them were males, cases of severe hemophilia A. Six of them initially were on prophylactic factor replacement therapy, three on demand therapy and the remaining one's initial presentation at our centre was after development of high titre inhibitor when he had to be given FEIBA here with no documentation of prior factor exposure available. Only two out of ten suffered an episode of breakthrough bleed during which they were administered FEIBA and the dose of ITI increased. Six showed complete response and are off ITI therapy now. Two patients showed an increase in inhibitor level after 3 months and the dose of ITI was increased thereafter. One of them received in addition Injection Rituximab. Conclusions: ITI therapy was successful in around 60?ses and none of the patients experienced adverse effects. Introduction: N8-GP is a recombinant, glycoPEGylated, extended half-life factor VIII (FVIII) replacement product approved for the treatment of patients with haemophilia A. Aims & Objectives: To evaluates safety and efficacy of N8-GP in previously untreated patients (PUPs) with severe haemophilia A. Materials & Methods: Pathfinder TM 6 (NCT02137850) is an ongoing, open-label, single-arm, phase 3a trial investigating N8-GP treatment in severe haemophilia A PUPs, enrolling male children, \ 6 years old, with no exposure to FVIII concentrates and no FVIII inhibitors. The primary endpoint was the FVIII inhibitor incidence (two consecutive tests C 0.6 Bethesda units (BU); high-titre was C 5 BU). For this analysis, C 50 patients had C 50 exposure days (EDs) to N8-GP. Patients with C 10 EDs or inhibitors were included in inhibitor incidence analysis. Patients \ 24 months old were treated with pre-prophylaxis or prophylaxis. Patients C 24 months old were treated with prophylaxis. Result: 80 patients received C 1 N8-GP dose and were included in this analysis. Of the 67 patients eligible for FVIII inhibitor analysis, 20 developed inhibitors (10 high-titre), resulting in an incidence rate of 29.9% (14.9% high-titre). Seven patients began immune tolerance induction therapy; 5 were successful, 1 withdrew and 1 has ongoing therapy. Sixty-five patients received N8-GP prophylaxis for an average 2.17 years. In these patients, the median ABR (interquartile range) was 1.42 (0.76; 3.13), 91.3% of bleeds were treated with B 2 injections and the haemostatic success rate was 90.5% (Table) . No unexpected AEs were observed. Temporarily decreased incremental recovery was observed in 17 non-inhibitor patients. Conclusions: Compared with previous studies, patients in pathfinder6 had an inhibitor incidence within the expected range and a high-titre incidence within the lower range. Patients on prophylaxis had a median 1.42 ABR and a 90.5% success rate for treatment of bleeding episodes, indicating that PUPs can be successfully treated with N8-GP. To determine the phenotype-genotype correlation in forty (thirty-one index cases and nine affected family members) VWD cases. Materials & Methods: Patients with bleeding history, decreased levels of VWF antigen, activity, and/or an abnormal ristocetin-induced platelet aggregation test were subcategorized. Informed consent along with complete history was taken. Thirty-one index cases were subjected to targeted resequencing using AmpliSeq custom panel for Illumina and the sequencing was performed on MiSeq. The data analysis was done using Local Run Manager and BaseSpace Variant Interpreter software (Illumina). Pathogenicity of variants was predicted using various in silico tools. Sanger validation of pathogenic variants was done in the index cases and family members. Result: Based on clinical and molecular findings, the type 3 subtype was the commonest (57%) followed by type 2 (32%). Consanguinity was noted in four families of which three were type 3. Family history was positive in 14 cases. Probably pathogenic variants were found in 28 cases (90%). Total 29 variants were found in VWF gene that include 13 missense (44.8%), 7 nonsense (24.1%), 5 splice site (17.2%) and 4 frameshift (13.8%) variants. Twelve variants (41.4%) were novel. Four variants (13.7%) were recurrent. The genetic analysis helped to confirm the diagnosis in three clinically miscategorized VWD subtypes. Homozygosity was seen in a majority of the cases (46%). Exon 28 was the hotspot (31%) for variants and the rest of the variants were distributed throughout the gene. Conclusions: Targeted next-generation sequencing yielded probably pathogenic variants in 90% of the cases. The results of the genetic analysis have helped for the accurate categorization of VWD subtypes and genetic counseling. Predictive testing and prenatal diagnosis can be provided to the affected families using this data in future.

All that is Swollen is Not a Tumour: Haemophilic Psuedotumour Confused for a High Grade Bone Malignancy Zuhair Ahmed Syed, Vinu Sarathy, Shreyas Hanmantgad Introduction: Haemophilic pseudotumours are an uncommon complication of haemophilia. Osseous pseudotumours are radiologically lytic and usually have a well-defined margin. It is difficult to identify whether a radiologically lytic lesion is malignant or a pseudotumour. Aims & Objectives: To highlight a rare presentation of haemophilia A and stress on the importance of history taking in the diagnosis of haemophilia in patients with raised APTT and family history of bleeding.

A 17-year-old male presented with right lower thigh pain with swelling for more than 2 months. He had significant weight loss and night pains. He had no loss of appetite, night sweats or fever. On examination, a 10 9 7 cm warm, tender, firm mass was noted in the right distal femur with no restriction of joint movement, no neurovascular deficit and no enlarged draining lymph nodes.

Result: X-ray of the right knee showed a large bone and soft tissue lesion involving the right distal femur with features suspicious of periosteal reaction. MRI of the right knee showed a large lesion in the metaphyseal region of the right distal femur of size 11.7 9 8.0 9 7.2 cm with features suspicious of high grade bone malignancy. In pre-anaesthetic workup for biopsy of the lesion, he was found to have an isolated prolonged activated partial thromboplastin time of 67.5 s. On probing, patient had episodes of recurrent epistaxis all through the childhood. He had previously never required blood products or factor concentrate transfusion. His father also had history of epistaxis. APTT mixing study showed full correction suggestive of factor deficiency. Factor VIII was 12%. He was diagnosed as mild Haemophilia A. He was referred to a haemophilia centre where biopsy of the lesion done under precautions reported a large haematoma in the distal femur. Bone margin histopathology reported lamellar bone with intervening marrow spaces with adjacent dense granulation tissue, inflammatory cell infiltrate and blood clot with no evidence of malignancy. Conclusions: Haemophilic pseudotumours are difficult to identify based on radiological evidence alone but a detailed history and targeted evaluation leads to the correct diagnosis.

Abhishek Sharma, Praveen Kumar, Kundan Mishra, kanwaljeet Singh, Suman Kumar Introduction: Immune thrombocytopenia (ITP) is a rare hematological disease characterized by platelet count less than 100,000/cmm. Risk of bleeding increases with falling platelet count. However, fatal bleeding complications are rare in ITP. Corticosteroids are the mainstay of the treatment. The data on clinical and hematological profile of ITP in India are mostly derived from retrospective study. Therefore, there is heterogeneity in data on clinical and hematological profile of ITP patients. Aims & Objectives: We aimed to analyze the clinical and hematological profile of newly diagnosed ITP. Materials & Methods: This prospective, observational study was conducted at a tertiary care hospital in northern India. We included patients with acute ITP (diagnosed within three months of inclusion in the study) diagnosed at our center or reported to our center for therapy. Result: Ninety-seven patients were included in this study. The median age was 33 years (10-68), and 80 (82.45%) were male. The median platelet was 15,000/cmm (IQR 8000-40,000). Mean hemoglobin and WBC at diagnosis were 13.25 g/dL (± 2.51) and 8507/cmm (± 2937) respectively. Fifty-four (55.6%) patients presented with bleeding manifestations, and WHO grade C 2 were present in 10 (10.3%) cases. Most patients (28/54, 58.15%) had cutaneous bleeding followed by menorrhagia (12/54, 22.22%), perrectal bleeding (4/54, 7.4%), epistaxis (4/54, 7.4%), intracerebral hemorrhage (2/54, 3.7%), gum bleeding (2/54, 3.7%), hemoptysis (1/ 54, 1.8%) and hematuria (1/54, 1.8%) (Fig. 1) . Fatigue was the second most common presentation seen in 11 (11.34%) patients. Twenty patients (20/97, 20.62%) did not require any therapy and were kept on observation only. Remaining 77 patients received steroid with or without immunoglobulin. Platelet (SDAP/RDP) were transfused in 21 (21/97, 21.64%) patients. Conclusions: While half of the patients with ITP presented with some bleeding manifestation, WHO bleeding grade C 2 was seen in only 10.3% of cases. A subgroup of patients with ITP only requires close observation without therapy. Platelet transfusion is required only in a small subgroup of patients (21%). This real world study will give an Indian J Hematol Blood Transfus overview of ITP from developing country to physicians and budding hematologist and will also help in planning better management.

Devesh Parashar, Chandrakala S, Farah Jijina Introduction: Hemophilia patients frequently suffer from disabling chronic arthopathy and osteoporosis. Although most surgical and invasive procedures can be performed safely in hemophilia patients the optimal level and duration of replacement therapy required to prevent bleeding complications have not been established. Aims & Objectives: A retrospective analysis of orthopedic surgeries carried out, amount of factors used and complications at a comprehensive Hemophilia centre in western India. Materials & Methods: This is a retrospective study of 50 orthopedic surgeries in hemophiliac patients at our centre in western India from 2016 to 2021 in age range of 5 years to 60 years. Of these pateints, 31 had hemophilia A, 3 had hemophilia A with inhibitors, 13 had hemophilia B, 1 patients was hemophilia B with inhibitors, 1 had combined factor 8 & 5 deficiency and 1 had factor 10 deficiency. In total 50 surgeries 10 was total hip replacements, 14 total knee replacements, 13 fratuers external fixations and repair, 2 ankle arthrodesis,9 pseudotumor surgeries, 1 tendon release, and 1 ACL repair was done. The factor concentrates are used along with antifibrinolytics drugs. Result: The factor concentrates used in these surgeries ranged from 130 to 827 IU/kg/surgery. 5 patients with inhibitors and facor X deficiency received FIEBA and factor 7a.Few patients required antifibrinolytics drugs. For THR and TKR factor support given for 10 days.Joint replacement surgeries required factor concentrates 342-460 IU/kg/surgery.For fracture surgeries factor replacements given for 4-5 days. Four patients develop bleeding complications postoperatively that were managed with factor corrections.There was no death due to bleeding complications. Conclusions: This study shows that with excellent operative techniques and intense hematological management in orthopedic surgeries in hemophilia patients can provide good outcome. The excellent functional improvement and low incidence of complications can be achieved with good coordination between surgeon, hematologist and laboratory.Thre are no standard guidelines and different centers use different dose and days of factor concentrates for surgery,the need to define these lower limits is essential in the developing world so that the limited resources may be used optimally.

A Rare Case of Immune Thrombocytopenic Purpura Secondary to Hashimoto's Thyroiditis Aditi Randev, Ila Pahwa Introduction: Immune Thrombocytopenic Purpura (ITP) is an entity characterized by a platelet count of less than 100 9 109/L in the absence of other causes of thrombocytopenia, such as viral infections, rheumatic diseases, or drugs. Hashimoto's Thyroiditis is an autoimmune condition in which thrombocytopenia has been observed rarely. Aims & Objectives: Patients with ITP with no underlying cause should be screened for thyroid autoantibodies.

The authors report the case of a 46 year old male with complaints of swelling in the neck from 3 months, illdefined with a size of 7 9 3 cm in midline of neck, which moved with deglutition, was firm in consistency, mobile and non tender.

A Complete blood count done at the time of admission reported a Platelet count of 9500/Ul and the Serum TSH was 18.4 mU/L. Serum Anti TPO level was 438 IU/ml. Ultrasonography of neck showed chronic thyroiditis. Bone marrow biopsy showed Megakaryocytic hyperplasia. Result: Initially due to a very low platelet count, the patient was treated with platelet transfusion, later started on steroids (prednisolone) which showed only little improvement in the platelet counts. It was after treating the patient with thyroxine 75 mcg od, that the platelet count significantly improved. A diagnosis of ITP secondary to Autoimmune thyroiditis was made. Patient was discharged after 14 days with steroid dose tapering for 4 weeks and thyroxine 75mcg OD to continue. Conclusions: Hashimoto's thyroiditis as the cause of secondary ITP is a very rare phenomenon. Treatment of Hashimoto's thyroiditis with levothyroxine may enhance response of standard ITP therapy. Patients with ITP with no underlying cause should be screened for thyroid autoantibodies.

Himani Bajaj, Taruna Bansal, Sadhna Marwah, Vijay Kumar

Introduction: Thrombocytopenia, defined as platelet counts below 1,50,000, can be caused due to increased destruction, decreased production or splenic sequestration/abnormal pooling. Bone marrow aspiration, considered as the gold standard method for evaluating the cause of thrombocytopenia. Is invasive, time consuming and carries risk of bleeding diathesis in critical thrombocytopenia cases.. Immature platelet fraction is an automated detection of reticulated platelets., Recently, immature platelet fraction (IPF) have been investigated as prospective platelet activation marker on the basis that the platelet RNA content correlates directly with megakaryocytic activity. Our study attempts to find the usefulness of this platelet parameter in the initial evaluation of patients with thrombocytopenia. Aims & Objectives: To obliviate the need of bone marrow examination for diagnosing the etiology of thrombocytopenia. Materials & Methods: This is a cross sectional study being conducted in Department of Pathology, tertiary care hospital, Delhi. All patients with thrombocytopenia either isolated or as part of pancytopenia have been included after careful bone marrow examination. Blood samples from the study population were collected on the same day of bone marrow examination in EDTA tubes and processed within 4 h. The Platelet count and IPF were noted and entered into excel spread sheets for 30 subjects with thrombocytopenia and equal number of healthy controls. The peripheral smears, bone marrow aspirates and biopsy slides were also evaluated. Appropriate statistical tests will be applied. Result: The patients with thrombocytopenia were classified into hypoproductive and hyperdestructive groups based on the clinical etiology and cellularity of bone marrow aspirate. The reference range of IPF was 0.2-6.90% in normal controls, 0.10-22.9% in hypercellular group and 1.4-9.4% in hypocellular group. The IPF % was significantly higher (p value \ 0.001) in the hyperdestructive group[median (IQR) = 6.8%(0.10-22.9%)] as compared to hypoproductive group[1.8%(1.45-6.65)]as well as normal control group[1. 80%(1.05-4.27) ]. Conclusions: IPF may serve as a valuable marker for identifying patients with increased platelet destruction. However further studies with a larger study group are required to evaluate the significance of IPF in determining the etiology in thrombocytopenia.

Introduction: Emicizumab is a bispecific, humanized, monoclonal antibody mimicking the factor (F) VIII cofactor activity in mediating the generation of FXa by FIXa in patients with hemophilia A. It has been approved for the prophylaxis for hemophiliacs with and without FVIII-inhibitors of all ages. Emicizumab prophylaxis significantly reduced bleeding rates compared to previous treatments. In addition, subcutaneous administration of emicizumab provided beneficial effects on health-related quality of life, and lessened the burden of the disease in patients as well as in their caregivers. Till date no studies have been published on the role of emicizimab in acute bleeding episodes.

Aims & Objectives: Role of low dose emicizumab in acute bleeding episodes in hemophilia A with inhibitors. Materials & Methods: A case series of 8 patients of hemophilia A with inhibitors presenting with acute bleeding episodes including 1 female with VWD (2 patients with tongue bleed, 1 with lower lip bleed, 1 with left hand palm hematoma with bleeding, 1 with trauma to face in mandibular region, 1 with retroperitoneal bleed, 2 with gum bleeding with pseudotumor), managed on bypassing agents and emicizumab.

Result: Use of emicizumab along with bypassing agents resulted in significant control of acute bleeding episodes, reduced requirement of bypassing agents, avoidance of surgical intervention, thereby reducing financial burden, morbidity and hospital stay. Conclusions: Use of emicizumab is beneficial in controlling acute bleeding episodes in hemophilia A with inhibitors. More trials are required to substantiate the same.

Kamlesh Ahari, Abhishek Purohit, Gopal Krishna Bohra, Karthikeyan Thangaraju, Mahendra K Garg Introduction: Frequency, clinical implication and effect of presence of antiphospholipid antibodies (APLA) on treatment in cases of immune thrombocytopenia (ITP) vary among different studies. There is paucity of literature about prevalence of APLA among ITP patients from Western part of India. The aim of the study was to evaluate the frequency and clinical relevance of APLA in adult ITP patients from Western Rajasthan.

Aims & Objectives: This study aimed to determine the frequency and clinical significance of elevated APLA in adult ITP patients.

In this prospective study, we studied 33 patients of ITP wherein male to female ratio was 1:2.3 and median age was 40 years (18-65). Bleeding manifestations of all cases were recorded and all patients were tested for lupus anticoagulant (LA), anti-b2glycoprotein I (b2GPI) immunoglobulin G (IgG) and IgM antibodies and anticardiolipin (aCL) IgG and IgM antibodies. Patients were assessed for treatment (including steroid) response. Clinical profile and response rates were compared between APLA-positive and APLA-negative patients. Result: APLA were detected in 14 (42.4%) patients with ITP. LA was the most frequent (21.2%). One and two patients showed dual-positivity and triple-positivity for APLA respectively. APLA were more common in females [12 (85.71%)] when compared to males. We did not find any statistically significant difference in the clinical profile between APLA-positive or APLA-negative ITP cases. None of the APLA-positive ITP patients developed thrombosis.

Conclusions: The incidence of APLA in our cohort correlated with Western literature, however, we did not observe any impact of APLApositivity on clinical profile as well as steroid responsiveness. We included patients above 18 years of age who meet the criteria of ITP. The diagnosis and response to treatment was adopted according to American society of hematology. Various investigation required are sent and data collected was studied in stata 13.0 software. Result: In the study majority of patients were in age group of less than 30(48.39%), male to female ratio was 1: 4.1. The baseline platelet count at presentation was less than 5000/ microL. The time since diagnosis was more than 12 months in 58.06%.The most common clinical presentation was skin bleed (64.52%), bleeding per vagina (12.90%). Primary ITP consist of 83.87% and secondary cause in 16.12%. Among secondary Evans syndrome was 9.68%. Among first line, intravenous high dose methylprednisolone has best response (45.16%) followed by intravenous high dose dexamethasone (50%) . splenectomy has response rate of 80%, rituximab of 33%, romiplostim (99%),eltrombopag (50%) . among third line azathioprine has response of 11%.

Conclusions: Primary ITP was more common than secondary ITP in Manipur, with female preponderance with age peak at less than 30 years. The most common presentation being skin bleed. Steroid was the most common first line and rituximab being the most commonly used as 2nd line but higher response seen with splenectomy and thrombopoeitin receptor agonist. Follow of patients and evaluation of various treatment outcome extend our knowledge on clinical profile and identify causes of ITP in our state.

Kundan Mishra, Suman Kumar

Introduction: Though immune thrombocytopenia (ITP) is a rare hematological disease, it is prevalent in hematology practice due to chronicity. ITP is characterized by platelet count less than 100,000/ cmm with varied bleeding manifestations. Corticosteroids are the first-line treatment with an overall response rate (ORR) of 70-90% but the majority ([ 2/3) of patients relapse. Fatigue is the second most common symptom in ITP patients after bleeding. There is a scarcity of data on the prevalence, characteristics, and effect on lifestyle due to fatigue in patients of ITP.

Aims & Objectives: We aimed to analyze fatigue in patients of ITP.

Materials & Methods: This prospective, cross-sectional study was conducted at a tertiary care hospital in northern India. We included patients with ITP (acute, persistent, and chronic) diagnosed at our center or reported to our center for therapy. Fatigue in our patients was assessed by using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) tool. The patient's perceptions of the effect of fatigue on their cognitive, physical, and psychosocial functioning in the previous week was recorded based on a set of a selfreported questionnaire. Healthy volunteers were taken as control.

Result: Fifty-one patients were included in this study. The median age was 37 years (18-80), and 31 (60.78%) were male. The median platelet was 66,000/cmm (3000-310,000). On FACIT-F score analysis, out of the seven parameters of physical well-being, for four parameters (pain, side effects of treatment, ill-feeling, and forced to spend time in bed) the ITP patients had significantly higher symptoms burden in comparison to control (p \ 0.05). On subgroup analysis, non-responders had a statistically significantly (p \ 0.05) higher symptoms burden than responders (Figure) . As far as physical wellbeing was concerned, there was no difference in symptoms burden based on the duration of the disease (acute, persistent, and chronic ITP).

Conclusions: The burden of fatigue affecting physical well-being was significantly higher in ITP patients when compared with healthy control. Moreover, the non-responders had a higher fatigue burden affecting physical well-being than the responder's subgroup of ITP.

The study will help in better understanding of patients' disease burden by the hematologists. Of the diagnosed cases, Glanzmann's thrombasthenia (seen in 65%) was the most common platelet function defect followed by storage pool disorder (11%) and Bernard Soulier syndrome (8%). One case each of grey platelet syndrome, glycophorin A deficiency, cyclooxygenase deficiency, macrothrombocytopenia with decreased ADP, inherited giant platelet disorder -constitutional megathrombocytopenia was seen. A rare case of acquired platelet dysfunction with eosinophilia (APDE) was also seen.

Conclusions: In our study, we found Glanzmann's thrombasthenia as the most commonly diagnosed platelet function disorder. We also acknowledge that tests like luminoaggregometry, granule release assay and molecular testing are more sensitive than platelet aggregometry. In developing countries where many cases remain undiagnosed, we should consider collaborating with specialised laboratories to identify undiagnosed cases. Most of the patients presented with petechiae and wet purpura with the onset of symptoms between 7-20 days (median 15 days) post-vaccination. All of these patients had severe thrombocytopenia at presentation with a median platelet count of 7 9 109/l (range 1-14 9 109/l). Anti PF4 antibody testing was done in two patients which were negative. Therapy details include IVIG (3), steroids (4), eltrombopag (2), azathioprine (1), and platelet transfusions (2) . Of these, two patients had no response to first-line therapies. One patient did not respond to IVIG, steroids, azathioprine, and subsequently developed an intracranial bleed. He was managed with platelet transfusions, IVIG, steroids, and eltrombopag. His platelet counts have stabilized at 50 9 109/l and he did not have further bleeding manifestations. At the last follow-up, 80% (n = 4) of our patients have achieved a response.

Conclusions: Immune thrombocytopenia is being increasingly recognized post-COVID vaccination. All our patients had severe thrombocytopenia requiring therapy. The question of whether these cases are actually primary ITP coinciding with the administration of the vaccine or ITP secondary to vaccination remains unanswered. Additional surveillance is needed to determine the true incidence of COVID-19 vaccine-induced ITP. Thrombocytopenia with platelet count (\ 150 9 10 9 /L) were taken which were further subdivided into hyperdestructive group and hypoproductive group. Controls with normal platelet count (150-450 9 10 9 /L) were taken. Platelet counts, MPV, PDW, P-LCR were studied in all these groups. The data was statistically analyzed and appropriate statistical tests were applied.

Result: Out of 100 study group, males are 44% and females are 56% with mean age group of 20-70. Among thrombocytopenia cases MPV was significantly higher in hyperdestructive group and was lower in hypoproductive group, whereas PDW and P-LCR were higher in hyperdestructive compared to hypoproductive group. Conclusions: These simple platelet indices can be routinely used in the initial evaluation of a patient with thrombocytopenia. 

Vijayalakshmi Aravindan Arun, Arihant Jain, Deepesh Lad, Gaurav Prakash, Alka K, Amanjit Bal, Pankaj Malhotra Introduction: Tuberculosis (TB) and is the leading infectious cause of death worldwide today. Tuberculosis (TB) and its treatment have been associated with a variety of hematological changes, including thrombocytosis (especially in pulmonary TB) and thrombocytopenia (associated with disseminated or miliary TB). TB is rarely considered amongst the possible differential diagnosis of acute undifferentiated febrile illness (AUFI) with thrombocytopenia. A review of literature show less than 50 cases of TB associated Immune Thrombocytopenia (ITP) reported till date. In most cases, treatment for ITP (steroids or other immune-modulating agents) was started prior to ATT, as the diagnosis of TB was only established later. Generally only a minor increase in platelet count was achieved under exclusive immune-modulatory medication; therapy extension or switching to ATT, however, resulted in a significant platelet count recovery over a period ranging from 2 days to 3 months. We report our experience of managing three cases of TB associated ITP in the last one year. Aims & Objectives: To highlight the importance of considering TB associated ITP in cases of AUFI with thrombocytopenia in the appropriate clinical setting. To highlight the need to avoid inadvertent use of steroids/IVIG in ITP secondary to ITP. Materials & Methods: We report our experience of managing three cases of TB associated ITP in the last one year. Result: As per table attached. Two out of the three cases had mucocutaneous bleeding related to severe thrombocytopenia at presentation. Although microbiological diagnosis was confirmed only in the third case; all three cases showed complete resolution of ITP with ATT only with no exposure to steroids/IVIG. Conclusions: TB can rarely present as AUFI with thrombocytopenia. It should be considered as an underlying cause of ITP in the appropriate clinical setting. Diagnosis of extra-pulmonary TB can be challenging and empirical ATT has to be started based on the available clinico-radiological findings. Early diagnosis of TB and initiation of ATT is crucial for rapid platelet count recovery and this can reduce the risks associated with inadvertent use of immune-suppression/immune modulation in TB associated ITP.

Genotypic-Phenotypic Correlation in DBA Anurag Dutta Chaudhury, Phaneendra Datari, Prasanth. S, Anup Devasia, Fouzia NA, Anu Korula, Uday Kulkarni, Biju George, Shaji R Velayudhan Introduction: Diamond Blackfan Anaemia (DBA) is a rare inherited bone marrow failure syndrome (BMFS), with an incidence of 7 cases per million live births, resulting in severe anaemia, early in the life. Haploinsufficiency of around 20 genes that encode for various ribosomal proteins is found to cause DBA with 90% of the cases showing defects in 6 genes-RPS19, RPL5, RPS26, RPL11, RPL35A and RPS24. About 50% of DBA cases show characteristic physical abnormalities. Aims & Objectives: We aim at evaluating and correlating the common genotypes and phenotypes of DBA cases that were diagnosed and treated at the Department of Haematology, Christian Medical College, Vellore. Materials & Methods: A total of 51 patients with clinical features of DBA between January 2018 and August 2021 were recruited and were evaluated for DBA specific gene mutations. Single nucleotide variations (SNVs) in the 20 known genes were analyzed using long amplicon based next generation sequencing. The copy number variations were analysed by Multiplex-Ligation based Probe Amplification (MLPA). Result: DBA associated mutations were found in 30/51 patients, with RPS19 being the most mutated gene (14/30), followed by RPL5 (5/ 30), RPS17 (4/30), RPS26 (2/30), and RPS3, RPL7A, RPS20, GATA1 and CECR1 mutations found in one patient each. The median age at presentation in mutation positive cases was 2 months (range: 1 month to 10 years). Hypopigmented lesions were the most common physical abnormality identified in 8/30 cases followed by craniofacial abnormalities in 5/30 cases. RPS19 gene mutations were associated with most of the physical anomalies. Glucocorticoids were given as the first line of treatment in all the cases. Initial steroid response was seen in 17 patients, 12 patients did not respond to this treatment and 1 was lost in the follow-up. Complete response was seen in 9/17 initial responders, whereas the other 8/17 relapsed either while still on steroids or after tapering. Mutation negative cases had a median age of 9 months (range: 2 months to 48 years) with 3/21 cases over the age of 25 years. Physical abnormalities were found in 3/21 cases. One case each were positive for Parvo virus serology and Indirect coombs test. Haematologic parameters like Hb, MCV, reticulocyte count and eADA were not compared as the patients were transfused prior to evaluation at our center. Conclusions: Lower age at onset and physical anomalies were more associated with DBA cases. Mutations in RPS19 are associated with poorer steroid response.

Ring Sideroblasts in Marrow-ssssNot Always Dysplastic! Surbhi Dahiya, Amit Nisal, Rachna Lakhe, Ravindra Nimbargi Introduction: Ring sideroblasts are erythroid precursors containing deposits of non-haem iron in the mitochondria in a ring like distribution (at least one third) around the nucleus. Sideroblastic anemia results from an abnormal erythropoiesis during haem production. It has two forms: hereditary (non-syndromic and syndromic) and acquired (primary: clonal and secondary: drugs, toxins etc.). We hereby describe two rare entities with ring sideroblasts in the bone marrow that are not pertaining to myelodysplasia. Aims & Objectives: To emphasize on the identification of ring sideroblasts in bone marrow and diagnose rare entities associated with their presence. Materials & Methods: Case 1-Nine months old male, exclusively breast fed presented with failure to thrive, severe pallor, severe malnutrition with metabolic acidosis and cardiogenic shock. Hemogram revealed pancytopenia with severe macrocytic anaemia. Case 2-Thirteen-year male, known case of Hodgkin's lymphoma and XDR-tuberculosis, post bone marrow transplant presented with anemia and thrombocytopenia. Bone marrow aspirate and biopsy were performed in both cases along with further investigations. Result: Case 1: Bone marrow aspirate was normocellular with erythroid suppression, vacuoles and mild dysplasia in erythroid and myeloid precursors. Iron stain revealed presence of few ring sideroblasts. Reticulocyte count was less than 0.5%. Serum vitamin B12: 217 pg/ml, serum homocysteine: [ 50.0umol/L, LDH: 1130U/L, serum ferritin: 2340 ng/ml, presence of ketones in urine. The findings raised the possibility of Pearson's bone marrow failure syndrome. Molecular studies for confirmation were advised. Case 2: Marrow was hypocellular with relative erythroid hyperplasia, evidence of dysplasia in the erythroid lineages and presence of numerous ring sideroblasts on iron stain. Further evaluation revealed the history of intake of linezolid for a year leading to drug induced sideroblastic anemia, which is a reversible condition. Conclusions: Presence of ring sideroblasts in the marrow aspirate does not always conclude to myelodysplastic syndrome, careful history taking and evaluation with clinical features leads us to the correct diagnosis of these rare entities which are likely to be misdiagnosed and thereby, prevent misguided management.

Shravanthi Naidu S Woodayagiri, Swathy Moorthy, Sri Gayathri Introduction: Primary Myelofibrosis is the least frequent among the chronic myeloproliferative disease. The median age at presentation is 67 years.

Aims & Objectives: To elaborate the need for bone marrow biopsies in patients presenting with anemia and splenomegaly. Materials & Methods: A case of a 57 year old female presented with weight loss and anorexia for 6 months, she also had multiple episodes of low grade fever. She had undergone a hysterectomy 15 years prior, past history was otherwise unremarkable. No known comorbidities. On examination she was poorly built and nourished. Massive splenomegaly was present, with enlargement of the spleen to the level of the umbilicus, non tender, no nodules palpable. No hepatomegaly or ascites. Routine labs showed pancytopenia. Hb-4.7, TC-3200. Plt-1.22. 2D echo was normal (EF 61%). LDH-165. DCT was negative. CECT of the whole abdomen was done, which showed gross splenomegaly with a dilated portal vein (16 mm), perisplenic collaterals and precaval lymph nodes. Bone marrow aspiration and bone marrow biopsy was done in suspicion of myelodysplasia. Initial biopsy was negative for malignant cells and aspirate showed a hypercellular marrow with no abnormal clones. However, repeat biopsy showed features suggestive of prefibrotic stage of myelofibrosis-grade III. Microscopy revealed hypercellular marrow with trilineage hematopoiesis with diffuse proliferation of megakaryocytes and multiple lymphoid nodules in interstitium. Pearl's stain showed iron stores 2 ? present and increased reticulocyte count. IHC markers revealed CD 45, CD 3 and CD 20 were positive with the presence of reactive lymphoid follicles. CD 34 and CD 31 negative. CD 117 was positive in scattered myeloid precursors. CD 15, MPO was positive in the myeloid cells. MT stain showed collagen fibres. Result: As this was suggestive of primary myelofibrosis (pre fibrotic stage), multiple packed cells transfusions given to correct the anemia and the patient was started on Tab Hydroxyurea 500 mg p/o once daily, Tab. Prednisolone 20 mg once daily and Tab. thalidomide 50 mg once daily. Genetic testing was planned, but deferred due to logistic reasons. Conclusions: Careful analysis of bone marrow aspirations may be required to differentiate prefibrotic myleofibrosis from other myleodysplastic syndromes.

Vijayalakshmi Aravindan Arun, Alka Khadwal, Prateek Bhatia, Pankaj Malhotra Introduction: Familial HLH is usually considered to be a disease affecting pediatric population and the diagnosis is overlooked or delayed in most cases. A retrospective analysis of 101 molecularly characterized FHL patients over the last 10 years from 20 different referral centers in India identified FHL2 and FHL3 accounting for 84% of cases. Measurement of perforin levels can serve as rapid screening test for identifying FHL patients. Identifying underlying genetic defect is important for both index case confirmation and offering genetic counseling and prenatal diagnosis in affected families. Allogenic transplant is the only curative option in these cases. Asymptomatic carriers (ACs) of pathogenic biallelic mutations in causative genes for primary HLH are at high risk of developing life threatening HLH. To date there are no data on the natural history of asymptomatic siblings to guide clinicians or families in making this decision. The heterogeneity of clinical presentation in these autosomal recessive diseases renders decision-making extremely challenging. The risks of HSCT, often performed at a very young age, need to be balanced with the risk of waiting for the first HLH episode to manifest, which can be fatal in up to 20% of the patients. There are no guidelines on the management of these asymptomatic patients. Nonetheless, preemptive allogenic transplant in patients of familial HLH with no active HLH manifestations has been done as part of clinical trial at few centres with favorable outcomes. Introduction: 5-FU is an anti-metabolite used in the treatment of various cancers including colorectal, stomach, pancreatic and breast cancers as a cytotoxic chemotherapy agent. Its topical formulation is used in actinic keratosis and warts. It is also a second line agent and a less popular alternative for the treatment of vitiligo. Although myelosuppression is a known side effect of systemic 5-Fu it has not been reported with use of topical formulation to our knowledge. Case Report: We report a 24 year old female who presented to us with complaints of easly bruising of skin, gum bleeding, sub-conjenctival heammorhage, menorrhagia and exertional dyspnea. Patient was evaluated with routine blood test and was found to have pancytopenia with A hb 5 g/Dl.tcl 3390 cells/cumm, tpc 10,000/cu mm. She is a known case of focal vitiligo (on the upper aspact of chest) and was treasted with topical 5-fu(5%), topical tacrolimus (0.03%), systemic and topical steroids and photosensitizer for 5 years. In view of pancytopenia bone marrow aspiration cytology and biopsy was done. Bone marrow biopsy showed trilineage hypoplasia and a diagnosis of drug/induced aplastic anaemic secondary to 5-fu was made. Patient was treated with multipal RDP and PRBC transfusion. She was started on filgrastim and romiplostim injection with partial response. She was treated finally with cyclosporine ans danazo; and her blood parameters improved partially (hb 6.1, TLC 2690 cell/cu mm and TPC 15,000/cu mm with amelioration of clinical complaints (no bleeding manifeastations, petechiae, ecchymosis, fever or fatigue on exertion) and was dischared on these medications with advice for complete cessation of 5FU and regular follow up.

Conclusions: 5 fu induced myelosuppesion leading to a plastic anemia is a rare entity and topical formulation causing aplastic anaemia is even rarer. Clinicians should be aware of the toxic effects of 5 fu while prescribing them for benign condition like vitiligo where the risks may clearly outweigh the benefits. Introduction: Gaucher's disease is one of the most common lysosomal storage diseases characterized by hematologic abnormalities, organomegaly, and skeletal involvement. Although about two-thirds of patients present before the age of 20, it should be considered in young adults presenting with unexplained cytopenias, organomegaly, or bone disease. Case Report: A 20 year old female presented with insidious onset generalized weakness and easy fatigability, menorrhagia and dragging sensation in the left upper quadrant of abdomen. There was no history of fever, rashes, joint or bone pain, yellowish discoloration of eyes and urine, night sweats, or weight loss. There was no history of similar illness in her family members. On physical examination, the patient had pallor but no icterus or lymphadenopathy. She had massive splenomegaly and mild hepatomegaly. On investigation, complete blood count showed pancytopenia (hemoglobin = 6.8 g/dl, white blood cells = 2.45 9 109/L and platelets = 40 9 109/L). Ultrasonography confirmed massive splenomegaly (23 cm) and mild hepatomegaly (15 cm) with normal portal vein diameter. Bone marrow biopsy revealed hypercellular marrow with clusters of ovoid macrophages with abundant fibrillary cytoplasm and round eccentric nucleus (gaucher cells). b-glucosidase enzyme assay by fluorometry method was done which showed bglucosidase level of 0.51 nmol/hour/ml (normal value [ 2 nmol/ hour/ml). Final diagnosis was Gaucher's disease type 1.

Result: Gaucher's disease is an autosomal recessive disorder characterized by the deficiency of the enzyme glucocerebrosidase which results in the accumulation of glucocerebroside in the cells of reticuloendothelial system. All suspected cases are confirmed by demonstrating decreased acid b-glucosidase activity in isolated leukocytes.

Conclusions: This case emphasizes the importance of considering storage disorders like Gaucher's disease in patients presenting with pancytopenia and organomegaly even in adulthood. A high index of suspicion is needed for early diagnosis so that timely and appropriate treatment can be administered. Introduction:

• The incidence of Epstein barr virus (EBV)-positive cells in the bone marrow ranges from 1 to 3%. However, EBV associated with hypoplastic marrow is a very rare, till now only 23 cases reported in literature. • The clinical manifestation are usually remitting, but repeated relapse & remission rarely seen.

Case Report:

• A 65 year male presented with high grade fever & pain in abdomen, recurrent oral ulcers since 1 month with pancytopenia (Hb-7.0 g/dl, RBC-2.92 9 1 0 6 /lL, WBC-0.94 9 10 3 /lL & Platelet count-5 9 10 3 /lL). • ORAL SWAB culture showed klebsiella pneumoniae.

• CT Abdomen showed bowel wall thickening. Result: On PBF, patient was found to have anaemia, thrombocytopenia, leukocytosis, leucoerythroblastic picture with 2% blasts and absolute monocytosis (10,187/ll). BM aspirate showed hypercellular marrow with presence of blasts. Blasts were positive for MPO. Bone marrow aspirate showed features of dysgranulopoiesis and erythroid hyperplasia. Bone marrow trephine biopsy was also hypercellular for age and showed adequate representation of myeloid and erythroid series with hyperplasia and focal clustering of the megakaryocytic series. The biopsy also showed 1 ? positivity on staining with reticulin. At this point, two possibilities i.e. CML with monocytosis and CMML were kept. Later, the mutation analysis was also found to be negative for BCR-ABL, PDGFRA, FGFR, PCM-1 JAK2. So, after complete hematological and mutational analysis a final diagnosis of CMML-1 was given.

Conclusions: All cases of bleeding in elderly should be thoroughly investigated to rule out underlying malignancies. Peripheral monocytosis may also be an indicator of underlying malignancy such as CMML especially in elderly. Bone marrow and other molecular investigations should be done for early and accurate diagnosis. Bone marrow aspiration and trephine biopsy revealed marked myelosuppression with no neutrophils in marrow and peripheral smear. Myeloid precursors markedly depleted. Erythropoiesis and megakaryopoiesis unremarkable. Result: Treated with antimicrobial therapy, granulocyte colony stimulating factor-GCSF and supportive care, discharged after 20 days. Followup was uneventful. Conclusions: With increasing superspecialities and newer immunomodulatory, immunosuppressent drugs and chemotherapy the awareness of effects on marrow especially myelosuppression and thrombocytopenia, one needs to be educated and trained to monitor cells counts periodically. A simple test as-Complete blood count done in a timed manner can save life.

Akshaya Dayal, Nitish Kumar Introduction: Certain viral infections like Parvovirus B19,lymphocytic Leukemias and thymoma are the commonest cause of PRCA.Chloramphenicol,penicillin,phenobarbital and diphenylhydantoin are the commonest drugs which are associated with PRCA,Where as phenytoin rarely causes pure red cell aplasia. Aims & Objectives: We are presenting a case of PRCA in a child which developed after initiation of phenytoin therapy. Materials & Methods: A 11 years old female child presented with long history of decreased appetite,easy fatigability,increased irritability and generalized body weakness since one month without any history of bleeding manifestation,fever, rashes and abdominal distension.Child had a history of taking phenytoin since last 5 month with good compliance as per mother. On general examination, visible pallor was present, child was irritable, tachycardia (126/min) and tachypnea (22/min) was present.

There was no other finding in systemic or general examination. On investigations there was normocytic anemia with normal TLC and platelet counts. Iron profiles were within normal limits. Reticulocyte count was reduced (0.5%). Bone marrow examination was done which showed severe erythroid hypoplasia with normal platelets and WBC lineage. Autoimmune markers, Monospot IgM for EBV, Parvovirus B19 were negative. On CECT thorax there is no evidence of thymoma.

With this evidence and ruling out other differentials we finally reached a diagnosis of Phenytoin induced PRCA and phenytoin was stopped.

Result: The patient improved hemodynamically and hemoglobin improved on follow up after phenytoin withdrawal and supportive treatment.

Conclusions: Pure red cell aplasia is a rare adverse effect of many drugs. Among them phenytoin, azathioprine, and isoniazid have proper evidence for causal association. Therefore drug history is an important aspect in evaluation of anemia. In patients presenting with anemia with normal TLC and platelet, drug induced Pure red cell aplasia is a rare but important differential.

Clinicohaematological Evaluation of Pancytopenia in a Tertiary Care Centre of Central India PARUL MURAB, Deepshikha Verma Introduction: The term pancytopenia is defined as the overall decrease in all the 3 main elements of blood causing leukopenia, anaemia and thrombocytopenia. The diagnosis is made when the haemoglobin is less than 10gm/dl, total leukocyte count is less than 3500 and platelet count is less than 1 lakhs/mm3. It has a wide spectrum of etiology and can occur in association with a wide spectrum of diseases affecting the bone marrow.

Aims & Objectives: This study is directed to correlate the bone marrow findings and haematological picture with the spectrum of pancytopenia. It also describes the incidence of pancytopenia in a defined population. Materials & Methods: Over a period of 1 year from July 2020 to June 2021, a retrospective study was conducted in the department of pathology of GMC Bhopal, a tertiary care centre in which 58 cases were included. Patients of both sexes having pancytopenia were included. Series of tests were conducted to correlate the haematological picture and the bone marrow findings with the severity of pancytopenia. Result: Out of the 58 cases taken, 15-45 years was the most common age group of presentation of pancytopenia. The most common symptom in these patients were fever and weakness. Males were affected more than females in a ratio of 2.1:1. The most common clinical signs were pallor and hepatosplenomegaly. On investigation hypercellular marrow and megaloblastic changes were the most common bone marrow aspirate findings. In more than 62?ses with megaloblastic anaemia like picture vitamin B 12 and folic acid levels were found to be low but these were normal in leukaemia/lymphoma cases. Conclusions: For the diagnosis and proper management of pancytopenia patients, a detailed clinical history, complete physical examination followed by correlation with haematological picture and bone marrow aspiration findings is very important.

Sagarika Pahwa, R. K. Nigam

Introduction: Myelodysplastic syndromes are clonal haemtopoietic stem cell disorders characterised by cytopenias, dysplaisa in or more of the major myeloid cell lines, ineffective hematopoiesis with cellular marrow and a risk for leukaemic transformation. Unexplained cytopenias are ''sine qua non'' of MDS. Dysplasia of haemtopoietic cell lines is the defining feature of MDS. It is a disease of the elderly with median age of presentation being 65 years. The hallmark of this syndrome is ineffective heamtopoiesis and resultant cytopenias. Aims & Objectives: To rule out causes of pancytopenia in this case of a 60 year old male who presented with pancytopenia, no organomegaly and had a history of chronic alcoholism. To evaluate this patient using a multi step approach of using various laboratory investigations and concluding with bone marrow findings. Materials & Methods: The patient was evaluated with a conjoint approach of history, clinical examination followed by routine complete blood count workup, peripheral smear evaluation, Vitamin B 12 levels, bone marrow aspiration and iron studies. The peripheral smear and bone marrow slides were stained with Leishman stain and iron studies were done using Perls Stain. Result: Elderly male, absence of organomegaly, history of chronic alcoholism, no vitamin B12 deficiency with pancytopenia and further evaluation with morphological findings of cell lines in peripheral smear and bone marrow aspirate revealed dyspoietic features in all the cell lines, ([ 10% in each). Morphological features like, Megaloblastic changes, nuclear budding, mitoses were observed in erythroid cell line. The myeloid series revealed-nuclear hypolobation, hypogranulation, pinc nez nuclei, monocytoid forms etc. Micromegakaryocytes, hypolobated nuclei and multinucleate megakaryocytic were seen. Conclusions: Based upon the clinical and laboratory findings the cause of pancytopenia in this patient was concluded as Myelodysplasia. Other causes of pancytopenia were ruled out and the patient was managed accordingly. Further molecular evaluation was also advised for confirmation.

How Common is Pancytopenia as Reason for Bone Marrow Examination: A Short Study from a Tertiary Care Centre of Western Rajasthsan Sangeeta Pradhan, Manali Satiza, Siyaram Didel, Gopal Krishna Bohra, Abhishek Purohit Introduction: Pancytopenia a relatively common clinico-haematological entity encountered in clinical practice. It is a striking indicator of many life-threatening illnesses, ranging from common drug-induced bone marrow hypoplasia, megaloblastic anemia to fatal bone marrow aplasia and leukemias. Relevant clinical history and complete hematological workup is often needed to evaluate and manage the cases of pancytopenia. Thus, identification of the correct etiology helps in determining underlying pathology, management, prognosis and implementing appropriate therapy.

Aims & Objectives: To study clinical and morphological spectrum of conditions producing pancytopenia. To estimate the frequency of different diseases producing pancytopenia. Materials & Methods: An ambispective study is being conducted on patients which are evaluated clinically, along with haematological parameters for pancytopenia in Haematology Clinic at AIIMS Jodhpur during the period 2018 to 2021. All of these cases were advised bone marrow examination, with Haemoglobin \ 10gm/dl, ANC \ 2000/cumm and platelets \ 100,000/cumm. Result: The present study included 67 cases of pancytopenia. Of all 31 were males and 36 females. Most common age group affected was 20-50 years. In majority of the patients (62.6%) Hb ranged between 6-10 g/dL, 56.7% had ANC between 1000-2000/cumm and 44.7% had platelet counts between 10,000 to 50,000/cumm. In this study, most common marrow finding was hypercellularity with megaloblastic erythropoiesis. Megaloblastic anaemia (16%) was the most common cause of pancytopenia, followed by aplastic anemia (12%), normocellular marrow with haemophagocytosis (10%), acute leukemia (8%) and uncommon causes of pancytopenia such as granulomatous inflammation, SLE and Non-Hodgkin lymphoma were also observed. Conclusions: Physicians practicing the primary care along with the pathologists, should be aware of clinical and morphological spectrum of pancytopenia present in different regions of India. This knowledge will not only prevent delay in diagnosis but will also prevent unnecessary laboratory investigations which may delay management of patient. Further, this will help understanding disease process, diagnose and rule out causes of pancytopenia along with planning further investigations, management and prognosis.

Mansi Mehrotra, Mansi Kala, Kunal Das, Manish Raturi, Sohaib Ahmed

Introduction: Pure red cell aplasia is defined as severe anemia. Proerythroblasts are markedly reduced, however may be present in nomal numbers or sometimes may even be increased There are numerous etiologies, constitutional or acquired, acute or chronic. Constitutional pure red cell aplasia is also called Blackfan-Diamond syndrome. It may be associated with thymoma, autoimmune disease, lymphomas, HIV infection or immunosuppressive therapy. It may be a part of PEM or hypersensitivity to drug reactions. The peripheral blood shows no specific abnormality except of reticulocytopenia. Introduction: Flow cytometry is the gold standard test for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH) and helps in identifying the small PNH clone seen in patients with aplastic anemia or myelodysplastic syndrome. The diagnosis is based on the loss of expression of GPI proteins such as CD55, CD59 on the surface of the affected cells. Various markers have been evaluated for the diagnosis of PNH. Aims & Objectives: To evaluate CD14, CD24 and FLAER as GPI markers for identifying PNH clones by flow cytometry.

The study includes 462 patients between March 2019 and August 2021 who were evaluated for the presence of PNH clone by flow cytometry. Peripheral blood samples from the patient and a healthy control were collected. A single tube panel with CD15 (neutrophils) and CD64 (monocytes) as gating markers and CD24 (neutrophils), CD14 (monocytes) and FLAER (both) as GPI markers was used for neutrophils and monocytes while CD59 was used as GPI marker for red blood cells. A minimum of 50,000 neutrophils, RBCs and 5000 monocytes were acquired from each sample wherever possible. Result: Among the 462 patients included in the analysis, PNH clone was identified in 161 patients (34.8%). This includes 74 patients with more than 10% PNH clone identified in at least 2 lineages, 17 patients with more than 10% PNH clone identified in only 1 lineage and 70 patients where small PNH clone was detected (less than 10%) in 2 or 3 lineages. The median size of the PNH clone in neutrophils, monocytes and RBCs were 9.6% (range: 0.04-99.8%), 19.2% (range: 0.1-99.5%) and 1.3% (range: 0.1-90.2%) respectively. In 38 samples, the PNH clone size was greater in monocytes than neutrophils by at least 5% (range: 5-40%). Within the lineages, the clone size was consistently higher with FLAER when compared to CD24 or CD14 at values greater than 1%. Conclusions: The use of lineage specific gating marker helps in better refinement of the target population while the use of two GPI markers for each lineage helps in more accurate quantification of PNH clone size in the neutrophils and monocytes.

Satarupa Mohapatra, Thiriveedi RSN Lakshmi, Somanath Padhi, Gaurav Chhabra, Prabodha Kumar Das Introduction: Myelodysplastic syndrome increased blasts with excess erythroid (MDS-EB-E) is a rare pre malignant hematopoietic neoplasm characterized by multilineage dysplasia, excess myeloid blast along with presence of C 50% non-myeloid erythroid precursors; and increased risk of transformation to acute myeloid leukemia(AML). Careful evaluation of bone marrow (BM) morphology supplemented with flow cytometric immunophenotyping and cytogenetics is essential for accurate diagnosis and differentiation from acute erythroleukemia (AEL) necessary for further management. We describe a case of MDS-EB2-E in a middle aged male with pancytopenia with morphologic, immunophenotypic and cytogenetic data with special emphasis on role of p53 immunochemistry in distinguishing the two entities. Result: Sixty six years old female, a known case of CKD, who was on regular hemodialysis since 6-7 years presented with shortness of breath while undergoing hemodialysis. Complete blood counts revealed anemia (Hb-8.3 g/dl), total leucocyte count of 5.30 9 10 9 / L, thrombocytopenia (Platelets-78 9 10 9 /L) and reticulocyte count of 2.3%. Bone marrow aspirate showed hypercellularity with mild megaloblastosis and adequate megakaryocytes. Perl's stain for haemosiderin showed increased iron (6?). Bone marrow trephine biopsy revealed normocellular to mildly hypercellular marrow spaces. Some marrow spaces showed irregular bony trabeculae with prominent resorption bays. Paratrabecular fibrosis with few intertrabecular spaces completely filled with fibrous tissue seen (Reticulin stain showed 1-2 positivity). Areas of trabecular surface excavation and tunnelling also noted. The overall findings were suggestive of renal osteodystrophy. Conclusions: The bone biopsy remains the gold standard for diagnosing the abnormalities of the bone turnover. It is the parameter to which all other non-invasive parameters must be compared for bone turnover. A bone marrow biopsy should be carried out in CKD-MBD patients when the clinical symptoms and the biochemical parameters are not conclusive.

Simran Sharma, Poonam Rani, Pragya Jain, Saurabh Goswami, Mrinalini Kotru Introduction: Myelodysplastic syndromes (MDS) are clonal hematopoietic stem cell disorders characterized by cytopenia, dysplasia in cell lines and risk of leukemic transformation. There are various secondary causes which resemble primary MDS morphologically. There should be awareness regarding these etiologies to avoid unnecessary work up.

Aims & Objectives: To study the morphological features of dysplasia in peripheral blood and bone marrow aspirate smears and to correlate them with clinicopathological characteristics. Materials & Methods: It is an observational study. Thirty Wright stained peripheral and bone marrow aspirate smears (BMA) were examined for all the morphological features of dysplasia as per latest WHO guidelines. BMA smears showing dysplasia in any of the lineage were randomly selected to study features of dysplasia. Result: A total of 136 bone marrow aspirate smears were screened of which dysplasia was present in 22?ses. Among these cases unilineage dysplasia was present in 10?ses, bilineage in 40 ?ses and multilineage dysplasia (MLD) in 50?ses. However, the MLD criteria as per WHO was fulfilled only by 13?ses which were associated with Parvovirus, post antipsychotic drug, chronic alcoholism and severe iron deficiency. There were 12 megaloblastic anemia, 8 cellular reactive marrow (CRM), 6 combined deficiency anemia and 4 cases showing significant dysplasia in all the lineages. The morphological and cytopenia criterias for MDS were fulfilled only in two cases; both were chronic alcoholic showing ring sideroblasts. Blasts, Auer rods and pseudo-chediak higashi granules were absent in all the cases. Features such as Bi/Multinucleation, internuclear bridging, karyorrhexis, ring sideroblasts and micromegakaryocytes were significantly present only in cases showing multilineage dysplasia as compared to CRM and combined deficiency anemia. In cellular reactive marrows with dysplasia; underlying diseases such as tuberculosis, autoimmune and hepatitis B virus were present. Conclusions: Whenever we encounter myelodysplasia, secondary causes should be kept in mind and latest criteria along with history and clinical details should be implemented. A repeat bone marrow examination after treatment or withdrawal of offending drugs should be preferred. Hence, it is imperative to acknowledge the various mimickers of MDS to prevent exhaustive work up associated with mislabelling as myelodysplastic syndrome.

Hematological Findings in a Suspected Case of Diamond Blackfan Anemia: A Case Report Vrinda Sharma, Anita Tahlan, Swathi Prabhu, Geetanjali Introduction: Diamond Blackfan Anemia (DBA) is a very rare disease with an incidence rate of 1 in 5 lakh live births and onset within the first year of life. It is a pure red cell aplasia which shows almost total absence of erythroid precursors in the bone marrow along with normal myelopoiesis and megakaryopoeisis. Timely diagnosis of DBA can lead to good prognosis in these patients. Aims & Objectives: To find out the underlying etiology for persistent severe refractory anemia in a 6-month-old baby who presented with pallor, lethargy and recurrent fevers and multiple blood transfusions. Materials & Methods: Peripheral blood was drawn and analysed on automated SYSMEX XN1000 as well as manually on smear. Hemolytic work-up was done. Bone marrow analysis was made on aspirate and trephine biopsy. Result: Peripheral blood revealed severe anemia with reticulocytopenia; platelets and total and differential leucocyte counts were within normal ranges.

Bone marrow aspirate was aparticulate and showed marked suppression of late erythroblasts (0.2%) in an otherwise normoblastic erythroid series. Only proerythroblasts were seen. The Non-Erythroid to Erythroid ratio was calculated as 13:1 with a predominance of lymphoid population (55% among the marrow nucleated cells). No discernible iron on Perl's stain was noted.

Trephine biopsy was normocellular with erythroid hypoplasia showing decrease in late erythroblasts. Myeloid and megakaryocyte series were adequately represented.

In view of marked suppression of late erythroid series, severe anemia and recurrent fevers in an infant, an over-all possibility of DBA was made. Testing for ribosomal protein S19 was advised but patient could not afford it. The patient is on follow up for 3 months and continues to have anemia and intermittent fevers. Conclusions: DBA is a rare clinical entity presenting as anemia of infancy without hepatosplenomegaly or lymphadenopathy. It has an autosomal dominant pattern of inheritance with 25% patients carrying a mutation in ribosomal protein S19 gene (RPS19). Bone marrow examination is important modality for diagnosing DBA. Clinical correlation along with RPS19 mutation analysis helps in further solidifying the diagnosis. , complete blood counts, bone marrow aspirate and biopsy of 36 adult pancytopenic MDS patients were reviewed at the department of pathology, Apollo Hospitals, Kolkata. MDS cases were categorised according to the WHO 2016 classification. All the cases underwent cytogenetic analysis either by conventional karyotyping or FISH or both. Risk stratification was done using the revised international prognostic scoring system(IPSS R). Result: The mean age of our study population was 60.5 years with M:F ratio of 2.2:1. 61.1% patients were above 60 years with only 4 patients below 40 years. Hemoglobin level was significantly higher in males than females (P = 0.03). Multilineage dysplasia (MDS MD) was the most common subgroup (47.22%) followed by single lineage dysplasia (22%) (MDS SLD). We found one case of hypoplastic MDS who had a tetraploid karyotype. Hypercellular marrow was the predominant finding (52.78%) followed by hypocellular (27.78%) and normocellular marrow (19.44%). Most cases of MDS MD had a hypercellular marrow (58.82%) while most MDS SLD presented with hypocellular marrow (62.5%).

Of the 36 cases, 14(41.67%) had chromosomal abnormalities-most of them(50%)belonging to the MDS MD group. Most patients had single chromosomal abnormalities (9 cases) with two cases of complex karytotype, both being MDS EB2. Deletions 5q and monosomy 7 were more prevalent, either singly or in combination. Based on IPSS R stratification, intermediate risk group was the commonest (50%) followed by low risk group(26%) and only 4% in the high risk group.

2 patients transformed to AML during our study period-one with MDS MD had trisomy 8 and RUNX1, ASXL1, EZH2 mutation, the other being MDS EB2 with normal karyotype. Conclusions: Our study showed that pancytopenic MDS tend to present at a higher age and with normal cytogenetics as compared to Asian and Indian MDS population. There was no significant correlation between MDS subtypes and cytogenetic abnormalities.

Smriti Gupta, Dr Kanwaljeet Singh Introduction: Gelatinous transformation of the bone marrow (GTBM) is a rare hematologic entity, which was first described by Paul Michael in 1930. GTBM is mostly associated with caloric intake/ anorexia nervosa, although it also has been described accompanying other pathologic conditions, such as malignancy, systemic lupus erythematosus, HIV infections. GMT is not a specific disease of the BM but, like a symptom, it is a morphologic sign of generalized severe illness of a patient. Aims & Objectives: Seven cases of GMT, diagnosed at a single tertiary care centre in New Delhi over a 2-year period (May 2019-Apr 2021), which were retrieved from departmental archives. Clinical information including age, sex, presenting symptoms, physical findings, underlying diseases, treatment history, and HIV status were recorded. Haematological parameters, BM aspiration (BMA), and BM biopsy (BMB) slides were studied. Materials & Methods: Total of 7 patients, 5 were males and 2 were females with ages ranging from 25 to 60 years and a mean age of 33 years. The presenting complaints were fever in 3 cases, lymphadenopathy in 2 cases, bleeding manifestation in 1 case, and abdominal distension in 1 case. History of significant weight loss was present in all 7 cases. Result: Anaemia was present in all cases with 2 cases having leucopenia, 3 cases with thrombocytopenia. BMA was unsatisfactory in 3 cases and reactive in 1 case. In 3 cases, gelatinous seromucinous material was seen. BMBs were hypocellular in 2 cases and normocellular in 1 case. Under low power examination, GMT appeared as amorphous, finely granular, light blue to pale pink material, which was stained by alcian blue at pH 2.5 A variable degree of atrophy of fat cells was seen. Conclusions: The most common association had been reported with cases of malnourishment, anorexia, c infections, or malignancy. GTBM has been reported with various hematopoietic malignancies like AML, APML. Many patients had bi-or pancytopenia at the initial presentation, and almost all had anemia, irrespective of the underlying associated disease. No correlation between the severity of GTBM and the peripheral hematological parameters have been reported, still it should be kept in the differential diagnosis of cytopenias. Bone marrow biopsy exhibits features of hematopoietic hypoplasia, adipose cell atrophy, and deposition of gelatinous substance in bone marrow that stains with Alcian blue at pH 2.5. However, a large number of cases present normocellular or hypercellular marrows or focal areas of hypocellularity surrounding the gelatinous substance, which easily can be misinterpreted as bone marrow edema, necrosis, or amyloid.

Neutrophil Count is Predicitive of Mortality in COVID (Long): An Easy-to-Use Biomarker Based Model to Predict Mortality at Admission Anju Esthepan, Linda Jacob, Grace Mary John, Alice David, Luke Mathew, S K Mathew, Riju Mathew, Christy V John, Chepsy C Philip Introduction: The second wave of COVID has been devastating in India and many developing countries. The mortality has been reported 40% higher than in the first wave overwhelming the nation's health infrastructure. Despite better understanding of the disease and established treatment protocols including steroids and heparin; the second wave was disastrous. Subsequent waves have the potential to further cripple health care deliveries affecting non COVID care also across many developing economies. It is then important to identify and triage high risk patients to best use the limited resources.

Aims & Objectives: The objective of this study was to identify potential predictors of mortality in the second wave who accessed health care at our academic setup. Materials & Methods: All patients admitted at our centre from 01 February through June 15 2021 were included in the analysis. A reduced set of potential predictor variables was selected a priori, which included routine investigations sent on patient admission at our center. These were bundled as groups namely; coagulation markers (INR, APTT, Fibrinogen, d-Dimer), Inflammatory markers (ESR, CRP, Ferritin), Hemogram, Liver function tests, Renal function tests, Arterial blood gas analytics and Glucose levels at admission (measured using the arterial blood gas analyzer). We used a two stage model building process. Result: We collected data from 790 patients. The overall mortality rate was 10% (79 patients). The median age of patients in the cohort was 57 years (range 1-99). Patients travelled a distance of 25 km (1-262 km) to seek care. We identified 78 candidate predictor variables measured at hospital admission.n entering variables into a logistic regression model [least absolute shrinkage and selection operator] 4 variables were retained within the final model. We identified 4 important (Table 1) there is a concern that care of non-COVID diseases could be affected. This impact is likely more profound in patients with hematological diseases (both benign and malignant) given the immunosuppression due to the disease and its treatment.

Aims & Objectives: The objective of this study was to identify the trend and challenges to non-COVID care in patients with hematological diseases at our academic setup. Materials & Methods: We conducted a cross-sectional, prospective, descriptive study of hematology outpatient visits from October 1st through December 31, 2020. Patients visiting the service were interviewed face to face or contacted telephonically through a questionnaire with their responses recorded into a computer-based form. A telephonic survey was done from March 1st to March 31, 2021 to record status and vaccination. Institutional Ethics Committee approval was taken. Descriptive statistics were used for analysis. Result: A total of 505 patients were interviewed in this period. 15 (2.9%) patients opted for teleconsultation. Baseline characteristic of patients attending our hematology service (Benign & Malignant Hematology) are detailed in Table 1a . Patients consulted a median of 2 centers before committing to their hematology care. Many [482 (95.4%)] developed unrelated complaints for which the patients did not opt for a consultation. There were 8 patients who tested positive for COVID in this period. Three (37.5%) continued COVID care at our center and 5 in the government center. 158(31.3%) patients transferred their hematology non-covid care from other centers to our setup. The changes to clinical care are tabulated in Table 1b . There were 20 deaths in this period. Conclusions: In our analysis, transfer from the primary care provider was the most common change in outpatient hematology practice. Despite a perception of compromise in care and vaccine hesitancy, most patients received the planned care and 25% received their vaccination despite the data collected in the first months of vaccination. Deferral or discontinuation of treatment, investigations and transfusions were very few. Inclusion criteria: Children aged 5-18 years living with HIV attending ART clinic BMD was assessed using DEXA (dual-energy x-ray absorptiometry) scan. Result: Out of the total 56 participants, 36(64.3%) at the distal radius, 27 (48.2%) at the lumbar spine, 22 (39.3%) at total body less head, and 5 (8.9%) at whole body have osteoporosis (BMD Z score \ -2). Similarly, Osteopenia (BMD Z score between -1 and -2) was observed in 21 (37.5%) at total body less head, 14 (25%) at the lumbar spine, 12 (21.4%) at the distal radius, and only 4 (7.1%) at the whole body.

Conclusions: Children infected with HIV had a lower BMD (bone mineral density); there is a high incidence of low BMD in our study population, the distal radius is most affected while whole-body BMD is least affected in our study population. Previous studies on influenza like illnesses have demonstrated the role of Neutrophil-to-lymphocyte as a preferable diagnostic tool to screen influenza virus-infected patients. In addition to these, volume conductivity and scatter has revealed significant findings in volume scatter and conductivity of monocytes and neutrophils in the past in influenza and influenza like illnesses.

Aims & Objectives: To study the hematological parameters of COVID-19 positive cases and to compare the hematological parameters in COVID-19 positive cases, patients with influenza and influenza like illness. Materials & Methods: 169 Covid positive cases, 113 influenza and influenza like illnesses and 140 healthy controls were included in the study. All samples were processed on DXH 800 and all parameters were recorded. Result: There was significant difference between Covid 19 and influenza and influenza like illness in terms of age, percentage of neutrophils, percentage of lymphocyte, percentage of monocyte, percentage of eosinophil and basophil. Significant difference was also found between mean neutrophilic and mean monocytic volume, and in all the scatter parameters of neutrophils. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) also showed significant difference in both the conditions. Multivariate analysis was performed and a joint probability was calculated which showed a cutoff in differentiating Covid 19 from influenza and influenza like illnesses. Conclusions: Covid 19 and Influenza can cause different changes in peripheral blood parameters and the diagnostic formula developed in this study will enable the clinicians to differentiate Covid 19 from influenza during the early stages.

Sexual Maturity Rating in Children Aged 6-18 Years Living with HIV Ashwini C Shivannavar, Alok Hemal Introduction: According to WHO, there are approximately 1.8 million CLHIV (Children Living with HIV) below 15yrs of age. With the introduction of HAART (Highly Active Antiretroviral Therapy), the number of perinatally infected children entering adolescence and adulthood are increasing. Puberty and growth which are important aspects of adolescence are known to be affected in HIV-infected children.

Aims & Objectives: To study sexual maturity rating in children aged 6-18 years living with HIV by Tanners staging of puberty.

The study was a cross-sectional observational study. The Sample size was 69. CLHIV attending the ART clinic aged 6-18 years were included in the study. Sexual maturity rating was done by Tanner's method.

Result: Out of 23 girls, 9(39.1%) were in Tanner's stage 1 whereas 3(13%), 2(8.7%), 8(34.8%) and 1(4.3%) were in Tanner stages 2, 3, 4 and 5 respectively. Among 46 boys, 24(52.2%), 14(30.4%), and 8(17.4%) boys were in Tanner's stages 1, 2, and 3 respectively. No boys were found in stages 4 and 5.3(6.5%) boys and 2(8.6%) girls were found to be have pubertal delay. (No pubertal signs by 14 years of age in boys and 13 years in girls). The median ages of girls at Tanners stage 1, 2, 3, 4 and 5 were 10, 11, 14.5, 14 and 17 years respectively according to breast development. The median age of boys in Tanners' stages 1, 2, 3 was 10.5, 14 and 16.5 years respectively according to testicular volume development. Conclusions: Pubertal delay was seen in 6.5% of boys and 8.6% of girls living with HIV. The median age of girls at breast stage 2 in our study showed a delay of 2.4 months and the median age of boys at testicular volume stage 2 showed a delay of 3.6 years when compared to the normal reference population.

Histoplasmosis and Secondary Hemophagocytic Lymphohistiocytosis in an Immunocompetent Patient: Causal Association or Coincidental Finding Deepsikha Bhanja, Pallavi Saraf, Deepak Kumar, Satyendra Kinchar, Abhishek Purohit Introduction: Hemophagocytic Lymphohistiocytosis (HLH) is a lifethreatening syndrome characterized by fever, cytopenias and hepatosplenomegaly. It is due to defective functioning of cytotoxic T cells and natural killer cells, leading to hyperstimulation of immune system causing multiorgan failure. HLH could be primary or secondary and can affect any age group. Causative factors include genetic defect, infection, autoimmune disease or malignancy. Histoplasma infection triggering HLH is rare and is even rarer in an immunocompetent host. Prompt treatment of the underlying cause in cases of HLH can significantly reduce mortality in patients.

The aim and objective of this case presentation is to highlight the importance of bone marrow examination in identifying the cause of HLH, so that prompt treatment can be started to save life of the patient.

A 53 year old sick male patient was admitted to the hospital with complaints of high grade fever, vomiting and breathing difficulty for a day and was shifted to intensive care unit. On examination, liver and spleen were enlarged. Laboratory parameters revealed cytopenias, deranged liver function tests with elevated serum bilirubin, serum ferritin, triglycerides and reduced fibrinogen. Infectious work up was normal. Blood culture to rule out any infection was sent. Based on this, a strong clinical suspicion of HLH was made and bone marrow was done. Result: Bone marrow smears showed all haematopoietic components with prominence of histiocytes showing haemophagocytosis. In addition to this, few histiocytes showed few intracytoplasmic organisms, morphologically consistent with Histoplasma capsulatum species. A diagnosis of HLH occurring secondary to Histoplasma infection was made and prompt treatment with liposomal amphotericin B was started. Patient gradually showed improvement. Blood culture reports were negative. Conclusions: Herein, we conclude the importance of bone marrow in identification of causative agent in a case of HLH, thereby reducing the mortality with prompt treatment of triggering factor.

Abha Singh, Akansha Bhatia, Umesh, Sadhna Marwah, Vijay Kumar

Introduction: A number of known causes of granulomas have been studied including tuberculosis, leprosy, sarcoidosis and many parasitic infections. However, bone marrow still remains a remote and rare site for granulomatous lesions with incidence of 0.59 to 0.97%. This study emphasises that although rare, granulomatous lesions can be seen in bone marrow biopsies in spectrum of diseases and effort has been made to correlate with the clinicopathological features.

Aims & Objectives: To study the incidence and spectrum of granulomas in bone marrow biopsy retrospectively and the clinicopathological spectrum. Materials & Methods: All the cases from the year 2015-2020 were taken retrospectively from the archives diagnosed as the granulomatous lesion on bone marrow biopsy. A total of fifteen such cases were found amongst the total 2148 bone marrow biopsies received in the time period of 6 years. These total 15 cases were broadly classified to Tubercular and Non-tubercular granuloma based on acid fast bacilli (AFB) demonstration. Result: Age group of patients varied from 14 to 72 years with almost equal male to female ratio. Out of fifteen confirmed cases with granuloma in bone marrow biopsy, three were confirmed for the diagnosis of tuberculosis and twelve were given a broad category of granulomatous lesions (non-tubercular). One case was reported as suspicious of Hodgkin lymphoma with granulomatous reaction. None of the cases showed evidence of any fungal infection and were PAS negative. Both ill-defined as well as well-formed epithelioid cell granulomas with central necrosis were seen in the bone marrow biopsies. Most of the corresponding bone marrow aspirates were diluted which could be the reason that no bone marrow aspirate showed evidence of granulomas. All the twelve (non-tubercular granulomatous lesion) were further worked up with ancillary investigations and out of these four were confirmed for Tuberculosis, two were diagnosed with secondary Hemophagocytic lympho-histiocytosis following salmonella infection, one with Hodgkin lymphoma while remaining five were inconclusive. Conclusions: This study reaffirms the need of bone marrow biopsy in addition to bone marrow aspirates where the aspirate alone was inconclusive. Ancillary investigations in conjunction with bone marrow studies are helpful to arrive at final diagnosis of longstanding cases like that of pyrexia of unknown origin. Introduction: Sepsis is life threatening organ dysfunction caused by dysregulated host response to infection. Septic shock is the subset of sepsis with circulatory and metabolic dysfunction (hypotension with metabolic acidosis) associated with high rate of mortality. qSOFA is quick sequential organ failure assessment used for early diagnosis of sepsis. qSOFA has three components-respiratory rate, mental status and systolic BP. qSOFA score C 2 is associated with poor outcome in sepsis patient. 1st Hour bundle in sepsis is used widely for initial resuscitation. This bundle comprises of four main measures-(1) measurement of blood lactate (2) obtaining blood culture before antibiotics (3) administration of broad spectrum antibiotics (4) rapid administration of crystalloid for hypotension and lactate [ 4 mmol/L. NEUT-GI and NEUT-RI is a marker of neutrophil activation. FGF21 is a subset fibroblast growth factor encoded by FGF21 gene on chromosome 19. Tissue specificity of FGF signaling is conferred by coexpression of FGF21 and KLB receptor. With the patient in supine position, sternal angle was located by digital palpation and marked using needle cover. Area was disinfected by using sterile alcohol swabs and covered with surgical aperture drape. Local anaesthetic (2 ml of 2% lidocaine) was administered in the skin, subcutaneous tissue upto the periosteum. After waiting for 3-5 min, the parts of an autoclaved size 16 Sahla's bone marrow aspiration needle were identified and guard was fixed. The needle was then inserted at previously marked site until it touched the bone and pushed through bony cortex rotating on its axis until it was fixed in place at desired depth.

The stylet was withdrawn and a 20 ml syringe was attached for aspiration. Multiple smears were prepared from the obtained aspirate and stained with Leishman stain. Result: Peripheral smear revealed pancytopenia (Hb = 4.3 g/dl, Wbc-2000/cumm, platelets-11,000/cumm), rouleaux formation in RBC. Bone marrow aspiration revealed hypercellular marrow with giant proerythroblast having ''dog ear'' protrusion of cytoplasm. On further investigation, Antiparvovirus B19 IgM was positive. Conclusions: All investigations including peripheral smear and BMA were indicating infection by Parvovirus B19 which was confirmed by serology. Although BMA findings are classical, they can be easily overlooked leading to delayed therapy. Our patient's pancytopenia improved after immunoglobulin administration.

Naman Maheshwari, Deepika Gupta,Parag Vijayvergiya, Gopal Krishana Bohra, Abhishek Purohit Introduction: Despite national tuberculosis elimination programme in place, Tuberculosis (TB) is still one of the commonest infectious disease in India with spectrum of clinical manifestations. Disseminated tuberculosis is an important cause for pyrexia of unknown origin (PUO) and can present with varied haematological and clinical presentations, like pancytopenia or leukemoid reaction, hepatosplenomegaly or lymphadenopathy. Pancytopenia is an extremely rare presentation and could be due to haemophagocytic lymphohistiocytosis, hypersplenism or infiltration of the bone marrow by granulomas which can cause reversible or irreversible fibrosis of the bone marrow. Aims & Objectives: Aim of the present case presentation is to highlight an uncommon presentation of a case of fatal disseminated tuberculosis.

A 35-year-old female, presented with history of generalized weakness, weight loss, high-grade fever (on and off) with bilateral pedal edema and history of multiple blood transfusions. On examination, she had pallor and fever. Investigations were carried out during her short hospital stay to find out the cause of fever, however, the cause could not be ascertained with preliminary investigations. In view of severe pancytopenia, bone marrow examination and culture studies were also performed. Result: CBC revealed pancytopenia (Haemoglobin-2.8 g/dL, Total leucocyte count-110 /ll and platelet count-12,000/ll) suggestive of bone marrow failure. Bone marrow aspirate smears showed hypocellular marrow fragments with mild prominence of histiocytes with an occasional cell showing evidence of haemophagocytosis and plasmacytosis. Bone marrow biopsy revealed hypocellular marrow with multiple well-formed non-necrotizing epithelioid cell granulomas with presence of all haematopoietic elements. There was marked interstitial prominence of histiocytes. Ziehl-Neelsen stain for acidfast bacilli was positive. Chest X-ray was done which was suggestive of miliary TB. However, patient succumbed to the illness after a very short hospital stay. Conclusions: We report a case of PUO with weight loss presenting with pancytopenia. The diagnosis was made on bone marrow trephine biopsy. Although pancytopenia is a rare manifestation of disseminated TB, its recognition is important as the infection is curable if detected early else may result in fatal outcome as in the present case.

Sandeep Kumar, Prabhat Verma, Shivam sharma Introduction: Hemophagicytic lymphohistiocytosis is a rare but potentially fatal hyper inflammatory syndrome that may occasionally be associated with scrub typhus. Aims & Objectives: To suspect hemophagocytic lymphohistiocytosis in cases of pancytopenia with fever with organomegaly due to scrub typhus infections. Materials & Methods: Case report: A 55 years male, farmer by occupation presented with complaints of generalized weakness and fever for 15 days. There was no history of cough, rash, joint pain, bleeding manifestation or glandular swelling. On examination, patient was febrile (101.8 f), liver and spleen were palpable 2 cm and 6 cm below subcoastal margin respectively.

On investigations, serology for malaria, typhoid, leptospirosis and dengue were negative. Blood and urine culture were sterile. Scrub typhus IgM using ELISA was positive. Bone marrow aspiration was done to assess the cause of pancytopenia which showed normocellular marrow with frequent hemophagocytic histiocytes. 6 out of 8 hlh 2004 criteria were fulfilled.

1. Fever 2. Splenomegaly (19 cm) 3. Cytopenias (Hb = 7.2 g/dl, TLC = 2300, platelets = 30,000/ul) 4. Hypertriglyceridemia (fasting level = 446 mg/dl) 5. Hemophagocytesin bone marrow 6. Ferritin = 2232 ug /ml Soluble cd 25 and nk cell activity were not assessed due to non availability of facilities.

Result: A diagnosis of hemophagocytic lymphohistiocytosis associated with scrub typhus was made. Patientwas treated with iv doxycycline. Conclusions: Hemophagocytic lymphohistiocytosis should be kept as a possibility in patients presenting with fever, pancytopenia with splenomegaly diagnosed as scrub typhus.

Vaibhav Mishra, Jaya Tapadar, Madhukar rai, Manaswi Chaubey,

Introduction: HLH should be considered in patients with underlying autoimmune disorder, immunodeficiency or infection presenting with fever, pancytopenia, organomegaly. Aims & Objectives: Treatable cause of pancytopenia in post-covid patient must be evaluated. Materials & Methods: A 58 yr female, known case of Type II Diabetes Mellitus, Hypertension and Rheumatoid Arthritis on treatment for 10 years; and Severe COVID-19 pneumonia 2 months back, presented with generalized weakness and easy fatiguability for 1.5 months and fever for 1 month.Patient had no history of cough, breathlessness, recent increase in joint pain, rash, bleeding or any other localizing sign of infection. On examinations patient was febrile (101.7 F) with PR-108/min and BP-150/88 mm.Pallor was present, Rest all general and systemic examination finding was unremarkable. On Investigating patient was found to have pancytopenia without Neutrophylic/lymphocytic reversal, with correct retic count of 3.3%, Ferritin-628 ng/ml, LDH-370 U/L, Fasting Triglyceride-310 mg/dl, Procalcitonin-0.5 ng/dl, Other causes of pancytopenia were ruled out. Result: Bone marrow aspiration was done which showed hypercellular particulate marrow with many macrophage exhibiting erythrophagocytosis. HLH 2004 Diagnostic Criteria score was 5/8 suggestive of HLH. H-Score of the patient 183. Patient was treated with oral prednisolone rest of the complains was managed symptomatically. Fever and pancytopenia improved and patient was discharged with stable vitals. Conclusions: HLH is a rare syndrome in adult. Delay in diagnosis due to lack of suspicion and non-specific clinical and lab findings. All HLH patient dont need aggressive chemotherapy. Clinically stable patients should undergo treatment for the trigger.

Zeany Cheran, Sant Kataria, Sonia Chhabra, Monika Gupta

Introduction: Hemophagocytic Lymphohistiocytosis (HLH) is an unusual and rare hyper inflammatory syndrome with a high mortality rate. This rare phenomenon of immune dysregulation, primarily recognised in paediatric patients, is characterised by nonmalignant proliferation of activated macrophages and histiocytes, and upregulation of inflammatory cytokines. The presenting features of HLH are non-specific, mimicking many other diseases, and hence its early recognition still remains a challenge and it is relatively underdiagnosed owing to its wide array of manifestations. It requires a high index of suspicion and detailed analysis of clinical and laboratory findings to arrive at a conclusive diagnosis.

Aims & Objectives: The objective of this study is to present detailed clinical and laboratory features of a series of HLH cases in children.

Materials & Methods: A retrospective study was conducted wherein all the bone marrow aspirate smears diagnosed as HLH between December 2020 to September 2021 were reviewed. Detailed correlation of clinical and laboratory criteria was done with the bone marrow findings. Result: A total of four cases were diagnosed as HLH from December 2020 to September 2021. After correlating clinical and laboratory criteria along with bone marrow findings, the diagnosis of HLH was confirmed in these cases. Conclusions: We present a series of four cases of Hemophagocytic Lymphohistiocytosis in children from a tertiary care hospital in Northern India which will add not only to the understanding of this rare life threatening disease but also aid in early diagnosis and prompt aggressive intervention which is vital for patient's survival and favorable outcome.

Saqib Rashid, Revanth Boddu, Kanwaljeet Singh, Kundan Mishra, Suman Pramanik Introduction: Salmonella enterica (typhi) is a facultative intracellular bacterium which can potentially spread to a diversity of cells like macrophages further causing erythrophagocytosis. Hemophagocytic lymphohistiocytosis (HLH) is an aberrant hyperinflammatory hyperferritinemic immune response syndrome. Infection is a common cause of HLH. Aims & Objectives: Herein, we report a previously healthy 21-yearold male, who presented with fever associated with chills and diffuse abdominal pain for the 10 days. He also complaint of decreased appetite. He was diagnosed as a case of HLH secondary to Salmonella infection. Herein, we discuss the diagnosis, clinical course, and management of secondary HLH induced by typhoid fever.

The patient was sick looking. On examination, he had tachycardia (pulse-110/min), pallor, and dry, coated tongue. Blood Investigation showed pancytopenia (hemoglobin-10.6 g/dL, WBC-2000/lL, and platelets-41000/lL). Serum transaminases were raised (AST/ALT-402/ 101U/L). He was tested negative for tropical infection. The patient was initial managed with empirical antibiotic (cefoperazone/sulbactam) and supportive care. The blood culture flagged and subsequently identified Salmonella typhi. The patient continued to be febrile despite of appropriate antibiotic and his leucopenia worsened (WBC-1000/lL). Bone marrow aspirate showed increase in histiocytes with florid hemophagocytosis (Fig. 1) . He had raised ferritin levels ([ 1200 ng/mL), low fibrinogen (134 mg), and raised triglycerides (180 mg/dL).As he had met five out of eight criteria (HLH-2004 diagnostic criteria) of HLH, the diagnosis of HLH was made. He was continued on antibiotics and dexamethasone was added to his treatment. Result: The patient became asymptomatic and showed gradual improvement in blood counts (hemoglobin-10.2 g/dL, WBC-6230/ lL, and platelets-294000/lL). In a week time, he became fit to be discharged from the hospital. Conclusions: The index case has the primary objective of alerting fellow practitioners of the likely possibility of HLH especially when persistent fever, splenomegaly, and worsening cytopenias are encountered in the setting of an inflammatory process. Antibiotics to treat the underlying infection remain the mainstay of treatment however, corticosteroids are key drugs to induce remission. Timely diagnosis and prompt initiation of therapy saved the life of the patient from this potentially fatal disease.

Introduction Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus of zoonotic origin that emerged in China at the end of 2019. The outbreak of COVID-19 was challenging to the health care professional across the globe. COVID-19 presents with a wide spectrum of clinical scenarios ranging from asymptomatic to ARDS with sepsis and multi-organ failure. Patients with various hematological malignancies are immunosuppressed and vulnerable to many infections including COVID-19.

Aims & Objectives: The objective of the study was to look at the prevalence of COVID-19 infection in patients with hematologic disorders who are admitted in a large tertiary care hospital and the aim was to describe the characteristics and outcome of Covid-19 infection.

A retrospective descriptive study was conducted at the Department of Hematology of CMC, Vellore. All admitted patients under Hematology department from 1st March, 2021 to 30th August, 2021 were included in the study and clinical data was extracted from the electronic medical records. The diagnosis of the COVID-19 infection was confirmed with Polymerase Chain reaction-based test and those cases with positive test results received ward-based care or ICU care as per their health condition.

Result: A total of 866 patients were admitted under Department of Hematology during the above-mentioned period. Among these patients, there were a total of 117 (13.5%) patients who had COVID-19. The median age was 42 years (Range: 2-70). There were 69 (59%) males. Fifty patients (42%) had mild and 46 (39%) had severe manifestation of the disease while the rest had moderate disease. A total of 90 (77%) patients received ward based care and the rest 27 (33%) required ICU care. Ninety-nine (84%) patients with COVID-19 were being treated for hematologic malignancy. The overall mortality was 32 (27%) which was accounted by 31 (96.8%) among those with hematologic malignancy and 1(3.2%) in benign disorders. NHL (n = 29, 25%) and ALL (n = 27, 23%) were the major disorders represented in those with malignancy. Conclusions: COVID -19 infection constituted a significant proportion of inpatient admissions in patients with hematological disorders during the six-month period when the pandemic was at its high. The mortality rate was higher in patients with hematological malignancy.

Shivam Sharma, Dr. Kailash Kumar, Farid Alam, Pappu Kumar, Saket Ramraika Introduction: Hemaphagocytic lymphohistocytosis (HLH) is an aggressive and life threatening syndrome of excessive dysregulated immune response. It occurs in primary (genetic) and secondary (acquired) forms. Infections are a common cause of secondary HLH.

Aims & Objectives: HLH should be considered as a differential in patient of malaria deteriorating post-treatment. Materials & Methods: A 22 years male presented with complaints of fever with chills and rigor, yellowish discolouration of eyes and urine and altered sensorium. On examination pallor/icterus were present along with hepatosplenomegaly.

There was no other significant past history. Malarial rapid antigen was positive. Patient initially responded to antimalarial. But fever again reappeared in range of 102-103 along with pancytopenia.Bone marrow biopsy was done which showed frequent hemophagocytic histiocytes. Bone Marrow Biopsy showed frequent hemophagocytes. Result: The cause of pancytopenia and fever after recovery from malaria in this young male was found as HLH. Conclusions: HLH should be considered in patients with fever, pancytopenia, organomegaly post infection.

Sruthi Pallekonda, Jyoti Garg, Rakesh Kumar, Kavita Garg, Shailaja Shukla, Sunita Sharma Introduction: Malaria is a ubiquitous health problem in the world caused by the protozoan Plasmodium. Plasmodium vivax forms 53% of the global burden with India accounting for a majority part (47%) of it. WHO has recommended confirmation of malarial parasite by light microscopy or Rapid Diagnostic Tests (RDT) as ''gold standard''. Haematological parameters are among the most common changes encountered in malaria which may help in predicting the disease in absence of other diagnostic methods. Aims & Objectives:

1. To determine the hematological abnormalities in malaria infected patients by a hematological autoanalyzer. 2. To determine if these abnormalities can assist in screening of malaria.

The study was conducted in the clinical haematology laboratory of LHMC & SSKH. A total of 550 patients who presented to emergency department with fever and for whom the attending consultants had a clinical suspicion of malaria were included in this study. Of these 120 were diagnosed to have malaria as confirmed by the detection of malarial parasite on peripheral smear examination. These samples were analysed using Sysmex XT 2000i. Their haematological parameters were observed and compared with controls.

Result: There was a significant difference (p \ 0.05) among the following variables between malaria positive and negative cases: Haemoglobin (g/dL), RBC Count (million/mm 3 ), RDW (%), TLC (9 10 3 /mm 3 ), Monocytes (%), Eosinophils (%), ANC (/cu.mm), ALC (/cu.mm) and Platelet Count (9 10 3 /mm 3 ). Thrombocytopenia was seen in 98% of the cases in the present study emerging as a strong predictor of malaria and a combination of the following parameters (Hb \ 10, TLC \ 4000, Platelets \ 1. 5 ) was the most common presenting complaint along with, unexplained weight loss. Lymphadenopathy was seen in 10 cases (56%), hepatosplenomegaly in 08 cases (44%), hepatomegaly and splenomegaly in 2 cases (11%) each. Complete haemogram and peripheral smear evaluation revealed 11 cases (61%) with pancytopenia, 05 cases (27%) with anemia, one case (6%) with bicytopenia (anemia with thrombocytopenia) and one case (6%) with leucocytosis with bicytopenia. Out of the 18 cases, 6 (33%) cases were diagnosed as tuberculosis, 2 cases (11%) were HIV ? (one case was associated with miliary TB and one with NHL of stomach), 2 cases (11%) were of Hodgkin's lymphoma with bone marrow involvement, 2 cases (11%) showed EBV ? IgM antibodies in serum, 1 case (6%) was known case of angioimmunoblastic T-cell lymphoma and 1 case (6%) showed presence of candida on bone marrow culture studies. For 4 cases (22%), cause could not be ascertained even after extensive work-up. Conclusions: Bone marrow aspiration and biopsy are very helpful in diagnosis of granulomatous lesions in the bone marrow which can be elemental to diagnose cases of PUO or unknown cause of pancytopenia or anaemia in immunocompetent patients.

Aakash Chozakade, Reashma Roshan, Afaq Ahmed Khan, Sajad Geelani, Javid Rasool

Introduction: The covid-19 pandemic had resulted in all the healthcare infrastructure being diverted to the management of the pandemic. This has resulted in other diseases being side-lined. The long term consequence of this is yet to be known. In our study, we aimed to study how the diagnosis of covid changed the management in hematological malignancies. We hope that the lessons learnt from Indian J Hematol Blood Transfus this will help us manage the treatment of hematological malignancies in a better way.

Aims & Objectives: In this study, we aimed to report the clinical profile and outcomes of COVID-19 in patients with haematological malignancy at a tertiary care hospital.

It is an observational study. Data from laboratory-confirmed 40 COVID-19 patients diagnosed between 1 January 2021 and 31 July 2021 were analysed retrospectively. All COVID-19 patients with haematological malignancy (n = 40) were included in the study.

Result: In this present study, total 40 patients were included. Of these, 25(62.5%) were males and 15(37. 5%) were females. The median age in this study was 43 years. (Range, . Of these 40 patients, acute myeloid leukemia was the commonest malignancy (27.5%), followed by acute lymphoblastic leukemia (22.5%) then non-Hodgkin lymphoma (12.5%), plasma cell dyscrasia (10%), chronic myeloid leukemia (10%), chronic lymphocytic leukemia (7.5%), acute promyelocytic leukemia (5%), chronic myelomonocytic leukemia (5%). Mean hemoglobin was (8.04 gm/dl), WBC count was (10.14 9 109/l), platelet count was (77.7 9 109/ l) creatinine was (0.86 mg/dl), bilirubin was (1.24 mg/dl). The median delay in initiating chemotherapy was 17 days. The average stay in the covid ward was 12.8 days. Over all Case fatality rate was 22.5%. The mean number of days for rt-pcr to turn negative was 11.2 days, with one patient with severe covid remaining positive for 27 days. Thrombosis was not seen in any of our patients even though malignancy and covid are both associated with increased thrombotic risk.

Conclusions: Patients with haematological malignancy are immunocompromised, and our study reveals that there is an increased case fatality rate among these patients. The delay in initiating chemotherapy-both because of covid illness and also because of limitation with initiating chemotherapy in the covid ward resulted in a higher case mortality. Therefore, physicians should pay great attention to the management of COVID-19 patients with haematological malignancy.

Dipti Sidam, Mukta Pujani, Abhilasha Yadav, Sujata Raychaudhuri

Introduction: COVID 19 pandemic, caused by SARS CoV-2 virus causes flu like mild symptoms to severe acute respiratory syndrome. Pathogenesis is Immune system dysregulation and is characterised by the presence of lymphopenia in the peripheral blood smears. The clinical laboratory plays an important role in the diagnosis, treatment and prognosis of coronavirus patients.

• To describe the morphological changes in white blood cells, red blood cells, and platelets in the peripheral blood smears of COVID 19 positive patients. • To correlate morphological changes with the haematological parameters obtained on complete blood counts. • To study the association of morphological changes with disease severity and survivor status of the patients.

A total of 100 adults, aged more than 18 years who tested positive on RT PCR were enrolled for the study.

Based on the symptoms, the patients were divided into two groups: mild to moderate and severe. Venous blood sample was collected and peripheral blood smears were examined by pathologists.

Result: The most characteristic haematological findings noted in peripheral blood smears in COVID 19 patients were leucocytosis, neutrophilia, lymphopenia, monocytosis and thrombocytopenia. In neutrophils both nuclear as well as cytoplasmic abnormalities were noted. Nuclear abnormalities ranged from ring shaped nucleus to hypolobular neutrophils termed as pseudo pelgerhuet anomaly to presence of band forms. Cytoplasmic abnormality included presence of dark blue granulation which is similar to toxic granules. Apoptotic bodies were also noted. In platelets, we observed strikingly a unique feature showing presence of large platelets and increased frequency of platelet clumps along with normal to low platelet counts. We noted significant positive correlation in morphology of neutrophils and platelets among severe, mild to moderate groups and survivors or non survivors groups.

Conclusions: These routinely used, non-invasive, quick and cost effective tests for morphological details along with routine CBC parameters can play an important role which will have great clinical relevance helping to predict the disease progression and severity at an early stage aiding in patient triage and management.

Malvika Gaur, Tushar Sehgal, Swati Singh

Introduction: The incidence of invasive fungal infection (IFI) is approximately 6 cases per 100,000 persons per year. The presence of intracytoplasmic budding yeast forms in neutrophils or monocytes in the peripheral blood film (PBF) is suggestive of IFI (Fig. 1) . This can be associated with non-specific signs and symptoms. Blood culture is required to confirm the diagnosis of IFI.

Aims & Objectives: To study the suspected cases of invasive fungal infection on peripheral blood smear examination and correlate with blood culture and antigen tests.

We present four cases of IFI detected in the PBF and confirmed by blood culture.

Result: Candida infection constitutes 10-12% of all nosocomial infections and 8-15% of all nosocomial blood stream infections. The common predisposing factors for the development of invasive candida infection (ICI) are length of stay in NICU [ 7 days, lack of hand hygiene of healthcare workers, broad spectrum antibiotics, chemotherapy, total parenteral nutrition, recent surgery, corticosteroids, intravascular catheters, malignancy, neutropenia, hospitalisation in ICU and fungal colonisation elsewhere in the body. Detection in PBF requires at least 1 9 10^5 CFU of yeast/ml of blood. Figure 1 shows intracellular and extracellular budding yeast forms with pseudohyphae in PBF. Blood cultures (gold standard) may be negative in patients with fungal sepsis. Prompt empirical therapy (antifungals) is usually started when clinical suspicion arises. Even with prompt antifungal therapy the mortality rates may be as high as 80%.Direct microscopic examination, histological examination, detection of fungal antigens (galactomannan, 1,3-beta-D-glucan) by ELISA or by immunofluorescence, detection of fungal DNA by polymerase chain reaction in blood and/or other biologic fluids can all aid in diagnosing ICI.

Prompt detection of IFI is paramount to reduce patient mortality. While most patient have mild influenza and may be asymptomatic, a minority of patients will develop severe pneumonia, acute respiratory distress syndrome, multi organ failure and death. Clinical and Laboratory biomarkers to predict the mortality and severity of COVID-19 are essential in this pandemic. According to studies and data Neutrophil Lymphocyte Ratio is the first and the most important parameter that is found to be associated with the course of the disease. Following SARS-COV 2 infection, most of the patients presented with Lymphopenia and elevated levels of infection related biomarkers, more interestingly, a higher number of Neutrophils and lower number of Lymphocytes, the increase of Neutrophil Lymphocyte Ratio were found in non-survivors with COVID-19 compared to survivors along with monocyte lymphocyte ratio, platelet lymphocyte ratio, D-Dimer level. These changes showed the degree of inflammation in the body was further intensified, triggering an inflammatory storm and leading to increased tissue and cell damage.

Aims & Objectives: Predicting the severity of COVID-19 patients by evaluating the blood parameters like neutrophils, lymphocyte, neutrophil lymphocyte ratio, monocyte lymphocyte ratio, platelet lymphocyte ratio, D-Dimer.

A total of 100 confirmed COVID 19 patients at DR PRABHAKAR KORE HOSPITAL OF JNMC, BELAGAVI between March 2021 and July 2021 were studied. Result: At hospital admission, the median leukocyte count was 5900 cell/ mm3. The median neutrophil count was 4240 cell/mm 3 and the median lymphocyte count was 925 cell/mm 3 . The median platelet-tolymphocyte ratio (PLR) was 191.7 while the median NLR was 4.5.

Conclusions: Blood parameters could be used as significant indicators in predicting the severity of COVID-19 patients.

Introduction: Chronic obstructive pulmonary disease, a progressive inflammatory airway disease is the third leading cause of death worldwide. Studies had shown abundance of Neutrophil extracellular trap (NET) in sputum of COPD patients. There are limited studies that assess correlation of circulating marker of NET formation and platelet indices in predicting exacerbation in these patients. Most of these Indian J Hematol Blood Transfus studies has been done in vitro and mice models. Comparing the NET formation and platelet indices between stable COPD, Acute exacerbated COPD (AECOPD) and control will help in better understanding the inflammatory process.

Aims & Objectives: Evaluation of citrullinated Histone H3 as circulating marker of NET formation and Platelet indices in stable COPD and AECOPD. Objectives:

(1) To calculate and compare citrullinated histone H3 level in patients with stable COPD, AECOPD and control group. (2) To compare the platelet indices in patients of stable COPD, AECOPD and control group. 

Introduction: Malaria is a major health problem in India. Thrombocytopenia is a frequent finding in malaria cases. In addition to reduction in platelet count and platelet function, changes in the volume and platelet distribution width (PDW) are the generally evidenced in these patients. • In this prospective study, we describe the clinical profile and outcome of IFIs in AL patients with FN. • To analyse the trend in fall of GMI at weekly intervals and the impact of baseline and weekly GMI in the outcome o. • To identify the appropriate time to start chemotherapy in patients with IA.

The present study is a single institutional prospective study carried out in the department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), LKO conducted between 2020 January and 2021 March. All patients with a diagnosis of Acute leukemia (AL) and febrile neutropenia (FN) admitted in the Hematology ward fulfilling the following inclusion criteria were included. All these patients will be tested for baseline serum GMI before starting of empirical antifungal therapy. The fungal load in the patients will be monitored on weekly basis by GM antigen for 6 weeks or or till there is an aspergillus attributable mortality. Conclusions: We report that more than half of our patients with IA are therapy naïve present with FN with IA as the initial presentation AL. So we propose that the treating physicians have to consider the possibility of IA and getting a baseline GMI before starting chemotherapy in patients.We conclude that GMI can be used as a surrogate marker for therapy response and tissue fungal burden. Serial GMI may be warranted to assess response to antifungal therapy and chemotherapy can be restarted or started after 4 weeks given clinical improvement of the patient. 

Nalla Mamatha, Jayashree G. Pawar

Introduction:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, is a highly contagious enveloped single-stranded RNA virus that belongs to the family of Betacoronaviruses. • Laboratory findings reported in association with COVID-19 include leukopenia, leukocytosis, lymphopenia, monocytosis, neutrophilia, eosinopenia, and thrombocytopenia • Activation of the immune system with subsequent immune dysregulation has also been implicated in the pathogenesis of COVID-19. Involvement of the immune system is evidenced by the presence of lymphopenia, particularly in those with severe disease • While lymphopenia and other quantitative abnormalities in the peripheral blood have been well described in the literature, little is known about the morphologic changes in circulating blood cells in COVID-19. 

Pinakin Kaushik, Aashit Yadav

Introduction: Dengue fever is the most rapidly spreading mosquitoborne viral disease in the world. An estimated 50 million infections per year occur across approximately 100 countries. India is one of those countries where dengue is an endemic in the true sense of the word. In recent past, an upsurge of dengue cases posed a significant menace to the existing dengue control policies and poses a toil on socio-economic burden on the developing nation.Immature platelet fraction (IPF) is a new parameter which is an automated measure of reticulated platelets in peripheral blood. Reticulated platelets contain RNA and are newly released platelets that are larger, more physiologically active and are the analogue of the red cell reticulocyte. The number of reticulated platelets reflects the rate of thrombopoiesis.

Aims & Objectives: The study was aimed at studying the platelet values in serologically confirmed dengue cases with their daily platelet and IPF values and predicting the rise in the platelet counts and evaluating the recovery.

The study was conducted in Delhi and a total of 30 patients with IgM positive dengue serology were evaluated for platelet counts and IPF fractionon a daily basis.

Result: The IPF was found to have a strong correlation with the raise in platelet count after IPF reaches its peak, 10% of patients showed raise in platelet within 12 h count after IPF peak was attained, 64% of patients showed raise in platelet count within 24 h after IPF peak was attained and 100% of patients showed raise in platelet count within 48 h after attaining the peak. In the study themales recovered faster after attaining a peak however the females recovered comparatively later. Total leucocyte counts however had no correlation with IPF values.

Conclusions: IPF can be used as predictive marker for platelet recovery. The platelet count tends to recover within 24 to 48 h in dengue patients after attaining the peak IPF levels.

Introduction: The burden of sepsis especially in India keeps increasing with the indiscriminate use of antibiotics and alarming rise in antimicrobial resistance patterns. There is a dire requirement of research into newer parameters to diagnose sepsis that are readily and widely available and are quick, sensitive and cost effective. One such parameter is Monocyte Distribution Width (MDW). MDW is an in vitro diagnostic parameter that reflects a change in circulating monocytes volume in response to pro-inflammatory signals from infectious organisms.

Aims & Objectives: The aim of our study was to look into MDW as an efficient, easily-employable surrogate marker for sepsis and compare it with conventional markers of sepsis like C-reactive Protein (CRP), Procalcitonin (PCT) and Blood Cultures. MDW as a standalone parameter has a sensitivity of 67% and specificity of 83% in diagnosing sepsis in our study. Similarly, CRP has a sensitivity of 64% and a specificity of 82% and PCT has a sensitivity of 68% and a specificity of 85%.

Conclusions: MDW as a parameter is available as a part of the extended differential count of a CBC and does not require any additional sampling or additional cost to the patient. MDW augments the diagnostic accuracy of other available tests such as CRP, PCT and Blood culture and that of scoring systems such as SOFA, qSOFA and SIRS when used in conjunction at the first encounter with the patient.

Utkarsha Patil, Ashwini Natekar,Sanjay Bijwe,Snehal Chavhan,Megha Kinake,Shweta Watane

Introduction: The pandemic of coronavirus disease 2019 caused by the SARS-CoV-2 is affecting many women during pregnancy and in the postpartum period worldwide. A peculiar characteristic of COVID-19 is the release of a large amount of inflammatory cytokines. Some biomarkers have been considered as tools to monitor the evaluation of COVID-19, namely CRP, LDH, D-dimer and ferritin. Currently the neutrophil lymphocyte ratio constitutes a new strong inflammatory marker for the detection of inflammation. Neutrophil lymphocyte ratio has also been used as a predictor of complication of pregnancy, such as pre-eclampsia, gestational diabetes mellitus, hyperemesis gravidarum, premature labour and ectopic pregnancy.

To study the neutrophil lymphocyte ratio (NLR) and ferritin levels in COVID-19 positive pregnancy and correlate it with the severity of the disease.

This is an observational study conducted in the obstetrics ward of a tertiary care center. The inclusion criteria were all the pregnant females admitted in the obstetrics ward with a diagnosis of COVID-19 by RT PCR in the period of 3 months. The exclusion criteria were patients with non reactive rapid test results. Clinical and demographic data were extracted from electronic medical records.

Result: In our study, 32 out of 70 patients showed ferritin values above 400 ng/ml. Lymphocytopenia, increased neutrophil lymphocyte ratio and increased ferritin had all been linked with disease severity or mortality. Decreased lymphocyte value was associated with an increased likelihood of receiving oxygen supplementation during hospitalization. These markers show abnormal values in obstetrics patients and reflects the course of the disease. It suggested that additional care should be reserved to patients presenting with decreased value of these blood cells. Pregnancy is a physiologic anemic state and high levels of ferritin, especially in third trimester are associated with negative outcomes like preterm delivery and gestational diabetes mellitus. Conclusions: Both neutrophil lymphocyte ratio and ferritin levels can act as independent markers in assessing the disease severity of COVID-19 in obstetrics patients. (2). T-LBL present with clinical manifestations including diaphragmatic lymph node enlargement, accompanied by local oppression and/or systemic lymphoma symptoms. However, extensive involvement of the mediastinum, pleura and pericardium is rare in T-LBL cases (3). We report an unusual case of a 3-year-old female child who presented with intracardiac tumour and was later diagnosed to have T cell LBL.

Aims & Objectives: Our main highlight of this case presentation was to demonstrate the lymphoblastic lymphoma as a cause of intra cardiac tumor in children.

A 3-year old female child with no significant past and family history presented with swelling over the face and neck with fever since l month and difficulty breathing since 1 day. The child was initially stabilised. On initial echocardiography, child was found to have a mass lesion infiltrating into the right atrium, further computed tomography depicted mass infiltrating into superior vena cava with pericardial and pleural involvement causing superior vena cava syndrome. Initial clinical possibility solid tumor like RMS, Ewing sarcoma, Lymphoma were considered. The child was taken up for USG guided biopsy which was suggestive of T cell lymphoblastic lymphoma. Further lumbar puncture and bone marrow aspiration and biopsy were done which was negative for malignant cells. The child was started on chemotherapy according to protocol and is currently undergoing treatment from a nearby centre.

Result: It is seen that most of the heart tumours are benign, mostly constituting rhabdomyomas, fibromas, myxomas, teratomas and angiomas. Rhabdomyomas usually arise from the ventricles of the atrioventricular valve mostly involving the left side. Fibromas mostly involve the intraventricular septum or left ventricle wall. Teratomas are large tumours that develop in the right atrium, right ventricle, and septum of the heart. The vast majority of myxomas develop from the left atrium. Angiomas can occur in any part of the heart, with a preference for right-sided chambers. Cardiac angiosarcomas tend to arise from the right atrium and result in right-sided heart failure. Based on our discussion, one would expect a right atrial tumour to be a benign teratoma or angiosarcoma. However, histological examination of the pathology sections revealed an intracardiac T-cell LBL. Immunohistochemical marker analysis corroborated these findings. Further mass was also infiltrating into the superior vena cava leading to symptoms of the superior mediastinal syndrome. Conclusions: In our index case we tried to demonstrate that though lymphoblastic lymphoma is a rare cause of cardiac tumour but should be kept as a possibility specially in presence of features of superior mediastinal syndrome.

Anand V, Shreyas Hanmantgad, Saro Jacob, Rohith G Chitrapur Introduction: Multiple primary malignancies are rare and identification of these are slowly increasing with advances in diagnostic and therapeutic modalities thus reflecting in increased life expectancy. The reasons may be environmental modifications, genetic predisposition or therapy induced. Here, we describe a case of a 69-year-old woman with four different primary malignancies over a period of 20 years.

Aims & Objectives: This is a case description of a patient who developed four different primary malignancies over a period of 20 years. The objective of this report is to describe the various treatment approaches used in this patient and study the incidence and approaches of similar malignancies reported in published medical literature.

Reports of previous malignancies and treatment of the patient were collected through hospital medical records and chart reviews. Literature review of triple and quadruple malignancies was performed through Pubmed. The results of the same were compared with the present case.

Result: A 69-year-old female was diagnosed with carcinoma right breast in 2001. She underwent modified radical mastectomy with axillary lymph node dissection followed by eight cycles of chemotherapy and radiotherapy. Eleven years later (2012), she was diagnosed with carcinoma left breast for which she underwent wide local excision and radiotherapy. Two years later (2014), she was evaluated for a swelling in the left side of neck and was diagnosed to have Non Hodgkins Lymphoma (Diffuse Large B cell Lymphoma) on biopsy. She underwent 6 cycles of chemotherapy with R-CHOP regimen. In August 2021, she developed a left-sided mandibular lymphadenopathy which on biopsy was found to be classical Hodgkins lymphoma. She was undergoing chemotherapy for the same when this report was written. Thus, four different malignancies; carcinoma right breast, carcinoma left breast, Non Hodgkins lymphoma and Hodgkins lymphoma were observed in one patient, over a period of 20 years. Conclusions: Our case report describes a quadruple primary malignancy in a patient who is undergoing treatment with the potential for a cure. Quadruple primary malignancies are very rare, with incidence of 0.3.

Anjali Dhanda, SudhirkumarAtri, Karthik. A, Shivkumaryadav

Introduction: Ibrutinib is an oral drug acting via inhibition of Bruton's tyrosine kinase pathway. It is generally a drug of choice for high risk patients with indolent lymphomas. It has been approved for B-cell malignancies including mantle cell lymphoma, chronic lymphocytic leukemia, waldenstrom's macroglobulinemia. Few systemic drugs are known to cause paronychia such as epidermal growth factor receptor (EGFR) inhibitor, EGFR tyrosine kinase inhibitor, BRAF inhibitors, vascular endothelial growth factor inhibitors, retinoids. Maculopapular rash, hair and nail abnormalities have been reported with Ibrutinib in past, but very few cases with paronychia have been reported. Paronychia is painful inflammation of nailfold. Periungual pyogenic granuloma can develop as complications of paronychia.

Aims & Objectives: To identify this unusual and severe side effect to improve patient care and reduce patient morbidity.

A 47 year male who was diagnosed with chronic lymphocytic leukemia Rai stage II, Binetsatge B with deletion 17p13 and 13q14.3 was started on Tab Ibrutinib 420 mg OD. Two months after initiation of drug patient started developing recurrent painful swellings involving toes and finger nail folds.

Result: After ruling out other possible causes Ibrutinib was suspected as causative agent, and was discontinued; subsequently the lesions began to resolve. Conclusions: Exact mechanism for this is not known but it is postulated that ibrutinib alters downstream NFKB mediated pathways leading to paronychia and excessive granulation tissue. It is very important to correctly identify these lesions as adverse event related to drug to avoid unnecessary aggressive treatments targeting infections as this is inflammatory in nature. Both physician and patient should be aware of these unusual drug side effects as this will improve patient quality of life, decrease morbidity and avoid unnecessary health care cost. Materials & Methods: Case Report: A 50 years male presented with chief complaints of generalized weakness and easy fatigability for last two months. On examination pallor was present and spleen was palpable 3 cm below subcostal margin. Hemoglobin was 7.7 g/dl, TLC = 6100/mm3, platelets = 27,000/ul. GBP showed Rouleax formation with features of hemolysis and corrected retic count 3.4%. Liver function test showed indirect hyperbilirubinemia (TB/DB = 2.8/0.9 mg/dl) and hypergammaglobulinemia with A: G reversal (total protein = 8.9, albumin = 3.4 g/dl. Serum LDH was 918u/l. Direct Coombs's test was positive. ANA, HCV, HbsAG, HIV was negative. Corrected calcium was 9 mg/dl. There was no lytic lesion on Xray skull or MRI spine. Myeloma profile showed M peak in IgG (8.6 g/dl) and lambda band (96 mg/l), B2-microglobulin was 4491 ng/ml. Bone marrow aspiration showed 10-15% plasma cells with occasional mottcells.Treatment started with Three bolus of 1000 mg methylprednisolone/day were intravenously administered and followed by oral prednisone 60 mg/day followed by tapering doses.

Result: There was an increase in Hemoglobin from 7.7 to 9.6 g/dl and platelets from 27,000 to 80,000/ul within 3 weeks of starting steroids and VRD, suggestive of autoimmune nature of anemia and thrombocytopenia.

Conclusions: Although autoimmune conditions are very rarely associated with multiple myeloma but they must be kept in mind.

Here we presented a case of secondary Evan's syndrome associated with multiple myeloma. Treatment options for ES is with high dose steroids; however, if the cause is secondary, the primary disease process should be treated. Higher levels of beta 2 microglobulin and lower levels of albumin were seen in high risk FISH group. IgG kappa was the predominant protein produced in FISH negative while IgG lambda, IgA and light chain only were seen in high risk FISH group. Anemia with renal failure was the most common presentation in high risk cytogenetic group while anemia with bone disease was the most common in non high risk and FISH negative group. Conclusions: A lower median age and a low frequency of t (11;14) and deletion 17p suggest ethnic diversity. Significant heterogeneity in clinical presentation associated with the cytogenetic subtype suggests that MM encompasses a group of cytogenetically and phenotypically distinct disorders rather than a single entity. Table- 1. The median overall survival (mOS) was not reached for the entire cohort and the median event free survival was 32 months. On univariate analysis, the median OS was statistically significant for GCB vs Non-GCB (NR vs 35 m, p = 0.02), stage III/ IV vs stage I/II (39 m vs NR, p = 0.04), elevated LDH vs normal LDH (33 vs 55 m, p = 0.01), bone marrow involved vs not involved (29 vs 49 m, p = 0.02). According to R-IPI, mOS for very good, good and poor risk patients were NR, 48 and 30 months respectively (p = 0.02). On multivariate analysis, ECOG PS [ 1, Non-GCB subtype, advanced stage and poor risk R-IPI were independent negative prognostic factors with a hazard ratio of 1.54 (95% CI 1.39-1.64, p = 0.01), 1.3 (95% CI 1.2-1.39, p = 0.009), 1.20 (95% CI 1.1-1.33, p = 0.02) and 1.41 (95% CI1.3-1.51, p = 0.04) respectively. Of thirty patients who relapsed/had progressive disease, 24 received salvage chemotherapy and 7 patients underwent autologous bone marrow transplantation. The mOS for these 7 patients was 53 months. Conclusions: DLBCL is one of the most common lymphomas seen in our daily practice. Outcomes are significantly inferior in patients with ECOG PS [ 1, Non-GCB subtype, advanced stage and poor risk R-IPI. Salvage chemotherapy followed by autologous BMT improves outcomes in relapsed setting.

Rima Mahapatra, S. Deepak, Amalnath, Debdutta Basu, Sujaya Mazumder, Kalayarasan Raja Introduction: Though spleen is a commonly involved organ in lymphomas, spleen as the primary site of involvement is very rare. The diagnosis is made after splenectomy or rarely splenic biopsy. Aims & Objectives: To describe the clinical, pathological and radiological correlation of primary splenic lymphoma. Materials & Methods: 3 cases were detected over a period of 2 years. 1st patient presented with right abdominal pain and fever. USG and CT abdomen was suggestive of splenic abscess. Splenectomy was done in view of suspected rupture of abscess. 2nd patient presented with fever and splenomegaly. He underwent diagnostic splenectomy. 3rd patient presented with fever and abdominal pain with hepatosplenomegaly. He also had pancytopenia with no atypical cells. Emergency open splenectomy was done for worsening abdominal pain. Result: All of the three patients were diagnosed as primary splenic lymphoma post splenectomy. Case 1: Enlarged spleen with necrotic irregular mass showed diffuse infiltration of the red pulp of spleen with medium to large atypical lymphoid cells having scant to moderate cytoplasm on HPE. The cells were positive for B cell markers CD20, CD10 and BCL-6 suggestive of primary splenic DLBCL, Germinal centre B cell type. Case 2: Entire spleen was replaced by multiple grayish white nodules with hemorrhagic foci. HPE showed large atypical lymphocytes positive for CD20, PAX5, MUM-1 suggestive of Primary splenic DLBCL, ABC subtype. Case 3: Beefy red spleen with atrophy of the white pulp. On histopathology there were plenty of monotonus cells with angulated nuclei, diffusely positive for CD3, CD2, CD7 suggestive of Hepatosplenic T cell lymphoma. All the 3 patients had interesting CT findings. Patient 1 had multiple nodular lesions with a large necrotic mass and subcapsular rupture. Patient 2 had diffuse hypodense lesions with a few specs of calcification which is a very rare radiological finding in lymphomas. Patient 3 had normal appearing spleen but the splenic vein was tortuous and multiple splenic and gastric collaterals were present, resembling non cirrhotic portal fibrosis.

Conclusions: Primary splenic lymphoma should be considered in patients with unexplained splenomegaly. Early splenectomy is essential for correct diagnosis and management.

Satarupa Mohapatra, Thomas Kuncheria, Alamelu Alagappan, Biswajit Sahoo, Ashutosh Panigrahi Introduction: Extranodal involvement in anaplastic large cell lymphoma (ALCL) ALK positive is common. However, central nervous system (CNS) and cardiac involvement is rare. Such cases are challenging to diagnose and treat. Here we present a case of ALCL ALK positive with disseminated disease, with involvement of the bone, skin as well as cardiac and CNS involvement. Aims & Objectives: NA. Materials & Methods: NA. Result: Case description: A 23 yr old male presented to the emergency with lesions over the left thigh, ulcerative lesion behind the left ear, weight loss, fever and shortness of breath. We did an urgent CECT which showed an ill-defined heterogeneously minimally enhancing lesion over the right ventricle in pericardial space which was contiguously infiltrating the adjacent pulmonary artery and extending along right pulmonary artery. Also, there was erosion and destruction of left petrous bone, carotid canal, mastoid, occipital bone on left side with associated large heterogeneously enhancing soft tissue component. Biopsy done from both the left thigh mass and the ulcerative lesion behind the ear was suggestive of ALK positive ALCL. This petrous bone mass was also seen involving left distal transverse sinus, sigmoid sinus and proximal IJV. Intra cranial extension was noted in the form of anterior thick irregular enhancing dural thickening in left temporal region and focal invasion of left temporal lobe and associated vasogenicedema. Conclusions: ALCL uncommonly presents with cardiac and CNS involvement. Among all case reports described in literature, our case differs from most of the cases in having minimal pericardial effusion.Reports of CNS involvement mostly describe ALCL with primary/isolated CNS involvement. However, our case had disseminated disease. Hence simultaneous CNS and cardiac involvement with disseminated disease is a distinguishing feature of our case. Managing such cases is a challenge. Patient was started on CHEOP with HDMTX. Patient is on treatment and follow up. 

Left sided bone marrow aspiration and bilateral trephine biopsy was performed in a known case of CKD who presented with bicytopenia since 2 weeks. Result: Sixty six years old female, a known case of CKD, who was on regular hemodialysis since 6-7 years presented with shortness of breath while undergoing hemodialysis. Complete blood counts revealed anemia (Hb-8.3 g/dl), total leucocyte count of 5.30 9 10 9 /L, thrombocytopenia (Platelets-78 9 10 9 /L) and reticulocyte count of 2.3%. Bone marrow aspirate showed hypercellularity with mild megaloblastosis and adequate megakaryocytes. Perl's stain for haemosiderin showed increased iron (6 ?). Bone marrow trephine biopsy revealed normocellular to mildly hypercellular marrow spaces. Some marrow spaces showed irregular bony trabeculae with prominent resorption bays. Paratrabecular fibrosis with few intertrabecular spaces completely filled with fibrous tissue seen (Reticulin stain showed 1-2 positivity). Areas of trabecular surface excavation and tunnelling also noted. The overall findings were suggestive of renal osteodystrophy. Conclusions: The bone biopsy remains the gold standard for diagnosing the abnormalities of the bone turnover. It is the parameter to which all other non-invasive parameters must be compared for bone turnover. A bone marrow biopsy should be carried out in CKD-MBD patients when the clinical symptoms and the biochemical parameters are not conclusive.

Tintu M V, Rahul T S Introduction: As per Globocan 2020 data, 14,641 new multiple myeloma cases were diagnosed per year in India. Myeloma constitute third most common hematological malignancy diagnosed in India. Because of the incurable and prolonged course of this disease, it has significant effect on overall cancer burden and QOL of patients.

This study is an attempt to study the profile of Multiple myeloma of north Tamilnadu.

This was a descriptive longitudinal study conducted in the department of medical oncology, madras medical college Chennai. 24 patients registered in our opd during the period from January 2019 to December 2019 were selected. Detailed history taking and clinical examination, laboratory evaluation were performed and the diagnosis of multiple myeloma was made based on the International Myeloma Working Group: criteria for the classification of monoclonal gammopathies, MM, and related disorders. Patients were treated with standard treatment regimen and the effect and outcome of treatment were analyzed at 4, 6 and 12 months from the commencement of treatment. Result: The male to female ratio was 1.3:1. The commonest symptoms noticed were fatigue 22 (91.6%) and bone pain 18 (75%). 6 (25%) patients had hypercalcemia and 9 (37.5%) patients had elevated serum creatinine levels. 21 (87.5%) patients had bone lytic lesions. One patient expired during the course of the treatment. 14 (58.3%) of 24 patients had partial response to treatment, 5 (20.8%) had complete response and 3 (12.5%) of them had stable disease. Conclusions: The present study had a male preponderance. Most common symptoms noticed were fatigue and bone pain and majority had lytic lesion in bone. Patients can present with non specific symptoms and variable presentations at onset. High index of suspicion helps to arrive in diagnosis the quality of life and symptom control, survival prolongation is possible with available standard regimens. Outcomes of MM patients can be improved significantly if there is access to newer therapies.

Victor Tomacinschii, Sanda Buruiana, Maria Robu Introduction: Non-Hodgkin's lymphomas (NHL) are malignant tumors that develop from lymphoid tissue. Primary lymph node involvement (l/n) is the most common localization (52-70%). Charlson comorbidity index (CCI) is a useful tool for estimation of the risk of death from comorbid diseases. CCI has been reported to be a useful index to predict outcomes in many non-hematologic malignancies.

Aims & Objectives: Appraising the impact of comorbidities on the efficiency of first-line treatment of NHL with primary involvement of the lymph nodes. Materials & Methods: The retrospective study included 64 patients with nodal NHL and diverse concomitant diseases, out of them aggressive NHLs (33) and indolent NHLs (31) patients. The comorbidities of each patient were noted, then the CCI was calculated. Result: The median age of the participants was 61 years old (range 48-74). Patients were separated into two groups: those with a low CCI (0-1 point) (46.87%) and those with a high CCI (2 points) (18.12%). Diabetes (17.1%), cardiovascular diseases (14.0%), chronic obstructive pulmonary disease (10.9%) and kidney diseases (9.37%) were the most common comorbidities. In two cases, a link to other cancers has been discovered (3.1 percent). 56 patients (87.5%) received R-CHOP treatment, 6 (9.37%) received conventional types of polychemotherapies, and 2 (3.12%) received the best supportive care. 3-year overall survival (OS) was seriously harmed in the group of patients with high CCI scores, with a three-year overall survival rate of only 27,7% (Fig. 1) .

Conclusions: OS survival rates in NHL are strongly associated with the comorbid level. And Charlson comorbidity score can be a useful prognostic index in the determination of survival of patients with nodal NHL, patients with high CCI having a 3-year OS = 27,7%.

Karthik A, Sudhir Atri, Anjali, Bhanu Pratap Singh Introduction: Waldenstrom macroglobulinemia (WM) is a rare low grade lymphoproliferative disorder with distinctive clinical features and the presence of Monoclonal IgM.The disease is rare, representing approximately 2% of all cases of non-Hodgkin Lymphoma. There is no complete cure for the disease but is treatable and long term survival can be achieved.The mutual association of both WM and HCV with cryoglobulinemia has led to speculation that HCV infection may play a causative role in WM. Aims & Objectives: To consider WM as a differential diagnosis in patients evaluated for organomegaly with paraproteinemia with no evidence of hypercalcemia or lyric lesions in bone. To consider the association between HCV infection and WM and screen all patients of WM for HCV. Materials & Methods: Our patient, 46 yr/male pt, recently diagnosed HCV positive (not on any treatment) presented with Generalized weakness and easy fatigability and no bleeding symptoms. On examination there was moderate pallor, no lymphadenopathy but hepatosplenomegaly was present along with the presence of symptoms suggestive of hyperviscosity as on the fundus examination in the form of dilated retinal veins and soft exudates. Routine investigations revealed anemia with thrombocytopenia and presence of hyperglobulinemia with reversal of A:G ratio with IgM PEAK on immunofixation and also Bone marrow done suggestive of lymphoplasmocytuc infiltration. MYD88 mutation was found to be positive and along with the above mentioned features a diagnosis of WM was inferred.

Result: Patient was started on treatment for HCV status and after few days he was given 6 cycles of BENDAMUSTINE-RITUXIMAB. There was marked improvement in the general condition of patient and even the hematological and metabolic parameters. Currently even the M spike is not detectable and the patient is on regular follow up but currently uneventful. Conclusions: WM is a rare lymphoproliferative disease which should be considered in the differential diagnosis of unexplained organomegaly with paraproteinemias. There is a association between hepatitis C infection and WM, each of which should be looked for while evaluating for either of the two conditions.

Pooja Rathee, Niti Dalal, Vibhuti Thukral, Rachna Yadav, Sunita Singh Introduction: Lymphomas are a heterogenous group of lymphoproliferative malignancies. Diagnosis is based on cell morphology, distortion of lymph node architecture and is confirmed by primary and secondary panels of immunohistochemistry. This study conducted in a tertiary care hospital in North India has taken into account light microscopic and immunohistochemistry findings and subclassified the lymphoproliferative disorder according to the WHO classification. Materials & Methods: This is a retrospective study comprising of total 50 cases of lymphoma over a period of one year, i.e. January to December 2020, diagnosed in the Department of Pathology, Pt. B.D. Sharma, PGIMS, Rohtak. Cases of both nodal and extranodal lymphoma were included in the study. The cases were diagnosed based on light microscopy and confirmed by immunohistochemistry. Result: Out of 50 cases, 12 cases were of Hodgkin's lymphoma (HL) and 38 were of Non Hodgkin's lymphoma (NHL). Among HL, 10 were nodal and 2 were extranodal and among, NHL, 22 were nodal and 16 were extranodal. Male predominance was seen in HL as well as NHL. Bimodal age distribution was seen in second and sixth decade. Cases of HL was diagnosed on the basis of presence of Reed Sternberg (RS) cells and positivity of CD15 & CD30. Cases of NHL was confirmed by using primary and secondary panel of IHC. Primary panel of IHC includes LCA, CD3, CD5, CD19, CD20, CD79, CD45 while secondary panel includes CD10, CD23, BCL2, BCL6, CYCLIN D1, ALK. Conclusions: The incidence of lymphomas is showing an upward trend in recent years worldwide. The pattern of lymphomas in India is different from that in the western countries.

NHL are more common than HL. Histopathology along with immunohistochemistry play an important role in subtyping lymphoma and also in prognosis and therapeutic approach.

Aeshrat Bano, Anupam Chakrapani, Nidhi Dikshit Introduction: Multiple myeloma (MM) is a very heterogeneous disease with nearly a quarter of patients dying within 3 years of diagnosis and others maintaining durable disease control for more than 10 years. RISS staging is a prognostic model developed to stratify multiple myeloma.

Aims & Objectives: The present study was conducted to identify the demographic pattern, various cytogenetic abnormalities and evaluate the R-ISS in 53 patients, treated in a single center.

A single institution retrospective study was conducted 53 newly diagnosed Multiple Myeloma patients. They were analyzed for cytogenetic anomalies by using FISH. Serum albumin levels, beta 2 microglobulin levels and LDH levels were documented at the time of diagnosis and the patients were staged according to Revised International Staging System (R-ISS). Patients belonging to both genders and all ages were taken into consideration. Result: Out of the 53 patients studied, 29 were males (54.7%) and 24 were females (45.2%). 92% (49 patients) were older than 50 yrs. Most common symptoms were bone pain (28 patients-52.8%) followed by anemia (26.4%) and renal failure (16.9%). 19 patients (35.8%) were classified as RISS stage I, 19 patients (35.8%) were classified as stage II and 15 patients ( 28.3%) were classified as stage III. FISH abnormalities were detected in 18 (33.9%) patients, the most common being deletion 13q in 8 (15%) patients followed by deletion 17p in 7 (13.2%) patients. 5 patients had more than one chromosomal abnormality. LDH levels were increased in 11 (20.7%) of patients. Conclusions: In this study, multiple myeloma was slightly more common in males and it mostly affected the older population. 18.8% of patients had high risk FISH cytogenetics. The most common cytogenetic abnormalities were del17 p and del 13q, similar to the study done by He et al. 28.3% of patients were RISS stage III, which was significantly higher than that of study done by Tandon et al. (12.7%).

Introduction: Plasma cell leukemia (PCL) is the rarest yet most aggressive plasma cell disorder. PCL was originally defined by an absolute plasma cell (PC) count greater than 2 9 109/L in the peripheral blood (PB) and more than 20% circulating PCs. PCL is referred to as primary when the leukemic phase presents at diagnosis, or secondary when leukemic progression occurs in the context of preexisting multiple myeloma (MM). Historically amongst PCL, 60-70% of cases have been reported to be primary PCL (pPCL), whereas * 40% are secondary (sPCL). In untimely diagnostic patients, sPCL has been proven to be fatal with poor prognosis. Therefore, the most significant lifesaving factors for better prognosis in such patients include prompt diagnosis and treatment with supportive and targeted therapy. In PCL, literature related to sPCL is much more limited due to non-feasibility of long term studies. Given the rarity of the disease & to add up to the literature for future studies, we are reporting and discussing the case series of sPCL and its related clinical, diagnostic, and treatment options available. Aims & Objectives: Here we are reporting rare cases of sPCL diagnosed at our center with their clinical, laboratory, diagnostic, and treatment work-up.

We retrospectively reviewed all cases of PCL, which were registered in Hematology department, HCG Manavata Cancer Centre, Nashik, India from January 2020 to August 2021. Result: There were 3 cases of sPCL among 100 consecutive cases of MM. The male to female sex distribution was 2:1 with a median age of * 68.5 years, on diagnosis. Most relevant clinical and laboratory features are presented in Table 1 . These cases had high tumor mass and when compared with comparable patients, displayed a higher incidence of stage 3 disease, thrombocytopenia, anemia, raised LDH levels and extramedullary involvement. Out of 3 cases of Secondary PCL first patient expired within a week of diagnosis. For Second patient Poor Prognosis Explained to the Patient. Patient Lost To Follow Up. For third patient treatment was started with bortezomib, dexamethasone, doxorubicin (PAD) chemotherapy.Patient completed 2 cycles of chemotherapy.But before treatment could be completed patient expired due to acute kidney injury with severe hyponatremia. Conclusions: Timely diagnosis and treatment with novel therapeutics/chemotherapy regimens can play vital role in the prognosis of sPCL.

Clinicopathological Profile of Multiple Myeloma: A Case Series at Tertiary Health Care Centre in Western Rajasthan Kanishka Chaurasia, ManaliSatiza, Adhiraj Singh, Gopal Krishana Bohra, Abhishek Purohit Introduction: Multiple myeloma (MM) is the most common plasma cell dyscrasia (PCD) and second most common haematological malignancy characterized by excessive proliferation of single clone of cells producing entire immunoglobulins, immunoglobulin fragments, heavy chains or light chains usually associated with M-protein spike in serum/urine and evidence of end organ damage. The symptoms and signs of MM may be nonspecific and include fatigue, bone pain, easy bruisability/bleeding, recurrent infections, anemia, hypercalcemia, renal insufficiency, lytic bone lesions, hyperviscosity, and hyper/hypogammaglobulinemia. In 2020, it was estimated that every year 32,000 new cases were diagnosed with MM and almost 13,000 died. Aims & Objectives: The aim of this study is to highlight the clinicopathological spectrum of multiple myeloma cases at our centre. Materials & Methods: This is an ambispective study which was being conducted at AIIMS Jodhpur on adult population over a period of four years (2017-2021). Total 65 patients were included in the study. A detailed history with presenting clinical complaints were noted. Complete laboratory workup was done keeping in view IMWG criteria for MM including-CBC, RFT, Serum Calcium, Bone Scan, serum protein electrophoresis and Immunofixation followed by Bone marrow examination. Result: Total 65 patients were included in the study. Of all, 45 were males and 20 were females. Mean age of patient was 52 years with a range of 20 to 85 years. Most common clinical presentation was Lower back pain (53%), pallor (41%), weakness/fatigue (33%), and pathologic fracture (23%). Investigations revealed anaemia (66%) as most common finding followed by hyperglobulinemia; raised creatinine (29%), lytic bone lesions (23%), and hypercalcaemia (16%). The most common monoclonal gammopathy was found out to be IgG. Conclusions: Diagnosis of plasma cell dyscrasias requires a systematic approach. The clinicopathological characteristic of different types of plasma cell dyscrasias has varied presentations but International Myeloma Working Group classification if applied carefully can help us to identify each type, evaluate and manage patients in a better way.

Manideepa Maji, Nita Radhakrishnan, Vinod Puri, Ravi Shankar, Shruti Saxena Introduction: Non-Hodgkin's lymphomas (NHLs) account for only 0.3-1.5% of all CNS neoplasms. Intramedullary lymphoma, presenting as non-compressive myelopathy and paraplegia is extremely rare. Aims & Objectives: 11-year old boy who presented with complaints of migratory pain in the joints of 2 months of duration with progressive severe pain in the upper and lower back of 15 days duration.

Materials & Methods: 11-year old boy who presented with complaints of migratory pain in the joints of 2 months of duration with progressive severe pain in the upper and lower back of 15 days duration. He developed swelling around left eye along with proptosis and oedema noted on face for 1 month duration. On examination, Proptosis of left eye and bilateral inguinal lymphadenopathy. There was no organomegaly. Bone marrow aspiration and biopsy was suggestive of infiltration (30% atypical cells) with mature B cell lymphoma (CD20-positive). CSF was negative for malignant cells. While in hospital he developed retention of urine and stools followed by weakness of both lower limbs. He developed paraplegia with complete sensory loss over next 24 h with motor level at T10 and sensory at T7. Magnetic resonance imaging of thoracolumbar spine was suggestive of altered signal intensity involving the inferior end plate of D8, D10 and D12 vertebrae due to Lymphoma involvement with no evidence of compression of spinal cord or leptomeningeal infiltration. Hyperintensity was noted in T2-T4 level on FLAIR and T2 weighted imaging with no corresponding vertebral or meningeal lesion. He was started on LMB protocol with Rituximab. 2 courses of pulse methyl prednisolone were given in addition. He has completed COPADM2 and repeat PET CT has shown metabolic remission. Repeat MRI after COPADM1 has shown improvement in the spinal cord lesion. Clinically, he has partial motor and sensory recovery in both limbs. Result: He was started on LMB protocol with Rituximab. 2 courses of pulse methyl prednisolone were given in addition. He has completed COPADM2 and repeat PET CT has shown metabolic remission. Repeat MRI after COPADM1 has shown improvement in the spinal cord lesion. Clinically, he has partial motor and sensory recovery in both limbs. Conclusions: Intramedullary spinal cord mature B-cell non-Hodgkin's lymphoma in a paediatric age group is very rare and hence requires a high index of suspicion in patients presented with myelopathy. Introduction: Carfilzomib is an irreversible proteasome inhibitor approved for use in relapsed/refractory and recently in newly diagnosed multiple myeloma (MM). In a country like ours, the use of the original molecule of Carfilzomib is limited by its high cost. There is limited data on the use and outcomes of generic Carfilzomib in patients with relapsed MM. Aims & Objectives: To analyse the outcomes of patients with relapsed MM treated with generic Carfilzomib. Materials & Methods: This is a retrospective data on the use and outcomes of generic Carfilzomib in patients with relapsed MM treated at the Department of Haematology, Christian Medical College, Vellore, India. Patients who were treated with generic Carfilzomib (CARFILNAT-NATCO Pharma) were included in this analysis. Patient demographics, clinical details and follow up data were retrieved from electronic medical records. Result: Fifty seven patients (42 males and 15 females) with relapsed MM were treated with generic Carfilzomib. The median age of the patients was 56 (38-72) years. The median no of previous lines of therapy were 3 (1-8) and majority of patients (n = 40, 70%) had undergone a prior autologous stem cell transplantation. Medullary relapse was common (n = 33) followed by combined medullary and extramedullary relapses (n = 20). Carfilzomib in combination with Pomalidomide and Dexamethasone (KPD) was the most common regimen used-51 patients (89%). Response could not be assessed in 10 patients (4 early deaths-3 due to cytopenic infections, 1 due to cardiac failure, 5 lost to follow up and 1 change in therapy due to financial reasons). Out of the rest 47 patients, 1 patient attained complete response (CR), 19 patients attained very good partial response (VGPR) and 5 patients attained a partial response. An overall response was seen in 25 (53%) patients. Twenty two (46%) patients had progressive disease. Conclusions: Generic Carfilzomib is a reasonable therapeutic option in our set of patients with relapsed MM. In a subset of heavily pretreated patients and especially after a prior autologous stem cell transplantation, responses may not be optimal.

Alen Antony Joy, Uday Kulkarni, Anu Korula, Sushil Selvarajan, Sharon Lionel, Anup J Devasia, Fouzia NA, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George Introduction: Subcutaneous panniculitis like T cell lymphoma (SPTCL) is a rare non-Hodgkin lymphoma. There is paucity of data on this disease to guide treatment decisions. Aims & Objectives: To describe the clinical outcomes of patients with SPTCL treated at our center.

We performed a retrospective analysis of patients with SPTCL who were evaluated at our center from January 2011 to December 2020. Result: During the study period, 36 patients with cutaneous lymphomas were evaluated at our center of which 22 had SPTCL. Median age was 30 years (IQR: 22.5 to 36 years), 21 were females. All had disease limited to skin except for 3 with marrow involvement and 1 with adenopathy. Five patients had concomitant hemophagocyticlymphohistiocytosis (HLH). Upfront treatment was CHOP/CVP (n = 12), CHEOP (n = 5), oral cyclosporine ?/-steroids (n = 4), and weekly oral methotrexate (n = 1). Following this, 1 died of sepsis following 1st cycle CHEOP, 1 was lost to follow after 2 cycles of CHOP with persistent HLH, 1 (5%) had partial remission, 16 (73%) attained complete clinical remission, 2 had progressive disease for which they received salvage GCD chemotherapy (1 attained CR and underwent autoSCT, 1 had progressive disease and was treated with cyclosporine and is in remission 4 years post-relapse), while 1 had resolution of skin lesions with persistent HLH following CVP chemotherapy and was started on cyclosporine for 2 years(subsequently relapsed after 2 years and was re-treated with cyclosporine and is in remission at 4.5 years post-relapse). Of the patients attaining CR/PR, 4 had disease relapse at a median time of 19 months. Of these, 1 was lost to follow up, while the remaining 3 received intensive salvage (1 underwent autoSCT). The median follow up for the entire cohort was 38 months (IQR: 19 to 58). All 4 patients (3 with disease limited to skin and 1 with marrow involvement and HLH) treated upfront with cyclosporine attained complete remission while none had a disease relapse at a median follow up of 30 months. Conclusions: Cyclosporine is an effective treatment option for SPTCL. Larger studies with longer follow up are needed to confirm its role in disease not limited to skin or with concomitant HLH and in chemo-refractory disease.

Introduction: Sclerotic bone lesions presentation in malignant monoclonal gammopathies is rare.Incidence is less than 3%, although they are occasionally associated with POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes).Presenting a case of plasma cell neoplasm with sclerotic bone lesions with no other features of POEMS. Discussion: A 49 years old male presented with complaints of low back and right hip pain since 1 year. He was evaluated, MRI LS Spine and pelvis showed multiple sclerotic lesions in vertebrae, soft tissue lesion at T3 level and pelvic bones. Work up for myeloma was done with CBC, S. Creatinine, LFT, TSH, Serum protein electrophoresis, Free light chains (blood and urine) which were normal and Bone marrow aspirations and biopsy was normal with no increased plasma cells. PET CT scan showed multiple sclerotic lesions of the bone including the spine and pelvis with soft tissue lesion at T3 level. In view of no evidence of para-protiens and impending cord compression, he underwent posterior stabilization of T2-T4 and biopsy from the soft tissue lesion. Morphology and IHC-Mum1-positive with Lambda chain restriction, consistent with plasmacytoma (Ig G Kappa). In view of multiple sclerotic lesions in spine and pelvis he was treated as Non-secretory Myeloma. He was started on chemotherapy (Bortezomib/cyclophosphamide/Dexamethasone) regimen with Bisphosphonates. Post 12 weeks of therapy, repeat PET CT scan was done which showed complete resolution of Sclerotic bone lesions suggestive of Complete Metabolic response. Conclusion: Multiple sclerotic lesions without other features of POEMS is a rare entity. Non-Secretory Myeloma presenting has multiple sclerotic bone lesions is not common. This case demonstrates importance of tissue Biopsy and PET scan in Non -Secretory Myeloma.

Chirag Trivedi, AnuKorula*, Uday Kulkarni, Sharon Lionel, SushilSelvarajan, Anup J Devasia, Fouzia N Aboobacker, Aby Abraham, Biju George, Alok Srivastava, and Vikram Mathew Introduction: Relapsed refractory Hodgkin lymphoma (R/R HL) is a challenging disease to treat. Check-point inhibitors have come to the forefront of therapy in many tumours, including R/R HL, with a recent shift from intensive salvage regimens to an immunotherapybased approach. Phase I/II studies have established the safety of these novel agents, however the optimal efficacy dose has not been established. Recently a few case reports and case series have reported efficacy of a low dose of nivolumab in refractory HL. Aims & Objectives: To assess the efficacy and immune-related adverse event profile (iRAE) profile of nivolumab in a fixed dose of 40 mg in patients with primary progressive (PP) and R/R classical HL. Materials & Methods: Single center retrospective analysis of patients with PP or R/R HL treated with low dose nivolumab at our centre. 4 doses of nivolumab 40 mg were administered at 2 weekly intervals. The response to therapy was assessed after 4 doses of nivolumab by PET/CT scan (reported as per the Deauville criteria). Result: 11 patients with HL were treated with low dose nivolumab, the median age of patients was 30.5 years (Range 14-61 years), out of which 8 patients were male. 3 had R/R disease, 6 patients had PP disease, and 2 had relapsed after ASCT (indication for transplant-PP disease). Patients received a median of 2 salvage regimens prior to therapy with nivolumab (Range 1-3)0.2 patients did not complete the planned 4 doses-1 died due to covid-19 pneumonia, 1 had disease progression after 2 doses. In 9 patients who completed 4 doses of nivolumab, 5 had a Deauville score of 1-3 (including one patient with post-autologous relapse), 2 had a Deauville score of 'X', and 2 had score of 5 and/or clinical evidence of disease.5 patients underwent ASCT in complete remission and 2 patients are currently planned for autologous (n = 1) and allogeneic stem cell transplant (n = 1). 4 patients did not undergo ASCT-suboptimal response/disease progression (n = 3) and inter-current infection resulting in death (n = 1).Commonly described iRAEs were not seen, however one patient developed a skin rash and transient elevation of liver enzymes. Conclusions: Low dose nivolumab in setting of PP and R/R HL is a cost-effective alternative to standard dosing, with equivalent efficacy in this small case series. Larger prospective studies are warranted to validate these findings.

Abhinab Bhuyan, Siyum Ganguly, Prabir Hazarika Introduction: Multiple myeloma is a plasma cell neoplasm, resulting from the proliferation in bone marrow of a clone of neoplastic cells that are closely related, both morphologically and functionally, to plasma cells. It is the second most common haematological malignancy. Multiple myeloma having cytopenias other than anemia at disease presentation is a rare event. We are presenting a case series with 4 cases of multiple myeloma presenting with pancytopenia. Aims & Objectives: To evaluate the unusual hematological presentation of multiple myeloma. Materials & Methods: An observational study of four cases of multiple myeloma presenting with pancytopenia was conducted in Jorhat Medical College and Hospital, Assam over a period of 12 months. The complete haemogram, peripheral blood examination, Bone Marrow Aspiration and biopsy study as well as serum protein electrophoresis of all the cases were conducted and analysed. Result: Out of 4 cases, the age at presentation ranged from 49 to 68 years. Generalized weakness and fatique was the most common symptom (100%). Peripheral blood examination showed normocytic normochromic picture with rouleaux formation in all the 4 cases. BMA study showed prominent plasmacytosis (C 60%) in the 4 cases and showed correlation with biopsy studies. Serum protein electrophoresis showed prominent M band in the gamma region in all the cases in the study. Conclusions: The study was conducted due to its rareity. Thus, though unusual, pancytopenia may be the presenting hematological presentation of multiple myeloma and proper biochemical as well as bone marrow studies should be followed up for its diagnosis.

Abhishek Nareda, R.K. Nigam Introduction: One of the rarest and most aggressive forms of plasma cell dyscarias is the plasma cell leukaemia. Hence there is no specific guidelines for its diagnosis and management or to significantly improve the overall condition of the patient. Aims & Objectives: Our aim is to present a rare case of primary plasma cell leukaemia which was diagnosed and managed in our hospital producing good prognosis.

Materials & Methods: Here we present a case, a 39-year-old male patient presented to the OPD of Gandhi Medical hospital Bhopal in 2020 with breathlessness and chest pain and decreased frequency of micturition. On clinical examination of patient mild pallor seen with No organomegaly. No previous history of drug abuse or chronic illness was found. MRI showed collapsed L1 vertebra with marrow oedema. Haemogram revealed bicytopenia with leucocytosis. The peripheral blood film portrayed rouleax formation with 40% of circulating plasma cells. Bone marrow aspiration revealed hypercellular marrow with 60% of the atypical plasma cells and further investigations showed kappa light chain restriction. All the investigations were suggestive of primary plasma cell leukaemia with involvement of both kidneys. Result: Final diagnosis of plasma cell leukemia was made. The patient was managed with oral lenalidomide chemotherapy, which improved the overall hematological and biochemical profile of the patient. Conclusions: The diagnosis of primary plasma cell leukemia is often based on bone marrow morphology, flow cytometry, cytogenetic studies, serum and urine protein electrophoresis. The differential diagnoses need to be considered are amyloidosis, multiple myeloma, B-cell chronic lymphocytic leukaemia, hairy cell leukaemia, marginal zone lymphoma and reactive polyclonal plasmacytosis. In this case report we describe the clinical and diagnostic features along with the management of primary plasma cell leukaemia and to differentiate it from multiple myeloma.

Ankita Jaiswal Govil, Tejindar Singh Introduction: Plasma cell myeloma (PCM) is a neoplastic proliferation of bone marrow plasma cells, usually associated with a serum/ urine M protein and evidence of organ dysfunction. IGH translocations and hyperdiploidy appear to be early events in the pathogenesis, unified by associated upregulation of one of the cyclin D genes. Aims & Objectives: We aimed to study the expression of Cyclin D1 and CD20 in PCM and correlate it with certain clinical and morphological features. Materials & Methods: We evaluated bone marrow biopsy sections from 32 cases of PCM at Oncquest Laboratories Ltd., New Delhi from July 2020 to June 2021. We evaluated the morphology of plasma cells, pattern of marrow involvement and association with fibrosis on H&E sections. Greipp plasma cell grading system was used. Cases were also subclassified as lymphoplasmactytic/lymphocytic type, as it is now an increasingly recognized subset of PCM having a prognostic significance and a cause of erroneous diagnosis. Immunohistochemistry was performed in all these cases using monoclonal antibodies against CD138, Kappa, Lambda, CD56, CD20, and CyclinD1. Result: On IHC, Cyclin D1 nuclear expression was noted in 13/32 (40.6%) cases. On morphology of Cyclin D1 ? group, 4 were lymphocytic/lymphoplasmacytic type. CD 20 was expressed by 7/32 (21.9%) cases. On morphology, 3 were lymphoplasmacytic type. 5 out of these 7 cases were also Cyclin D1 positive. Total 6/32 (18.8%) cases had lymphoplasmacytic morphology, 4/6 cases (66.6%) were positive for CD20 * and Cyclin D1 each. 1/6 cases were negative for both CD20 and Cyclin D1. Conclusions: This study revealed that though CD20 and Cyclin D1 positive PCM is a heterogenous disease and not a unique clinicopathologic entity, yet lymphoplasmacytic morphology has a strong correlation with CD20 and CyclinD1 expression. Hence we propose that CD20 and Cyclin D1 IHC should be carried out in all cases of lymphocytic/lymphoplasmacyic morphology and suggest that Cyclin D1 IHC can be used as a surrogate marker for t (11;14) in a resource poor setting and help predict better overall survival. Conclusions: DLBCL-non germinal center type is the most common NHL reported. T-cell lymphoma was the second commonest group. We encountered almost similar occurrence of Nodal and extra nodal lymphomas. Cervical lymph node was the most common site of biopsy in our patient population.

Introduction: Multiple Myeloma is neoplastic proliferation of plasma cells that commonly results in multiple skeletal lesions, hypercalcemia, renal insufficiency, and anemia. Patients typically present at ages [ 40 with localized bone pain or a pathologic fracture. Diagnosis is made with a bone marrow biopsy showing monoclonal plasma cells C 10%.It is most common primary bone malignancy Diagnosis requires synthesis of clinical, laboratory, radiologic and histologic findings. Aims & Objectives: To present a case of multiple myeloma with its bone marrow aspiration and bone marrow biopsy findings. Materials & Methods: Peripheral smear of patient was made. Bone marrow aspiration was done followed by bone marrow biopsy through posterior superior iliac spine. PS smear and BMA smear was stained using leishman stain and BMB was processed and stained using H&E stain and results were analysed. Result: Bone marrow aspiration was showing megaloblsatic erythropoiesis with increased plasma cells upto 9% and this picture was suggestive of monoclonal gammapathy of undetermined significance or Smoldering myeloma. Bone marrow biopsy was showing features of multiple myeloma with plasma cells [ 60%.

Conclusions: This case study suggested that the combined analyses of bone marrow aspiration and biopsy findings are useful to achieve more accurate and diagnostic information in a case of multiple myeloma. Introduction: Marrow emancipation of plasma cells is considered to be a hallmark of aggressive disease and likely malignant transformation in plasma cell dyscrasias. The multiple myeloma patients usually present with lytic bony lesions suggesting a hematogenous dissemination once a malignant transformation has occurred. Studies have shown that patients who lie on the plasma cell spectrum with an increased circulating plasma cells in the peripheral blood have a higher risk of progression to multiple myeloma. Aims & Objectives: Here we report three cases presenting with a myriad of non specific symptoms with plasma cells masquerading in the high fluorescence lymphocyte monocyte region of WBC scattergram with subsequent morphological evaluation of peripheral blood revealing mature plasma cells; further workup was done in those cases including bone marrow aspirate, biopsy and relevant biochemical investigations. Materials & Methods: Three patients-a 65 yr old female and two males of 55 and 41 yrs of age presented with non specific complaints of fever, cough, generalised weakness. Biochemical analyses showed mildly elevated serum creatinine in all three cases. The complete blood count samples in EDTA vials were processed on automated hematology analyser Sysmex XN 550 at our Hematology section at Assam Medical College and Hospital and the results were recorded. Result: Peripheral blood smear revealed 2%, 5% and 10% circulating plasma cells. The differential WBC scattergram (Fluorescence vs side scatter) of all three showed an relatively discontinuous, isolated population above the lymphocyte monocyte region with increased fluorescence. Serum protein electrophoresis revealed an M band in all three which was followed by a bone marrow aspiration and biopsy; all were reported as plasma cell dyscrasias owing to an elevated plasma cell count in the marrow. Conclusions: The rate of clonal plasma cell proliferation is an important indicator of disease outcome and higher levels particularly correspond with progressive disease activity. In these cases the WBC scattergram was infact the first indicator of the circulating plasma cells and thorough morphological evaluation helped establish a definitive diagnoses of plasma cell dyscrasias.

Shuchismita, Iffat Jamal, Vijayanand Chaudhary, Ravi Bhushan Raman, Kaushal Kumar, Satish Kumar, Rawi Agrawal Introduction: Hairy cell leukemia (HCL) is a rare B-cell neoplasm of middle age presenting with pancytopenia, splenomegaly, and hairy cells in the bone marrow. Splenomegaly accounts for 80-90% of associated features in HCL. Here, we represent an atypical case of HCL with weakness only but no splenomegaly. Aims & Objectives: Aim: This report of an unusual presentation of such a rare disease could lead to earlier diagnosis of HCL, even without a typical clinical presentation. Case Report: A 48 years old male presented with three months history of weakness and fatigability. On examination, he had pallor; however had no organomegaly or lymphadenopathy. Hemogram revealed pancytopenia with haemoglobin-9.0 gm/dl, total leucocyte count-3200/cumm with a differential count revealing 68% hairy cells which are of intermediate size and abundant blue cytoplasm, some with circumferential projections, Neutrophils-12%, Lymphocytes-18%, Eosinophil-2%, and platelets-90,000/cumm (Fig-1a) . Bone marrow aspiration (BMA) was carried out for evaluation of pancytopenia. BMA smears were hypercellular for age and showed infiltration by hairy cells. Other cell lineages were markedly suppressed (Fig. 1b & c) . Immunophenotyping by flow cytometry revealed a monoclonal small B-cell population with an expression of CD19 (bright), CD20 (bright), CD79b (bright), CD25 (moderate), CD103 (moderate to bright), CD200 (dim), FMC-7 (dim), CD11c (bright), and surface kappa restricted (moderate) (Fig. 1d & e) . Subsequently the patient received standard dose chemotherapy with cladribine and achieved hematological remission. Splenomegaly is by far the most constant physical finding in HCL and HCL is typically included in the differential diagnosis of enlarged spleen. Hence a case of hairy cell leukemia presenting without splenomegaly puts both the clinician and pathologist in diagnostic dilemma many a times, as these cases show only a small percentage of classical abnormal mononuclear cells with circumferential projections in the peripheral blood as well as in the bone marrow aspirate. Conclusions: Conclusion: A careful attention to morphological details is important for early diagnosis even in absence of classical symptoms facilitating maximum benefit to the patients. 

Conclusions: The combination of these techniques helped us to achieve faster diagnosis in aggressive lymphomas. It also enabled us to achieve the diagnosis from inaccessible sites. Therefore we emphasize that the combination FNAC with cell block preparation and Fow Cytometry on FNAC samples can help in diagnosing and excluding lymphomas and to avoid an excision biopsy. Result: From above clinical findings and investigations there is evidence of monoclonal IG associated renal disease with no mylemoa defining events and no bone marrow clonal plasma cells, suggestive of monoclonal gammopathy of renal significance. Conclusions: MGRS represents, conditions in which monoclonal immunoglobulin is secreted by nonmaligant or pre malignant B Cells or Plasma Cells which causes kidney damage,may progress to multiple myeloma in future and hence necessary to diagnose early for early interventions.

Introduction: Flow cytometry has unparalleled significance as a diagnostic and staging tool in the treatment of Lymphoma. We present two cases of NonHodgkin Lymphoma posing as a diagnostic and a therapeutic challenge to the clinician and the pathologist. Aims & Objectives: Use of Flowcytometry as a main diagnostic tool in the diagnosis of unusual lymphoma. Materials & Methods: Case1: A 51 year female presented with massive splenomegaly and pancytopenia. Flow cytometry of the bone marrow aspirate showed 12% clonal B lymphocytes which were CD5 and CD10 negative. The bone marrow biopsy had 3-4 lymphoid aggregates, some of which showedparatrabecular localization. Cytogenetic and FISH studies did not show any abnormalities. The flow cytometry was instrumental in providing diagnosis of this patient as Splenic Marginal Zone Lymphoma.

Case2: 52 years old male patient came to OPD with a diagnosis of liver cirrhosis with portal hypertension. PET-CT was done and showed multiple low grade FDG positive lymph nodes in the cervical and axillary region. Peripheral smear examination revealed 61% lymphocytes with an absolute lymphocyte count of 12,600 cells/ul. On morphology these cells were medium sized with irregular nuclei and prominent nucleoli. Flow cytometry examination showed 88% atypical T cells with a bright CD45 expression and CD4 restriction. These cells were positive for CD3,CD7, CD2, CD5, HLA-DR and TCR-AB. Special markers CD52 and TCL1 were positive suggestive of T-cell prolymphocytic Lymphoma. Result: The above two cases highlight the significance of flow cytometry as a primary diagnostic tool in Unusual presentation of Chronic Lymphoproliferative disorders. Conclusions: Use of Flowcytometry as a primary diagnostic tool in chronic lymphoproliferative disorders. Introduction: Subcutaneous panniculitis-like T cell lymphomas (SPTCLs) are rare cytotoxic T-Cell lymphoma accounting for \ 1% of all extra nodal non-Hodgkin's lymphomas and typically afflict adults with a median age of 35 years (age range 25-45 years). Cutaneous involvement by T-cell leukemia/lymphoma is a rare occurrence with a reported frequency of around 4.3%. About 20% of patients have associated autoimmune diseases and the early lesions may closely mimic lobular panniculitis.

Here we present a case of 25 year old male patient who presented with generalised weakness, skin erythematous lesion and lymphadenopathy since 02 years duration and was treated as a case in septal lobular panniculitis (previous documents unavailable) and finally turned out to be SPTCL. Materials & Methods: Patient was thoroughly investigated for attaining conclusive diagnosis, in view of rapidly progressive symptoms and unresponsiveness to steroids. FNAC lymph nodes was inconclusive. Bone marrow evaluation do not show any features of HLH/lymphoid aggregate. The patient had lower respiratory tract symptoms, was further evaluated and showed pulmonary infiltrates on CT chest along with matted axillary and inguinal lymph nodes on PET scan. Skin biopsy was repeated to evaluate the patient for any hematolymphoid malignancy. Result: Skin biopsy showed lobules of adipocytes which are infiltrated by small and medium sized lymphocytes showing atypical, hyperchromatic nuclei with foci of karyorrhexis. Foci of fat necrosis with fibrosis and proliferating capillaries were also seen. Immunohistochemistry showed the atypical lymphoid cells rosetting along the septa and were found positive for CD3 & CD8 and negative for CD20, CD4, CD7 and CD30. Ki67 (mib-1) was 30% in most proliferative areas. Patient was started on chemotherapy and is doing well till date. Conclusions: Subcutaneous panniculitis like T cell lymphoma is a rare disease which is often misdiagnosed by clinicians as well as pathologists for other benign conditions. This case highlights the variable clinical presentation of SPTCL and role of good histomorphology along with ancillary techniques such as IHC in attaining the final diagnosis and further management of the patient. Introduction: Chronic lymphocytic leukemia/ small lymphocytic lymphoma (CLL/SLL) is characterized by accumulation of monomorphic small mature B-cells that co-express CD5 and CD23. The typical cases of CLL express CD19, dim sIgM/IgD, CD20, CD22 and CD79b. CD5 and CD43 is expressed in the cells along with bright CD23 and CD200. CD10 is negative and FMC7 is usually negative or dim. However there are atypical cases of CLL wherein CD5, CD23 may be negative and bright expression of FMC7/surface immunoglobulin and CD79b. Recently CD43 and CD200 expressions were analysed in cases of B-CLPDs and found to contribute to differentiating CLL from other B-CLPDs.

Aims & Objectives: To study the expression of CD43, CD200 expression in B-CLPD and compare the expression in cases of CLL from other B-CLPDs.

It was a retrospective observational study done in Department of Haematology from August 2020 to September 2021. Peripheral blood/ bone marrow samples of patients with suspected B-CLPDs were used for immunophenotyping by flowcytometry. They were initially screened using the Lymphoid screening tube recommended by Euroflow consortium. This 8-colour 12-marker tube assesses the B-cell clonality and CD5, CD38 expression on B-cells. The markers used were CD45, CD19, CD20, CD23, CD200, CD79b, CD10, CD43. The marker profile were compared between CLL and other B-CLPDs. Result: A total of 70 patients were included consisting of 47 males and 23 females. Mean age was 58.5 years. 46 patients were diagnosed as CLL, 14 patients with a diagnosis of CD5 and CD10 negative CLPD, 4 cases of high grade lymphoma, 2 cases of Hairy cell leukemia (HCL), 2 cases of prolymphocytic leukemia (PLL), 1 case of mantle cell lymphoma (MCL). A differential diagnosis of atypical CLL/MCL/PLL was given in 1 case. CD5, CD43 and CD200 expression was noted in 46/46 (100%) of CLL cases whereas CD23 was positive in 42/46 cases (91.3%). In one case of atypical CLL, CD23 was negative whereas CD43, CD200 were positive. Conclusions: CD43 and CD200 were expressed in 100 percent cases of CLL including a case of atypical CLL and can be useful markers in differentiating CLL from other B-CLPDs.

Niharika Mishra, Kanwaljeet Singh, Vikram Singh, Pragya Sharma Introduction: Plasmablastic Lymphoma (PBL), an uncommon but aggressive subtype of diffuse large B cell lymphoma (DLBCL) occurring most commonly in setting of immunocompromised status of the patient. The diagnosis of PBL is difficult because its features overlap with myeloma and lymphoma. Patients usually present with B symptoms: fever, weight loss and night sweats. The primary organs involved are usually the gastrointestinal system, lymph nodes, oral mucosa and sometimes the skin. Aims & Objectives: We studied a case of 49 year old male patient who presented initially at a peripheral hospital with complaints of perianal mass associated with difficulty in defecation and per rectal bleeding since 02 years duration without any history of fever, weight loss or any other usual B symptoms. Materials & Methods: On examination, patient had bilateral inguinal lymphadenopathy & biopsy from peri-anal mass was suggestive of a poorly differentiated malignancy at peripheral hospital. MRI pelvis showed ulceroproliferative mass lesion in perineum involving external anal sphincter. PET CT suggested metabolically active circumferential wall thickening involving anal canal. Result: On review of slides/blocks and IHC characterization of lymph node biopsy at AHRR, sub epithelium showed presence of tumor cells with plasmacytoid morphology and were CD38/138, and CD79a positive with a Ki67 index of 60-70% in most proliferative area and negative for CD45 and panCK. On HPE, the tumor was diagnosed as Plasmablastic lymphoma. Patient was advised for HIV & EBV studies, which later turned out to be HIV positive. Bone marrow was however not involved. Patient was started on chemotherapy and is doing well till date and on regular follow-up. Conclusions: This case report highlights the importance of multidisciplinary approach in form of histomorphology, immunohistochemistry in combination with clinico-radiological input in achieving timely diagnosis of rare asymptomatic patients with unusual presentation of aggressive high grade lymphomas like PBL. Introduction: Hairy cell leukemia (HCL) is a rare lymphoproliferative disorder of B-cells; it is characterized by progressive pancytopenia, splenomegaly and presence of B cells with abnormal hairy cytoplasmic projections. The BRAF V600E mutation is most common molecular variant associated with classical HCL and plays key role in its pathogenesis. The dd-PCR is a newer highly Sensitive molecular technique utilized for detection of BRAF V600E s mutation for disease diagnosis and monitoring. Aims & Objectives: Demonstrate the role of dd PCR in absolute quantification and detection of small clone of HCL. Materials & Methods: DNA was isolated from Bone Marrow (BM)/ Peripheral blood (PB) sample using qiasymphony (Qiagen) as per manufacturer instruction. The assay was performed on ddPCR using in-house, probe synthesized from invitrogen (ABI UK) which specifically detects the V600E mutation associated with a (T [ A) transversion of nucleotide 1799 of the BRAF oncogene.Simultaneously qualitative Allele specific PCR (AS PCR) was performed to confirm the presence of B-RAF variant. Result: We present two cases with pancytopenia, splenomegaly and presence of Atypical lymphoid cells on peripheral blood smear.Flowcytometry analysis (FCM) on peripheral blood(PB)/bone marrow(BM) sample with chronic lympho proliferative disorder (CLPD) panel showed clonal CD 19 positive B cells with co expression of CD20, CD11c, CD103, CD25 and FMC-7. In the molecular study, in one of the cases B-RAF V600E variant was detected by ddPCR in PB at fractional abundance (FA) of 0.17% where as in the peripheral blood B-RAF V600E variant was negative by AS-PCR. The B-RAF V600E mutation analysis performed on the BM sample of the same case showed concordant positive result by both ddPCR (FA-6.52%) and AS-PCR. The discordant result in the PB on both the platform was due to higher sensitivity of dd PCR technique to detect small clone of HCL, which was confirmed by BM Rituximab monotherapy was started & on follow up, the patient responded very well to single regimen rituximab, with gradually reduction of spleen size (19.1-15. 2-4.5 cm) . Currently the patient is doing well with normal CBC counts & no palpable splenomegaly. Result: BM trephine biopsy revealed nodular, interstitial, paratrabecular infiltration of small to medium sized atypical lymphoid cells, which are highlighted by CD45 & these are strongly & diffusely positive for CD20, CD79a, PAX5, BCL-2 & negative for CD5, CD10, CD23, BCL-6, Cyclin D1& TP53. Intrasinusoidal infiltration of the atypical lymphoid cells are also seen. The atypical cells exhibit a high proliferative index (Ki67 [ 80%) .

The overall clinical, radiological BMBxcytomorphological&immunohistochemical features were suggestive of SMZL with a high proliferative index. Conclusions: This case is suggestive of an Aggressive Variant of SMZL, which is a rare & provisional entity [1] [2] [3] [4] [5] , usually related to an increased in large blastoid cells, high proliferative index and TP53 abnormalities. This need proper Gene sequencing analysis for definitive diagnosis as well as a standardised treatment regimen. Nni8?.

Somnath Ghosal, Subrata Banerjee Introduction: Multiple myeloma (MM) which accounts for approximately 10% of all haematological malignancies, still remains incurable because of acquirement of drug resistance. Glucocorticoid (GC) therapy which is used as one of the front-line therapies against MM, is obstructed by the incidence of GC resistance. The precise mechanism behind this acquired GC resistance in MM is not fully understood.

Aims & Objectives: The present study was aimed to identify the differentially expressed genes (DEGs), associated micro RNAs (miRNAs) and transcription factors (TFs) from the microarray datasets of GC resistance and GC sensitive MM cell lines, obtained from Gene Expression Omnibus (GEO) database, to understand the molecular players and the mechanism of the GC resistance in MM. Materials & Methods: From two microarray datasets DEGs were identified using GEO2R tool and common DEGs were obtained by constructing Venn diagram. Then the Gene ontology (GO) and pathway enrichment analysis were performed by using DAVID database. Genetic alterations in DEGs were examined using COSMIC database. Protein-protein interaction (PPI) network of DEGs was constructed by using STRING database and Cytoscape tool. Network of interaction of DEGs and miRNAs as well as TFs were obtained and constructed by using mirDIP, TRRUST and miRNet tools. Drug gene interaction was studied to identify potential drug molecules by DGIdb tool. Result: Several common DEGs such as, NLRP11, BTK, CD52 and RELN were found to be significantly upregulated in GC resistant MM and selected for further analysis. miRNA analysis detected various miRNAs that could interact with maximum target DEGs. Several TFs were found to regulate the expression of selected DEGs. DEGs were mostly enriched in B cell activation pathway, p53 pathway, apoptosis signaling pathway, Wntsignaling pathway and EGF signaling pathway, shown by KEGG pathway enrichment analysis. Several drug molecules such as Ibrutinib have been identified to combat the DEGs. Conclusions: In this study, we have identified various DEGs, miR-NAs, TFs as potential players in regulation of MM. We have also detected potential drug molecules to inhibit MM progression. The entire study may provide a new understanding about the GC resistance in MM.

Chandan Mishra, Tushar Sehgal Introduction: Chronic lymphocytic leukemia (CLL) is a clonal disorder of mature B cells and is the most common lymphoproliferative disorder in the West. The incidence rate in India is 0.41 per 100,000. CNS involvement in CLL is rare and even rarer is CLL presenting with upfront CNS symptoms. We report one such case. Case report 42 years male presented to the emergency with altered sensorium and clonic movements of limbs. On examination he was disoriented (GCS score 6) with mild pallor. There was generalised lymphadenopathy and mild splenomegaly. CBC showed hyperleukocytosis of 979 9 109/L, with haemoglobin of 5.4 g/dL and platelets of 90 9 109/L. His blood sugar and electrolytes were within normal limits. Blood film showed 85% mature lymphoid cells against a background of smudge cells (Fig. 1a) . Immunophenotyping on peripheral blood showed 96% kappa restricted B-cell population expressing CD5, CD23, CD20, CD79a and CD200 suggestive of CLL. CT head revealed multiple hyperdense lesions in bilateral cortex, right thalamus, basal ganglia and bilateral cerebellar region suggestive of leukemic deposits (Fig. 1b) . Patient's condition deteriorated with respiratory distress and he succumbed to his illness on fourth day of admission.

Conclusions: CLL is an indolent haematological neoplasm. The median age at diagnosis is seventh decade. Only a few (* 10%) present in the fifth decade. It is mostly an incidental finding on routine blood analysis in asymptomatic patients. Uncommonly patients may present with lymphadenopathy, splenomegaly and anemia or thrombocytopenia. Extramedullary involvement of CNS is very uncommon. The sign and symptoms of CNS involvement are heterogenous and include headache, cerebellar signs, cranial nerve palsies, visual problems, and motor or sensory deficits. The time from CLL diagnosis to CNS varies from 0 day to 15 years (median-4.5 years). Our patient was a young CLL who presented with extramedullary involvement of brain parenchyma. Only a handful of cases have been reported in literature. CLL with upfront CNS involvement is an uncommon manifestation.

Chandan Mishra, Tushar Sehgal, Saurabh Jain Introduction: Plasma cell leukemia (PCL) is a rare and an aggressive neoplasm with extremely poor prognosis. PCL can be primary or secondary. Here we present two interesting cases of PCL. PCL is a rare haematological neoplasm in which clonal plasma cells constitute [ 20% of total leucocytes or absolute count of [ 2 9 109/ L. Primary PCL is more common. Secondary PCL occurs through clonal evolution of an underlying MM. Patients with primary PCL do not have significant MM prodrome but have more extramedullary disease and renal failure. In contrast, patients with secondary PCL have more bone disease and worser prognosis. In both the diagnosis is based upon the percentage or absolute number of circulating clonal plasma cells in the peripheral blood. Presence of plasma cells is confirmed by flow cytometry positivity for CD 38 and CD 138. It is important to note that expression of CD20 is more frequent and expression of CD56 is less common in PCL. Genetically PCL have high-risk genetic abnormalities with poor prognosis. Result: Seven cases were diagnosed as HSTCL with a median age of 35 years (range 19-62 years) and male predominance. All the seven patients showed splenomegaly, cytopenias and evidence of peripheral blood involvement. Only one case had lymphadenopathy. Five of these cases were referred to our center with outside diagnosis of Acute Leukemia and rest two as Lymphoproliferative disorder. Six patients showed the typical cdimmunophenotype (CD2/CD3/CD7/ TCRcd?) on flowcytometryimmunophenotyping while there was a single case of the rare ab phenotype. Characteristic intrasinusoidal infiltration of atypical lymphoid cells (CD3 positive) in the bone marrow biopsy and characteristic chromosomal abnormalities associated with HSTCL (iso7q/ring chromosome7/ amplification7q/ trisomy8) on FISH/Karyotyping were observed in every single case. All the cases were treated with chemotherapy and subsequently two patients underwent Hematopoietic Stem Cell Transplant (HSCT). Five patients died of disease and related complications whereas two were alive and in remission at their last follow up. Conclusions: This case series highlights the importance of multimodal approach in diagnosing hematolymphoid neoplasms. The rarity of this disorder, lack of nodal involvement, morphology mimicking different entities, requirement of comprehensive IHCs/elaborate flowcytometry panels and cytogenetics makes HSTCL a significant diagnostic challenge. It is important to be aware of this rare and unique entity and to differentiate it from Acute Leukemia especially T-ALL, as they have different treatment and prognosis. These findings were suggestive of CD5/CD 10 negative, non-hairy, Marginal Zone Lymphoma. PET-CT does not show any significant FDG uptake; no significant splenomegaly or lymphadenopathy were noted. Bone marrow was also performed subsequently which reveal hypercellular marrow with startling presence 36.6% plasma cells which expressed CD 138, MUM 1 & IgG and were immunonegative for CD 20.On light chain immunohistochemistry, the plasma cells show lambda light chain restriction. Serum protein electrophoresis revealed hyperproteinaemia, increase in beta-2 region of globulin chain, monoclonal gammopathy ''M'' spike (2.6 g/dl) seen in beta-2 globulin region. Serum immunoglobulin levels showed an immunoglobulin (Ig) G gamma type of monoclonal gammopathy. IgG level was 3557 mg/dL (normal:-552 to 1631 mg/dL). Beta-2 microglobulin level was raised to 6874.00 ng/mL (670.00-2143.00 ng/mL). On electrophoretic immunofixation band is seen in IgG lambda region suggesting clonal gammopathy. Genetic analysis by NGS showed mutation in TP53 gene, however MYD88 was negative. Introduction: Richter transformation/syndrome is the development of an aggressive lymphoma in * 2-10% chronic lymphocytic leukaemia (CLL) patients, occurring at a mean duration of 1.9 years (range, 0-6.8 years).

We report a CLL, Rai-stage IV, treatment-naive patient with a near-concomitant large B-cell (Richter) transformation. Case Report: A 43-year-old diabetic lady developed lymphocytosis, morphologically suggestive of CLL. A month later, she developed fever, breathlessness, easy fatiguability, anorexia, weight-loss, vomiting and vertigo. Examination revealed generalised lymphadenopathy and hepatosplenomegaly. LDH was elevated, but liver and renal function, Coombs test, viral serologies and chest X-ray were normal. Hemogram revealed hemoglobin 87 gm%, TLC 24.0 9 10^9/L, platelets 19 9 10^9/L and corrected reticulocytes 0.4%. Bone marrow aspirate showed 66?normal, variably-sized lymphoid cells with clumped chromatin (absolute lymphocyte count 20.4 9 10^9/L). Hypercellular trephine biopsies showed diffuse infiltration by abnormal lymphoid cells with round-to-angulated, hyperchromatic nuclei, focally showing nuclear enlargement and prominent nucleoli. Flow cytometrically, the CD19-positive cells showed increased forward scatter and expressed CD23, anti-kappa, moderate CD20, moderate-to-bright CD79b and CD5, CD200, CD49d, CD38 and CD43. They were CD10 and CD25 negative. On ploidy analysis, smaller B-cells were diploid (DNA index 0.98) while the larger B-cells were near-tetraploid (DNA index 1.89). On interphase FISH, the abnormal cells showed four copies each of BCL6, BCL2, IGH, MYC and CCND1 genes and tetrasomy of chromosomes 4, 10 and 17. They were negative for BCL2, BCL6, MYC, CCND1 or IGH translocations; and ATM gene deletions. The TP53 probe showed only 2 copies despite tetrasomy 17, indicating a heterozygous TP53 deletion. Right axillary lymph node FNAC showed lymphoid cells with CLL/SLL immunophenotype. The final interpretation was diffuse marrow infiltration by a high-grade B-lymphoid neoplasm in a patient with CLL, overall consistent with Richter transformation. Conclusions: Our patient illustrates a severe and prognostically adverse clinical presentation of Richter transformation in a relatively young case of untreated CLL, within a month of diagnosis. A strong index of suspicion of transformation in CLL patients with persistent lymphadenopathy, biochemical abnormalities and clinical deterioration/treatment unresponsiveness (if on therapy) may help in early recognition of this complication. However, confirmatory morphological and ancillary studies remain indispensable to clinch the diagnosis. (1) Retrospective collection of cases diagnosed as DLBCL and the archieval blocks from the department of Pathology (2) Immunohistochemical staining with C-MYC,BCL2& BCL6 monoclonal antibodies (3) Interpretation of the slides and analysis of the findings Result: A total of 51 cases of DLBCL were studied. The age of presentation ranged from 16 to 84 years. The male to female ratio was 1.1:1. Majority of the cases were of the type DLBCL, NOS but however few cases of DLBCL anaplastic type, EBV associated DLBCL and T cell rich DLBCL were reported. Hans algorithm was applied and 63% of the cases were found to be of B cell, non-germinal center subtype. Based on the immunohistochemistry expression of c-myc, bcl2 and bcl6, 33% were double expressors (DE), 17% were triple expressors (TE) and 51% were non expressors (NE). Conclusions: Diffuse large B-cell lymphoma (DLBCL) is a neoplasm of medium or large B lymphoid cells. When compared with NE, DE and TE have worse prognosis and poor response to the standard RCHOP chemotherapy. Thus identification of these prognostic factors is of great significance. This study shows the prevalence of DE and TE lymphomas in our population.

Introduction: High grade lymphomas with cmyc, bcl2, bcl6 rearrangements (Double Hit Lymphomas, DHL) often have aggressive clinical behaviour. Lymphomas showing expression of CMYC and BCL2 at IHC are termed double-expressor (DEL). In the present study, we attempted to identify such cases to assess the relationship between DEL and DHL with various clinicopathological parameters and outcomes.

Aims & Objectives: The study aimed to analyse double expressor and double hit lymphomas by using IHC and FISH respectively. The objectives of our study were (1) to correlate DEL and DHL and (2) simultaneously study the immunoprofile using cell of origin (COO) classification in DEL and DHL.

Materials & Methods: The study was retrospective and prospective observational study conducted between January 2016 and July 2021 in 90 patients included all patients diagnosed as high grade non-Hodgkin lymphomas/DLBCLs with Ki67 proliferation index [ 60%. IHC and FISH were performed for cmyc, bcl2 and bcl6 in order to classify cases as DEL and DHL respectively. Result: The patients had a mean age of 54 years with male to female ratio of 1.6:1. We identified 15/90 patients as DHL and 29/57 patients as DEL. Both the groups presented with male predominance, advanced stage and germinal centre phenotype (GCB). On survival analysis, DEL had lesser overall survival as compared to non-DEL. However, DHL showed a better overall survival as compared to non-DHL, probably owing to intensive chemotherapy. The study allowed identification of DHL/DEL patients along with their distinctive clinicopathological profile and OS. These findings might help delineate a smaller cohort of patients that require rearrangement studies in order to select patients with DHL/THL. FISH is the gold standard for testing for cmyc, bcl2 and bcl6 gene rearrangements, however IHC expressors also demonstrate poor prognostic cases. Conclusions: Our study showed a higher proportion of GCB cases displaying protein expression or molecular alteration for cmyc, bcl2 and bcl6. All patients of this phenotype therefore must undergo additional CMYC and BCL2 IHC to identify DEL. DEL however, concentrate DHL to the extent of 75% and hence once identified, all DEL should be tested for DHL.

Aditi Priya, Jai Kumar Chaurasia, Shubhra Prasad, Hemlata Panwar, Deepti Joshi, Vaishali Walke, Narendra Chaudhary, Neelkamal Kapoor Introduction: Neuroblastoma (NB) is the most common extracranial solid tumor in children accounting for 8-10% of pediatric malignancies and 15% of childhood tumor-related deaths. It originates from embryonal remnants of the sympathoadrenal lineage of neural crest cells, can develop in any part of the sympathetic nervous system. Nearly 50% of all patients are diagnosed with metastases at presentation. The bone marrow (BM) is the main site of metastasis in advanced neuroblastoma. Aims & Objectives: In this case report, we highlight the heterogenous clinico-hematopathological presentation of metastatic neuroblastoma in 3 cases. Materials & Methods: The first two cases of neuroblastoma were diagnosed in a 2 year male and 3 year female, both presented with abdominal mass with MRI revealing heterogenous, lobulated retroperitoneal tumor. Peripheral smear (PS) revealed pancytopenia and bicytopenia respectively. Scintigraphy showed multiple foci of diffuse heterogenous tracer uptake in skull, vertebrae and ribs in the 2 year male patient. USG guided FNAC from retroperitoneal mass was possible in one case. 3rd case is of a 14 year male with complaints of multiple swelling in knees, shoulders and ankles since 2 months. MRI was suggestive of epidural soft tissue thickening in upper and lower dorsal spine level. Blood counts and PS showed no cytopenias. Result: Bone marrow aspiration and biopsy and IHC in all the three cases showed metastasis from Neuroblastoma. Conclusions: Bone marrow metastasis of Neuroblastoma may sometimes be the only diagnostic feature as many times biopsy of the primary lesion/tumor is not possible. Bicytopenia, pancytopenia and morphological features of Neuroblastoma in bone marrow such as formation of rosettes, presence of neuropil, calcification, moulding may not always be present posing diagnostic challenges.

Introduction: Sideroblastic anemias may be congenital or acquired. Acquired sideroblastic anemia is frequently associated with myelodysplastic syndrome, various drugs, toxins and nutritional deficiencies. Sideroblastic anemia is characterized by inadequate marrow utilization of iron for heme synthesis despite the presence of adequate or increased amounts of iron, leading to the formation of ringed sideroblasts. Diagnostic panel of tests include complete blood count (CBC), reticulocyte count, peripheral blood smear, iron studies, bone marrow examination and genetic testing for a suspected inherited or acquired mutation. Treatment requires stopping causative agent and vitamin supplementation.

Aims & Objectives: To study hematological manifestations, presentation, underlying cause and outcome in cases of acquired sideroblastic anemia. Materials & Methods: Present study is a retrospective study. Bone marrow cases from 2018 to 2021 were analysed. We evaluated the clinical presentation, CBC, peripheral blood smear, bone marrow aspirate smears and bone marrow biopsies of selected cases. Iron profile and perl's stain was done to look for iron status. Features of dysplasia, toxin exposure and nutritional deficiencies were evaluated. Result: We had three cases of acquired sideroblastic anemia. First, 17 years old male, presented with pancytopenia with dimorphic picture on peripheral smear. Bone marrow was normocellular with erythroid series showing normoblastic maturation, increased iron stores and 54% ringed sideroblasts. Possibilities suggested were copper deficiency, zinc toxicity and thiamine responsive sideroblastic anemia. Second case was 72 years old male presenting with pancytopenia following linezolid intake for MRSA positive synovial fluid following knee replacement. Peripheral smear demonstrated dimorphic picture. Bone marrow was normocellular with depressed erythroid series and 80% ringed sideroblasts. Erythroid precursors had prominent cytoplasmic vacoulations and iron stores were increased. Features of dysmegakaryopoiesis (55%) were also found. The blood counts of patient improved after withdrawal of drug. Third, was 31 years old male who presented with abdominal pain. Peripheral smear demonstrated coarse basophilic stippling in RBCs. Bone marrow was mildly hypercellular and demonstrated erythroid hyperplasia with increased iron stores and 8% ringed sideroblasts.

Conclusions: Sideroblastic anemia is rare disorder with variable severity. It has many potential causes. Pathognomic feature is presence of ringed sideroblasts in bone marrow aspirate. Serum iron, ferritin and transferrin are typically increased. Management is mainly treating the underlying cause. Prognosis also varies depending on the causative factor.

Archana Yadav, Chetna Singh Introduction: Maneb/MB and paraquat/PQ are known to cause toxicity in polymorphonuclear leukocytes (PMNs) polymorphs in rodents. Involvement of increased oxidative stress, mitochondrial dysfunction and inflammation is reported in MB ? PQ-induced toxicity. Cyclooxygenase-2/COX-2 is recognized as major inflammatory mediator in pathological as well as toxicological manifestations however, its role in MB ? PQ-induced toxicity in polymorphs is not yet been reported.

Aims & Objectives: The current study aimed to explore the involvement of cyclooxygenase-2/COX-2 in maneb and paraquatinduced oxidative stress and its link with apoptosis in polymorphs.

Male wistar rats (180-200 g) were treated with maneb/MB and paraquat/PQ in combination intraperitoneally, twice weekly for two weeks in presence or absence of celecoxib/ CXB. PMNs were isolated from whole blood using Histopaque density gradient centrifugation. The cell viability and cell count were determined employing Trypan blue exclusion test and Hemocytometer respectively. Oxidative stress indices (Free radical generation, lipid peroxidation/LPO and superoxide dismutase/SOD) were assessed in PMNs of control and treated groups. Additionally, protein expression of COX-2, procaspase-3/9 and mitochondrial cytochrome-C were analyzed by Western blotting. Result: MB ? PQ exposure elevated superoxide dismutase (SOD) activity, lipid peroxidation (LPO) levels and ROS production in rat PMNs. Furthermore, MB ? PQ augmented the protein levels of COX-2 in exposed groups along with increase in mitochondrial cytochrome-C release. Conversely, MB ? PQ exposure exhibited attenuated level of procaspase-3 and procaspase-9 in PMNs of exposed rats. Celecoxib, however ameliorated MB ? PQ induced increase in oxidative stress indices and restored the level of COX-2 and procaspase-3/9 in PMNs of MB ? PQ treated groups. Celecoxib also alleviated MB ? PQ-induced modulation in cytochrome-C release.

Conclusions: The result of the present study suggested that COX-2 mediates MB ? PQ-induced increase in oxidative stress, which might be responsible for increased apoptosis of polymorphonuclear leukocytes in exposed rats.

Bhawana Adhikari, Mansi Kala, Manish Raturi, Anuradha Kusum, Smita Chandra

Introduction: Controlling pre-analytical errors [PAE] are imperative to sustain the quality of work in any laboratory. Therefore, focusing on understanding, monitoring and rectifying errors on a daily basis is crucial as these errors can directly influence the clinical outcomes. Aims & Objectives: To evaluate our hematology laboratory performance level as per the quality indicators [QI] defined by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Materials & Methods: It was a Cross sectional analytical. The data was obtained from hematology laboratory of Himalayan Central Diagnostics Research Laboratory (a constituent unit of SRHU) Dehradun and collected from period-I [1st Jan'18 to 31st Dec'19]. All the samples were collected for various investigations including complete hemograms, urine examination and coagulation studies. These were for misidentification, incorrect vials, inadequate samples, clotted samples; heparin contaminated and wrongly billed samples. An algorithm was proposed and enforced from period-II [1st Jan'20 to Sept'21] to minimize PAE. We also included certain training programmes for phlebotomy related errors and improved upon our communication with the clinicians and the nursing staff. The data was collected again following the above changes. We calculated sigma values for QI proposed by IFCC Working Group on Laboratory Errors and Patient Safety (WG-LEPS) in both the cohorts i.e. the pre-algorithm data [period-I] and post-algorithm data [period-II] .

Result: A total of 431,557 samples and 390,381 samples were collected in period-I & II respectively. We documented 3073 and 1005 samples with PAE during both the time-periods. These errors were categorized under various QI proposed by the IFCC: WG-LEPS as shown [ Table 1 ]. There was a significant reduction in the percentage optimal value to around 64% from period-I to period-II. Conclusions: Following the implementation of the algorithm, along with training and communication, there was a decrease in percentage error and improvement in sigma values. This highlights the fact that with close monitoring all PAE can be controlled. There was also an increase in the overall satisfaction of the clinicians towards our services following this algorithm, more so, since we were able to trouble shoot the errors, inform the staff and rectify them.

Bibhas Kar, Tanmay Wairkar, Mamta Belnekar, Yash Tiwarekar, Shital Virulkar, Samrudhi Rane, Anjali Patil, Sameer Tulpule, Kiran Ghodke, Nikhil Rabade, Varsha Vadera Introduction: Thrombocytosis is a condition in which there are an excessive number of platelets in the blood. The primary cause of thrombocytosis are essential thrombocythemia, chronic myeloid leukemia (CML), polycythemia vera, primary myelofibrosis. CML, a myeloproliferative neoplasm (MPN) is characterized by the presence of the philadelphia (Ph) chromosome. Ph chromosome is a balanced genetic translocation, t(9;22)(q34;q11.2), which leads to BCR-ABL1 gene rearrangement. The product of this rearrangement is constitutively active tyrosine kinase.

To present an unusual case of BCR-ABL1 fusion with isolated thrombocytosis.

We present a case of a 66 year-old-female presented with chief complaints of chest discomfort, fatigue, numbness in right iliac fossa and breathlessness on exertion since two months. USG abdomen showed fatty liver and mild hepatomegaly (15.2 cm). The hemogram was indicative of isolated thrombocytosis (platelet count 674 9 10 3 /lL, Hb 12.4 g/dL, haematocrit 36.5%, WBC count 9.69 9 10 3 /lL). Peripheral blood specimen was sent for BCR-ABL1 fusion detection by fluorescence in-situ hybridization (FISH) using dual color dual fusion probe and mutations detection in JAK2 exon 14 (V617F), JAK2 exon 12, MPL(S505/W515), CALR exon 9 genes were analyzed by real time PCR, Sanger sequencing and fragment length analysis respectively. Result: Molecular studies showed that the patient was negative for mutations in JAK2 exon 14 (V617F), JAK2 exon 12, MPL (S505/ W515), CALR exon 9 genes. FISH results showed positivity with typical BCR-ABL1 fusion signals (37%). Hence bone marrow aspiration was performed for confirmation and sent for Real time PCR and conventional cytogenetics. Bone marrow biopsy revealed a normocellular bone marrow with increased number of megakaryocytes with dyspoiesis. Real time PCR confirmed BCR-ABL1translocation, depicting major transcript (p210). Moreover, cytogenetics showed translocation of chromosome 9 and 22 in 95% metaphases out of which 16% metaphases showed trisomy 8 as a secondary abnormality. Conclusions: The presented clinical symptoms and hematological findings were indicative of isolated thrombocytosis with no evidence of CML. Although no mutations were detected in JAK2, MPL and CALR genes, FISH and real time PCR was helpful in detecting BCR-ABL1 gene rearrangement. Such cases may progress to overt CML, hence follow up is recommended.

Binu Jacob, Shanaz Khodaiji, Dia Mansukhani Introduction: Introduction: Abnormalities of hemoglobin (Hb) synthesis are among the most common inherited disorders of man. The frequency of b-thalassemia in India ranges from 3.5 to 15% in general population. A classical bthalassemia trait has Hb A2 value between 4 and 9%. However there is always a diagnostic dilemma about cases that are in the range of 3.5-3.9%. In such cases only HPLC is not sufficient and the patient has to resort to DNA analysis to rule out the b-thalassemia carrier status. Aims & Objectives: Aims & Objectives: To correlate borderline Hb A2 values with mutation analysis in order to accurately diagnose patients with borderline (3.5-4.0) HbA2 values for the possibility of beta thalassemia trait and to modify hospital protocol if necessary. Materials & Methods: Method: Three subject groups were taken: Group 1(Normal group) included patients with normal Hemoglobin and normal HPLC with normal RBC indices, Group 2(Control Group) had subjects with microcytic anemia with normal HPLC excluding borderline HbA2 levels and Group 3 (Study Group) Subjects with Normal Hemoglobin, normal RBC indices/Anemia with microcytic indices and with Hb A2 between 3.5 and 9%.

DNA analysis and PCR: DNA was isolated from blood samples. Mutation studies in the beta globulin gene were carried out by the ARMS PCR. Samples were initially screened for five common mutations. If no mutation was detected in these samples then they were analyzed for the rare mutations.

The study had only two subjects with borderline HbA2, harbor underlying b-globin gene mutations. DNA studies were done to confirm mutation. Conclusions: Larger, and especially population-based studies may be more precise in this regard. Individuals with microcytic hypochromic indices and/or an HbA2 value C 3.5% are most likely to show the presence of an underlying b-thalassemia mutation and should certainly be investigated further. If resources for sequencing are unavailable, then screening for the five mutations common in the Indian population by the relatively inexpensive ARMS PCR is likely to reveal a substantial proportion of those with a b-thalassemia mutation.

Chaitali Patnaik, Samira Kumar Behera, Prasanta Purohit Introduction: Hemoglobin disorders are the leading health concern in India including the state of Odisha. Hemoglobinopathies particularly Hb S, HbD and Hb E and b-thalassemia are important challenges mainly restricted to the tribals of north-east, West-bengal, Odisha. There is paucity of literature on HbE in Southern districts of Odisha state. This study was undertaken to elucidate the occurrence of HbE heterozygote and its co-inheritance with other hemoglobin disorders in Southern Odisha state, India.

Aims & Objectives: To study the hematological and clinical profiles of HbE hemoglobinopathy in Southern Odisha.

The study was conducted in the department of Pathology and Multi-Disciplinary Research Unit between August 2020 and September 2021. Hemoglobin variants was analyzed by using Variant-II (Bio-Rad) and CBC was carried out by XN1000 (Sysmex). Hemoglobin E was suspected with an A2 level of more than 20%. Other associated hemoglobin variants were analyzed as per the manufacturer's instructions. Result: Over a period of 1 year, 982 samples have been analyzed. Out of this, 10 samples were found to have HbE disorders i.e. 5 cases were HbE trait, 3 cases of HbE/b thalassemia and 2 cases of HbS/E double heterozygous. There were 2 pediatric cases with 50% of being females. All the cases had microcytic hypochromic red cells indices with milder to moderate anemia. In cases with HbE trait and HbS/E, HbE (A2) values ranges from 23.5 to 27.5%. However, in cases with HbE/b thalassemia, HbE (A2) values ranges from 56.8 to 74.8% with HbF value of 14.9-26.7%. None of the cases with either HbE trait or HbS/E had any clinical symptoms except mild anemia, but all the cases with HbE/b thalassemia had repeated history of blood transfusion and hospitalization. Two cases with HbE/b thalassemia had hepatosplenomagaly. Conclusions: HbE variant results from a b-chain mutation (b26 Glu-Lys) and tend to elute in A2 window within retention time ranging from 3.3 to 3.9 min. The cases with HbE trait found to be asymptomatic. However, the co-Inheritance of HbE with either b thalassemia or HbS lead to severe clinical manifestations. The double heterozygousity of HbE (typically prevalent in North India) states with HbS in this population may be due to the migration of population from are North Indian states in due course of time.

Aishwarya Murthy P, Parimala Puttaiah, Shanthala Devi A.M Introduction: HIV infection is associated with increased risk of developing hematologic malignancies (HM) particularly non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL). Other haematological malignancies though rare, there is a higher risk ratio for these cancers when compared to non-HIV infected population. Aims & Objectives: To study the spectrum of HIV associated malignancies involving the bone marrow.

The study was conducted retrospectively and included patients presenting with haematological malignancies involving bone marrow and co-existing HIV-AIDS from March 2020 to August 2021. Result: A total of 2 cases were identified, both adults. One was case of Plasma cell myeloma (1) and other was case of Chronic myeloid leukemia (2) . In both the cases the diagnosis of HIV was prior to the diagnosis of the malignancies and both of them are on HAART therapy. Patient 1, a 65 year old lady with HIV for 10 years, presented with bilateral lower limb swelling with decline in renal function and was diagnosed with renal amyloidosis (AL). Myeloma workup done showed lytic lesions in the skull. SPEP showed 'M'spike, with low CD4 count of 76.5 cells/mm3. Patient 2, a 38 year old male with HIV for 13 years presented with abdominal pain and respiratory distress. Ultrasound showed hepatosplenomegaly, and peripheral blood smear showed features of CML. Molecular studies showed positivity for Philadelphia chromosome, with normal CD4 count of 812 cells/mm 3 . Both the patients were started on standard chemotherapy and HAART was continued with it. At the time of last follow up both the patients have shown good response to therapy. Conclusions: In the era of HAART therapy, the survival of patients diagnosed with HIV-AIDS has increased markedly. There is also a significant increase in malignancies in these patients which may become major cause of death. Even though the incidence of NHL and HL is more common in this spectrum, one must keep in mind the rare possibilities of other hematological malignancies.

Introduction: Coronavirus disease 2019 (COVID-19) pandemic has rapidly spread to many countries around the world and is still spreading due to newer variants. Clinico-hematological characteristics of COVID-19 have been reported from different countries but only few large scale studies have been conducted in India.

Aims & Objectives: This study aims to describe routine clinical hematologic parameters and outcome of COVID-19 patients admitted to tertiary care COVID center in North India. Materials & Methods: This is a cross sectional observational study including total 170 patients. Data was collected from medical records department, regarding epidemiological parameters, co-morbidities, symptoms, laboratory parameters and outcome of patients with COVID-19 disease admitted to our hospital over a period of 4 months. Out of 170 patients, 54 required ICU care. Result: Mean age of patients was 46.5 years with male preponderance (male: female ratio: 2:1). Comorbidities were present in 103 (60.6%) patients, of which diabetes mellitus (n = 65; 38.2%) was most common. Significant proportion of patients were symptomatic (n = 148; 87.1%); most common symptom being fever followed by dyspnoea in 65% and 60% patients respectively. Anemia was present in 36.5% patients, leucocytosis in 15.3% patients, neutrophilia in 26.5% while lymphopenia was noted in 41.2% patients. 12.9% patients had thrombocytopenia.NLR ratio was higher at the time of admission while it was low at the time of discharge. Majority of patients were managed with supportive treatment. 79 (46.5%) patients required oxygen supplementation and 29 (17%) patients had severe disease. Mortality occurred in 20 (11.8%) patients. Conclusions: In this single-centre study of hospitalized COVID-19 patients, majority of patients were symptomatic and having comorbidities. Most common symptoms were fever and shortness of breath. We demonstrated that routine clinical hematology parameters are important predictors of COVID-19 severity.

Monika Gupta, Rajeev Sen, Sunita Singh Introduction: Aplastic anaemia (AA) is a life-threatening bone marrow failure disorder and if untreated is associated with very high mortality. The incidence of AA appears to be 2-threefold more common in Asia than in Europe. The precise incidence of AA in India is not known due to lack of epidemiological study.

Aims & Objectives: This study was carried out to investigate and identify the causes of AA and to find out the incidence of Paroxysmal nocturnal haemoglobinuria (PNH) in these cases.

A prospective study was carried out in the Department of Pathology, PGIMS Rohtak from January 2019 to May 2020. The detail clinical history, physical examination, complete blood count, bone marrow aspirate and biopsy were performed. The diagnosis of AA was confirmed as per criteria laid down by International Agranulocytosis and Aplastic Anaemia Study Group, 1987. Flow cytometry was performed using 6 colour 2-laser flow cytometry (BD Biosciences, FACS CANTO II) using gating antibodies CD45, CD15, CD64 and the GPI-linked antibodies CD59, CD14, CD24, as well as fluorescent Aerolysin (FLAER) for evidence of PNH clone on RBCs, granulocytes and monocytes. Result: Out of 202 cases of pancytopenia, 36 (17.8%) cases having hypocellular/dry tap on BMA and hypoplastic bone marrow on biopsy. Severe pancytopenia was noted in 58.3% (21/36) cases while 41.6% (15/36) cases had very severe pancytopenia. Demographic parameters studied revealed that the median age at presentation was 27.5 years with M:F Ratio 1.25:1 and most common presenting complaint was weakness. Two patients contained the PNH clone on Flow cytometry. Conclusions: To reduce the high mortality associated with AA it is important to decrease the delay between diagnosis and treatment and curtailing such delays will help reduce multiple transfusions and pretreatment infections. Thereby, improving the survival rate in these patients. The incidence on PNH in aplastic anaemia was found to be 5.5% in our study which is lower than the literature. However, the presence of the PNH clone has been postulated to be a good prognostic sign as regards response to immunosuppressive therapy.

Aims & Objectives: To describe the haematological manifestations and peripheral smear findings of SAR-CoV-2 infection in COVID-19 positive symptomatic children and to study the association between different haematological parameters with patient age, disease severity, and patient outcomes. Materials & Methods: A retrospective cum prospective review of the haematological parameters and peripheral smear findings of the children diagnosed with COVID-19 positive status over four months was conducted in the Department of Pathology, Maulana Azad Medical College from September 2020 to December 2020. All symptomatic paediatric patients less than 18 years of age, with laboratory-confirmed SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) infection were included. Complete blood count and peripheral smear findings were reviewed and a comparison of the proportion of children with abnormal hematological parameters across various age groups and different disease severity (mild, moderate, and severe) was done. The data obtained were analyzed using MS Excel and Statistical Package for the Social Sciences (SPSS) software, version 26. Prior approval of the institutional ethical committee was taken. Result: Seventy-two SARS-CoV-2 proven infection (RT-PCR positive) cases were included ranging in age from 2 days to 18 years. Anaemia was the most common haematological abnormality (62.5%) followed by leucopoenia (21%). Lymphopenia and neutropenia were seen in 18% of cases respectively. Leucocytosis was seen in 10% of cases with raised neutrophil to leucocyte ratio (NLR) seen in 30. Conclusions: Children have milder disease outcomes and a lesser degree of haematological changes than adults. This can be attributed to a better immune response in otherwise healthy children. However larger studies are required for further understanding of paediatric population outcomes.

Deepshikha Rana, Himadri, Mrinalini Kotru, Richa Gupta Introduction: Neonatal sepsis is considered a ubiquitous worldwide cause of mortality and morbidity in newborn infants. The incidence is one out of five cases per 1000 live births. For early and rapid evaluation of neonatal sepsis, biomarkers and hematological indices can be used before the onset of clinical manifestation so that the treatment of sepsis can be started and neonate can be properly managed. Aims & Objectives: Purpose was to investigate the clinical significance of platelet to lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR) in neonates and its impact on management of Early-Onset Neonatal Sepsis (EOS).

This retrospective case-control study was conducted in 266 neonates diagnosed with EOS and compared with 300 healthy controls. The statistical analysis was performed by using graph pad prism. Student-t-test and Mann-Whitney U test was performed for comparing the categorical variables. Conclusions: NLR and PLR are predictors of early-onset neonatal sepsis. There is a significant modest positive correlation between NLR, PLR and sepsis. Platelet count, White blood cells (WBCs), Red blood cells (RBCs) and Hemoglobin (Hb) show a significant moderate positive correlation.

Iffat Jamal, Shuchismita, V.N.Choudhary, Ravi Bhushan Raman Introduction: Drug induced leucopenia complicates any clinical situation especially when it's associated with COVID-19 infection.

Here we report a case of vancomycin induced myeloid maturation arrest in a patient with COVID-19 infection where his condition reverted to normal after stopping the drug. Aims & Objectives: It highlights the adverse effects of Vancomycin leading to promyelocyte proliferation posing a diagnostic challenge to differentiate it from neoplastic promyelocyte proliferation. Materials & Methods: Case report: A 47 year old male presented with fever, dry cough and difficulty in breathing for 12 days. He was COVID-19 positive with CT lung showing bilateral pneumonic consolidations for which Vancomycin was started. Hemogram showed hemoglobin-6.8 gm/dl, total leucocyte count-3200/cumm with a differential count revealing: Neutrophil-28% (with left shift and features of dyspoiesis), Lymphocyte-66%, Monocyte-4%, Eosinophil-2% (Fig. 1a) , and platelets-90,000/cumm. Bone marrow aspiration (BMA) and biopsy was advised. BMA was hypercellular for age with marked promyelocyte proliferation & maturation arrest with strong MPO positivity (1b, c &d). Bone marrow biopsy also reflected similar findings (Fig-1e) . FISH for PML-RARA translocation turned out to be negative, differentiating it from Acute promyeloytic leukemia (Fig. 1f) . A diagnosis of drug induced leucopenia with reactive promyelocyte proliferation was made. Considering worsening of these hematological findings, Vancomycin was stopped and patient's hematological findings improved drastically with stabilization of hematological parameters. Result: Discussion: Drug induced leukopenia occurs in a dose dependent or dose-independent (idiosyncratic) reaction. Vancomycin dependent antibodies against neutrophils lead to an autoimmune reaction directly affecting progenitor cell growth especially of myeloid cell lineage leading to maturation arrest. Secondly cytotoxic T-cell mediated response also has damaging effects on hematopoietic cells. Infections like COVID-19 can also lead to suppression of normal myeloid maturation due to release of interleukins. Conclusions: Myeloid maturation arrest with marked promyelocyte proliferation poses a diagnostic dilemma especially in patients presenting with cytopenia as they are confused with Acute promyelocytic leukemia. This case highlights the importance of detailed knowledge related to drug induced myeloid maturation arrest which is reversible after stoppage of the offending drug.

Priyanka Moulem, Surbhi Singh, Sabina Langer, Jyoti Kotwal Introduction: Infection with SARS CoV2 leads to respiratory failure and can lead to support of extracorporeal oxygenation (ECMO) leading to exposure to heparin. Exposure to heparin and development of thrombocytopenia raises the suspicion of HIT. The strong positive IgG PF4-heparin antigen test by immunochromatography is followed by platelet aggregation test in our center. We present a case of covid-19 in which HIT was strongly positive on gel agglutination but functional assay was negative. Review of literature shows that this Indian J Hematol Blood Transfus could be due to circulating platelet immune complexes in critically ill covid patients which simulate HIT antibodies. Aims & Objectives: Materials & Methods: 7 months pregnant female, non-vaccinated, asthmatic, COVID 19 positive patient was admitted to our hospital. On admission her fetal ultrasound was normal and was started on non-invasive ventilation along with supportive care. However she deteriorated and shifted to veno-arterial extracorporeal membrane oxygenation support (ECMO). Her platelet count dropped by [ 50% at day 6 of heparin exposure with an intermediate probability for HIT (4Tscore 5). HIT gel agglutination test was positive for IgG antibodies for antiheparin/PF4 antibodies but functional assay based on heparin-induced platelet aggregation (HIPA) revealed no increase in aggregation of patient serum with 0.5U/ml and 1U/ml heparin dosage. Heparin induced thrombocytopenia was ruled out due to PAT and patient continued on ECMO. This could be due to increased platelet activating immune complexes or anti-PF4 antibodies mimicking antiheparin/PF4 antibodies. However, patient deteriorated and succumbed to the disease. Result: Heparin induced thrombocytopenia was ruled out due to PAT and patient continued on ECMO. This could be due to increased platelet activating immune complexes or anti-PF4 antibodies mimicking antiheparin/PF4 antibodies. However, patient deteriorated and succumbed to the disease. Conclusions: Pathophysiology of Covid 19 disease in critical cases has shown exacerbated immune reactions, increased endothelial injury, which causes increased release of PF4 leading to platelet activation.3 A recent work has also shown significantly increased platelet apoptosis, secondary to IgG-mediated FccRIIA signaling, in critically ill COVID-19 patients.4 It is also possible that the circulating immune complexes may be formed by corona virus-antibody complexes (as seen in H1N1 viral infection) 0.5 A high titre of anti-PF4/heparin antibody test may not strongly predict the presence of clinically relevant HIT antibodies, thus a confirmatory functional test should be performed.

Deepika Mishra, Samira Kumar Behera Introduction: Granulomatous disease of marrow can result from a varied group of disorders ranging from Infectious diseases to Haematological malignancies. Finding granuloma in bone marrow biopsy is a rare finding. Detection of granulomatous disease is more in case of Bone marrow biopsy as compared to aspiration. Aims & Objectives: To study the clinicopathological co-relation in granulomatous diseses of marrow.

We reviewed 191 cases of Bone marrow aspirations and 110 cases of Bone marrow biopsy done between 1/1/ 21 to 7/9/21 confirming presence of granuloma in bone marrow biopsy of 5 patients. The age of the patients varied from 5 to 35 years. Out of the 5 cases two had history of fever, two with history of pain in abdomen, and one with swelling of foot. Four out of the five cases had organomegaly of which three had splenomegaly and one had hepatosplenomegaly. CBC and peripheral smear evaluation of all the cases were done and the finding was pancytopenia in two cases followed by bicytopenia in two cases and Lymphocytosis in one case. All the cases undergone Bone marrow aspiration and biopsy. Result: One out of the five cases were diagnosed as case of Tuberculosis (AFB detected) and one as Hogdkin's Lymphoma in Bone marrow trephine biopsy, (other 3 cases were AFB Negative in bone marrow biopsy). None of these cases showed evidence of granuloma in bone marrow aspiration. Conclusions: Bone marrow trephine biopsy is very helpful in finding out Granuloma which may get missed in Bone marrow aspiration.Hence biopsy must be done in unknown causes of Pancytopenia to rule out granulomatous diseases.

Simran Thakkar, Niteek Karnik, Namita Padwal, Digambar Panchal Introduction: Pancytopenia is an important hematologic condition encountered frequently in clinical practice. It has a myriad of etiologies which are of immense importance for defining diagnostic and therapeutic strategies. This study was conducted to investigate the various causes of pancytopenia, their clinico-hematological features, laboratory investigations including bone marrow studies and patient outcome.

Aims & Objectives:

1. To study various etiologies of Pancytopenia. 2. To outline clinical manifestations and study the hematological and laboratory parameters. 3. To assess the outcome of indoor patients with Pancytopenia.

This prospective observational study was conducted in Department of Medicine, Lokmanya Tilak Municipal General Hospital over a period of 21 months from April 2019 to January 2021. After obtaining a relevant clinical history and physical examination, detailed haematological investigations were done including complete blood count with peripheral smears examination, relevant biochemical and radiological investigations. Bone marrow aspiration and biopsy were performed and microscopically examined in indicated patients. Result: 62 patients with age group 14-75 years were enrolled in the study, with a mean age of 38.96 years. There was a slight male predominance with 1.2:1 (male: female) ratio. 51.63% patients revealed a hypocellular marrow, while 32.25% patients had a hypercellular marrow and rest had normocellular marrow. Megaloblastic anemia comprised the largest etiological group (40.32%) followed by aplastic anaemia (12.91%) and Infection-associated pancytopenia (12.91%). Other causes were dimorphic anaemia (8.1%), haematological malignancy (6.5%), Systemic lupus erythematosus (4.8%) hypersplenism, Iron deficiency anaemia (3.12) . Conclusions: The etiologies of pancytopenia depends on patients' age, gender, and other conditions. Bone marrow Aspiration-biopsy is a precise and cost effective diagnostic tool to establish various aetiologies. Megaloblastic anaemia is the leading cause followed by aplastic anaemia. Nutritional anaemias, Infections and SLE were found to be treatable causes of pancytopenia. Therefore, early and accurate diagnosis is instrumental in saving lives.

Sourabh Kumar, Anita Tahlan, Anshu Palta, Sanjay D Cruz Introduction: Bone marrow may be involved & sometimes affected in conditions that for a broader part are predominantly haematological which further may be benign or malignant or they may be nonhaematological. Depending upon diagnosis suspected from the clinical features & peripheral blood examination, the procedure of bone marrow examination comprising of a bone marrow aspirate &/or trephine biopsy is indicated. 2 In this audit we analysed the spectrum of bone marrow findings in our setup which is a tertiary care hospital Conclusions: D-Dimer increased in thrombotic events lead to fibrinolysis.Increased in IL-6 and Fibrinogen shows link between inflammation and procoagulant changes. In late stage thrombolysis decreases fibrinogen levels and increase fibrin degradation products. If coagulation remains unchecked lead to consumptive coagulopathy and bleeding. Coagulation affects inflammatory activity and inflammation leads to coagulation activation so a cross link between coagulation and inflammation. Aims & Objectives: The study objective is to evaluate the use of flow cytometry as a screening tool for primary immunodeficiency disorders and the advantages of doing a flow cytometry based lymphocyte subset analysis before mutation analysis by next generation sequencing.

The study includes 65 patients clinically suspected with PID between April 2020 and August 2021. Heparinized peripheral blood samples were collected, and one million events were acquired after from each sample in DxFlex flow cytometer and analyzed using Kaluza software. A single tube 13 antibody panel was used for characterizing 19 different lymphocyte subsets from each patient. Templates were created with normal control samples. Among the 65 patients, 40 patients had their molecular analysis done by next generation sequencing (NGS) with a focused exome panel.

Result: The study cohort included 64 patients with 41 males and 23 females. The median age was 7.5 years (range: 0-53 years). Among the 64 patients, abnormalities in one or more lymphocyte subsets were identified in 43 patients (67.2%). Mutation analysis was done in 28 of the 43 patients with abnormal subset results and pathogenic or likely pathogenic variants were identified in 16 (57.1%) of them. Among the remaining 21 patients where lymphocyte subset results were equivocal, mutation analysis was done in 14 patients and pathogenic or likely pathogenic variants were identified in 3 patients (21.4%). All 3 patients had mutations in genes (IL12RB1, NCF2, RFX5) that does not significantly alter the lymphocyte subset numbers.

Conclusions: The study shows that flow cytometry is an ideal screening tool that can potentially identify patients who would benefit with a molecular analysis. However, not all immunodeficiency disorders alter the lymphocyte subset percentages, and the result should always be interpreted along with clinical phenotype and other laboratory results.

Introduction: Inflammation can be reflected in peripheral blood smears in the form of toxic granules (TGNs), vacuoles and Dohle bodies (high RNA content). The granularity of TGNs is graded according to their intensity by manual microscopy (Zimmermann M et al.) . Granularity content of neutrophils can also be assessed by hematology analysers as Cell population data (CPD) parameters e.g. Neut X and Neut Y which are automatically generated with CBC.

The objective of the present study was to evaluate if Granularity content of neutrophils by visual estimation on peripheral blood smears examination and that by hematology counter have any correlation in critically ill patients with sepsis.

In 105 patients MGG stained peripheral blood smears were visually examined for toxic granules, cytoplasmic vacuole and Dohle bodies. Neutrophil granularity was estimated on Sysmax 2000 i as Neut X. TGNs were graded, by manual microscopy using a newly proposed grading system. Result: The samples were analysed and compared with Pearson's coefficient of correlation(r). There was statistically significant correlation between Neut X and grading of TGNs (r = 0.658; p \ 0.001). Neut X was significantly higher in those 16 (15%) patients who had Dohle bodies [Neut-X = 1382 ± 51.2) as compared to those who had not. Neut X had no significant correlation with cytoplasmic vacuoles. Conclusions: We conclude from this study that CPD parameters may be used to replace labour intensive, poorly reproducible grading of TGNs by manual microscopy, as an early and rapid indicator of infection and may help the clinicians in management of patients with sepsi.

Swetambari Acharya, Samira Kumar Behera, Prasanta Purohit Introduction: A reduced absolute lymphocyte count in peripheral blood along with relative increase in neutrophil count has been observed consistently in hospitalized COVID-19 patients. The role of baseline lymphocyte subsets in COVID-19 is still unknown.

Aims & Objectives: We aimed at analyzing the baseline lymphocyte subsets in COVID-19 patients and its impact on the outcome and severity of the disease.

Materials & Methods: Study was conducted retrospectively from hospital electronic records. Diagnosis of COVID-19 disease was based on the RTPCR for SARS-COV-2 virus. Lymphocyte subsets were determined using flowcytometry in COVID-19 patients on admission to COVID ward. The variation in the baseline lymphocyte subsets according to the severity and outcome of the disease was analyzed.

Result: Patients who died of COVID-19 disease had higher mean B lymphocytes and NK cells than the survivors but was not statistically significant. T lymphocyte counts and CD8 ? T cell counts showed statistically significant (p \ 0.05) reduction in patients who expired than who survived COVID-19 disease.

Conclusions: We concluded that low CD8 ? T cell counts at admission may be predictive of patient outcomes in COVID-19.

Aashish Kumar Gupta, Anjana Mittal, Niharika Jain, Arpita Mathur, Manoj Sharma

Introduction: Coagulation activation and thrombo-embolic manifestations are common features in patients with cancer. Malignant tumors are often associated with thrombo-embolic episodes and disturbed coagulative processes. Thrombosis may occur spontaneously after surgical processes, anti-cancer treatment or might be a signal for underlying cancer. Various coagulation parameters are useful for the assessment of intravascular coagulation and fibrinolysis (ICF) syndrome.

Aims & Objectives: To assess the coagulation parameters, platelet count and study the association of ICF in patients with malignant conditions.

This study comprised of 25 cases which included patients with already diagnosed malignant lesions and those who are undergoing chemotherapy. Blood samples of these patients were collected and were tested for PT, APTT, FDP, Fibrinogen, plasma D-dimer and platelet count.

Result: A total of 25 cases were evaluated in our study. A significant association was seen between the malignant lesions and the elevated D-dimer levels, indicating the presence of ICF in these patients along with other altered levels of coagulation parameters.

Conclusions: Increased levels of D-dimer and altered coagulation parameters have a significant correlation with malignant tumors and their spread. This can be useful for the assessment of thrombosis, aggressive tumor behavior and chemotherapy for disease prognosis.

Are We Really Dealing with Acute Leukemia?? A Diagnostic Dilema Ani Baghla, Shashi Bansal, Upendra Sharma

Introduction: The Impaired proliferation and maturation of progenitor cells in bone marrow of any lineage is maturation arrest. Some, if not all, AL is likely arranged in a hierarchical fashion ranging from a primitive cell population through to the 'bulk' population of leukemic blasts which may display a profile akin to a 'maturation arrest' of an equivalent normal precursor cell.

Aims & Objectives: To diagnose a disturbed disease state which often mimic as acute leukemia, clinically, morphologically as well as phenotypically.

Materials & Methods: 47 years old female presented a with chief complaint of swelling in bilateral legs since 10 days associated with red rashes on both legs and ulcers in mouth with history of platelet transfusion a day back. Her complete blood counts and peripheral blood examination reveals pancytopenia with 6% atypical cells with fine chromatin. Bone marrow examination was done revealing 19-20% atypical large blastoid cells with adequate erythroid and megakaryocytes leading to suspicion of acute myeloid leukemia on MDS background. Flowcytometric immunophenotyping was done revealing homogeneous CD45 dim clusters of cell blast window with expression of CD11c, CD13, CD33, CD34, CD38, CD64, CD71, CD117, CD123, HLADR and cyto MPO. On subsequent PBF examination patient starts showing sudden improvement in peripheral blood findings to near normal range within 4 days of admission with supportive care.

Result: In view of continuous improvement in pb findings leading to suspicion of a disturbed diseased state of unknown aetiology leading to MATURATION ARREST of myeloid lineage. However patient was follow up and planned for repeat bone marrow examination revealing cellular marrow with trilineage haematopoiesis with \ 5% phenotypically normal myeloblast seen.

Conclusions: Failure of cells to mature into terminally differentiated cells is known as Maturation arrest. It is useful to emphasize that antibodies used currently in flow cytometry of AL are not specific to neoplastic precursor cells and can be expressed on normal stem and precursor cells. Maturation arrest of single lineage is rare entity with scarce literature available, to best of our knowledge and to reach on this conclusion is extremely important to prevent patient from over treatment.

Bela Sharda Akotiya, Kamal Malukani, Amit V Varma Introduction: Bone marrow examination refers to pathologic analysis of samples of bone marrow obtained by bone marrow aspiration and bone marrow biopsy. Bone marrow examination is used in diagnosis of number of hematological and non hematological conditions.Aspirate and biopsy specimens are considered complementary and when both are obtained, they provide comprehensive study of bone marrow.

Aims & Objectives:

1. To compare simultaneous evaluation of bone marrow aspirates and biopsies. • Most common clinical indication for bone marrow examination in our study was Anemia (28.2%) followed by Acute Leukemias (21.9%). • In our study of 156 cases, bone marrow aspiration and biopsy together were diagnostic in 116 cases (74.3%) and in 27 cases (17.3%) biopsy alone was diagnostic. • 13 cases (8.3%) required further ancillary techniques (flow cytometry or IHC) for definitive diagnosis and were excluded from calculating the concordance rate. • Sensitivity and specificity of BMA and BMB when performed together was 81.11% and 100% respectively. • Positive predictive value is 100% and negative predictive value is 32.5% in our study. • Concordance rate and discordance rate between aspirates and biopsy was found to be of 74.3% and 17.3% respectively. • Diagnostic accuracy of bone marrow aspirate, keeping bone marrow biopsy as gold standard was 82.69%.

Conclusions: Bone marrow biopsy remains the gold standard procedure for bone marrow analysis as it is more reliable and sensitive method. However BMA and BMB when used together, gives higher diagnostic yield.

Introduction: Thalassemia is a heterogeneous group of genetical disorders of haemoglobin (Hb) characterized by reduced or absent production of globin chains. Worldwide it affects approximately 4.4 out of every 10,000 live births. Survival of these cases depends on regular blood transfusions and iron chelating therapy. Because of repeated transfusion Iron toxicity (hemosi-derosis) is one of the devastating complications which case organ damage and stunted growth.

Aims & Objectives: The aim of this study is to evaluate anthropometric and serum ferritin level of transfusion dependent betathalassemia cases.

Materials & Methods: This is a prospective study carried out at the Haematology Department of SCBMCH, Cuttack, Odisha, India. Betathalassemia major cases who were coming to hospital for regular transfusion were included in this study. All the data including demographic, clinical, haematological, level of serum ferritin and alkaline phosphatase were retrieved from patient record.

Result: From July 2021-Sept 2021 data of 120 cases were collected. Because of incomplete clinical data 10 cases were excluded from this study. Age group of our study population was in between 3 months and 11 years. Male female ratio was 3.76:1. Fever was the most common presenting symptom. Pallor, hepatomegaly, splenomegaly and bone deformities were the most common signs among cases. Our study result showed that 74% patients were found to be underweight, 21.73% were short stature, 39.68% were hypocalcaemia, 54.5% had low serum alkaline phosphatase. Level of Hb, RBC, MCH, MCHC was found to be low as compared to control groups. Mean Hb F levels was 92.44 ± 4.76%. Whereas Mean Hb A0 and A2 were 20.12 and 1.2 respectively. Our study also found that level of serum ferritin was significantly high among in this cases (3996.84 ± 2695.9 ng/ml).

The study showed that children with beta thalassemia major are anaemic, underweight and delayed physical growth that may be due to iron overload. Effective and early iron chelation, nutrition therapy is needed for preventing growth failure in transfusion-dependent beta thalassemia children.

Platelet Indices: Establishing the Biological Reference interval in Healthy Adults of Central Gujarat Dharti Pravinbhai Padharia, Keyuri B Patel, Mustafa Ranapurwala

Introduction: The Platelet indices include mean platelet volume (MPV), platelet large cell ratio (P-LCR), plateletcrit (PCT) and platelet distribution width. In addition to their pivotal role in hemostasis, platelets also contribute to the inflammatory process, microbial host defence, wound healing, angiogenesis and remodeling; hence making their indices hold a significant value in the diagnosis and prognosis of certain diseases.

Aims & Objectives: The present study was undertaken to establish the biological reference intervals of the platelet indices-mean platelet volume (MPV), platelet large cell ratio (P-LCR), plateletcrit (PCT) and platelet distribution width (PDW) for population residing in Central Gujarat.

This is a prospective observational study, conducted over a period of five months (May-September 2021); that used 500 EDTA samples of healthy adults ranging from 18 to 52 years (250 males and females each) that have come for routine health checkup. Samples were run in Sysmex XN550 automated hematology analyzer and the platelet indices were obtained directly from the screens.

Result: The normal range for various parameters obtained from samples of 250 males and 250 females: Table 1 : Biological reference interval for various platelet indices (n = 500).

The new reference intervals for the platelet indices were based on the healthy population of Central Gujarat. However, multicenter investigations based on different regions need to be conducted to reach an Indian consensus on the biological reference intervals of these parameters. 

Introduction: Anemia is an enormous problem worldwide, iron deficiency anemia (IDA) is the most common nutritional deficiency anemia globally.

• CBC is used to guide the clinicians regarding the underlying pathology of anemia. • Routinely CBC (Hb, MCV/MCH, RDW) & Serum ferritin is used for diagnosis of IDA & to look for its treatment response. • Serum ferritin is also an inflammatory marker and hemoglobin & MCV does not change significantly immediately. • So we proposed a simple method like Scattergram change in RBC to diagnose & find out early response of IDA treatment.

Aims & Objectives: The aim of this study was to evaluate the significance of RBC Scattergram using an Automated Hematoanalyzer in the diagnosis of Iron deficiency Anemia (IDA) and to see the treatment response in comparison to other conventional iron parameters.

• This study was conducted in MKCG Medical College and Hospital, Brahmapur, Odisha from May 2021 to June 2021. • A total of thirty adult diagnosed cases of IDA (Hb \ 11 g [).

• The hematology analysis of the samples was performed using a Sysmex XN 550 N automated hematology analyzer. Biochemical testing (ferritin) was carried out using an automated Dimensseq. Ferritin was measured using a chemiluminescence immunoassay (Elecsys 1010).

Result: RBC Scattergram in Iron Deficiency Anemia patients consisted mostly of microcytic RBCs which gradually changed to normocytic RBCs with treatment response. RBC Scattergram showed a significant positive correlation with Hemoglobin, MCV & RDW.

Conclusions: Our data demonstrates that analysis of RBC Scattergram is a simple yet rewarding technique that can be confidently used in diagnosing Iron Deficiency Anemia and also in evaluating the response to treatment.

Srilata Chitti, Swati Rao, Taruna, Garima Baweja Madaan, Vijay Kumar Introduction: The spectrum of haematological disorders in children is comprehensive. According to WHO, in 2019, anaemia constituted the majority of benign blood disorders, accounting for more than 53.4%. Although invasive, combined evaluation of bone marrow aspiration (BMA) and bone marrow biopsy (BMB) increases the accuracy for diagnosing benign blood disorders.

Aims & Objectives: This study aimed to assess the diagnostic value of the BMA and BMB individually and when done in combination.

A retrospective study was conducted in the pathology department from November 2010 until July 2021 at ABVIMS & DR RML hospital. All the patients who underwent bone marrow examination were included in the study. Patients with hematolymphoid neoplasms, non-haematological organ metastases and acute leukaemia follow-up were excluded from the study.

Result: A total 126 cases who were diagnosed with benign blood disorders were included in the study. The patients included in the study ranged from 5 months to 18 years with a male to female ratio of 1.6:1. The most common clinical presentation of our study was generalised weakness (57.9%) and pallor (50.7%). Cases were divided into two broad categories. Category 1: cases diagnosed on bone marrow aspiration and bone marrow biopsy together (n = 71 cases).

Category 2: cases diagnosed on bone marrow aspiration only (n = 55 cases). The benign blood disorders included in category I and II were subdivided into RBC disorders (including aplastic anaemia, megaloblastic anaemia, pure red cell aplasia, microcytic hypochromic anaemia), infections (including Haemophagocytic lymphohistiocytosis, malaria, parvovirus, visceral leishmaniasis), platelet disorders (megakaryocytic thrombocytopenia), autoimmune disorders and miscellaneous group including descriptive, only fibrosis, reactive cellular marrow cases. Details of the cases will be discussed.

Conclusions: Bone marrow examination is an important modality for the early diagnosis of benign blood disorder.

Abhinab Bhuyan, Prabir Hazarika, Rasadhar Deka Introduction: Pancytopenia is not a disease entity by itself but a triad of clinical findings that result from reduction of all the three cellular components of blood namely erythrocytes, leucocytes and platelets leading to anemia, leucopenia and thrombocytopenia.

Aims & Objectives: The aim and objectives of this study is to evaluate the clinical presentation and etiological spectrum of pancytopenia and the role of bone marrow study for etiological categorisation.

In this cross sectional observational study, a total of 42 cases presenting with pancytopenia in adults were evaluated by performing complete haemogram, peripheral blood examination, Bone Marrow Study and few biochemical investigation and special stain as per indications in cases.

Result: Among the 42 cases studied, the age of patients ranged from 19 to 80 years with slight male preponderance. The most common clinical findings was generalised weakness (100%), pallor (100%) followed by splenomegaly (50%) . The most common etiology of pancytopenia was megaloblastic anemia with 24 cases (57.14%) followed by hypoplastic anemia with 6 cases (14.29%). The most common bone marrow findings was hypercellular marrow with erythroid hyperplasia. Perl's staining showed 18 cases (42.86%) in grade 2 and reticulin staining showed Grade 0 in 6 indicated cases.

Conclusions: This study highlights the importance of bone marrow study and other haematological investigations in evaluating pancytopenia which plays a pivotal role in proper diagnosis and management.

Result: Patients age whose bone marrow aspiration samples were received ranged from 9 months to 77 years. The samples and slides received were categorized according to indication for which bone marrow aspiration was done: diagnostic purpose-194, post induction follow up bone marrows-70 and for staging purpose-41. Out of 305 marrows 206 were neoplastic, 38 non neoplastic, 15 indeterminate and 46 diluted. Out of 70 follow up bone marrow aspiration samples, 32 were of acute leukemia (22 in remission and 10 in relapse/Persistent disease). Rare findings seen in our study included-1 metastatic deposits of adenocarcinoma, 1 primary myelofibrosis and 6 of the staging bone marrow aspiration samples showed bone marrow involvement by various malignancies.

Conclusions: Bone Marrow Aspiration is a mildly invasive technique which can aid in diagnosing many hematological and non hematological diseases that can be confirmed by more advanced investigations, if needed-biochemical, serological, biopsy or molecular techniques.

Minakshi Swain, Samira Kumar Behera, Prashant Purohit

Introduction: Sickle cell disease (SCD) is a common inherited genetic disorder of blood. In low-income countries especially among tribal populations most of the affected homozygous cases die at early age due to lack of early diagnosis and intervention. In this study, we describe and compare a simple, rapid, low-cost diagnostic paperbased test for the screening of SCD, which is based on principle of haemoglobin solubility. This assay is highly portable and can be set up quickly in any resource limited clinical setting, including those in which the supply of electricity may be uncertain. Also this test can be performed with minimal technical training by any operator with basic laboratory skills and without the use of microscope or high end instruments like Hb electrophoresis and HPLC (High performance liquid chromatography).

Aims & Objectives: To find out sensitivity and specificity of a rapid diagnostic procedure i.e. paper-based Sickle solubility test for the diagnosis of sickle cell anaemia.

A known case of Sickle cell anaemia was taken and serially diluted with adult haemoglobin. Diluted blood was run for HPLC and also paper based sickle solubility test was done. Introduction: Neonatal sepsis contributes significantly to neonatal mortality posing a major global public health challenge. Flow cytometry based monitoring with biomarkers for sepsis like significantly upregulated expression of CD64 on neutrophils and downregulated expression of HLA-DR on monocytes which are proinflammatory and anti-inflammatory response respectively to the infection in neonates. Few studies showed that calculation of sepsis Index (nCD64 9 100/mHLA-DR) can be more useful. These can be used as newer tools for early diagnosis and management of neonatal sepsis.

Aims & Objectives: To study the role of Flow Cytometry derived sepsis Index (nCD64 9 100/mHLA-DR) as a novel parameter in diagnosis of neonatal sepsis.

A prospective study was undertaken which included 40 control and 34 cases. Controls were the admitted neonates with no clinical suspicion of sepsis. The neonates admitted to NICU with possible or at risk sepsis were taken as cases. Complete blood count, sepsis screen and cultures were performed for cases prior to starting on antibiotics. 1 ml of blood sample is collected in EDTA vial for both cases and controls and were processed for flow cytometry parameters using Anti-Human HLA-DR PE/ Monocyte PerCP-CyTM5.5 (BD QuantibriteTM), Anti-Human CD64 PE/CD45 PerCP (BD QuantibriteTM) antibodies on BD FACS Canto II flow cytometer (BD Biosciences, USA). The expression was measured as median fluorescence intensity of neutrophilic CD64 (nCD64) and monocytic HLA DR (mHLA-DR). It was then converted into antibodies per cell by use of a precalibrated plot which were prepared by use of BD PE quantibrite beads. Result: We found that the sepsis index (SI) observed in the control group was 17.97 (95% CI 12. 6-24.6) , whereas in cases it is 54.6 (95% CI 34.0-75.1), which is statistically significant (p \ 0.0001). The ROC analysis showed an area under the curve of 0.722 with p = 0.001. With a threshold of SI = 20.14, the sensitivity and specificity are 0.618 & 0.756 respectively. We also found sepsis index as valuable when other sepsis screen parameters were negative. Conclusions: Flow cytometry derived sepsis index is a novel and sensitive biomarker of neonatal sepsis.

Sanjeev Ranjan, Seema Kumari, Waquil Ahmad, Aakash

Introduction: Malaria is a disease of tropical and sub tropical country particularly Africa & Asia. Hematological dysfunction is very common in malaria and involves one or more cell lines. Anemia and high Red cell distribution width (RDW) are frequent malaria-associated hematological findings.

Aims & Objectives: The aim of present study is to determine the effect of Plasmodium parasitaemia on Hb and RDW among 44 patients.

This observational study was conducted in a tertiary care hospital in south Bihar India, over a period of 12 months. Patients who were found positive in Rapid Card Test or Peripheral smear for malaria were studied. Result: In our study of 44 patients, P.vivax infestation was seen in 29 cases (65%), 11cases with mixed infestation (25%) and 4 cases (9%) with P.falciparum infestation. Hb was decreased in 18 cases (41%), in which 11 patients (61%) were positive for P.vivax, 5 patients (27%) with mixed and 3(12%) were positive for P.falciparum. Lowest hemoglobin percentage was 8.8gm/dl. Increased RDW was seen in 8(18%) out of 44 patients. RDW was increased in 5 cases (62.5%) in case of P.Vivax, 2 (25%) in case of P.falciparum and 1(12.5%) with mixed infestation. Conclusions: We conclude that routinely used laboratory findings such as hemoglobin, and red cell distribution width values can provide a diagnostic clue in patient of malaria with acute febrile illness, and decrease in Hb and increase in RDW are seen more in cases of P.vivax as compared to P.falciparum or mixed infestation. Patient was managed on the line of dengue infection with conservative fluid management and blood product transfusion. Trial of artesunate, doxycycline and eldervit was given. After two weeks of hospital stay there was no improvement, pancytopenia persisted along with jaundice. On further workup Ferritin-4796 ng/ml, triglyceride-515 mg/dl. Bone marrow aspiration showed significant hemophagocytes. With above evidence this case was labelled as Hemophagocytic lymphohistiocytosis secondary to dengue infection.

Result: Patient was started on dexamethasone 10 mg/m 2 . Initially there was a gradual rise in cell counts and hemoglobin. Significant increase in total cell counts and hemoglobin was seen after addition of oral cyclosporine.Patient was afebrile with clinically non palpable spleen. Total bilirubin and ferritin were on falling trend.Patient did not show much improvement in platelet count. Patient is on our regular followup after being discharged at 2 weeks of starting therapy.

Conclusions: Effective treatment of secondary HLH requires aggressive immunosuppression to control the hyperinflammatory state, in combination with targeted treatment against triggering fact.

Admitted to a Tertiary Care Centre in Andhra Pradesh Talari Rajeswari, Shobhitha D, Arathi C.A, Janakiraman

Introduction: Wuhan, China witnessed an increasing number of Pneumonia cases attributed to a novel Corona virus (2019-nCoV).

Hematological changes were noted in COVID-19 patients and a difference between the hematological manifestations was noted between the severe and non-severe cases. -19) pandemic, many studies have described the quantitative blood findings seen in COVID-19 patients. However, morphologic changes have been described by only few studies. We report morphologic and quantitative changes in peripheral blood of COVID-19 patients.

Aims & Objectives: To examine the complete blood count (CBC), characteristics of the cells detected on peripheral blood smear (PBS) and to correlate whether these findings are related to the clinical course by evaluating the smear.

Materials & Methods: Clinical features, complete blood count and peripheral blood smears findings of 100 RT-PCR positive COVID-19 patients were evaluated in pathology department of Indira Gandhi Government Medical College, Nagpur. Patients were divided into different groups depending on thrombocytopenia, bicytopenia and pancytopenia. Peripheral smears of patients were evaluated for cellular morphology. The relationship between the CBC and PBS of all patients with the severity of disease was analyzed.

Result: Red blood cells did not show any significant abnormalities. Neutrophils, lymphocytes showed changes in morphology. Neutrophils showed neutrophillia with pseudo Pelger-Huet anomaly, abnormal segmentation, abnormal shapes of nuclei, pyknotic nuclei, toxic granules in cytoplasm. Relative lymphopenia with atypical lymphocytes, large granular lymphocytes were also seen. Eosinophils were low which could be attributed to use of steroids in covid 19 patients.There was no significant abnormality in basophil and monocytes. Platelets were decreased and giant platelets were found in few cases.Study showed positive correlation between the severity of disease and neutrophil abnormalities and thrombocytopenia. Presence of mature lymphocytes showed negative correlation with disease severity.

Conclusions: CBC and PBS are inexpensive and rapid tests which can be done at any institute. Neutrophillic abnormalities and lymphocytopenia along with large granular lymphocytes are the findings associated with COVID 19 infection, while high initial mature lymphocyte at the time of diagnosis may be an indicator of better prognosis and short duration of hospital stay.

Deepshikha Verma, Parul Murab, R.K.Nigam

Introduction: Thrombocytopenia (platelet counts less than 150,000/ ll) can lead to inadequate clot formation and increased risk of bleeding. It is a common indication for bone marrow aspiration. Dysplastic changes are well known in megakaryocytes in thrombocytopenia associated with myelodysplastic syndromes (MDS). However, they are also observed in megakaryocytes in nonmyelodysplastic syndromes.

Aims & Objectives: The present study was undertaken to calculate the prevalence of various conditions associated with thrombocytopenia and to record the megakaryocytic alterations in various cases of thrombocytopenia in central India.

A prospective series of 100 bone marrow aspirations was conducted in a tertiary care centre catering to both urban as well as rural population in central India.

Result: A Total of 100 cases of thrombocytopenia were included in this study predominated by Acute Leukemia (28 cases/100 followed by Dimorphic anemia (15 cases/100), Megaloblastic anemia (11 cases/100), Hypocellular marrow, Infection, Immune thrombocytopenic purpura 9 cases each, granulomatous disease 4 cases, chronic myeloid leukemia 3 cases, acute promyelocytic leukemia, myelofibrosis, MPD 2 cases each, Parvovirus infection, hemophagocytic lympho-histiocytosis, Plasma cell leukemia, Gaucher's disease, Solitary plasmacytoma, ?smoldering myeloma, Nutritional anemia, aplastic anemia 1 case each. In cases of myelodysplasia; dysplastic forms, bare megakaryocytic nuclei, hypo-granular forms and micromegakaryocytes were seen. Comparison between frequencies of normal, high and low number of nuclear lobes among MDS and non MDS conditions were found to be statistically significant.

Conclusions: Understanding the morphological changes of megakaryocytes in bone marrow aspirates can improve diagnostic accuracy for wide range of haematological disorders, allowing for appropriate therapeutic interventions. Introduction: Neonate term is for infant from birth to less than 28 days. Newborn health is the key to child health and survival. During pregnancy, mother's well being affects directly the newborn development Complete blood count (CBC) correlates highly with gestational age, birth weight, blood sampling site, crying, physical therapy, mode of delivery and other factors. Despite advances in perineonatology over the past few years, the exact influence of perinatal factors on haematological values in cord blood is still unclear.

Aims & Objectives: To evaluate the effect of mode of delivery on haematological parameters of term and preterm neonates.

This study was carried out on 500 neonates delivered vaginally and by caesarean section. Group I included 258 Term neonates delivered to mothers without maternal complications, Group II were 139 neonates delivered to mothers with maternal complications and Group III included 103 preterm neonates. CBC was performed on these neonates from umbilical cord blood immediately after birth. Result: Haemoglobin, red blood cell count, haematocrit in full-term neonates delivered to healthy mothers vaginally were significantly higher than those of neonates delivered by caesarean section. Whereas, Total leucocyte count, absolute neutrophil count and eosinophils were significantly higher with term neonates delivered by caesarean and no significant difference in the other parameters. When CBC of term neonates born to mothers with complications were compared, a significant increase in absolute neutrophil count was observed in those delivered by caesarean section. There was no significant difference in CBC of preterm neonates delivered vaginally than those by caesarean section. Conclusions: We successfully obtained the normal CBC and WBC DC reference values of the cord blood in India. Delivery routes, maternal condition and gestation age were important confounding factors that influenced the cord blood CBC and WBC values.

Parul Murab, Deepshikha Verma, RK Nigam

Introduction: High-performance liquid chromatography (HPLC) is a technique introduced for the accurate diagnosis of hemoglobinopathies and thalassemias. The advantage of the HPLC system is the excellent resolution, reproducibility & quantification of several normal & abnormal hemoglobin resulting in accurate diagnosis of thalassemia syndromes.

Aims & Objectives: To aid in a cut off value for suspected haemoglobinopathies in Central India.

To determine Haemoglobin profile in suspected cases of Haemoglobinopathies in Central India.

A total of 148 cases were diagnosed as hemoglobinopathies by Bio-Rad variant II HPLC system by b-thal short program. The retention times, proportion of the haemoglobin (%), and peak characteristics for all hemoglobin (Hb) fractions were recorded. Other tests performed were HbF estimation by Betke's method, sickling tests using 2% metabisulphite and serum Ferritin estimation. Family studies were carried out wherever required.

Result: Out of the 148 cases included in the study in a duration of 1 and half year from 1 January 2020 to 30 June 2021,147 cases were from Madhya Pradesh and 1 from Chattisgarh (not included in our study). Out of these 147 cases, 32 cases show absence of any abnormal variant, 26 were inconclusive and 08 were contaminated or clotted samples. 81 cases were of Hemoglobinopathies. (22 cases of thalassaemic disorders-21 cases of bthalassemia trait, 1 case of bthalassemia major. 13 cases were compound heterozygotes-12 of which were for HbS/ bthalassemia and 1 for dbthalassemia. 30 cases sickle cell disease and 16 cases of sickle cell trait.

The cut off values of HbA2 for suspected haemoglobinopathies came out as 3.35% in central India and HbS peak at 8?me out as significant.

Conclusions: HPLC is a sensitive, specific, and reproducible alternative to electrophoresis. With automation and quantitative power, it appears to be a sensitive and accurate technique for direct identification and quantification of normal and abnormal haemoglobins.

Preetinanda M. Dash, Rajan S. Bindu, Praveen K. Sahu Introduction: Non-deletional a-thalassemia mutations result in unstable haemoglobins that usually precipitates in red blood cells (RBC) forming insoluble inclusion bodies and leads to destruction of RBC membranes, manifesting moderate to severe disease characterised by ineffective erythropoiesis, recurrent transfusion and delayed growth. Aims & Objectives: We evaluated the underlying non-deletional athalassemia in a hospitalized anemic population of Marathwada region using HPLC and molecular investigation. Materials & Methods: Both symptomatic and asymptomatic enrolled subjects from IPD and OPD underwent hematological profiling and quantification of Hb-variants (A, A2, S, F) via alkaline Hb Electrophoresis, automated Hb-variant testing specifically designed for HbQ and HbJ. Polymerase chain reaction (PCR) based investigations were done to characterize major Asian type b-thalassemias, South-East Asian deletonal a-thalassemias and non-deletional mutations. Result: One case of HbJ-Meerut (a 120 Glu ? Ala) i.e. FMH confirmed by AHE, HPLC and eight cases of HbQ (a 64 Asp ? His) confirmed by HPLC, molecular diagnosis and family study. The carrier of HbJ was a 36 years diabetic Maharashtrian female, presented with raised FBS and normal Hb indices (Hb-12.8 g/dl, MCV-81.2 fl). HbJ interferes with HbA1c (4.6%) in diabetic patients which is a reliable marker used for the diagnosis of patient metabolic control. We also found compound double heterozygote of b-thalassemia with HbQ-India (aa 64 Asp ? His /bbIVS1-5[G ? C]), a 10 yr male with anemia (Hb-10.3 g/dl) related weakness. The rest subjects of HbQ (n = 07) were from three consequent generations of a single-Sindhi family. HbQ trait (16.33 ± 0.60%) was clinically asymptomatic except for one female with mild anaemia. The single-subject HbQ trait with the b-thal trait had severe microcytosis (MCV-62.2 fl) and anemia comparatively with decreased HbQ (7.7%) and increase HbA2 (6%). Conclusions: This is the first report on an extremely rare Hb J-Meerut (a120 Glu ? Ala) and eight cases of HbQ (a64 Asp ? His) from Marathwada region, with atypical clinical presentation. Rare Hb variant entities are difficult to be characterized from routine hematological features, occasionally mimicking iron-deficiency anemia (IDA) or organized with IDA for underlined microcytic anemia. A systematic genetic carrier screening program backed with genetic characterization is highly essential to look for the inheritance and burden in suspected population.

Rakesh Kumar, Kavita Gaur, Vandana Puri, Shruti, Shaileja Shukla, Sunita Sharma, Nazma K Introduction: Platelet count assessment is an essential part of hematology practice. Various methods of platelet counting include estimation from peripheral smears, manual platelet counting by Neubauer chamber and automated analyzer based on impedance and optical methods. Questionable reproducibility between various methods, interobserver variation and varying multiplication factors used for slide estimation remain major hurdles in releasing an accurate platelet count. Aims & Objectives: The aim of this study was to ascertain the correlation between the different methods (both slide estimation and Indian J Hematol Blood Transfus automated) with the Neubauer chamber count and whether significant difference existed in the accuracy of the various methods. Materials & Methods: Blood samples of 326 patients of three categories-thrombocytopenia, normal platelet count and thrombocytosis delineated by the original six -part analyzer reading were examined at our laboratory. Slide estimation of platelet count was done by two observers on Wright-stained smears. Five and ten field mean of platelets, observed under oil immersion (10009) of a standard Nikon Eclipse E100 microscope was multiplied by 10,000. Automated values (impedance and optical) were generated by six-part hematology analyzers (Sysmex XN-1000) and tabulated. Correlation between manual and automated methods was established by Spearman correlation analysis.

Result: There was a strong correlation between manual and optical platelet count which was statistically significant (Interclass Correlation Coefficient = 0.88, p = \ 0.001). Optical and impedance methods of automated platelet counting and ten field slide estimation demonstrated a strong positive correlation with Neubauer chamber analysis. This correlation was statistically significant (p = \ 0.001). There was a strong correlation between manual and impedance platelet count which was statistically significant. However, difference between five fields and ten fields slide estimation was statistically significant (t = -2.711, p = 0.007). Correlation between all methods was highest in thrombocytosis category Vis-a Vis thrombocytopenia where the difference was significant (p = 0.006). Conclusions: Slide estimation of platelet count (ten fields mean with multiplication factor of 10,000) has a good correlation with manual, impedance and optical platelet counts and may be a reliable adjunct to diagnosis in routine laboratory practice.

Rasheeda, Renuka patil, Krishnaraj upadhyaya Introduction: Diabetes mellitus is a global health disease. Hyperglycemia contributes to greater platelet reactivity through direct effects and by promoting glycation of proteins. Mean platelet volume and platelet count is an indicator of average size and activity of the platelets and is reported to be high in diabetes mellitus. Platelet activity is important in atherothrombotic disease mainly acting on vascular endothelium eventually leading to complications. Hence it is crucial to assess the platelet activity with aid of Mean Platelet Volume (MPV), Platelet count and Platelet distribution width.

• To find the association between platelet count and MPV with HBA1C in diabetic patients • To find the association of platelet count and MPV with vascular complications in diabetic patients.

Retrospective study conducted in the Department of Pathology, Yenepoya Medical College from January 2021 to June 2021. Data was collected from backbone stored in digital form.

The study was performed on 92 diabetic patients (female: 38; male: 54). Diabetic patients divided into 2 groups.

(1) GROUP 1: HBA1C \ 7 [ Result: Out of 92 cases, 74 had vascular complications. Mean platelet count in group 1 and group 2 was found to be 231.727 and 312.346 respectively which was highly significant with p value of 0.036. Mean platelet volume in group 1 and group 2 was found to be 10.200 and 9.999 respectively. The mean platelet count and mean platelet volume was found to be high in diabetes associated with complications than non-complicated diabetes. Conclusions: Platelet count between the 2 groups showed statically significant value. However mean platelet volume did not show any significance between the two groups, but was found to be higher in diabetes with complications. Diabetic patients suffer mostly from vascular complications, therefore platelet activity can be used as prognostic marker for vascular complications of diabetes.

Rasheeda, Krishnaraj upadhyaya, Renuka patil Introduction: Diabetes mellitus is a global pandemic disease. Hyperglycemia contributes to greater platelet reactivity through direct effects and by promoting glycation of proteins. Mean platelet volume and platelet count is an indicator of average size and activity of the platelets and is reported to be high in diabetes mellitus. Similarly Platelet distribution width is an indicator of variation in platelet size which may be a sign of active platelet release. Aims & Objectives: To correlate the platelet indices with HBA1C in diabetic patients with or without complications.

The study was performed by retrieving records (Laboratory parameters) of 92 diabetic patients and then divided into two groups.

(1) GROUP 1: HBA1C less than 7 (10 diabetic patients).

(2) GROUP 2: HBA1C more than or equal to 7 (82 diabetic patients).

Platelet indices were collected from those 92 diabetic patients and was correlated with the HBA1C values.

Result: Mean fasting blood glucose in group 1 and group 2 was found to be 101.909 and 168.198 respectively which was highly significant with p value of 0.028 and mean difference of -66.2884. Mean platelet count in group 1 and group 2 was found to be 231.727 and 312.346 respectively which was highly significant with p value of 0.036 and mean difference of -80.6184. Mean platelet volume in group 1 and group 2 was found to be 10.200 and 9.999 respectively which showed no significant correlation with p value of 0.528 and mean difference of 0.2012.

The platelet indices (platelet count and mean platelet volume) were found to be raised in group 2 with HBA1C more than or equal to 7. But the platelet count and fasting blood glucose between the two groups shows statistically significant difference with p value of 0.036 and 0.028 respectively. However mean platelet volume does not show any significance between the two groups with p value of 0.528. Diabetic patients suffer mostly from vascular complications, therefore platelet count and HBA1C can be a useful prognostic marker of vascular complications in diabetics. Platelet indices are simple and cost effective laboratory test in the follow up of Diabetes mellitus.

Care Hospital, South-West Bihar Shipra Jyoti, Md Wakeel Ahmad, Kumari Seema

Introduction: Chronic Kidney Disease (CKD) is one of the major health problems worldwide. The morbidity and mortality related to CKD is of great concern in developing nation like India. The various hematological parameters and their correlation to different stages of CKD helps assess the severity, prognosis and outcome of these patients.

Aims & Objectives: To study the hematological parameters in patients of CKD undergoing hemodialysis.

To correlate various hematological parameters with different stages of CKD.

Materials & Methods: A hospital based cross-sectional study was done on 100 patients of CKD on hemodialysis to detect the prevalence of hematological abnormalities, correlation and typing of anemia with CKD stages (stage 3-5) of the patients were included in this study. Presence of anemia (Hb%, MCV and peripheral smear), RDW, platelet count, leucocyte and differential leucocyte counts in different stages of CKD were studied. Result: Most of the patients belong to stage 5 CKD (62%), followed by stage 4 (24%) and stage 3 (14%). 66% of the subjects are males whereas 34% are females. 99% subjects in this study group are anemic. 61% subjects have normocytic and normochromic findings on peripheral smear. 57% subjects have TLC count in normal range. MCV and platelets are within normal range with only slight variation. Increased RDW has a positive correlation with CKD.

Conclusions: CKD patients have various changes in hematological parameters. A study should be carried out for an early initiation of treatment and the improvement in quality of life in CKD patients.

Sneha Pawde, Jagdish Laddha

Introduction: Hematological disorders are quite frequent in population than non hematological disorders. Most of times the diagnosis can be arrived by clinical examination and few simple investigations. Bone marrow examination is one of the most frequent and relatively safe invasive procedure for diagnosis of hematological and non hematological disorders, typing of anemia, evaluation of pyrexia of unknown origin and infective diseases. Bone marrow aspiration is alone is usually sufficient to diagnose nutritional anemias, most of acute leukemias and immune thrombocytopenia. Trephine biopsy does provide important diagnostic information in patients with Granulomatous disorders, myelofibrosis and bone marrow infiltration. Non hematological disorders where bone marrow examination can provide an exact diagnosis are granulomatous diseases storage disorders, metastatic diseases and various systemic infections.

Aims & Objectives: AIM: To find out and diagnose the spectrum of hematological and non hematological disorders using bone marrow aspiration and trephine biopsy.

Objectives:

1. To study the spectrum of hematological and non hematological disorders. 2. To know the underlying pathology and correlate the bone marrow findings with clinical findings and peripheral blood findings. 3. To find out the spectrum in relation to age groups and sex.

The study was Hospital based observational cross sectional study conducted in Department of Pathology in Tertiary care center during the period of January 2021 to June 2021.A total 50 bone marrow examinations were done. Clinical data with reference to age, sex, socioeconomic status, history of drug intake, bone pains, hepatosplenomegaly and lymphadenopathy were recorded. The following investigations were carried out in clinical laboratory like Hb, TLC, DLC, Bleeding time, clotting time, platelet count and peripheral blood smear. Result: Among 50 cases studied, age of patients ranged from 7 months to 77 years with male predominance (M:F ratio is 1.5: 1). Most of the patients presented with fever, shortness of breath, easy fatigability and generalized weakness. The commonest physical findings were pallor followed by splenomegaly and hepatomegaly and in hematological parameters predominantly pancytopenia. Nutritional anemia (52%) contributed highest number of cases among was nonmalignant hematological disorders. Megaloblastic anemia is the most common among nutritional anemias. Acute myeloid leukemia (8%) was the most common malignant hematological disorder. Out of 50 cases, only 2 cases are of non hematological disorders among which one was granulomatous disorder (2%) and second was storage disorder (2%). Conclusions: Bone marrow examination is an important tool in establishing the diagnosis in various hematological and non hematological disorders.

Sukanya Sarkar, Amit Nisal, Ravindra Nimbargi, N.S. Mani

Introduction: Pregnancy-induced hypertension (PIH) is the most common disorder of pregnancy affecting approximately 5-7% of pregnancies and is a significant cause of maternal and fetal morbidity and mortality. Pre-eclampsia is defined as the onset of hypertension (blood pressure of 140/90 mmHg or greater, 6 h or more apart) and consistent proteinuria (300 mg/day or more) during the latter half of the pregnancy with both remitting remotely after delivery. Eclampsia is defined as convulsions in association with above findings. In a proportion of these patients, the risk to the mother can be significant and includes the possible development of disseminated intravascular coagulation (DIC). Altered Haemogram and coagulation abnormalities such as anaemia, thrombocytopenia, presence of schistocytes, deranged prothrombin time (PT), activated partial thromboplastin time (APTT) and serum LDH values are hallmark of these patients. Aims & Objectives: To study the various hematological and coagulation parameters in patients of pre eclampsia and normal pregnancy and to see their progress into DIC. Materials & Methods: Total 60 patients were analyzed over a period of 2 years. Complete Haemogram with peripheral blood smear, coagulation tests of PT, activated APTT and serum LDH were done on patients with pre eclampsia (30) and normal pregnancy (30). Result: Patients with pre eclampsia were found to have low platelet count, low PT value and a high Serum LDH value in comparison to normal pregnant patients. No significant difference in APTT values was observed in our study. Conclusions: These markers can be utilized the disease severity in pre eclampsia patients and also as an early indicator of progression to DIC.

Tanima Dwivedi, Ritu Gupta, Nupur Das, Apurva Raj, Pawan Tiwari, Saurabh Vig, Brajesh Ratre, Sushma Bhatnagar, Anant Mohan Introduction: COVID-19 pandemic has placed the health system worldwide in unprecedented stress, therefore, prompt identification Indian J Hematol Blood Transfus and management of patients having severe disease is essential for triaging of patients at the time of admission. Aims & Objectives: To identify hematological biomarkers of COVID-19 disease severity in patients admitted in a tertiary care hospital.

A retrospective study was conducted over a period of 17 months (20th March 2020-19 August 2021) on 7416 COVID-19 patients. Patients with cancers, pregnancy and chronic hematological diseases were excluded from the study. Patients were classified clinically as per severity of disease as non-severe (asymptomatic, mild, moderate) or severe and their hematological parameters were analyzed. Mann-Whitney test was used to compare between the groups. Optimal predictive cut off points for the variables were defined by receiver operating characteristic (AUC) curve to dichotomize the variables. Univariate analysis was performed to screen out independent variables to be used in the binary logistic regression (BLR). A p value of \ = 0.05 was considered as statistically significant. PT and 57(51.81%) in APTT. In mild to moderate cases significant variation of coagulation parameters was found in the first week of admission whereas in severe and critically ill cases the variations were more in the last week of their hospital stay. Gender variation is not significant in the study population. The above 50 yrs age group had poorer prognosis with higher variation and higher levels of all the parameters studied as compared to the age group below 50 yrs. Conclusions: Coagulation parameters could be used as significant indicators in predicting the severity and prognosis of COVID-19 patients in the Second Wave.

Anusha Gupta, Ramesh Chavan, Hardik Jain Introduction: Pregnancy-induced hypertension (PIH) is one of the common medical disorder of pregnancy contributing significantly to maternal/fetal morbidity and mortality. This study is undertaken to know the hematological, biochemical and coagulative derangement in preeclampsia and further access the prognosis and severity of the complications and thus will help as a treatment guide for cases of preeclampsia and eclampsia. Aims & Objectives: To know the diagnostic markers in patients with pregnancy induced hypertension and to predict the severity of the disease based on these laboratory markers.

A hospital based study of 150 patients clinically diagnosed mild preeclampsia (75), severe preeclampsia (50), eclampsia (25). The blood and urine samples were collected for hematological, biochemical and coagulative studies in PIH over a period of 1 years will be included in the study. Hematological-hemoglobin, platelet count, mean platelet volume. Biochemical-LDH, Alkaline phosphate, serum uric acid, serum creatinine, urine protein.

Coagulative-prothrombin time (PT), activated partial thromboplastin time (aPTT), D-dimer, fibrinogen. Result: The hemoglobin level of all 150 patients varied from 2.3 to 14.8 g./., the mean being 9.05 g./. The platelet count and mean platelet volume decreased significantly with the increase in severity. Values of LDH, ALP, Creatinine, uric acid, urine protein increased significantly with severity of disease. Coagulative profile (PT, aPTT, D-dimer, fibrinogen) in severe preeclampsia group and eclampsia group were significantly higher than mild preeclampsia group in which these values were mildly raised. Conclusions: Standard antenatal follow up should be carried out for the early detection and prevention of PIH. Thrombocytopenia and MPV are significant markers for early diagnosis and prediction of severity of PIH. Reduced hemoglobin is associated with fetal complications like IUGR and IUD. Coagulative parameters such as PT, aPTT, D-dimer, Fibrinogen were associated with the severity of disease. Test like LDH,uric acid,creatinine,alkaline phosphate, urine protein could help predict and to deal with the adverse complications of PIH,which are considered as cost effective as they are done routinely in most of laboratories. KEY WORDS:-prothrombin time(PT), activated partial thromboplastin time(aPTT), lactate dehydrogenase (LDH),Alkaline phosphatase(ALP). Introduction: Chronic renal failure is a major global public health problem, estimated to affect more than 10% of general adult population and up to 50% of some high-risk subpopulations, such as the elderly, type-2 diabetes mellitus (T2D) and hypertension and HIV/ AIDS patients. Haematological parameters, particularly red blood cell (RBC) indices are generally affected, giving rise to anemia.

Deficiency of erythropoietin (EPO) is the primary cause for anemia.

The combination of serum transferrin receptor and serum ferritin provides complete information about storage and functional iron compartments.

Aims & Objectives: To study red cell parameters, serum Erythropoietin status and iron profile in Chronic Renal Failure patients and correlate with other parameters. Materials & Methods: This prospective study spanning from June 2020 to May 2021 conducted at a tertiary care centre of Southern Assam. A total of 75 chronic renal failure (CRF) patients, taken according to the inclusion and exclusion criteria in this study. These cases were diagnosed by history, signs and symptoms, CBC, S.iron profile, S.erythropoietin assay etc. Statistical analysis was performed using SPSS (Version 25.0, Armonk). Result: A total of 75 chronic renal failure (CRF) patients, taken according to the inclusion and exclusion criteria. Patients in the age group of 51-60 years cover the maximum cases i.e. 49%. Male cases outnumbered the females. Anemia was present in every case, irrespective of the etiology. The mean serum Ferritin was 184.39 ± 74.91 (ng/mL). It ranked highest in Stage V CRF. The mean serum Erythropoietin in stage III was 10.1 ± 1.8 (mIU/mL), in stage IV was 17.3 ± 3.1 (mIU/mL) and in stage V was 13.3 ± 3.4 (mIU/mL). A weak negative correlation was seen between serum Erythropoietin and Hb levels in stage III CRF patients. This correlation was gradually lost in stage IV and V patients. Conclusions: Chronic Renal Failure patients develop various abnormalities in the hematological profile commonly anemia. Normocytic normochromic is the commonest morphological pattern. Functional iron deficiency is predominant in the present study. Erythropoietin biosynthesis and secretion are inversely regulated by haemoglobin levels. . Detection of Coronavirus by RT-PCR is the primary method which requires expert skills. RT-PCR test is not widely available in all the laboratories. Cost effective screening of COVID-19 could be possible with the automated analysers which may provide a hint for early diagnosis. Histogram analysis is neglected part of the automated haemogram when interpreted efficaciously has noteworthy capacity to contribute for diagnostically pertinent information before higher level investigations are requested. 

Durre Aden, Sufian Zaheer, Sunil Ranga Introduction: Activated Thromboplastin Time (APTT) and INR are routinely used to assess the haemostatic parameters and to make urgent clinical decisions about the patients treatment. Diferent techniques have been used to reduce the TAT of these emergency assays which comprises reducing the pre analytical stage of sample processing.Centrifugation is one of the most important steps used in the processing and pre-analytical stage. The rapid method of centrifugation can reduce the time taken in centrifugation and thus help in overall minimizing the TAT without affecting the quality of results.

Aims & Objectives: Aim of the study was to devise a minimal suitable centrifugation time for coagulation testing to improve the TAT which in turn will help in the reduction of the ED LOS. Materials & Methods: The PT, aPTT and INR were determined for each sample which was centrifuged at two different centrifugation speeds i.e. at 3000 rpm for 15 min and 4000 rpm for 5 min. Result: The effects of centrifugation of blood samples were analysed and compared.We observed that there were no significant differences in the results between the two methods used and there was a good correlation between both the centrifugation speed. Conclusions: A high-speed technique for the preparation of plateletpoor plasma (PPP) can be a reliable and safe method to be used in the emergency setting without affecting the quality of assays and thus help in reducing the laboratory TAT.

Gaurav Singh, Sumita Chaudhary, Ashok Kumawat Introduction: Anemia is common in cancer patients and it's pathophysiology is complex and multifactorial. Conventional methods (Serum Iron, serum ferritin, TIBC, TSAT) to diagnosing iron deficiency anemia in cancer patients is affected by cancer type, duration, treatment, infection and inflammation related to cancer. RET-He measure the recent functional availability of iron and the correlation with iron deficient / restricted erythropoiesis, and it is not affected by infection and inflammation related to cancer so it can be useful marker to rapidly rule out iron deficiency in cancer patients. Aims & Objectives: To evaluate role of RET-He in differential diagnosis of anemia in cancer patients and to determine the diagnostic performance of RET-He against existing diagnostic tests for diagnosing IDA. Materials & Methods: This is observation longitudinal study and study subjects including all type of diagnosed cancer patients with anemia with or without treatment. Study duration was 18 month and 200 sample size was taken. Complete blood count along with RET-He were analysed on SYSMEX XN 1000i. Serum Ferritin was estimated using AVANTOR CL-1000i and Serum iron, TIBC, TSAT were run on EBRA MANHEIN CHEM 5X machine. Bone marrow xamination was done for diagnosis/staging. Iron stores were evaluated by Perl's Prussian blue stain. Result: At a cut off of 28.4 pg, RET-He achieved sensitivity of 96.77% and specificity of 81.66% with NPV of 99.3% and PPV of 49.2% for iron deficient state in cancer patients. This cut off value rules out iron deficient erythropoiesis, reduces unnecessary iron studies and encourage early treatment of iron deficiency. Their is also moderate agreement exist between iron stores of bone marrow and RET-He with Kappa 0.411 and p value \ 0.0001. Conclusions: RET-He is better indicator of IDA in cancer patients as compared to other conventional methods of diagnosing IDA. This study also revealed a direct correlation between RET-He and bone marrow iron stores. In future it is advisable to use RET-He as a predictor of IDA, which is sensitive and specific at perticular cut off points in routine evaluation in IDA in cancer patients. -19) is an infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since there is activation of both inflammatory and thrombotic pathways in this disease, indices derived from routinely measured blood parameters, whose role is established in severe sepsis, are being evaluated worldwide as potential prognostic markers. Aims & Objectives: In this study we aimed to evaluate the role of Absolute Neutrophil count (ANC), Absolute Lymphocyte Count (ALC), Mean platelet volume (MPV), platelet distribution width (PDW), Plateletcrit (PCT), Platelet-large cell ratio( P-LCR), Neutrophil Platelet ratio (NPR) and Platelet Lymphocyte ratio (PLR) in predicting survival amongst patients admitted with COVID-19 infection.

We conducted a retrospective chart review of all moderate to severely ill adult patients admitted with COVID-19 pneumonia admitted at All India Institute of Medical Sciences, Bhopal, a tertiary care hospital in Central India from April 2020-November 2020. Information about their demography, clinical features, laboratory investigations and in-hospital survival were collected from charts. Result: The study included 1331 patients, out of these 1181 were survivors (389 females; 792 males) and 150 were non survivors (35 females; 115 males). Amongst the various parameters studied ANC, NPR and PCT were found to be significantly lower amongst the survivors as compared to the non survivors whereas ALC was significantly higher amongst the survivors.

The results of the current study showed that ANC, ALC, NPR and PCT can be used as useful cost-effective prognostic markers in patients with COVID-19 infection. Result: The analysis showed that there is a significant of association between the prognosis and PDW level at Day-1, Last day-5 and Day-5.

Conclusions: This study concludes that the PDW value could be a very important cost effective indicator for clinicians.PDW in ventilated patients and increasing trend in PDW may predict mortality in near future, so care should be taken before mortality occurs and precautions may be taken 96-120 h before to prevent mortality.

When Should We Start Work-Up for Thrombocytosis: Frequently Seen as a Snapshot of a Movie Nagarjun Sai Jaine, Manali Satiza, Abhishek Purohit, Poonam Abhay Elhence Introduction: Thrombocytosis refers to a platelet count above the normal value. Today, with the widespread use of electronic cell counters and the subsequent availability of a platelet count as part of a 'routine' blood count, thrombocytosis is more often observed as an unexpected finding. Thus, an elevated platelet count has become an important clinical problem for differential diagnosis. The term primary thrombocytosis refers to a persistent elevation of platelet count due to clonal thrombopoiesis as it occurs in chronic myeloproliferative or in some myelodysplastic disorders. Secondary or reactive thrombocytosis is due to a variety of underlying conditions. Aims & Objectives: To determine the incidence and laboratory significance of elevated platelet counts.

In this prospective study, we reviewed the Haematology analyzer records of consecutive 4500 patients in our Haematology laboratory at AIIMS Jodhpur. Patients with platelet counts of greater than or equal to 400 9 109/L were encountered during a period of one month. All platelet counts were performed on fully automated haematology analyzers Sysmex-XN100 and Mindray BC-6200 using EDTA anticoagulated fresh blood. High counts were confirmed by repeat examinations and/or peripheral smear examination.

Result: A total of 500 patients of all age groups with a platelet count [ 400 9 109/L were observed during the study period. Of all, 258 were males and 242 were females. Platelet counts ranged from 400 to 1300 9 109/L. 40.6%(n = 203) of all patients had platelet counts 400-450 9 109/L, 20.8%(n = 104) had platelet counts between 450-500 9 109/L, 37.6%(n = 188) had platelet counts of 500-1000 9 109/L and 0.01%(n = 5) cases had platelet counts [ 1000 9 109/L. Conclusions: After the introduction of Haematology cell counters, accurate platelet counts are part of the routine complete Blood count and therefore thrombocytosis is being encountered much more frequently. Elevated platelet counts, except in myeloproliferative disorders, have often been ignored as thrombocytosis has been considered inconsequential. As observed in our short study, thrombocytosis is quite common in hospital settings, but it is uncertain how frequently this is follow-up thoroughly. Looking at the consequences which clonal thrombocytosis can have on health, cases must be evaluated adequately to rule out reactive causes.

Nidhya Ganesan, T.M. Subba Rao, Eliz Thomas, Karthikeyan, Lawanya G Introduction: COVID-19 is an infectious disease caused by novel coronavirus and changes in haematological parameters are recorded. Among which platelet parameters play an indirect role in assessing the coagulation status of the patients. Aims & Objectives: The aim of this study is to (1) compare the platelet parameters and PLR among ICU and non-ICU COVID-19 patients (2) evaluate the role of platelet parameters in assessing the severity in COVID-19 patients.

This was a prospective observational study from June 2020 to December 2020 (during the first wave of pandemic). The clinical data of patients were recruited from hospital medical records to stratify the disease severity. Parameters such as Absolute lymphocyte count (ALC), Platelet count (PLT), Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), D-dimer, Prothrombin Time (PT) and activated Partial Thromboplastin Time (aPTT) were included. Values of Erythrocyte Sedimentation Rate (ESR) and Interlukein-6 (IL6) were also included wherever available. Serial platelet count values were noted for ICU patients for assessing the platelet trend. From ALC and PLT count, platelet to lymphocyte ratio (PLR) was calculated using the formula: PLR = ALC/PLT 9 100. Non-parametric independent 't' test was used to obtain the difference between the study variables. ROC analysis was done to find the optimum cut-off value of PLR between the tested groups. Result: A total of 218 RT-PCR proven COVID-19 patients were included. Of these 145 (66.5%) patients were treated in ICU and 73(33.5%) patients were treated in wards (non-ICU group). 39% patients showed thrombocytopenia at the time of admission. PLR, ALC and PDW showed statistically significant difference between ICU and non-ICU group. Patients with cytopenias referred to the department for Bone marrow examination were included in the study.Bone marrow aspiration and /or trephine Bone biopsy was performed from posterior superior iliac spine of the patients.Bone marrow aspiration smears were stained with Leishman stain for microscopic examination. Eligibility Criteria: Cases with haemoglobin less than 10gm/dl and/or total leucocyte count of less than 4000/cubic mm and/or platelet count less than 1lac/cubic mm were included in the study.Patients receiving chemotherapy/ radiotherapy/any known case of malignancy were excluded from the study.

Result: A total of 95 cases were studied during a period of 8 months.

Median age of the patients was 42 years (range from 2 months to 74 years).Forty nine patients were male and 46 were female with male:female ratio of 1.06:1. In current study, 51(53%) patients had normocellular, 22(23%) patients had hypercellular while 9(9.5%) patients had hypocellular marrow. Among 95 paients 40(42%) patients had only peripheral cytopenia with normal bone marrow findings while 55(58%) patients had abnormal bone marrow findings. Among 55patients with abnormal bone marrow findings, 39(70%)patients had benign pathology while 16(30%) patients had malignant pathology.Among 39(70%) patients 11(20%) patients had nutritional anaemia, 10(18%) had aplastic anaemia, 9(16%) had Megaloblastic anemia,6 (10%) had ITP, and 1(1.8%) patients each of essential thrombocytosis,sickle cell anaemia and Gauchers disease,and among 16patients with malignant findings 5(9%) patients had ALL,4(7.2%) had multiple myeloma 3(5.5%) had CLL 2(3.6%)had MDS, and 1(1.8%) patient each had CML and solid malignancy.

Conclusions: Bone marrow examination in patients of pancytopenia helps in the identification of the underlying cause in most cases. It is helpful for understanding the disease process and in planning further investigations and management of cytopenia patients. Introduction: Pediatric bone marrow have a different histological spectrum as compared to adults. While childhood leukemia, anemia, storage disorders dominated the lower strata of the study age group; hemolytic anemia, hypersplenism, macrophage activation syndrome, aplastic anemia dominated the higher age group. Again, bone marrow aspiration and biopsies though complementary to each other, each have its own genre of importance. Early diagnosis demands recognizing the more accurate diagnostic entity among them for early intervention.

Aims & Objectives: The aim of this study is to evaluate the diagnostic accuracy and to find out the degree of correlation (kappa value) between the two procedures.

We retrospectively reviewed a total number of 149 bone marrow aspirate (BMA) and bone marrow biopsies (BMB) in the department of pathology of our institution from July 2020 to August 2021. A total of 149 cases where both BMA and BMB were done simultaneously were included in the study. BMA were stained with Leishman Giemsa stain, the BMB were stained with haematoxylin and eosin stain. Other special stains such as PAS, Reticulin and Perl's were also done on all relevant cases.

Result: Bone marrow aspiration studies were conclusive to study the cytomorphology, infectious agent and diffuse disorders of the bone marrow, while study of focal diseases, cellularity assessment and pattern of infiltration were arrived after bone marrow biopsy. The most frequent presentation in pediatric age group was fever with repeated blood transfusion. The most affected age group was between 5 to 15 years and mostly male. The highest recorded lesion was Acute Lymphoblastic Leukemia. However, the most correlated lesion was iron deficiency anemia (100% correlation). Overall there was significant correlation proved between the two procedures (kappa value 0.6295).

Conclusions: Bone marrow aspiration and biopsies should not be performed in isolation rather they should be performed simultaneously to arrive at a diagnosis. , Non-Hodgkin lymphoma (NHL) and metastasis to marrow like malignant round cell tumour (MRCT) and neuroblastoma. Cases were divided into three categories. Category 1-Diagnosis on bone marrow aspirate (BMA) alone when bone marrow biopsy (BMB) was not available (NA) or non diagnostic (ND).Category 2-Diagnosis on BMB alone when aspirate was NA or ND.Category 3-Both aspirate and biopsy were available and showed correlation. Result: The age of patients ranged from 2 months to 18 years with male:female ratio of 1.68:1. Category 1-99 (58%) cases (AL, CML, NHL and MRCT). BMA alone was diagnostic in leukemia cases, however, we do not suggest that aspirate should replace biopsy as we could not confirm and categorise the diagnosis of lymphoma and round cell tumour based on aspirate alone because immunohistochemistry (IHC) was non-contributory.Category 2-60 (36%) cases (AL, HL, NHL, neuroblastoma and MRCT). Biopsy was more useful than BMA in diagnosing patients with HL and NHL in whom aspirates were ND. IHC was applied to aid the diagnosis. Category 3-10 (6%) cases (AL, HL, NHL, neuroblastoma and MRCT). Both BMA and BMB were found to be useful in confirming the diagnosis of MRCT, lymphoma and neuroblastoma. Conclusions: The information gathered from BME comprising of both aspirate and biopsy which are complementary to each other leads to the accurate diagnosis in most of the cases. Neither BMA nor BMB done alone is superior to their combination as both go hand in hand.

Introduction: There is a constant ongoing evolution in the clinical practices attributable to the changing lifestyle, newer diseases (#COVID is the newest Trend!) and increasing longevity. Laboratory medicine has to keep up with the changing face of medicine and has to cater to the unmet challenges of diagnosis and treatment. By now we all know that master of one can never win the race, and a coalition works in everyone's favour. This amalgamation of biochemistry, hematology and microbiology provides flexibility in service provision in the light of increasing expectations, shifts in population demographics and constraint in resource availability.

Aims & Objectives: Our aim is to overcome the challenges of this integration or consolidation, whatever it may be referred to as and the objective was one, streamlining the lab services for best patient care.

The consolidation had to be at the level of individuals-be it technicians, residents and consultants or at the level of technology, be it Sysmex, Stago or Roche or at the level of our approach be it the methods, measures and principles and last but not the least, consolidation of funds for this ever expanding technology.

The process has to start at all levels simultaneously. The decision makers have to draft a policy and then comes the implementation of plans. Finance, IT department and human resources have to be acquainted with the process and brought to one platform for all to work in unison. Not all stake holders will agree to the plan, but that is the beauty of a coalition-each new idea helps the lab move one step forward. The laboratory information system is an excellent example of this integration. Connectivity to almost every part of the hospital has already been achieved. This has led to better communication, coordination and execution. We aim to highlight a case of essential thrombocythemia which presented to us with symptoms arising from splenic infarction.

A 34-year-old lady presented to emergency with history of sudden onset of severe pricking pain in the left upper abdomen with non-projectile vomiting. Family and past history were non-significant. On examination, she had pallor and tender, moderate splenomegaly. CECT-abdomen indicated an evolving pseudopancreatic cyst with ischemic insult of spleen.

Result: On investigations, haemoglobin, total leucocyte count and platelet count were 7.6 g/dL, 27 9 10 9 /L and 970 9 10 9 /L respectively. Case was reviewed in haematology clinic. Her iron deficiency was corrected with parenteral iron therapy. Her symptoms worsened and she underwent splenectomy. On histopathological examination, large infarcted areas with only focally preserved splenic parenchyma was noted. Platelet count remained persistently high. All possible reactive causes of thrombocytosis were ruled out. Bone marrow examination revealed normocellular marrow with marked megakaryocytic prominence with hyperlobulated nuclei suggestive of essential thrombocythemia. Patient was positive for JAK2V617F mutation. Patient has been administered prophylaxis for thrombotic events and being followed-up in haematology clinic presently.

Conclusions: Although haemorrhagic and thrombotic complications are known to occur with essential thrombocythemia, splenic infarction is extremely rare. An early recognition and management of essential thrombocythemia could be of importance in averting such thrombotic manifestations.

Abhishek Introduction: Myelofibrosis (MF) is a BCR-ABL1 negative myeloproliferative neoplasm (MPN) and arises de novo (primary myelofibrosis; PMF) or as sequelae to polycythemiavera (PV) or essential thrombocythemia (ET). One of the complications of MF is extramedullaryhematopoiesis (EMH) in sites other than the bone marrow with most common sites being liver and spleen; other sites include mediastinum, pericardium, pleura, peritoneum, gastrointestinal tract, central nervous system, skin, and lymph nodes. Cardiovascular events represent the leading cause of morbidity and mortality associated MPNs, but the underlying mechanism is not well understood.

Aims & Objectives: The aim of this case presentation is to highlight incidental finding of myeloproliferative neoplasm by keeping a high index of suspicion on high blood counts.

A 60-year old female presented with history of 2 episodes of epistaxis with no known comorbidities and onemonth back with pain in left side of chest radiating to left upper arm. She was evaluated and found to have ischaemic heart disease, was started on antiplatelets, statins and parentral anticoagulants in view of unstable angina. On hemogram, hemoglobin, total leucocyte count and platelet count were 14.1gm/dl, 51,120/uL, and 9,28,000/cumm respectively. USG abdomen reveled mild hepatosplenomegaly. Haematology reference was taken in suspicion of high TLC and smear revealed neutrophilic leukocytosis. Serum LDH was elevated. Reactive causes of high counts were ruled out. Bone marrow biopsy revealed features suggestive of early-PMF. Molecular work-up revealed BCR-ABL negative and JAK2V617F positive.

Result: Patient was diagnosed as myeloproliferative neoplasm (Early-PMF) and hydroxyurea was administered. Patient is being followedup in Haematology clinic. Blasts have not increased and patient is asymptomatic.

Conclusions: In WHO-defined PMF, JAK2 V617F mutation is found in 50-60% of cases, CALR mutations in about 24% of cases and MPL mutations in 8%. About 12% of cases are triple-negative. One third of the cases are detected in pre-fibrotic stage showing myeloid and megakaryocytic proliferation. We conclude that the heart may be involved in patients with MPD which can be incidentally detected in routine blood counts evaluated for other diseases followed by molecular workup as in this scenario. However larger studies are required to document the evidence. Fig. 1 . Thirteen patients (13%) had two mutations while remaining had single mutations. Only six mutations accounted for * 75% of cases. T315I (18%) was the most common mutation, followed by Y253H (12%), F317L (12%), L298V (10%), G250E (9%), E459K (8%). Prior drug history was available in 68 of these patients, which showed the administration of Imatinib in 27(39.6%), nilotinib in 29 (42.6%), and dasatinib in 12 (18?ses).

Conclusions: T315I was the most common TKD mutation accounting for 18?ses. This is known to be associated with poor prognosis due to its resistance to most TKIs and advanced disease. Conclusions: Our cases showed a sudden development of unexpected thromboticmicroangioapthy, which did not respond to transfusion support. It is imperative for the clinicians and the pathologist to observe the patient for these rare complications which may accompany CML in blast crisis and worsen the outcome.

Nayana Talukdar, ProjnanSaikia, SiyumGanguly

Introduction: The myeloproliferative neoplasms (MPNs) are characterized by a proliferation of myeloid cells in the bone marrow. They are clonal neoplasms with typical increased marrow cellularity, maturation of cell lineages and organomegaly. The MPNs show effective hematopoiesis and varying degrees of marrow fibrosis, but generally differ by which myeloid cell lineage dominates hematopoiesis. Of the MPNs, the four common disorders are Chronic Myeloid Leukemia (CML), with its characteristic 9;22 translocation and BCR-ABL1 fusion protein, Polycythemia Vera (PV), Essential Thrombocythemia (ET), and Primary Myelofibrosis (PMF). Polycythemiavera usually occurs in elderly patients with a male predominance, that presents as an expansion of the RBC mass. It is a rare disease with an incidence of 2.3/100,000 people per year. This expansion is secondary to increased red cell production from dysregulated erythropoiesis. The WHO 2016 criteria for PV include JAK2 STAT mutations as a major criterion for diagnosis.

Aims & Objectives:

1. To evaluate the bone marrow picture in a case of polycythemia with thrombocytosis and neutrophilia. 2. Ancillary testing to confirm JAK 2 STAT mutation.

hospital was referred to our hospital. He was on Hydroxurea and symptomatic treatment. However due to absence of follow up and further treatment as a result of Covid 19 pandemic, he presented with a flare up of the disease, in the form of generalised significant lymphadenopathy (cervical, mediastinal, abdominopelvic) along with hepatosplenomegaly. Materials & Methods: Peripheral smear and bone marrow were suggestive of a myeloproliferative neoplasm. Bone marrow showed MF grade 2 fibrosis with atypical megakaryocytes/blasts. Biospy from cervical and abdominal lymph nodes were done. Result: Histology and IHC studies revealed myeloid sarcoma (AML M7 type). Conclusions: Myeloid sarcomas are an infrequent neoplasms with only around 2000 case reports in Pubmed. Myeloid sarcoma with megakaryoblastic transformation in chronic myelofibrosis is very rare, with extremely poor prognosis. The incidence of myeloid sarcoma occurring at multiple anatomical sites is less than 10%. Since only a few comprehensive studies have been published, treatment also poses many difficulties. Hence reporting of cases of myeloid sarcoma is significant. Introduction: The management of CML has undergone a paradigm shift with the advent of the tyrosine kinase inhibitor (TKI), namely imatinib. However, a significant proportion of patients showed imatinib failure. Aims & Objectives: To observe the incidence of imatinib failure and the presence of TKI-KD mutation in those with imatinib failure. Materials & Methods: A retrospective study was done on 96 newly diagnosed CML-CP patients attending hematology OPD from September 2019 to September 2020. CBC, qualitative PCR for bcr-abl from peripheral blood and bone marrow was done for all patients. The diagnosis was made based on WHO 2016 criteria. Patients were treated with imatinib and for response evaluation, quantitative PCR for bcr-abl IS value at 3, 6, and 12 months was advised and the available data were analyzed. All patients with bcr-abl IS value [ 1% at 12 months or those who lost response were advised TKI-KD mutation either by Sanger sequencing or NGS. Result: Among 96 patients, the median age of presentation was 40 years , M: F ratio was 1.92: 1. The most common presenting complaints were abdominal fullness 94.79% (91/96) followed by fatigue in 69.7% (67/96). Median WBC counts at diagnosis was 74,800/lL (range 1300-273,000), median Hb 9.7 g/dl, thrombocytopenia was seen in 5 patients. Optimal response, warning, and failure at 12 months were 44% (42/96), 14% (6/96), and 42% (48/96) respectively. TKI-KD Mutation was done for patients with imatinib failure at 12 months in 40/48 (83%) cases. No mutation was seen in 32/40 (80%) while TKI domain mutation was seen in 8/40 (20%) . Bcr-abl levels status was not available for all the patients at recommended time points however 12 months value was available for all the patients. Conclusions: The incidence of imatinib failure as assessed at 12 months is 42% in our population which is much higher compared to the available data. Given the non-availability of bcr-abl IS and TKI-KD mutation status at recommended time points patients with Imatinib failure were detected late in our population, so stringent assessment at earlier time points with early detection of TKI mutation status may help to switch TKI therapy for a better outcome. '11 to August'21. Mutation screening for JAK2V617F on peripheral blood was performed for all patients attending hematology OPD with suspected PV in whom WHO (World Health Organization) diagnostic criteria were strictly applied and the diagnosis was confirmed by bone marrow histology. Result: A total of 50 patients diagnosed as PV according to WHO criteria visiting Hematology OPD from August '11 to August'21 were analyzed retrospectively. The median age at presentation was 52 years. Male: Female ratio was 5:1. Sixty-eight percent (34/50) were JAK2V617F mutated while 32% (16/50) were unmutated. A statistical comparison between JAK2V617F mutated and unmutated did not reveal any significant association with regards to gender, incidence of thrombosis (18.75% versus 11.76%; p = 0.396), bleeding (6.25% versus 8.82%; p = 0.617), pruritus (18.75% versus 8.82%; p = 0.285), transformation to myelofibrosis (0 versus 2.94; p = 0.680), and high risk disease (56.25% versus 32.3%; p = 0.097). However there was significant statistical difference in terms of median age at presentation (61 versus 44.5 years, p = 0.002), median haemoglobin at time of presentation(20.7 versus 17.5 gm/dl; p = 0.001), median total leukocyte count at time of presentation (15,700 versus 8,100/ll; p = 0.001), median platelet count at time of presentation (3, 20 ,000 versus 1,90,000/ll; p = 0.044) and low serum erythropoietin (EPO) level (p = 0.00).

The results of the study assess JAK2V617F mutation status with the PV phenotype in terms of clinical and other laboratory features. Although there was no difference in most of the clinical features between the two groups, the age of presentation and other laboratory parameters (hemoglobin, total leukocyte count, platelet count, EPO level) showed a significant difference. A larger prospective study is needed to explore any real difference of clinical and laboratory features of JAK-2 mutated and unmutated subtypes of PV.

Introduction: JMML is a rare MDS/MPN (Myelodysplastic/Myeloproliferative neoplasm) disorder, with an annual incidence of 0.13 case per 100,000 children. It is characterized by a proliferation of myeloid and monocytic lineages both in the peripheral blood and bone marrow. The blast and promonocyte percentage should be less than 20% both in peripheral blood and bone marrow. They are seen to be associated with aberrant RAS/MAPK signaling pathway. Aims & Objectives: In the present study we attempt to study the clinicopathological profile of JMML patients that had been encountered by the present institute. Materials & Methods: This is a retrospective study that includes all the JMML cases that had been encountered from the year 2014 till present. All the relevant data that includes demographic profile, clinical presentation, radiology, laboratory parameters, cytogenetics, Indian J Hematol Blood Transfus follow ups etc. were collected from the Health management information system (HMIS) and Medical records department. The diagnostic criteria as mentioned in the recent 2016 WHO classification of Hemato-lymphoid Tumors has been strictly followed and only those cases were included which were compliant with the same. All the cases were negative for BCR-ABL fusion/Philadelphia chromosome. All the cases of other entities of MDS/MPN were excluded. Result: Total 5 cases of JMML were seen in the past 7 years by the present institute. The median age seen in the present study was 5 years (range 4-7yrs). The male is to female ratio in present study was 2:3. Fever and hepato-splenomegaly was seen universally. HbF was raised in three cases. We found monosomy 7 and translocation (2;5) in 2 cases, respectively. Three (3/5) patients received Hematopoietic stem cell transplantation (HSCT) after receiving aazacitidine based pre-transplant chemo-regimen. Conclusions: With recent advances more studies and trials are required for development of newer and safer targeted therapies as well as newer molecular alterations which can determine the course of the disease better.

Himani Rai, R.K. Nigam

Introduction: Myelofibrosis (MF) is a hematological disorder which is characterized by progressive anemia, bone marrow fibrosis, hypercellularity, excessive deposits of extracellular matrix, extramedullary hematopoiesis with splenomegaly. Myelofibrosis may be Primary (more common).Secondary myelofibrosis occurs as a result of various pathological processes that involve the bone marrow such as Neoplastic-infiltration by cancer cells, Infective causes such as tuberculosis, fungal infections, HIV. PMF is diagnosed after exluding the secondary causes. In this case report we present a case report of myelofibrosis secondary to granulomatous disease. In most cases that have been published, patients with tuberculosis existed preexisting chronic myeloproliferative disorders associated with myelofibrosis, we here present a rare case that a myelofibrosis happened due to the granulomatous disease probably tuberculosis. Aims & Objectives:

1. Case report of myelofibrosis with its bone marrow aspiration and biopsy findings. 2. To rule out various causes of secondary myelofibrosis.

A 35 year female presented with complaints of fever, Abdominal pain, epistaxis, hemetemesis, weakeness. USG abdomen was suggestive of mild splenomegaly and moderate ascitis. LFT, RFT, Urinanalysis, Coagulation profile, CBC & PS examination was done. Patients was taken for BM aspiration and biopsy. BMA smears were staine usingleishman stain and Bone marrow biopsy was processed and stained using h& E stain. Result: Peripheral smear was suggestive of pancytopenia. Bone marrow aspirate was dry tap. Bone marrow biopsy shows hypercellular marrow showing normal myeloid and erythroid cells along with increased megakaryocytes and few of them were dysmorphic. Focal aggregates of lymphocytes with scattered epithelioid cells forming an ill formed granuloma also seen. The dry tap in marrow and increased megakaryocytes along with fibrosis revealesmyelofibrosis secondary to a granulomatous disease. Conclusions: Infections like tuberculosis can induce meolyfibrosis as a complication. In case of myelofibrosis various causes of secondary myelofibrosis should always be ruled out before making diagnosis of primary myelofibrosis. A 48 year male presented with generalised body weakness and easy fatigability, hematemesis and Malena and heaviness in left upper quadrant of abdomen. There was no history of fever, cough, yellowish discolouration of eyes or urine, jointpain, rashes, night sweats or weight loss and alcohol intake. On physical examination, patient had pallor and massive splenomegaly.

On investigation, Complete blood count revealed anemia with leucocytosis and thrombocytosis. Colour Doppler Ultrasonography of abdomen showed liver with normal echotexture and regular surface, massive splenomegaly (17 cm) and extrahepatic portal vein wall thickened (8.8 mm) with narrowed lumen (5.9 mm). Upper gastrointestinal endoscopy showed 5 column grade 3 esophagealvaries.Bone marrow aspiration showed cellular marrow with microcytic and hypochromic anemia with leucocytosis and thrombocytosis. Patient was further investigated for JAK 2 V617 F mutation which was detected on qualitative PCR and JAK2 Exon 12 mutation was not detected. On the basis of history, examination and investigation diagnosis of Polycythemia Vera was made. Result: Polycythemia Vera is a chronic myeloproliferative neoplasms which can cause portal vein thrombosis leading to portal hypertension and patients can present with upper gastrointestinal bleed. All suspected cases are confirmed by demonstrating mutations in JAK2 inhibitor, LNK or rarely calreticulin (CALR), an ER chaperone. Conclusions: This case emphasises the importance of considering Myeloproliferative neoplasms like Polycythemia Vera in patients presenting with symptoms of upper gastrointestinal bleed due to portal hypertension as a consequence of portal vein thrombosis. A high degree of clinical suspicion is required for early diagnosis so that appropriate treatment could be offered to the patients.

Persistent Eosinophilia: A Complex Rare Diagnosis!! Sushilsongara, R. K. Nigam Introduction: Chronic Eosinophilic Leukemia is rare myeloproliferative neoplasm associated with an autonomous, clonal proliferation of eosinophilic series resulting in persistent eosinophilia. Aims & Objectives: To differentiate chronic eosinophilic leukemia with hypereosinophilic syndrome and to present a case of persistent eosinophilia diagnosed in central India.

A 40-year-old female came to department of pathology, Gandhi medical college, Bhopal with complaints of recurrent cough, shortness of breath. Primarily, Pulmonary TB was suspected which was later turns out to be negative. Result: CBC reveals 84% eosinophils which was persistently increased for 4-5 months. Bone marrow aspiration was advised for the same patient and it showed [ 5% blasts in bone marrow smear along with increased eosinophilic precursor.

Conclusions: Hyper-eosinophilic syndrome and chronic eosinophilic syndrome have many overlapping features. It is important to differentiate between these two for further evaluation and better management of patient. Conclusions: Initial presenting feature of Chronic Myeloid Leukemia is variable but in certain instances patients may present with symptoms of leukostasis as a result of hyperleukocytosis, which includes headache, visual disturbance, priapism and in unfortunate circumstances may present as myocardial ischemia and cerebrovascular accident, therefore similar symptoms in CML patients should be considered as a red flag sign and must be treated promptly with modalities such as cytoreductive therapy, leukapheresis, early initiation of Thyrosine Kinase inhibitor (TKI) therapy and supportive management.

Ingitha P, E Jayashankar, Ujjawal Khurana, Ashwani Tandon, Narendra Chaudhary Introduction: Juvenile myelomonocytic leukemia (JMML) is a rare chronic leukemia of pediatric population and rarely Chronic myeloid leukemia (CML) may be seen in this population. JMML is classified under Myelodysplastic/Myeloproliferative neoplasm and chronic myeloid Leukemia as Myeloproliferative neoplasm in the WHO classification. These two chronic leukemias are distinct with aspect to their genetics, therapeutics and prognostics.

Aims & Objectives: To study the clinical presentations, peripheral blood findings, bone marrow findings, genetics, therapeutics and follow up in chronic leukemias with the help of two pediatric chronic leukemia cases.

The clinical details of the patients were collected from the pediatric department. Various tests like CBC, Peripheral smear, Bone marrow aspirate and trephine biopsy, cytogenetics and molecular diagnosis were performed. Result: Case1: Juvenile Myelomonocyticleukemia was diagnosed in a 2 months old child presented with complaints of abdominal distension for 15 days. Clinically revealed splenomegaly, peripheral blood showed marked leucocytosis with presence of blasts and absolute monocytosis, and severe thrombocytopenia. Negative for Philadelphia chromosome by PCR and cytogenetics. Case 2: Pediatric CML was diagnosed in a 9 yr old male child with marked hepatosplenomegaly, marked neutrophilic leucocytosis with shift to left and presence of basophils. Philadelphia chromosome was positive on both PCR and Cytogenetics. Treated as per protocol.

Both cases were treated appropriately and were responding well to the given treatment. Conclusions: Diagnosing chronic leukemias like pediatric CML and Juvenile Myelomonocyticleukemia in children accurately is challenging as they may show some overlapping features like similar clinical picture and peripheral blood leukocytosis. However, Absolute monocyte count, HbF, Ph chromosome studies and other genetic studies like monosomy 7, NF1 mutation, STAT 5 pathway may be helpful in definite categorization which is essential for treatment as the treatment protocols are different for the two entities.

Karthik Rengaraj, Sharon Anbumalar Lionel, Uday Prakash Kulkarni, Anup J Devasia, Fouzia N Aboobacker, Anu Korula, Alok Srivastava, Vikram Mathews, Biju George, Aby Abraham, Sushil Selvarajan Introduction: Several prognostic indices are in use to stratify chronic myeloid leukaemia (CML) patients: Sokal, the European Treatment and Outcome Study (EUTOS) and EUTOS long term survival score (ELTS) being the most reported ones. The application of different scores may cause variability in the determination of disease prognosis. This study was conducted to enumerate the distribution in patients with CML in accordance with Sokal, EUTOS and ELTS scoring systems attending a tertiary care centre in India. Aims & Objectives: To risk stratify patients as per their baseline characteristics and to enumerate the patients under each category. Materials & Methods: This is a retrospective study conducted at the Department of Haematology, CMC Vellore. All patients diagnosed with CML in chronic phase from January 2015 to December 2020 were included in the analysis. Variables of interest were computed using Microsoft Excel. These variables include age, spleen size, platelet count, the percentage of myeloblasts in the peripheral blood, as well as the percentage of basophils in the peripheral blood. Using these baseline variables, the prognostic category of each patient was calculated using Sokal, EUTOS and ELTS scores. Result: A total of 520 patients were diagnosed with CML in chronic phase during the study period. The median age was 36 years (Range: . Out of these, 376 (72%) were males. There were 161 (31%), 323 (62%) and 217 (42%) patients in low-risk category as per Sokal score, EUTOS score and ELTS respectively. In the high-risk group, there were 198 (38%), 197 (37.8%) and 133 (26%) patients respectively. Conclusions: There is considerable inter-variability between the various prognostic indicators. The Sokal and EUTOS score classified many patients as higher risk as compared to ELTS.

Introduction: Polycythemiavera (PV) is the most common myeloproliferative neoplasm (MPN) and the ultimate phenotype of the JAK2V617F and JAK2exon12 mutation. PV has highest incidence of thromboembolic complications among MPNs. WHO has revised criteria for diagnosing PV in 2016 wherein cut-off for haemoglobin has been lowered to 16.5 g/dL and 16 g/dL for males and females respectively. Aims & Objectives: To re-evaluate the revised WHO diagnostic criteria for PV and to do clinicopathological correlation of PV cases in our setup. Materials & Methods: This prospective observational study is being conducted in haematology clinic at AIIMS, Jodhpur. Patients having persistently high haemoglobin above new cut-off are screened for reactive causes of erythrocytosis with detailed clinical history, SpO2 levels and chest X-rays. After ruling out reactive causes, patients are evaluated for serum erythropoietin (EPO) levels, JAK-2V617F, JAK2exon12 mutation and bone marrow examination wherever required. We tried to re-evaluate revised cut-off by dividing cases in to two groups (Group: With Hbcutoff as per WHO2008; Group2: With Hb values between old and revised cut-off).

Result: A total of 40 cases were included in study. Of all, 35 were males, 05 were females. Majority of the cases were among age group 18-29 years. 04/35males were in Group1 while 31/35males in Group2. 03/05females were in Group1and 02/05females in Group2. On follow-up, 13 cases had normal Hb value. Rest 27 cases were further evaluated. Of these 27 cases, EPO was subnormal, normal and high in four, 21 and two cases. Two cases with subnormal EPO were found to have JAK2V617F mutation confirming them as PV cases. Bonemarrow biopsy was done in JAK 2 negative cases (02/04) among which one case showed hypercellular marrow with panmyelosiscompatible with PV. Total 03/40cases were diagnosed as PV, 31/40 had reactive erythrocytosis, 04/40 died during the course of study and 02/40 were lost to follow up. Conclusions: Findings of the present study favors newer lowered cutoffs as per revised WHO criteria for PV. Working-up with lowered values may increase utilization of resources but working-up cases of high haemoglobin with WHO 2008 criteria would have lead to high false negative cases and would have missed true PV cases.

Neha Aggarwal, Shashikant Singh, Abha Singh, Monika Sharma, Taruna Bansal, Vijay Kumar Introduction: CMML is a hematopoietic stem cell disorder with features of both myelodysplastic syndrome and myeloproliferative neoplasm. The incidence rate is 0.4 per 100,000 population. CMML is divided into 3 categories (Cmml 0, Cmml 1 and Cmml 2) based on the percentage of blasts and promonocytes in the peripheral blood and bone marrow. Cmml 0 Cmml 1 patients have longer survival time than Cmml 2 patients. Morphology of normal and abnormal monocytes is often inconsistent and is prone to escape recognition. Knowledge of this variable morphology is crucial to diagnosis. Aims & Objectives: To study the variable and deceptive morphology of monocyte lineage cells to reach a correct diagnosis.

A 52 year old patient presented to medicine OPD with complaints of generalized weakness, loose stools and vomiting since 2 months. On examination, patient had hepatomegaly. CBC testing, Bone marrow examination, cytochemistry and flow cytometry was performed. Result: CBC showed monocytosis with raised monocytes constituting 62% of all nucleated cells(Blasts-03%, promonocytes-01%, abnormal ? mature monocytes-58%).On cytochemistry these cells were positive for non specific esterase(NSE). Bone marrow examination showed a prominence of monocytoidcells (monoblasts-05%, promonocytes-07%, abnormal ? mature monocytes-36%) with mildly raised plasma cells (6%). Cells of all the three lineages showed features of marked dysplasia. Flow cytometry showed an abnormal cluster in the monocytoid region comprising 69% of all events on CD 45/SSC analysis. These cells were immunopositive forCD13, CD33, CD14, CD64 and HLA-DR. These cells were immunonegative for cCD3, CD5, CD7, CD19, CD10, CD22, cMPO, CD34, CD117 and TdT. Conclusions: The variable morphology of monocytes series cells can pose a diagnostic challenge and prove to be a pitfall leading to a missed diagnosis. Association of CMML-2 with reactive plasmacytosis is not known and has not been reported in the literature till date. Hence, cases with raised monocyte count need to be studied closely with focus on morphology and all differentials should be kept in mind. Correct morphology in conjunction with flowcytometry, cytochemistry and cytogenetics helps to accurately diagnose the case which in turn will help for better management of the patient. (Table 1 ) For patient 1, common causes of secondary myelofibrosis such autoimmune myelofibrosis, vitamin D deficiency and hyperparathyroidism were ruled out. He was initially suspected to have triple negative primary myelofibrosis (PMF) and treated with Ruxolitinib for 6 months. However, due to lack of response, presence of grade 4 clubbing and progericfacies, a possibility of PHO was considered, which we then confirmed by the presence of SLCO2A1 mutation on genetic studies. This helped in revising our initial diagnosis, starting appropriate management, and making accurate and timely diagnoses of the next three patients. Patients 2, 3 and 4 presented with IDA and myelofibrosis. No specific management exists for myelofibrosis associated with PHO. Existing literature mentions the use of blood transfusions, steroids and NSAIDs. Most patients treated with steroids achieved some form of response with some achieving prolonged remission. A better understanding of the pathogenesis has led to addition of Etoricoxib, a COX2 inhibitor which has been reported to be of benefit for both myelofibrosis, and the musculoskeletal symptoms of PHO. All our patients had a remarkable improvement with prednisolone 0.5 mg/kg OD and Etoricoxib 60 mg OD. Conclusions: In conclusion, myelofibrosis associated with PHO is a distinct entity that responds to therapy with steroids and etoricoxib and must be strongly considered in patients with PHO presenting with unexplained anemia.

Anindita Paul, Priyanka Samal, Sarita Pradhan, Pritish Chandra Patra, Rajesh Kumar Bhola, Raka Hota Introduction: Myelofibrosis (MF) is a myeloproliferative neoplasm that is characterised by reactive bone marrow fibrosis, extramedullary haematopoiesis, anaemia, hepatosplenomegaly, constitutional symptoms, leukaemic progression, and shortened survival. Aims & Objectives: To evaluate baseline clinical characteristics and treatment outcome in patients diagnosed with Primary Myelofibrosis. Materials & Methods: Patients: Total 13 cases of Primary Myelofibrosis between June 2018 to 2020 evaluated for clinical presentation, bone marrow biopsy, molecular studies. Response to treatment assessed with hematological parameters and reduction in spleen size at 1, 2, 3, 6, 12 months.Following parameters analysed:-Age \ 65y, [ 65 y, Hemoglobin, Platelet count, LDH, DIPSS score and Splenomegaly. Result: Out of 13 patients, 12 were males and 1 female (12:1), median age of presentation 55y (range 40-71 years). Fever, fatigue, anemia found in 100% patients. Moderate splenomegaly (\ 7 cm) in 8%, massive splenomegaly ([ 7 cm) in 92% (12/13). Bone marrow aspiration showed dry tap, biopsy showed grade 2/3 fibosis in 85%, grade 3/3 in 1 patient as per WHO. MPN reflex panel showed 31% (4/ 13) JAK 2V617F Exon 14, CAL-R exon 9 in 31% (4/13), MPL in 15% (2/13), triple negative in 15% (2/13). DIPSS Score more than 3 found in 92% (12/13), 1 had a score of 1. Hb increment more than 2gm/dl seen at the end of 3 months in 7%, 6 months in 7%, 12 months in 23%. Introduction: Adverse effect of Imatinib on endocrine organs notably thyroid gland is an emerging and important toxicity to recognize since Imatinib has to be continued on a long term basis in CML. Imatinib related common side effects may simulate clinical thyroid dysfunction which may create dilemma for clinicians and affect the quality of life. There is a scarcity of literature highlighting the impact of Imatinib on thyroid function and their clinical implications.

Aims & Objectives: The study aims to (1) To evaluate the effects of ImatinibMesylate used in CML-Chronic phase on thyroid function test (TFT) after 12 and 24 weeks of therapy. (2) To asses change in dose /frequency of Imatinib due to thyroid dysfunction. Materials & Methods: Our study enrolled 27 newly diagnosed CML subjects in chronic phase (both adult and pediatric) with or without preexisting thyroid dysfunction. Apart from hematological investigations at baseline, TFT (FT3, FT4, TSH) were done in all subjects and Anti-TPO antibodies level were done for those with subclinical hypothyroidism. Subjects were reassessed for TFT after 3 and 6 months of Imatinib therapy. Result: Most of the euthyroid subjects (n = 21/27) at baseline continued to remaneuthyroid with the exception of a single patient who developed subclinical hypothyroidism after 6 months. Majority of the subjects incidentally detected having subclinical hypothyroidism (n = 4) reverted back to euthyroid state after 3 months with the exception of 1 subject who developed frank hypothyroidism with elevated Anti-TPO levels. Among the previously hypothyroid subjects (n = 2), 1 subject required increasing doses of levothyroxine due to worsening symptomps of hypothyroidism. Overall changes in FT3, FT4 at 3 and 6 months were not statistically significant while there was a significant increase in TSH level after 3 and 6 months of therapy.

1. Transient subclinical hypothyroidism, may be an incidental finding in CML patients at diagnosis, which may resolve spontaneously without levothyroxine. 2. Although there is significant changes in TSH values post Imatinib, in euthyroid patients, it largely remains in euthyroid range. 3. Previously hypothyroid patients on levothyroxine supplementation may require increased dose of levothyroxine. 4. Changes in thyroid function during Imatinib therapy does not require any dose modification of Imatinib therapy.

Kumar Raktyutpal, Aparna Dutta, SamratBordoloi, Sanghamitra Mukherjee

Introduction: Chronic myeloid leukemia is a myeloproliferative neoplasm in which granulocytes are the major proliferative component. It arises in a haematopoietic stem cell and is characterized by the chromosomal translocation t(9;22), which results in the formation of the Philadelphia (Ph) chromosome, containing the BCR-ABL 1 fusion gene largely seen in adults. Pediatric CML is relatively rare and accounts for only 2-3% of cases of newly diagnosed pediatricleukemias. Breakpoints in BCR-ABL rearrangements result in b2a2 transcripts more commonly followed by b3a2 transcripts which has been shown to have a prognosis.

Aims & Objectives: AIM: To describe cases of Chronic myeloid leukemia in pediatric age group. OBJECTIVE: (I) Morphological evaluation of peripheral blood. (II) Cytogenetic and molecular study for BCR-ABL translocation. Materials & Methods: Three patients a 7 yr old male and two females of 5 and 9yrs of age presented with complaints of fever, cough, generalised weakness. Complete blood count samples in EDTA vials were processed on automated hematology analyser followed by study of peripheral blood smear and the results were recorded. Cytogenetic study was done to determine BCR-ABL rearrangement. Result: Peripheral blood smear revealed myeloid predominant leucocytosis along with presence of basophilia along with presence of 4%, 5% and 2% circulating blasts in the three cases respectively. Cytogenetic study of all three cases confirms the presence of BCR-ABL fusion with b2a2 transcript.

Conclusions: Although CML is common in adults, it can occur in the pediatric age group. Careful evaluation of peripheral blood smear along with cytogenetic studies for BCR-ABL fusion helps us to arrive at a diagnosis. At present there is a dearth of data of pediatric CML and lack of clear guidelines. Further studies are needed to assess the various pediatric fusion transcripts for setting up new treatment modalities as an alternative to TKIs which makes the pediatric patients prone to long term side-effects.

Morphological Changes in Bone Marrow Induced by Imatinib Therapy in Patients with Chronic Myeloid Leukemia Nency Narola, Shyama Chag, Sanjay Chaudhari Introduction: Chronic myeloid leukemia is a myeloproliferative malignant hemopoietic stem cell disorder which is characterized by presence of Philadelphia chromosome, which contains BCR-ABL fusion gene encoding constitutively active tyrosine kinase. Imatinibmesylate is a tyrosine kinase inhibitor which is extensively used as a first line treatment in Chronic Myeloid Leukemia-Chronic Phase, as it induces hematological remission in almost all the patients. However, not many researches have documented morphological changes in all three lineage in bone marrow aspiration and biopsy during Imatinibmesylate therapy. Aims & Objectives: To evaluate the morphological changes produced in bone marrow during Imatinibmesylate therapy. Materials & Methods: It is a retrospective study including 26 Philadelphia-chromosome positive Chronic Myeloid Leukemia-Chronic Phase cases, receiving Imatinibmesylate therapy. Data were collected from Laboratory Information System, patient records and analyzed from January 2019 to September 2021, in Tertiary Oncology Center. Result: Out of total 26 cases studied, complete hematologic response is seen in 2 cases (7.6%), Erythroid hyperplasia in 1 case (3.8%), Megaloblastic maturation in 5 cases (19.23%), Myelocyte bulge in 22 cases (84.61%) and eosinophilic precursors in 16 case (61.53%). Out of 26 patients, megakaryocytes are normal in number in 9 cases (34.61%), increased in 2 cases (7.6%) and decreased in 13 cases (57.69%). Megakaryocytic series shows normal morphology in 17 cases (65.38%), hypolobated forms in 6 cases (23.07%), hyperlobated forms in 1 case (3.84%), micromegakaryocytes in 1 case (3.84%) and remaining 1 case (3.84%) shows pawn ball megakaryocytes. Conclusions: Trephine biopsies are superior to aspiration reports to ovoid problems associated with hemodilution and dry tap. However, cellular morphology is better appreciated in bone marrow aspiration. In our study, most common morphological pattern in myeloid series is myelocyte bulge, in erythroid series is megaloblastic maturation and megakaryocytic series is normal morphology. Imatinibmesylate therapy reduces marrow cellularity and induces hematologic remission. However, more studies.

Reema Miria Abraham, Jasmita Dass, Ganesh Kumar V, Manoranjan Mahapatra, Seema Tyagi Introduction: Chronic myelomonocyticleukemia (CMML) is a clonal stem cell disorder defined as a MDS/MPN. Diagnosis requires persistent monocytosis ([ 1000/lL) and myelodysplasia or, if dysplasia is not evident, cytogenetic abnormalities or exclusion of other causes of persistent monocytosis (C 3 months). However, disease specific cytogeneticsis found in only 20-40% of cases and persistent monocytosis of CMML has to be distinguished from reactive monocytosis and other hematologic neoplasms with monocytosis. This complex biological and clinical heterogeneity with poor prognosis stimulated an attempt to study the monocyte subsets by flow cytometry and it was seen that CMML shows a characteristic dominance of CD14 ? CD16-classical monocytes (cut off value 94%). Aims & Objectives: To study the Monocyte subsets based on CD14 and CD16 expression in peripheral blood by multiparametric flow cytometry (MFC), in cases of monocytosis including reactive monocytosis/ non-CMML and CMML. Materials & Methods: Using MFC we evaluated peripheral blood of patients (n = 30) with CMML (n = 8), non-CMML and reactive monocytosis (n = 22) with 1-tube 8-colour antibody panel: CD14-APC H7, CD16-PE, CD2-V450, CD56-FITC,CD45-V500,CD19-PECy7 & CD33-APC on BD FACS CANTO-II. Analysis was done on FACS DIVA software (BD Biosciences, San Jose, California). Monocytes were gated using CD45-SSC gating followed by CD33-SSC gating and exclusion of B-cells, Nk-cells and T-cells. Monocytes were separated on a CD14/CD16 scattergram into CD14??/ CD16-(cMo, classical), CD14??/CD16? (iMo, intermediate), and CD14 -/CD16 ? (ncMo, nonclassical) subsets. This was correlated with the available peripheral smear/bone marrow aspirate/biopsy, cytogenetics and molecular studies. Result: A comparison of the CMML and other reactive monocytosis is presented in Fig. 1 . Among the 8 CMML patients, 7 showed a cMo of [ 94% and ncMo of \1[ 93.1% with a sensitivity of 87.5% and specificity of 100%. Area under the curve (AUC) was 0.947 (SD = 0.052, 95%CI = 0.000-1.000, p value = 0.000). AUC was low using ncMo \1[. Conclsions: The simplicity and robustness of the peripheral blood monocyte assaywith a limited panel of antibodies demonstrates its potential to reliably differentiate CMML from reactive monocytosis. National multicenter prospective study for harmonization of protocols is required.

Shilpi More, Varsha Chauhan, Sujata Raychaudhari, Sanjay Rai, Rahul Bhargawa, Tathagata Chatterjee Introduction: Myelodysplastic syndrome (MDS) with fibrosis (MDS-F) is seen in 10-15?ses of MDS and is associated with a more aggressive clinical course. The closest differential of MDS-F is Primary Myelofibrosis (PMF) and morphology plays an important role in differentiating between the two. We hereby describe a case of 44-years-old-male who came with a provisional diagnosis of MDS-F with excess blasts and? Myeloproliferative neoplasm (MPN).

To determine the role of morphology in the world of molecular pathology.

A 44-years-old-male patient on treatment for MDS for 8-9 months presented with complaints of fever and headache. On examination, splenomegaly was noted. Peripheral smear revealed anemia with 2-3 nucleated RBCs, pseudo pelgerheut neutrophils and 3% blasts. Patient's Bone marrow aspirate (BMA) report revealed Chronic MPN with early myelofibrosis. The bone marrow biopsy revealed MDS/MPN with excess blasts. Cytogenetic studies were normal. Molecular profile revealed ASXL1 and RUNX1 mutation. JAK2, CALR, MPL mutations were negative. With these investigations we received the patient and his BMA and BMB were reviewed. BMB revealed marked megakaryopoiesis with atypia and granulopoiesis along with intrasinusoidalhematopoiesis. Final impression was MPN, favoring PMF-cellular phase. Result: MDS-F and PMF are two distinct entities with completely different therapeutic regimens. Features favouring PMF include presence of splenomegaly, leukoerythroblastic blood picture and intrasinusoidal haematopoiesis while MDS-F is characterized by MDS like megakaryocyte morphology (micromegakaryocytes) and increased blasts. Our patient had markedly abnormal megakaryocytes with intrasinusoidal haematopoiesis suggestive of MPN. The three most common driver mutations of MPN, that is JAK2, CALR, MPL were negative, however ASXL1 and RUNX1 mutations (more common in MDS) were seen. ASXL1 mutation can be a driver mutation in PMF patients and is associated with poor overall survival. Morphology led us to a definitive diagnosis in this patient, complemented by the clinical findings and special stains. Conclusions: Morphology still plays a critical role in ever changing era of modern pathology. The case is a magnificent example of morphology not being extinct in the world of molecular profiling.

Juvenile Myelomonocytic Leukemia with Langerhans Cell Histiocytosis Like Proliferation Aswathy Gopalakrishnan, Kiruthiga KG, Ketki Kelkar, Ravibhushan Godbole, Priyanka Nayar, Aparna Joshi Introduction: Juvenile myelomonocyticleukemia (JMML), a rare malignancy classified under Myelodysplastic/Myeloproliferative neoplasms, affects children. Langerhans cell histiocytosis (LCH), a disorder of the Langerhans dendritic cells, usually presents with skin and lytic bone lesions. LCH like proliferation in JMML is known to occur since both the entities are proliferations of histiocytic/ monocytic cells.

To learn more about the Langerhans histiocytosis-like cells in JMML so that a misdiagnosis can be avoided.

A two year old boy presented with fever and abdominal distension. Examination revealed axillary lymphadenopathy and hepatosplenomegaly. CBC-Hemoglobin: 10.0 g/dl, Total leucocyte count (TLC): 53,150/ll, platelet count: 41,000/ll and an absolute monocyte count: 3720/ll. Bone marrow: Marked myeloid hyperplasia. Hemoglobin electrophoresis: HbF-34.6%. In view of peripheral blood monocytosis, myeloid hyperplasia, splenomegaly and high HbF, possibility of JMML was considered and molecular work-up was sent. Meanwhile, axillary lymph node biopsy revealed sheets of macrophages in sinuses and paracortical areas (S100, CD68 and CD 1a positive), with sheets of eosinophils.

Patient was started on LCH high risk protocol, with only a transient response after 3 weeks, followed by rising TLC and decreasing platelet counts.

Molecular analysis revealed a somatic heterozygous, missense mutation in PTPN11 exon 3, which is a known pathogenic hotspot mutation in JMML. Germline mutations were not detected. Result: JMML diagnosis was made on the basis of molecular work up. Conclusions: JMML and LCH share common clinical features like fever, hepatosplenomegaly, cutaneous lesions, pulmonary infiltration, anemia and thrombocytopenia. However, they are pathologically different diseases and their prognosis and treatment vary. The treatment for LCH is chemotherapy while that of JMML, a rapidly progressive fatal disease, is hematopoietic stem cell transplantation. It is important for pathologists to be aware of the proliferation of Langerhans cells in cases of JMML, so that a misdiagnosis of LCH can be avoided. Introduction: Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusiondependent thalassemia major. As a pre-transplant workup for HSCT patients, liver biopsy is routinely done to assess the degree of liver fibrosis, which is one of the predictive variables of the outcome as per the Lucarelli classification. Liver biopsy is an invasive procedure and is associated with complications: pain (84%), bleeding (0.5%). These limitations have given urgency for development of noninvasive tests (NITs). Aims & Objectives: To evaluate transient elastography, hepatic iron concentration by MRI T2* liver, serum liver fibrosis indexes versus liver biopsy in Thalassemia major patients who are candidates for HSCT.

This was a prospective cross-sectional comparative study. 6 thalassemia major patients who were candidates for HSCT were recruited. The recruited Thalassemia major patients underwent a T2* liver biopsy (standard of care), transient elastography, MRI T2* Liver and serum liver fibrosis indexes . Result: Out of 6 Thalassemia Major patients, 4 were males, the mean age was 4.3 years. (Table 1-Comparative table) . Thalassemia Major patients with grade 3/F2 liver fibrosis or higher grade as per Metavir and Ishak classifications respectively had mild to moderate hepatic iron overload on T2* MRI. However, patients with mild hepatic iron overload by T2* MRI had mild to no fibrosis. It was feasible to conduct T2* MRI (fast MR) and transient elastography studies in this young age group (3-6 years) of Thalassemia Major patients. The cost of combining the NITs (MRI T2*, Transient Elastography, and serum fibrosis index) is not higher as compared to the cost of liver biopsy. Complication rates were nil with NITs. The utility of transient elastography seems to be limited in patients with mild to moderate liver fibrosis in this age group (3-6 years) . Liver fibrosis indexes can serve to rule out severe fibrosis. Conclusions: With more and more older children with Thalassemia Major being transplanted, the utility of combining T2* MRI, Transient elastography, and liver fibrosis indexes can be better studied, and the need for liver biopsy can be reduced. Introduction: Bone marrow transplantation is the collection and transplantation of hematopoietic stem cells. Bone marrow transplantation (BMT) is used to treat patients with an abnormal but nonmalignantlymphohematopoietic system by replacing it with one from a normal donor. BMT is also used to treat malignancy by allowing the administration of higher doses of myelosuppressive therapy than would otherwise be possible and in the setting of allogeneic BMT, by conferring an immunologic graft-versus-tumor effect. BMT is of two types:-Allogeneic and Autologous. Allogeneic transplantation involves a donor and recipient who are not genetically identical. Autologous transplantation involves the removal and the storage of the patients own stem cells with subsequent reinfusion after the patient receives high-dose myeloablative therapy. The use of BMT has been increasing, both because of its efficacy in selected diseases and because of increasing availability of donors. So, the need of the hour is to increase the number of specialized bone-marrow transplant centers. We, here share our experience with BMT from our centre which was started at this tertiary care hospital in 2017. Conclusions: At our centre both allogeneic and autologous transplants were performed. The most common reason of transplant at our centre was multiple Myeloma, Aplastic anemia being the 2nd most common. With the increasing efficacy of diagnosis and treatment, we intend to continue giving our best in future and hope for more centres in India and in Bihar.

John Roy, Sharon Lionel, Sushil Selvarajan, Anup J Devasia, Anu Korula, Kavitha M Lakshmi, Fouzia N Aboobacker, Uday Kulkarni, Alok Srivastava, Aby Abraham, Vikram Mathews, Asha Mary Abraham, Biju George Introduction: Cytomegalovirus (CMV) viremia and invasive disease are uncommon complications following autologous stem cell transplant. Bortezomib use as a putative risk factor is described; hence we sought to explore CMV infection in patients with multiple myeloma post autologous transplant. Aims & Objectives: To describe the prevalence, risk factors, organ involvement, treatment and outcomes of CMV viremia and infection post autologous stem cell transplant for multiple myeloma (ASCT). Materials & Methods: Retrospective case and control study between 2000 and 2020. Patients with multiple myeloma undergoing autologous stem cell transplant with blood or tissue CMV positivity were taken as cases, and controls were matched for age and sex in a 1:3 ratio.

Result: There were 456 autologous transplants performed for multiple myeloma between 2000 and 2020, amongst which fourteen patients (3%) had fifteen CMV infective episodes. The median age at diagnosis was 51 years (range 34-60), and there were nine (64%) males. Cyclophosphamide, Bortezomib and Dexamethasone was used in 8(57%), and bortezomib containing regimens were used in all patients except two. Six of the patients treated with bortezomib received acyclovir prophylaxis. Persistent fever lead to a diagnosis of CMV viremia (CMV copy number between 551 and 1,223,192. Log 2 to log 6) in seven of the fifteen infections, at a median of 34 days (17-57 days). In eight cases, CMV involving the gastrointestinal tract was diagnosed based on typical histopathology (8, 100%) , presence of inclusion body (6, 75%) , tissue CMV IHC positivity (5, 62 .5%) and positive tissue PCR (6, 75%) . Concomitant elevated blood CMV copy numbers were seen in four cases. We treated all patients with intravenous Ganciclovir except one patient with CMV colitis. All patients responded to therapy, and no patients succumbed to the infection.

There were no significant demographic differences between cases and controls. There were significantly fewer bortezomib-based induction regimens in controls than in the cases (p = 0.007). Length of stay in hospital, ICU and inotropic requirements were significantly higher in the cases (P [).

Conclusions: CMV viremia and infection are uncommon (3%) complications of autologous transplant in multiple myeloma and present as fever or GI tract involvement. Treatment with Ganciclovir is effective. Larger numbers are required to ascertain risk factors. infection. Out of the 12 patients, 6 (50%) had mild, 3 (25%) had moderate and 3 (25%) had severe disease. 10 patients were on immunosuppression at the time of COVID 19 with steroids being the most common (n = 7) followed by MMF (n = 5) and cyclosporine (n = 3). 3 (25%) patients required ventilatory support out of which only one survived. The overall 30-day mortality rate was 25% (n = 3). One patient expired later due to unrelated cause (PTLD). 6 (50%) patients had developed secondary infection after COVID 19. The median D dimer and CRP values were 209 ng/ml and 30.9 mg/L respectively. The median ferritin values for mild and severe disease were 1457 ng/ml and 3260 ng/ml respectively. Conclusions: COVID 19 infection in post-transplant setting is a highly fatal disease with overall mortality of 25% comparable to available western studies. There is also increased incidence of secondary infections with 50% of them developing various infections post COVID 19. The foremost factor is Human Leucocyte antigen system (HLA).However, H LA is inherited independently of ABO system. Around 50% of transplants are ABO mismatched leading to hemolytic complications as well as Pure red cell Aplasia (PRCA). Aims & Objectives: We have studied the incidence of ABO mismatched transplant in our Centre. Our aim is to study the impact of type of ABO mismatch transplant and therapeutic intervention done to reduce the morbidities and outcome related to such transplants. Materials & Methods: This is a retrospective chart review of allogenic transplant at our center from June 2016 to Jan 2021. Result: From 2016 to 2020 total of 30 allogeneic transplant done at our center out which 17(43.3%) were ABO match and 13(56.7%) were ABO mismatch. Out of 13 patients 7(53%) patients were minor ABO mismatch, 6 (47%) patients were major ABO mismatch. Successful engraftment happened in 9 patients and pure red cell aplasia (PRCA) was noticed in 5 patients (4 in major and 1 in minor mismatch group). The interventions done in our patients were tapering of immunosuppression, Erythropoetin support, 2 patients received Rituximab, 4 patients received Bortezomib and Danazol. All responded to this approach. Conclusions: Our experience demonstrates a high incidence of PRCA in ABO mismatched transplant requiring multiple lines of therapy and transfusion support which causes significant morbidity and financial burden. Parvo virus infection was negative in our study. The intervention done in our patients were, modification of IST, Bortezomib, Rituximab, Erythropoetin. The median time for response 10 month (range 2-17 months). To study the spectrum of regimen-related dermatological toxicities with Treosulfan/Thiotepa-based conditioning in the peri-engraftment period in patients undergoing hematopoietic stem cell transplant. Materials & Methods: All patients undergoing HSCT from January 2019 to September 2021 were reviewed. The nature of the dermatological manifestations during peri-engraftment period were noted. All patients receiving this regimen were subjected to rigorous sponging (6 hourly for upto 48 h after the end of conditioning) of the body with emphasis to the cleft and crevices, with daily changes of occlusive dressing and linen. Result: During the study period, 45 patients underwent transplant of which 46% (n = 21) underwent Allogenic HSCT. Treosulfan/Thiotepa-based regimen was given to 61.9% (n = 13). Of these Males were 54% (n = 7) and females were 46% (n = 6). Forty-six % (n = 6) were matched sibling donor, 46% (n = 6) were haploidentical donor transplants and one was an autologous transplant. Among these all except one developed dermatological toxicity during the peri-engraftment period. Exfoliative dermatitis was the most common manifestation observed and was graded according to WHO criteria for exfoliative dermatitis. Among those affected grade1-2 exfoliative dermatitis was seen in 66% (n = 8) patients, grade 3-4 exfoliative dermatitis was seen in 33% (n = 4) patients. The details of the patient characteristics and results are as depicted in Table 1 . Conclusions: Dermatological toxicities were most seen in patients undergoing allogenic transplant. These were commonly observed after a Treosulfan/Thiotepa-based conditioning regimen which are known to be excreted through the skin. While manifestations of acute or chronic skin GVHD are diligently sought after, dermatological affection during conditioning is often not anticipated but however, can lead to significant comorbidity due to increased infectious complications during the neutropenic phase of transplant thus affecting the transplant outcome. Introduction: Allogeneic stem cell transplantation (allo-SCT) is an effective curative modality for relapsed/refractory Hodgkin lymphoma (R/R HL). Aims & Objectives: To describe the allo-SCT outcomes in R/R HL and to compare the event-free survival (event defined as death or relapse) with patients who underwent autologous SCT (auto-SCT) while not in complete remission or required more than 1 salvage pretransplant.

We performed a retrospectively analysis of the clinical outcomes of patients underwent allo-SCT for R/R HL at our center from January 2001 to December 2020 and compared the event-free survival (EFS) with 81 patients underwent auto-SCT while not in complete remission (n = 45) or required more than 1 salvage pre-transplant (n = 36) during the same time period. Result: During the study period, 20 patients with R/R HL underwent an allo-SCT. The mean age was 26.5 years (SD 8.9), seven (35%) were females. The median number of lines of prior chemotherapies were 5 (IQR: 4 to 5). Ten (50%) had received prior radiotherapy. Four had primary refractory disease; the median duration of first remission for the remaining 16 was 18.5 months (IQR: 6 to 24.5). Nine (45%) had progressed after a prior autologous transplant. Prior to allo-SCT, 6 were in CR, 10 in PR and 4 had refractory disease. The donor for allo-SCT was matched sibling (n = 12), mismatched family donor (n = 2), matched unrelated donor (n = 1) or family haploidentical donor (n = 5). The conditioning regimen used was Fludarabine ? Melphalan ± TBI (n = 17), Fludarabine ? Cyclophosphamide ? TBI (n = 2), and Cyclophosphamide ? TBI (n = 1). Following allo-SCT, 9 patients died (6 due to infections in the immediate pos-transplant period, 2 following relapse, and 1 with grade IV GVHD). The EFS of these patients was comparable to that of patients who underwent auto-SCT while not in complete remission or required more than 1 salvage chemotherapy ( Fig. 1: 4 -year EFS: 54.5% ± 11.2% versus 59.8% ± 6%, log rank p 0.463). The median follow up of surviving patients in the auto-SCT and allo-SCT group was 38 months and 47 months respectively. Conclusions: Allo-SCT is an effective treatment modality for patients with R/R HL and upfront allo-SCT merits prospectively evaluation in patients who require more than 1 salvage at relapse or are not in complete remission following salvage chemotherapy. Introduction: Pure red cell aplasia (PRCA) is a well-recognized but rare immunohematological complication that occurs if there is major ABO-incompatible hematopoietic stem cell transplant (HSCT). The persistence of antibody producing plasma cells of recipient origin has been found to be the cause. These recipient plasma cells survive the conditioning regimen and produce isohemagglutinins causing inhibition of donor erythroid progenitors in the marrow. In past, patients have been treated with various strategies including high-dose EPO, plasma exchange, donor lymphocyte infusion (DLI), steroids, and more recently, with rituximab and even mesenchymal stem cells, with varying degrees of success. Aims & Objectives: Here, we report a case of 44 years old male patient of severe aplastic anemia who underwent HSCT from his HLA matched brother and developed pure red cell aplasia (PRCA) post transplant. He responded to Bortezomib. Materials & Methods: There was major ABO incompatibility and the donor was HBsAg positive. The patient was given the FluCyAtg conditioning and cyclosporine with methotrexate as GVHD prophylaxis. But he developed refractory anemia for which he received multiple transfusions for about 2 months. The investigations revealed normocytic, normochromic anemia with reticulocytopenia. DCT was -ve, Bone Marrow revealed decreased erythroid precursors, Parvo B-19 virus and CMV were negative. Chimerism was showing 90% of donor cells i.e. the graft was successful but the Blood grouping was still showing that of the recipient i.e. there was no RBC engraftment. So, a diagnosis of post transplant pure red cell aplasia was made. He was treated with steroids in a dose of 1 mg/kg/day but there was no response. Higher doses of steroids were not used as there were chances of Hepatitis B as well as CMV reactivation. Rituximab and IVIG were not affordable to the patient. Result: So, we gave him Bortezomib-2 mg subcutaneously weekly for 4 weeks and he started responding after the 3rd dose. Now, he is doing well and does not require transfusions. Introduction: The prognosis of adrenoleukodystrophy (ALD) with neurological involvement is generally dismal; however, allogeneic stem cell transplantation (SCT) is recognized as effective to stabilize or improve the clinical symptoms of ALD. Aims & Objectives: To analyse the long term clinical outcomes of patients with ALD who consecutively underwent allogeneic stem cell transplantation with reduced-intensity conditioning at our institution. Materials & Methods: Single center retrospective analysis of patients who underwent SCT for X-linked ALD between 2007 and 2020. The conditioning regimen prior to transplantation consisted of fludarabine and Busulphan along with thymoglobulin for matched unrelated donor and low dose total body irradiation for (TBI) for haplo-SCT. Graft versus host disease (GVHD) prophylaxis was with Cyclosporine and Methotrexate for HLA identical and Cyclophosphamide, Tacrolimus and Mycophenolate for haplo SCT. Result: Nine patients with ALD, with median age of 8 years (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , received SCT from 2007 to 2020. The pre SCT Loes score ranged from 3 to 13. The stem cell source was bone marrow (n = 2), or peripheral blood (n = 7) from HLA identical donor (related = 2 carrier sister, unrelated = 1) or haplo identical donor (father = 4, carrier mother = 2). Primary engraftment was obtained in all 9 patients. None had severe grade GVHD. Three had grade 1-2 acute and 2 had limited chronic GVHD. Loes score stabilized or improved by 18 months after transplantation in 4/9 patients, while 5 had progressive disease. Among those with progressive disease, 2 succumbed at 1 and 3 years post SCT respectively, while 3 of them stabilised with no further progression by 3-4 years of transplant. All the 3 patients with internal capsule involvement developed progressive disease. At a median follow up of 3 years (range: 1-14) post SCT, the overall and event-free survival were 77.8%% and 44.4% respectively. Conclusions: Allogeneic SCT for patients with ALD was safely performed without major transplant-related complications even in symptomatic patients and neurological symptoms were stabilized after SCT in patients without internal capsule involvement. Introduction: Hematopoietic stem cell transplantation (HSCT) has been particularly challenging during the COVID-19 pandemic. We aimed to analyse the impact of infection with COVID-19 in children post-HSCT and describe the clinical syndromes and the disease manifestations in this cohort. Aims & Objectives: We aimed to analyze the impact of COVID-19 on children post HSCT. Materials & Methods: Children who underwent HSCT between January 2014 to June 2021 and acquired COVID-19 infection were included in the study. The symptomatic children were hospitalized for supportive care. Asymptomatic children were treated in home isolation with azithromycin and zinc supplements. The immunosuppressants were continued in all children. Result: The incidence was 1.1% (9/752) A total of 9 children who underwent HSCT in the study period were diagnosed with COVID 19. The cycle threshold value in all children was low (\ 17), indicating a profound viremia. All children had cytopenia, four had hyponatremia, and two had grade 2 cytokine release syndrome. The severity of the disease was mild in 5 children, moderate in 1 child, and severe in 3 children. Post COVID sequelae included ARDS (n = 1), MIS-C and DVT (n = 1), rhinocerebral Rhizopusinfection (n = 1). Mortality in the cohort was 33% (3/9). Conclusions: Children who underwent HSCT have an overall good outcome following COVID-19 infection despite immunosuppressants. Cytopenia and hyponatremia are associated with viremia and should alert the clinician to check for COVID-19 in this cohort. Prophylaxis for mucormycosis in high-risk children with GVHD is an essential aspect of management. The presence of GVHD, opportunistic fungal infection, and hyponatremia predict a severe course and mortality.

Mithun Abraham Prakash, Fouzia N.A, AnuKorula, Anup J Devasia, Uday P Kulkarni, Sharon Lionel, SushilSelvarajan, Aby Abraham, Alok Srivastava, Vikram Mathews, Biju George Introduction: Osteopetrosis (OP) is a rare genetic disorder that is characterized by abnormal osteoclast function resulting in dense bones and marrow failure. The only curative option for OP is stem cell transplantation (SCT). Aims & Objectives: To assess long term outcomes after Haematopoietic stem cell transplantation (HSCT) in osteopetrosis. Materials & Methods: A retrospective analysis was made of 6 children who had received an allogeneic HSCT for osteopetrosis between 2000 and 2020. Conditioning was with Thiotepa/Treosulfan/ Fludrabine in 5 and Busulfan/Cyclophosphamide in one patient. GVHD prophylaxis with Cyclosporine and Methotrexate in matched related and Cyclosporine or Tacrolimus with MMF and cyclophosphamide in Haploidentical transplants. Result: Six Infants, all males with a median age of 9 months (3-12) underwent allogeneic HSCT for osteopetrosis. Five of them were born to consanguineous parents and genetic workup was available in two (CLCN7 and TNFRSF11A). One each had hydrocephalus, deafness and bilateral optic atrophy at the time of transplant. Stem cell source was bone marrow in five and peripheral blood in 1 from matched Result: A total of seven children were included. Demographics and HSCT details have been presented in table 1. All children were transfusion dependent and three children required intensive care unit admission prior to transplantation. Haploidentical donors were used in five children and two were transplanted with matched unrelated donor. Myeloablative conditioning and PBSC were used in all patients. Engraftment was observed in all patients; however mixed chimerism was documented in three patients by day ? 45. One child with mixed chimerism was stable post donor lymphocyte infusion (DLI) with no evidence of cytopenia. All children with complete chimerism were well with no evidence of GVHD and infection. The child with ERCC6L2 mutation developed glomerular sclerosis and mesangiolysis suggestive of calcineurin inhibitors induced renal injury. Six out of seven children (86%) are alive and one died after mixed chimerism. Conclusions: Although traditionally reduced intensity conditioning is used for aplastic anemia, newer variants of IBMFS require myeloablation in view of high risk of graft rejection. Mixed chimerism is not tolerated in these patients; those with complete chimerism have intact survival. Long term follow-up is required to monitor for possible late effects and non-hematopoietic organ involvement. Introduction: Calcineurin inhibitors continue to be the preferred prophylaxis against graft versus host disease (GVHD) in children undergoing hematopoietic stem cell transplantation.

Aims & Objectives: We aimed to analyze the impact of Tacrolimus in the prevention of graft versus host disease and its toxicity profile. Materials & Methods: We included children under 18 years of age who underwent HSCT between January 2017 and December 2020 on Tacrolimus and excluded children who had a primary graft failure or switched over to other prophylaxis due to toxicity. Tacrolimus was initiated at a fixed dose of 0.25 mg BD in children less than one year of age and 0.5 mg BD beyond infancy, and we modified the dose based on trough levels. In addition, Tacrolimus was administered sublingually in children with mucositis. Result: We analyzed data on a total of 214 children with a median age of 7 years 0.5-18). The indication for HSCT was a benign disorder in 165 children and for malignancy in 49. The source of stem cells was peripheral blood in 190, bone marrow in 22, and bone marrow and cord blood in 2 children. We observed hypertension leading to PRES in 10 children, but none required renal replacement therapy for AKI. The mortality rate was 19.1. Conclusions: Graded dose increments in oral Tacrolimus based on trough levels in combination with methotrexate provides optimal GVHD prophylaxis with 84% of acute GVHD being grade I/II with tolerable side effects. In addition, the sublingual route of administration during gut mucositis achieves adequate trough levels.

Satish Kumar Meena, Rumesh Chandar, Harika Varla, Venkateswaran Vellaichamy Swaminathan, Ramya Uppuluri, Indra Jayakumar, Revathi Raj Introduction: The IL-2 and IFN-g pathway mediated immunity is essential for host defence against mycobacterium tuberculosis, atypical mycobacteria and intracellular organisms like salomonella. In mendelian susceptibility to mycobacterial disease (MSMD) due to IFN-g receptor defect, hematopoietic stem cell transplantation (HSCT) is a curative option. High levels of IFN-g in these children are hostile to stem cell proliferation and can mediate graft rejection. Aims & Objectives: We describe the outcome of children with MSMD due to IFN-g receptor (IFN-R1 and IFN-R2) defect who underwent HSCT in our unit. Materials & Methods: In view of graft rejection in a child who received reduced intensity conditioning for a haploidentical HSCT and the high levels of IFN-g levels, pre-transplant immune suppression (PTIS) with 2 cycles of Fludarabine (40 mg/m 2 for 5 days) and dexamethasone (25 mg/m 2 ) followed by double volume plasma exchange, a myeloablative conditioning, peripheral blood stem cells and a high stem cell dose of 10 million cells per kg of recipient was performed. Anti-tubercular therapy was given prior to HSCT for disease control and post HSCT until immune reconstitution. Result: Four children with IFN-g receptor defect underwent five HSCT in our unit between January 2016 and June 2021. The median age was 4 years (3 months-6 years). Three children underwent haploidentical stem cell transplantation and one child had a matched sibling (MSD) and family donor (MFD) HSCT. Graft rejection was seen in two children. One child received a myeloablative conditioning but only 5 million stem cells per kg from the MFD and ultimately died due to progressive disease. The other child received a reduced intensity conditioning and 3 million stem cells per kg from haploidentical donor. He underwent second haploidentical HSCT 5 years later and is having complete chimerism after graded whole blood DLI for mixed chimerism. Remaining three children who received myeloablative conditioning and 10 million peripheral blood stem cells per kg are having a complete donor chimerism and free of any infection. Conclusions: PTIS with fludarabine and dexamethasone followed by plasma exchange, use of myeloablative conditioning, providing high peripheral blood stem cell dose of atleast 10 million cells per kilogram of recipient are needed for durable engraftment and to prevent graft rejection.

Cycylophosphamide-Induced Acute Hemorrhagic Myo-Pericarditis: A Case Series and Literature Review SpandanaTammiraju, Sushil Selvarajan, Uday Kulkarni, Sharon Lionel, Anup J Devasia, Fouzia NA, Anu Korula, Aby Abraham, Vikram Mathews,Alok Srivastava, Biju George Introduction: Cyclophosphamide is a potent DNA alkylating agent used in chemotherapy and immunosuppression for many decades. Its use in the present day has expanded, especially in the area of hematopoietic stem cell transplantation (HSCT). Along with other cytotoxic agents (Fludarabine, Busulfan, etc.), cyclophosphamide is a core component of conditioning regimens. In addition, post-transplant cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical donor HSCT is now widely used to reduce graft versus host disease. Here, we report a rare case-series with established hemorrhagicmyopericarditis post-Cyclophosphamide, which we have encountered at our transplant facility. These patients demonstrated devastating effects from high-dose therapy, which should be recognized as a potential risk of therapy. Aims & Objectives:

• Descriptive case series of 3 patients with Cyclophosphamideinduced acute hemorrhagicmyopericarditis in setting of Hematopoietic stem cell transplantation. • Review of the published literature on topic.

We report our single-center experience (Christian Medical College, Vellore) with hemorrhagicmyo-pericarditis following Cyclophosphamide in the HSCT setting and we describe these with a brief literature review to provide perspective on the issue. Result: Since 2015, we found 3 documented cases with this devastating complication of high dose cyclophosphamide. All patients were cleared as fit towards HSCT by expert panel of transplant physicians. Case 1 had a regional wall motion abnormality noted on chocardiogram in the pre-transplant workup. CT Coronary angiogram did not show evidence of coronary arterial disease. He was cleared for procedure after expert Cardiology consultation and clearance. All patients received [ 3 L/day of intravenous hyperhydration during Cyclophosphamide administration along with Mesna to prevent uroepithelial damage. Their peri-transplant course and findings are described in the tabulation figure attached.

A literature review conducted highlighted the rarity of this entity, with less than 60 cases reported worldwide. A proposed diagnostic criteria was identified in one of the publications and all 3 cases in our series fit the clinic-radiological features listed. Conclusions: Peri-transplant congestive heart failure especially after high dose Cyclophosphamide may be due to acute haemorrhagic myo-pericarditis. Validated clinico-radiological diagnostic criteria may help in the early recognition and management of this rare yet devastating complication. Introduction: Refractory acute myeloid leukemia (AML), defined as failure of 2 cycles of induction therapy at diagnosis or of 1 cycle at relapse, represents a subgroup with poor outcomes. In our transplant cohort, the long-term survival in this subgroup was 16%. Haploidentical natural killer cell (NK) therapy is a strategy that is being explored in refractory malignancies. Our in-vitro and animal model data suggest that exposure to arsenic trioxide (ATO) results in enhanced NK cytotoxicity. Aims & Objectives: To evaluate the role of addition of NK cell therapy in a sequential transplant for refractory AML. Materials & Methods: At our center, patients with refractory AML have been treated with cytoreductive therapy followed by 1-week rest and a reduced-intensity transplant. We used the same strategy for this trial (CTRI/2019/02/017505) with addition of CD56 positive cells from a haploidentical family donor infused 1-day after chemotherapy (Fig. 1a and 1b) . CD56 selection was done using CliniMACS prodigy followed by overnight incubation in autologous plasma ? 2 lMATO ? 500U/mL IL-2. Result: From February 2019, 14 patients with a median age of 29 years (IQR: 16.5-38.5) were enrolled. Six were females. Six had primary-refractory AML while 8 had relapsed-refractory AML. Cytoreductive chemotherapy was FLAG ± idarubicin (n = 7), Mitoxantrone ? Etoposide (n = 6) and GCLAC (n = 1). Median blast percentage before NK infusion was 15.9% (IQR: 9.1%-54.5%) (n = 11). Pre-defined release criteria, including sterile cultures, and endotoxin negativity were met in all cases. There was no infusion related toxicity. Median blast percentage following NK cell infusion was 11.9% (IQR: 4.9-47.6%) (n = 8). One patient withdrew consent after NK cell infusion and did not undergo transplant. For the remaining 13 patients, the stem cell donor was HLA matched (n = 4), HLA 9/10 matched (n = 1) or HLA haplomatched (n = 8). Five (38.5%) patients died of immediate post-transplant complications before engraftment while 2(15.4%) did not engraft and died following a second transplant. Of the remaining 6 (46.2%) patients who engrafted, the day 28 post-transplant MRD was negative for 5 patients. On follow up, 2(15.4%) patients developed disease relapse (on days 54 and 218 respectively) and died. The remaining 4(30.8%) patients are alive and relapse free at last follow up (mean follow up of surviving patients is 16 months). The estimated 1-year EFS was 28.8% ± 13.1% (Fig. 1d) . Conclusions: Thus, haploidentical NK cell therapy as an adjunct to transplant is safe and merits further evaluation in patients with AML.

Factor XI and COX2 Gene Polymorphisms and Susceptibility to Venous Thrombo-Embolism Introduction: Coagulopathy in COVID-19 progresses from initial pulmonary microthrombi without systemic coagulation activation to a systemic hypercoagulable stage with widespread activation of coagulation and then to a hypocoagulable picture seen in later phases of the disease. Aims & Objectives: We decided to conduct this study because of the severe infections in 2021 compared to 2020 to understand the Coagulopathy in COVID-19 among our population using Thromboelastography (TEG) and V curve. Materials & Methods: All adult patients with a confirmed COVID-19 and TEG report were recruited in the study and followed up for two months. Citrated Kaolin TEG parameters included were R and K time, alpha angle, maximum amplitude, clotting index, lysis 30. The first-degree velocity curve of (V curve) TEG which extrapolates thrombin generation potential with maximum rate of thrombin generation and time as well as thrombin generated. Comparison between survivors and thromboembolisms were made with TEG parameters. Result: Study included 43 patients after excluding three patients. Average age was 58.34 (± 15.35) and majority of them were males (34/43). TEG as well as V-curve were hypercoagulable compared to age matched reference range. Systemic hypercoagulable stage (34/43) and interestingly 13/34 patients had secondary fibrinolysis activity. Mortality rate and thrombotic incidents was 32.56% and 30.23% respectively. Risk factors for mortality were MA, LY 30, TG, Hypercoagulable TEG (OR-7.36), D Dimer (OR-1.40) and Thrombosis (OR-1.37). Incidents of Thrombosis in decreasing order was acute coronary syndrome (n = 10), DVT with PTE (n = 2) and MCA infarction (n-1). LY 30 was associated with an increased thrombotic risk (OR-15.3, r = 0.122, Correlation-0.40, P = 0.02). Repeat TEG was performed in 11 patients which was consistent with a hypercoagulable picture even after 5 days of thromboprophylaxis. Conclusions: TEG is useful in diagnosing and categorizing Coagulopathy associated with COVID-19.

Prabin Phukan, Abhishekh Purohit, Ravindra Shukla, Poonam Elhence, Praveen Sharma Introduction: Background: The excess mortality and morbidity among diabetics from cardiovascular disease and cerebrovascular accidents have not been fully explained by major coexisting risk factors such as hypertension, cigarette smoking and hypercholesterolemia. Increased attention is being paid to disordered haemostatic mechanisms in pathogenesis of both large vessel and small vessel disease in diabetes. The study aimed to evaluate fibrinogen levels and antithrombin activity in patients of type2 diabetes mellitus.

Aims & Objectives: The study aimed to evaluate fibrinogen levels and antithrombin activity in patients of type2 diabetes mellitus.

In this prospective study, 105 type2 diabetes patients between 25 and 65 years and 30 age-matched controls were enrolled according to the inclusion and exclusion criteria between September'2019 and 31st December'2020 at a tertiary care centre of Western Rajasthan. Parameters like fasting blood glucose, HbA1c, plasma fibrinogen levels and antithrombin activity of both groups were measured and compared. All patients were followed for a period of 3-15 months depending on time of enrolment for any adverse effects related to thromboembolism. 

The mean fibrinogen level in patients with diabetes was significantly higher than non-diabetic controls and showed increased levels with increase in age and HbA1c levels. Antithrombin activity was higher in cases than in the controls. Antithrombin did not show significant change with increasing age but change was significant with increasing HbA1c levels.

Kaninika Sanyal, Mrinalini Kotru, Richa Gupta, Alpana Raizada Introduction: Diabetes Mellitus (DM) is a global pandemic. The long term complications related to DM are the main cause of mortality and morbidity in DM. However, many of the Diabetes related complications can be prevented or delayed with early detection. Thus, there is a need for early diagnosis of the complications and a biomarker that predicts the outcome of the disease and its complications. Platelet derived microparticles (PMPs) are small sized membrane bound vesicles released from platelets during platelet activation. They now have emerged as important markers associated with endothelial injury, inflammation and prothrombotic state seen in DM. Hence, in this present study we will compare the levels of PMPs in Diabetics and non-diabetics. Aims & Objectives: Aim-To study the role of PMPs in DM. Objectives-To compare the levels of PMPs in adults who are Diabetics and non-diabetics. Materials & Methods: A prospective case control study was done in Department of Pathology and Department of Medicine. 30 Diabetic patients were taken as cases while 30 healthy adults were taken as controls. Complete hematological profile was done for both the groups. Immunophenotyping using antibodies like Cd 45, CD41, Cd61 and Annexin V? was used to distinguish PMPs from platelets. The annexin V? particles were identified first and separately gated and subsequently observed in the CD41 vs CD 61 plots. The particles that were annexin V? , CD41? , CD 61? were taken as PMPs.

Result: There was significant difference found in the hemoglobin, total leucocyte count, platelet count and total annexin V positive particles between cases and controls as p \ 0.05. PMPs ranged from 2 ± 169 with a mean ± SD of 53.7 ± 57.49 in controls and from 36 ± 2256 with a mean ± SD of 574.50 ± 647.98 in cases. There was significant difference observed between the two groups as p \ 0.05. Conclusions: Thus, this study shows that there is increase in the levels of PMPs in DM and thereby can play a role in the thrombotic state of the disease as well as can give rise to various DM related complications. Introduction: Snake bite is an important cause of morbidity and mortality in tropical countries. Higher percentage of rural population working in fields and bare foot accounts for it. The common species of snakes causing acute kidney injury (AKI) in Rajasthan are Viper species, among which, Echiscarinatussochureki is the most common in Western Rajasthan. Two major causes of snake bite induced AKI are acute tubular injury (ATN) and acute interstitial nephritis (AIN). Thrombotic Microangiopathy (TMA) is a rare cause of Acute kidney injury (AKI) in snake bite with a reported incidence of 5-29?cording to various case series. It is a triad of hemolyticanemia, thrombocytopenia and renal failure.

Aims & Objectives: The aim of this case presentation is to highlight the importance of TMA in viper envenomation and role of peripheral blood smear in its diagnosis.

We present a case of a 60 year old female with history of snake bite on left foot 4 days back presenting with vomiting and swelling of left lower limb. Laboratory parameters revealed anemia and thrombocytopenia with 10-12% schistocytes on peripheral blood smear. PT, APTT and D-Dimer were elevated. Fibrinogen was reduced. Renal function tests were significantly deranged with elevated serum urea (124 mg/dl) and creatinine (11.2 mg/dl) . Urine examination showed increased pus cells (90-95/ high power field), red blood cells (10-12/high power field) and proteinuria.

Result: Based on these, diagnosis of TMA leading to AKI was made. ANA was positive with nuclear speckled pattern on immunofluorescence. Patient was given 30 vials (300 mL) of antisnake venom and administered 1 unit of packed red blood cells along with 6-7 rounds of haemodialysis. Gradually, RFTs showed improvement with correction of coagulation profile. Conclusions: Snake envenomation is a neglected life threatening condition in tropical countries. Awareness about this entity and prompt treatment can significantly reduce mortality in these patients. TMA, a cause of AKI in these cases can be detected early by peripheral blood smear and coagulation studies.

Kamal Kishor, Samarjit Maharana, Chitrali Laha Roy, Amit Sharma, Ravi Ranjan, SeemaTyagi, Manoranjan Mahapatra Introduction: Deep vein thrombosis is multifactorial disease and leading cause of morbidity and mortality. However, * 30% of individuals with a history of DVT, no underlying risk factor has been found. Earlier we reported that low Tissue factor pathway inhibitor (TFPI) is a predisposing factor of Deep Vein Thrombosis. The significance 287T [ C polymorphism in idiopathic Indian DVT, on the other hand, has yet to be determined. Aims & Objectives: To look for the association of TFPI 287T/C gene polymorphism with Idiopathic DVT in young Indians. Materials & Methods: Doppler proved idiopathic DVT patients (age \ 45 years) and age and sex-matched healthy controls were studied. Exclusion criteria included patients on anticoagulants or those with a history of malignancy, pregnancy, or sepsis. TFPI gene polymorphism 287T [ C was detected by PCR-RFLP. Result: 100 DVT subjects, median age 35 years range (20-43 years) and M: F (48:52) were recruited. TT, TC, and CC genotype of 287T [ C polymorphism was seen in 68%, 24% and 8% in patients and 83%, 14% and 3% in controls respectively (p = 0.041, v 2 : 6.394). The allelic frequency of the 287C allele was significantly higher in patients (20%) as compared to controls (10%), which was statistically significant (p = 0.005, v 2 : 7.843). Patients with 287T [ C polymorphism had Odds Ratio (OR) of 2.092 (95% CI 1.005-4.354) in TC genotype and 3.254 (95% CI 0.831-12.74) in CC genotype as compared to TT genotype. After multiple logistic regression analysis adjusting for BMI, DM, alcoholic and smoking, the association persisted and adjusted OR (ORa) was 2.44 (95% CI 1.092-5.44) for TC genotype and 3.85 (95% CI 0.92-16.11) for CC genotype (p = 0.046). Conclusions: As in the West, low TFPI level predisposes to Idiopathic DVT in Indians. In contrast to prior research, the TFPI 287T [ C polymorphism was found to be significantly associated with DVT, increasing the risk by 3.85-fold. As a result, detecting the TFPI 287T [ C polymorphism may aid in identifying young Indians who are at high risk of developing DVT.

Introduction: Thrombophilia is an abnormal predisposition for arterial and/or venous thrombosis and can be acquired or inherited. Thrombophilia testing for inherited causes includes testing for natural anticoagulants, viz., Protein C(PC), Protein S(PS) and antithrombin (AT). Results of thrombophilia testing helps in decision making about the duration of anticoagulant therapy after first episode and may predict the risk of recurrence. Aims & Objectives: The aim of this retrospective study was to audit thrombophilia testing pattern at our institute and to look for the frequency of PS, PC, and AT deficiency in our patient population. Materials & Methods: This cross-sectional study was conducted at AIIMS, Jodhpur over a period of four years and laboratory and clinical details were extracted from hospital information system. PS, PC and AT assays were performed by automated coagulation analyzer (Sysmex CA-1500) using reagents from Siemens Healthcare Diagnostics products, GmbH. Normal antithrombin activity from 80 to 120% was taken as normal. Both PS and PC activity from 70 to 140% was taken as normal. (PE) or both. It is the third major vascular complication and a preventable cause of death. Fatal condition arises due to the thrombus that breaks off from the site of formation and travels through the blood stream to lodge at the site of lungs thereby blocking blood flow. The most widely used clinical biomarker for diagnosis of VTE is D-dimer, which often yield inaccurate and false positive results. Thus, there is an urgent need for specific and sensitive biomarker for VTE diagnosis. MicroRNAs (miRNAs) have recently emerged as potential diagnostic biomarker for severe complications. These non-coding small RNA sequences regulate post transcriptional gene expression. Many recent studies have been done on miRNA profiling in cardiovascular diseases like coronary artery disease, atherosclerosis, acute myocardial infarction, chronic obstructive pulmonary disease etc. for diagnostic and prognostic purpose, including few non-conclusive reports on VTE.

Aims & Objectives: The present study aims to evaluate miRNA-320 as candidate for early diagnosis and having therapeutic potential against VTE. Materials & Methods: Syetematic review and meta-analysis of published literature was done to prepare a comprehensive list of miRNAs that could have potential linkage with VTE. In-silico analysis was done using various bio-informatic tools to further narrow down to candidate miRNAs for VTE. Antagonist and mimic of these candidate miRNAs are being injected (on-going) into stasis induced animal model of DVT to evaluate their therapeutic potential in reducing thrombus size. Result: Meta-analysis of published literature generated a panel of12 miRNAs (miRNA-134, miR-27a, miR-27b, miR-1233, miR-221, miR-424-5p, miR-136-5p, miR-28-3p, miR-338-5p, miR-374-5p , and miR-320a, miR-320b) which could be associated with VTE pathophysiology. Further, In-silico analysis results condensed of research to two target miRNAs. Antagonist of miRNA-320, which was overexpressed during VTE, was injected into 150-200gm male SD rats as per ethical guidelines. Initial findings demonstrate decrease in size of thrombus and increase clotting time in miR-320 treated SD rats compared to surgical controls. Conclusions: Present study suggested that miR-320 could be a potential target for early diagnosis and treatment of VTE. These results further provides insights into molecular mechanism of VTE prognosis.

The Usuals and Unusuals of TTP: Experience from a Tertiary Care Hospital from Eastern India Harshwardhan Bahirat, Pritish Chandra Patra, Priyanka Samal Introduction: Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy (TMA) caused by severely reduced activity of the VWF cleaving protease ADAMTS13. It's not an uncommon disease as thought earlier but is easily missed because of low index for suspicion. Course of treatment is usually not a smooth one. We present here, our experience of managing TTP in a tertiary care hospital.

reports of Vaccine-induced thrombocytopenia and thrombosis raised few eyebrows regarding the safety. Apheresis-derived platelet concentrates are frequently required in all sorts of clinical illnesses and post-vaccination decrement of platelet counts might lead to increased deferral of the plateletpheresis donors.

Aims & Objectives: The study aims to find out the effect of Covishield vaccination on deferral rates of plateletpheresis donors. The primary objective is to compare deferral rates of vaccinated platelet donors (cases) from non-vaccinated ones (control) and the secondary objective is to correlate vaccination with pre-donation platelet counts of the donors. Materials & Methods: A blood sample was collected from the potential platelet donors after the standard questionnaire for a complete blood count. Data collected were tabulated in an MS Excel spreadsheet and was analyzed with SPSS v23, p-value \ 0.05 was taken as significant. We compared this data with an equal number of age and sex-matched platelet donors (controls) from the year 2019. Result: The mean age of cases and controls was 29.69 ± 8.57 and 30.15 ± 7.11 respectively. There is a marked difference between platelet counts of cases (188,496.35 ± 72,065.66/mm 3 ) and controls (269,524.50 ± 53,981.60/mm 3 ) with p-value of \ 0 [ 3 than those who received 2 doses 179,970.83 ± 66,773.73/mm 3 . The difference in deferral rates was remarkable between the two groups 34.7% vs 0.9% with p-value \ 0.001. Weak positive correlation is established between days after 2nd dose and platelet count (rho = 0.2, p = 0.002). Conclusions: Vaccination undoubtedly increased the deferral rates of plateletpheresis donors due to low platelet counts. Average platelet counts were low in fully vaccinated individuals, however, platelet returned to normal counts as the days progress post-vaccination.

Ashna George, Vasudeva Bhat K, Archana M V, Vinay M V, Ashwin Kumar Vaidya, Ganesh Mohan, Shamee Shastry Introduction: Granulocyte transfusions (GTXs) have been used as an adjunct to antibiotics in patients with refractory neutropenic sepsis and febrile neutropenia. In LMIC like ours where multidrug-resistant infections are rampant, along with appropriate antibiotics GTX has shown promise when used in the correct setting. Aims & Objectives: The aim of the present study is to assess the quality parameters of the granulocyte concentrate derived by apheresis and to study its efficacy in managing refractory neutropenic sepsis and febrile neutropenia. Materials & Methods: A retrospective clinical audit on granulocyte transfusion was performed for a period of two years from October 2019 to September 2021. Granulocyte concentrates were prepared by using continuous flow apheresis equipment (TerumoBCT spectra optia). Donors meeting selection criteria as per national standards were selected. Following written informed consent, granulocyte mobilization was done by administering Dexamethasone and G-CSF 12 h prior to collection. Mid-procedure total WBC and neutrophil counts were calculated at 100 mL of collection volume, and end volume was determined accordingly. Patient data were collected from medical records and laboratory software. Clinical efficacy was assessed by patient outcome and change in WBC count after transfusions.

Result: A total of 19 granulocyte apheresis was done for 10 patients. All the donors were males with a mean age of 32 years ± 10.33 and the majority (79%) were first-time donors. The post mobilization increment in WBC and Absolute Neutrophil count (ANC) was 2.92% and 78% respectively (P \ 0.0001). Acute myeloid leukemia (n = 6) and acute lymphocytic leukemia (n = 4) were the patient diagnosis and five patients received more than 1 transfusion. Post transfusion percentage change of Hb, Platelet count, WBC count and ANC was 3.3%, 48.49% (P = 0.007), 69.14% (P = 0.003) and 83.84% (P = 0.009) respectively. Adverse events to GTX were nil and the outcome was favorable in 90% of patients. Conclusions: GTX was found to benefit our patients suffering from multidrug-resistant sepsis. GTX should be considered early during the course of MDR sepsis however should be avoided if lung is the focus for infection.

Goal Based Transfusion Support in Massive Obstetric Hemorrhage Using Thromboelastogram Bemma Paonam, Ganesh Mohan, Dhivya Kandasamy, Deepika Chenna, Vinu Rajendran, Shamee Shastry Introduction: Massive obstetric hemorrhage (MOH) is one of the leading causes of early maternal mortality observed globally. Pregnancy is a hypercoagulable condition and managing MOH can be challenging at times due to unique pathophysiology. Aims & Objectives: The aim of the study was to assess the role of Thromboelastogram (TEG) in guiding the transfusion in MOH.

We conducted a retrospective study on Obstetric patients with massive bleeding (antenatal & postnatal) in whom TEG was performed from 2019 to 2021. Patient demographic details, TEG parameters, pre, and post-transfusion hemoglobin, hematocrit, Platelet count, Prothrombin time (PT), Activated partial thromboplastin time (aPTT) and fibrinogen along with transfusion details and clinical outcome were collected and analyzed. Coagulopathy was defined based on conventional tests as well as TEG. Result: Of total 39 patients of MOH, majority had Post-Partum Hemorrhage (64%). TEG parameters showed hypocoagulable, hypercoagulable status in 16 (41.02%) and 6 (15.38%) patients respectively. Primary and secondary fibrinolysis was noted in 4 (10.25%) and 2 (5.12%) patients respectively. The coagulopathy status and the blood components transfused are shown in Table 1 . Antifibrinolytics therapy was advised in 4 (10.25%) patients showing features of primary fibrinolysis. Total of 101 packed red blood cells (PRBC), 58 random donor platelets (RDP), 131 fresh frozen plasma (FFP), and 178 cryoprecipitates were given to 28, 12, 26, and 14 patients respectively. The mean Hemoglobin and Platelet count following transfusion were 9.4 (± 1.63) and 122.8 (± 95.35). The comparison of pre and post-transfusion coagulation parameters showed significant change in PT (decrement 36.5%), aPTT (decrement 20.4%), and 66.4% increase in Fibrinogen levels. A favorable clinical outcome was observed in majority of the cases 37 (94.87%). At least 10-20 units of blood component transfusions were avoided among the hypercoagulable group. Cryoprecipitate transfusion was more among hypocoagulable patients based on TEG guided algorithm (Table 1) . Conclusions: Incorporating TEG in the management of massive obstetric hemorrhage will lead to better hemostasis and patient survival. We were able to avoid plasma containing products transfusions among the hypercoagulable group by using the goal-based transfusion therapy.

Anti-C 1 Anti-D Reactivity Pattern in Pregnant Women the Grand Delusion-Not Everything is What it Seems! Deeksha Singh, Sangeeta Pahuja, Geetika Sharma, Shruti Chauhan, Ram Vilash, Manisha Singh Introduction: Anti-D is the most common alloantibody found in pregnant women. However, sometimes it's identification is complicated by a reactivity pattern of anti-C ? anti-D. Such antenatal cases should be worked-up for resolution of multiple alloantibodies; whether anti-C, anti-D or anti-G or a combination thereof as these may cause hemolytic disease of newborn.

Aims & Objectives: To study the immunohematological approach to cases of presumed anti-C ? anti-D pattern and differentiate the presence of anti-C/D/G in pregnant women. To perform the titres of anti-D &/or anti-C alloantibodies. Materials & Methods: All Rh negative pregnant women presenting with apparent anti-C ? anti-D reactivity pattern, from January 2019 to September 2021 were included in the study. Maternal obstetric history, past history of anti-D prophylaxis and blood transfusion were obtained. ABO RhD blood grouping, weak D testing & Rh/Kell antigen typing were done. Commercially available 3-cell panel and 11-cell panel were used for maternal antibody screening & identification respectively by Indirect Antiglobulin Test. Patient's plasma was tested by differential adsorption and elution using r'r and R2R2 RBCs in parallel. Titres were done by using R2R2 RBCs for anti-D and using r'r RBCs for anti-C alloantibody by tube method at 37°C. The results were correlated with husband's and baby's ABO RhD group and Rh/kell antigen profile as well as baby's direct antiglobulin test (DAT) wherever possible. Result: Fifteen pregnant women presented with apparent anti-C ? anti-D pattern over the study period. Out of these, vast majority of cases were anti-C ? D ? G (14 cases) and only 01 was anti-C ? D. None of the cases were anti-C ? G/anti-D ? G/anti-G. Most of the cases showed higher titre of anti-D as compared to anti-C alloantibody.

Conclusions: The incidence of anti-C ? D ? G seems to be higher than reported in literature probably due to under-reporting of anti-G and lack of awareness & expertise in performing the complex immuno-hematological procedures required for differentiation. The differentiation of anti-D/C/G is essential as this serological complexity may lead to: (1) diagnostic dilemma like anti-D in mother despite previous RhIg prophylaxis; (2) therapeutic dilemma to give RhIg or not; and (3) difficulty in arranging compatible blood for maternal/fetal/neonatal transfusion.

Match Pre-transfusion Testing in a Tertiary Care Centre Kuralarasi Priyadarshini, Megala. C, Thamilselvi Introduction: Pre transfusion testing an important mandatory investigation performed in view of avoiding immune mediated hemolytic transfusion reaction due to incompatible donor RBCs.Introduction of type and screen (T and S) approach,will save precious time,also detect clinically significant alloantibodies and thereby increase transfusion safety.

Aims & Objectives: To compare safety of type and screen (T and S) procedure by commercial 3 red cell panel in antibody screen negative recipients with AHG phase cross match for patients requiring PRBC under elective protocol.

A cross-sectional analytical study was conducted between March 2019 to March 2020.All blood transfusion requests and blood samples under elective protocol with previous history of transfusion and pregnancy along with positive Antibody screening were included in the study.Any blood sample which showed incompatibility in Immediate Saline phase crossmatch at room temperature after negative type and screen were excluded. Result: Out of 1000 recipient blood samples that were subjected to 3 cell screening panel, antibody screening was negative in 995 samples and positive in 5 samples.Clinically significant alloantibodies identified were anti-E, anti-M, anti-c, anti-Lea.Crossmatch transfusion (CT) ratio was reduced from 1.70 with routine AHG (anti-human globulin) protocol to 1.5 with Type & Screen protocol.Man hour utilization was 673.04 man hours.Total man hours saved in this study was 315.04 man hours. Conclusions: With Type and screen protocol the C:T ratio and turn around time (TAT) was reduced, particularly in patients requiring repeat transfusions within their admission period.Clinically significant alloantibodies were also identified (anti-E, anti-M,anti-c, anti-Lea).Therefore,Type and screen protocol is as safe as conventional AHG protocol.

Shanthini Gilda V, G. Saranya, A. Ruth Jenila, M. Sintha. Introduction: The ABO system initially described by Karl Lansteiner in 1900, remains the most important blood group system in transfusion and organ transplantation medicine.The ABO system contains four major ABO phenotypes: A,B,O and AB. ABO subgroups are phenotypes that differ in amount of A and B antigen carried on red cells and present in secretions.In general,A subgroups are most common than B subgroups. Clinically, the two most common subgroups encountered are A1 and A2.In addition to A2, several weaker A subgroups have been described (eg.A3,Ax,Am and Ael) and B subgroups (eg.B3,Bx,B(A)).Most weak A and B subgroups were originally described before the advent of monoclonal typing reagents and were based on reactivity with human poly-clonal anti-A,anti-B and anti-AB reagents. Aims & Objectives: To stress the importance of reverse (serum) grouping during routine ABO grouping and saliva testing in all ABO blood group discrepancy. Materials & Methods: 31 years antenatal mother G2P1L0D1/PIH/ Hypothyoidism with gestational period of 24 weeks.H/O intrauterine death 10 years back,male child,normal vaginal delivery and H/O long term infertility for past 10 years referred from peripheral primary health centre to our tertiary care hospital for confirmation of ABO blood grouping and RhD typing.No H/O blood transfusion in the past.Blood grouping done by tube method, forward(cell) grouping done using monoclonal IgM anti-A,anti-B,anti-D,anti-AB,anti-H and reverse(serum) grouping done using freshly prepared pooled A,B and O cells prepared in-house.Saliva test done by inhibition technique.Indirect coombs test done by tube method. Result: Forward (cell) grouping typed as B RhD negative and reverse (serum) grouping showed as AB.Cell grouping test tubes incubated at room temperature for 30 min, then centrifuged,showed 1 ? agglutination with anti-A.Cross matching with plasma of B and AB donors was compatible,also done with plasma of A and O donors were incompatible.Saliva test confirms the presence of A,B and H substance in saliva,hence secretor of A,B,H.Indirect coombs test were negative. Conclusions: ABO discrepancy in this particular case due to weak subgroup of A.Reverse grouping is mandatory for routine ABO grouping to avoid untoward blood transfusion reaction.In ABO grouping discrepancy secretor status helps a lot in arriving a conclusion.

Sonu Choudhary, Nimisha Sharma, Tathagata Chatterjee, Reetika Menia, Khushboo Kataria, Chitra Introduction: Corona virus disease also named as severe respiratory corona virus 2 (SARS-COV 2) has emerged as global pandemic with 3,40,00,500 cases in India till date and 23,82,72,207 cases worldwide. Lack of evidence of effective treatment modalities for covid 19 and delay in vaccination led to experimenting with classical and historical interventions as treatment options. In past convalescent plasma has been proven effectiveness against various viral diseases. Aims & Objectives:

1. Analyzing the reason for convalescent plasma donor deferral. 2. Assessment of IgG COVID 19 antibody levels for convalescent plasma donor 3. Enumerating donation frequency and stage of deferral.

Materials & Methods: Donor were recruited as per ICMR protocol version 1.6 PLACID trial and ICMR bulletin released thereafter. A pre set convalescent plasma donor selection criteria & screening investigation were designed according to national guideline. All the potential donor were screened telephonically and in person by medical expert from blood center. The retrospective analysis of CCP donor deferral record from May 2020 to April 2021 was done. Frequency of donation was noted. Stage of deferral were defined as (1) Pre donation, (2) Screening, (3) Medical examination, (4) Phlebotomy. Brief physical examination and COVID 19 Ig G antibody work up was done on fully automated Vitros Electro Chemiluminescence system. Result: Total number of donors screened were 992, out of which 544 were deferred. Most common deferral was due to low antibody titre (50.55%), Unclear vein (8.63%), Anaemia (7.4%) High Blood Pressure (5.51%), Low Blood Pressure (2.20%), and others reasons 33.08%. Average IgG antibody levels against COVID 19 in our set up was 4.6 AU (Absorbance Unit/ml9). However the benchmark set by ICMR advisory was 13 AU. Most deferrals were observed at Medical examination Stage. 11% of the donors deferred were repeat donors. Conclusions: The deferral rate in Convalescent plasma donors (55%) was much higher as compared to deferral rates observed in whole blood donors (10-15%).Higher rates were mostly due to stricter donor selection criteria and low antibody levels prevailing in Indian population post COVID.

Gajender Singh, Pooja Pawaria Introduction: Transfusion of blood and its components is lifesaving; However the patient are at significant risk of contacting TTI's. There is 1% chance of transfusion associated problems including TTI's with every units of blood transfused. Most common TTI's are human immunodefficiency virus (HIV), Hepatitis B virus (HBV), Hepatitis C virus (HCV), syphilis and malaria. Accurate estimates of risk of TTI's are essential for monitoring the safety of blood supply.

Aims & Objectives: The study was done to estimate the the seroprevalence and trend of these five TTI's among the donors during study period. Materials & Methods: The retrospective study was done in Blood Transfusion Department, PGIMS, Rohtak Haryana, a tertiary care centre in North India from January 2019 to July 2021. All donor Blood samples were screened for mandatory tests i.e. Malaria, Venereal Disease and Research Laboratory (VDRL), Hepatitis B antigen (HbsAg), Anti HCV and Anti HIV (1 and 2). All samples with reactive results were repeat tested before labeling as reactive and respective Blood units were discarded. Result: A total of 94,917 donors were screened over study period (Jan 2019-July 2021), majority were voluntary donors. Out of 94,917 blood donors, 1692 (1.78%) were found positive for TTI's. The prevalence of HIV, HBV, HCV, Syphilis and malaria infections among donors was 0.20%, 0.78%, 0.18%, 0.60% and 0.0001% respectively. Prevalence of Hepatitis B infection (0.78%) formed the majority of total TTI's over the study period. Conclusions: Blood Transfusion service (BTs) is an integral and indispensable component of health care system with primary objective to ensure safety, adequacy, accessibility and efficiently of Blood supply at all levels. Avoiding unnecessary Blood Transfusion and use of highly sensitive Tests including nucleic Acid Testing can help to further reduce the risk of TTI's.

Associated with Febrile Non hemolytic and Allergic Transfusion Reactions in a Tertiary Care Centre Harsha Michael, Shaiji P S Introduction: Knowledge of recipients and donors involved in transfusion reactions (TR) aids in better management and hemovigilance practices.

Aims & Objectives: To study the whole blood recipient and donor characteristics with FNHTR and allergic TR in a tertiary care centre.

A hospital based retrospective study on TR which occurred between July 2020-July 2021. Standard hemovigilance definitions were used to define type of reactions. Characteristics of whole blood donors and recipients associated with such reactions were analysed using SPSS. Result: 44 transfusion reactions occurred during the study period and majority (57%) were allergic transfusion reactions and rest was FNHTR. Most (65%) of the allergic reaction (n = 25) were seen in females and majority of reactions occurred in 30 plus age group (68%). 44% reported with previous transfusion history and 65% had a previous pregnancy. 64% of allergic reactions occurred when packed cells were transfused, 71% occurred with \7 days[ . Among 19 FNHTR cases, 79% were females, 68% were age [ 30 yrs, 42% with previous transfusion history, 73% with previous pregnancy, 95% were with PRC component and 74% with fresh PRC. Predominant symptom was fever in all cases.24% reactions were with obstetrics and in chronic anemia, 20% with surgical cases, 4. Conclusions: Female gender, age, multiple transfusion and pregnancy as risk factor for FNHTR & allergic reactions in patients should be explored by analytical studies. Fresh RBCs causing more TR and history of allergic reactions in 1/3rd donors of allergic reactions are notable.

Manisha Agrawal, Shanthi Bonagiri, Sudhir Kumar Vujhini, Mahesh Kumar Kandukuri, Murali Krishna Bogi Introduction: Introduction-Blood transfusion is a vital part of healthcare system, and providing safe blood to recipients is paramount importance. The requirement of blood in India is 8 million units every year, but number of units collected annually is 5.5-6 million units which contributes to significant shortage of blood units. Therefore it is necessary to overcome shortage of blood products and improve the effectiveness of medical health care. Aims & Objectives: To analyse deferral incidence among registered blood donor. We also analysed the demographic details of deferred donor and the reasons for temporary and permanent deferral to plan and implement strategy to reduce number of deferred donors. Materials & Methods: A retrospective study of all blood donors who were deferred from blood donation in NIMS hospital blood bank, Hyderabad for period of 5 yrs from January 2016 to December 2020 were analysed. Data were obtained from donor deferral register and were analysed based on causes for deferral. Result: A total of 84,952 prospective blood donors registered for blood donation and 80,921 (95.25%) donated blood during study period. The deferral rate is 4.74% (4031/84953).Among the deferred donors 3911 were males and 120 females. The mean age group for maximum deferral of donors was observed to be 18-29 yrs(47.63%).Deferral rate in male was 4.47% and female was 20.45% with p value \ 0.05. A total of 3735(92.65%) were temporary deferrals and 296 (7.34%) were permanent deferral. Anemia 2759(68.44%) was the major reason of temporary deferral followed by alcohol/smoking 226(5.6%), night sleep 139(3.44%), skin lesion 83(2%),infection 71(1.76%),frequent donations 70(1.73%),medication 64 (1.59%), cold 52(1.29%),failed phlebotomy 49(1.21%), Tattoo 42 (1.04%), underweight/underage 36 (0.89%)surgery 20(0.49%),jaundice 10(0.24%),vaccination 8(0.19 nd miscellaneous 106(2.62%).Among anemic donors, donor deferred due to mild anemia is 2517(91.22%), moderate anemia 224(8.11%), severe anemia 18(0.65%) respectively. The most common cause for permanent deferral were uncontrolled Hypertension 86(2.13%) followed by Diabetes Mellitus on Insulin 57(1.41%). Conclusions: Analysis of rejection pattern may help medical personnel to focus in donor screening, so that donor safety and healthy donor pool is maintained. Donor recruitment strategies with more liberal criterion without affecting blood safety may reduce the number of deferrals. Efforts must be taken to increase awareness and encouragement for future donations to reduce the loss of useful units of blood.

Introduction: Blood donation is a lifesaving intervention but the risk of transmitting transfusion transmissible infections (TTI) still remain even after use of sensitive techniques in TTI screening of blood units. Donor notification and counselling is an important and efficient method of preventing TTI transmission. Aims & Objectives: To evaluate the response rate of transfusion transmissible infections (TTI) reactive donors after notifying their abnormal test results. Materials & Methods: It was a retrospective study conducted at tertiary care centre from January 2020 to December 2020. Reactive donors were called to the blood bank by telephonic call and letters. Reactive donors on complying at centre were counselled and referred to appropriate centre for further management. Result: There were 34,416 blood donation over period of 1 year, out of which 606 (1.76%) were TTI reactive donors. Among these 606 reactive donors, 444 (73.2%) could be contacted and remaining 162 (26.8%) could not be contacted due to wrong and incomplete demographic details. Out of 444 contacted donors, only 302 (68.01%) responded positively to the notifications calls and attended counselling at blood bank i.e. response rate of 68.01%. Introduction: Alloimmunization is a great matter of concern with pregnant females who are multigravida and having bad obstetric history. Pretransfusion testing in each and every women of child bearing age group is essential along with antibody screening and identification to minimize risk of Hemolytic disease of fetus and newborn (HDFN).

( Introduction: Alloimmunisation is a commonly encountered problem in transfusion medicine. However, sometimes the alloantibody can be masked by autoantibody which makes its identification and compatibilitity testing challenging. A thorough immunohaematological work up is needed to correctly diagnose and arrange the best matched blood for the patient.

Aims & Objectives: To highlight the importance of diagnostic work up in cases with difficulty in cross match due to coexistent autoantibody and alloantibody.

Materials & Methods: A 4.5 year old male child, known case of transfusion dependent Beta thalassemia major with massive spleen and hepatomegaly presented to our Regional Blood Transfusion Centre with difficulty in cross match. Patient was diagnosed at 5 months of age at an outside hospital and was on regular blood transfusion. He was referred to Kalawati Saran Children Hospital in view of worsening pallor and increased frequency of blood transfusion. Patient's previous direct Coombs' test (DCT) was negative and indirect Coombs' test (ICT) was trace positive. No specific antibody was identified. Result: Patient's blood group was AB positive and Rh/Kell antigen profile was negative for c, E and Kell antigens. Multiple blood units putup for cross match were found to be incompatible. Patient's DCT was positive (2?) and ICT showed panagglutination reaction of variable strength. Papain treatment was done, upon which panagglutination was enhanced to 4? which was suggestive of warm autoantibody. ICT was also done in saline phase in which reactivity pattern for Anti E was identified. Thus, he was diagnosed as a case of Warm Auto-Immune Haemolytic Anaemia with Anti-E alloantibody and the child was transfused with least incompatible, Rh/kell profile matched (c, E, K negative), leucoreduced red cell concentrate under steroid cover and strict clinical supervision. Transfusion was tolerated well and the child was discharged in stable condition and advised follow up.

Conclusions: This case highlights that autoantibody can often mask the underlying alloantibody which can result in difficulty in crossmatch. Though labour intensive, immunohaematological workup should be done to identify underlying alloantibody so that best matched and safest blood can be transfused to the patient. This case also emphasizes the importance of transfusing profile matched blood in multitransfused patients so as to minimise the risk of alloimmunisation.

Retrospective Analysis of Donor Hemovigilance in a Tertiary Care Center Olivia Cynthia Badwar Introduction: Donor hemovigilance is an important aspect of the hemovigilance system. It contributes to the decrease in blood donor's complications and improves blood donor safety. Reporting of adverse donor reactions and measures to improve the donor return rate are crucial tasks.

Aims & Objectives: The aim of this study is to analyze the spectrum of adverse reactions in whole blood donors in a tertiary care center.

In this retrospective study, details of all the adverse donor reactions in whole blood donation was collected from the department archives recorded in the Adverse Donor Reaction Forms over a period of 2 years from July 1, 2019 to June 30, 2021.

Result: 286 adverse donor reactions were reported out of 36,481 whole blood donors over a period of 2 years resulting in an overall adverse reaction rate of 0.78%. 56.29% of the reactions occurred in first time blood donors. 56.64% were donors under 25 years of age and 74.12% were replacement donors. Spectrum of adverse donor reactions recorded in decreasing order of frequency were vasovagal reaction (87.06%), hematoma (3.14%), arterial puncture (1.74%), rebleed from venipuncture site (1.04%), tingling sensation in the arm (0.34%) and allergic reaction (0.34%). Vasovagal reactions reported were mostly presyncopal symptoms with pallor, sweating or light headedness without loss of consciousness (66.78%) followed by minor syncopal symptoms with transient loss of consciousness less than 1 min (20.27%). Major syncopal complications like seizures and loss of consciousness of more than 1 min were not reported. Out of 286 adverse donor reaction forms recorded, 18 forms were incompletely filled (6.29%) which is a major drawback in the study since vital data was lost which has affected the donor hemovigilance. Conclusions: As only 0.78% of blood donors experienced adverse reactions, this study confirms that the overall rate of adverse donor reactions is low hence blood donation is a very safe procedure. However, it can be made safer with certain tactful practices. To improve the donor hemovigilance, more stringent methods should be implemented to avoid improper or underreporting of such adverse events.

Parmatma Prasad Tripathi, Vijay Kumawat, Anchan Vidyashree Introduction: Therapeutic plasma exchange (TPE) or plasmapheresis is an extracorporeal blood purification technique that is designed to remove substances with a large molecular weight and is the treatment of choice in many neurological disorders. Even though it is safe in experienced hands, there is a major concern about its safety among physicians and costs related to it.

Aims & Objectives: To analyze our experience with 2507 patients who underwent plasmapheresis for various neurological disorders. Materials & Methods: Retrospective study of five years from January 2015 to December 2019 in transfusion medicine department of a tertiary care neurological center in South India. Removal of approximately 150-200 ml of plasma per kg body weight was targeted during each procedure with the help of MCS plus 9000 (Hemonetics, Unites States) apheresis platform (intermittent flow technique) alternatively over a period of five days and replaced with adequate replacement fluid. Various neurological indications, categorical distributions, and complications are discussed. Result: A total of 13,387 procedures (2507 patients) were performed. The male to female ratio was 1.34:1. The age of the patients ranged from 9 to 86 years (mean age 38.18). The top seven indications were Guillain Barre Syndrome (GBS) in 1409 cases (56.20%) followed by Neuromyelitis Optica Spectrum Disorder (NMOSD) in 334 cases (13.32%), Myasthenia gravis (MG) in 290 cases (11.57%), Autoimmune Encephalitis (AIE) in 209 cases (8.34%), myelitis in 58 cases (2.31%), chronic inflammatory demyelinating polyneuropathy (CIDP) in 4 cases (1.87%) and demyelination in 44 cases (1.76%). Indications were categorized according to ASFA 2019 guidelines into a category I to category IV. Over these five years, category I accounted for 9664 procedures (72.19%), category II for 1873 procedures (13.9%), category III for1790 procedures (13.37%), and category IV accounted for 60 procedures (0.45%). The most common complication was hypotension. There was no procedure-related mortality in the time period of the study. Conclusions: Plasmapheresis is a safe and efficient procedure and also a cost-effective alternative. The benefit of the procedure can be extended to many neurological diseases.

A Rare Riveting RH Phenotype: Case Report Priya Suneja, Somnath Mahapatra, Priyanka Gogoi, Preeti Diwaker, Sunita Rani Introduction: The Rh system includes at least 45 independent antigens, out of which D, C, c, E, and e are primary antigens encoded by RHD and RHCE genes. As Rh antigens play a pertinent role in blood transfusion reactions, it is important to know the phenotype before blood transfusion to prevent any adverse reaction. We came across a variant D-phenotype in which D antigen is expressed but none of the RhCE antigens C, c, E or e are expressed on the red cell surface. Molecular basis for D-phenotype is not clear but recombination of RHD and RHCE genes have been documented. Also, individuals having D-phenotype are capable of producing a rare alloantibody in response to transfusion and has the potential to react with C/c and E/e antigens causing severe haemolytic transfusion reaction. Herewith, we describe a rare case with D-phenotype in a 33-year-old male detected during routine screening of blood donors. Aims & Objectives: To describe the occurrence of a rare Rh phenotype D-in a blood donor and highlight it's clinical relevance.

Materials & Methods: Routine serological tests were performed for this donor's blood. Extended phenotyping was done by two methods; gel card method (Bio-Rad) and by hemagglutination method (Immucor, Inc). It was also subjected to direct agglutination test (DAT) and antibody screening, done by gel cards (Bio-Rad). Result: Rh Kell extended phenotyping gel card showed expression of only D antigen and rest all antigens i.e. C, c, E, e and Kell were found to be negative. DAT and irregular antibodies were reported negative. Conclusions: Rare phenotypes are of great concern at times of transfusion to prevent alloimmunization and mishaps. It is important to register them to the rare donor pool and to adopt adequate patient blood management strategies. Thus, appropriate identification of rare phenotypes and their characterization by molecular methods can help resolve transfusion-related problems in such individuals.

Saina Abdul Salam, Safdar Basheer, Shaiji PS Introduction: The platelet rich plasma (PRP) is an endogenous therapeutic technology that has immense scope in regenerative medicine due to its potential to stimulate and accelerate tissue healing. This is due to their hemostatic potential and presence of multiple growth factors and cytokines. There is no standardized procedure/ protocol to facilitate the PRP extraction in EPPENDORF 5810 R. Most studies are based in REMI-R8C centrifuge.

Aims & Objectives: The aim is to check the various parameters (centrifugation time, speed, acceleration, decceleration) and standardization of EPPENDORF 5810R (double centrifugation technique in swing bucket) which would aid in maximum PRP yield. The Assessment criteria were the platelet concentration or the final yield and quality control of the final platelet concentrate. The quantity of whole blood, type of anticoagulant, the speed/duration of centrifugation, platelet agitation favourability, various pellet extraction methods were all considered for better standardisation in my study.

Materials & Methods: 40 samples of whole anticoagulated donor blood, 14 ml each was collected in a falcon tube. Initial blood count was done. Double centrifugation of all the samples were done using different permutations of parameters-centrifugation time, speed, amount of whole blood, various anticoagulants in swing bucket rotor of EPENDORF-5810R. The volume and the platelet count was assessed after each centrifugation as part of quality control. Result: The optimum yield (3 times baseline) was obtained with a low spin of 1600 rpm 9 15 min with acceleration of 9 and deceleration of 4, and a high spin of 3200 rpm 9 8 min with acceleration of 9 and deceleration of 4. Platelet agitation and incubation of final Platelet concentrate for 1 h (than 2 h) was a major prerequisite. 14 ml whole blood in CPD (than ACD) was adequate for a preparation of 2 ml PRP. Homogenising of the platelet pellets in final platelet concentrate yielded low platelet count compared to platelet extraction to concentrate. No red cell contamination was found by altering centrifugation parameters. Conclusions: The optimum platelet yield was obtained with above configurations in EPENDORF 5810 R and the results were reproducible.

Shruti Chauhan, Sangeeta Pahuja, Deeksha Singh, Geetika Sharma, Ramvilas, Manisha Introduction: Alloimmunisation with dual or multiple alloantibodies is not an uncommon phenomenon in Transfusion Medicine. We encounter cases where clinically significant alloantibodies are masked by one or more antibodies leading to diagnostic dilemma and delay in transfusion therapy of patients.

Aims & Objectives: The aim of our study is to correctly identify alloantibody specificities in patients with dual and multiple alloimmunization by various immunohematological techniques with special emphasis on use of selected cells.

We have included a series of 12 cases which presented at the Department of Immunohematology and Blood Transfusion, Lady Hardinge Medical College. Various immunohematological techniques like ID-Diacell I II III Asia, ID Diapanel, selected cells, adsorption and elution method, Dithiotreitol and enzymatic methods were used as and when required. Result: Result: Out of 12 cases, we thus confirmed one case each of extremely rare combination of anti D ? M, anti E ? s, anti E ? S, anti Jka with ?anti E and ?anti S, anti C with anti Jkb and anti s, 2 cases of anti D ? E and 5 cases of anti c ? E. Conclusions: It is necessary to correctly identify and confirm highly immunogenic alloantibodies so that timely intervention is ensured and corresponding antigen negative blood is made available to the patient.

Sreethu Chand, Amita R, Debasish Gupta Introduction: The occurrence of red coloured urine following blood transfusion is a cause for concern. The possibility of an immune mediated acute haemolytic transfusion reaction (AHTR) should be ruled out in all such cases. Next in consideration is the non-immune mediated haemolysis which can be due to thermal, osmotic, or mechanical injury to red blood cells. The authors report three cases of non-immune AHTR which occurred in cardiac surgery patients. Aims & Objectives: We aimed to perform a root cause analysis (RCA) to identify the reason for AHTR. Materials & Methods: AHTR was reported to the Transfusion Medicine Department, in three patients who underwent cardiac surgery and received a blood transfusion in the intra-operative period. Haemolytic transfusion reaction workup and RCA were performed to identify the cause of AHTR. Result: The initial presentation was red coloured urine and suspicion of an immune AHTR. Visual inspection of the patients' blood and urine samples showed haemolysis (Fig. 1) . HTR workup for immune mediated haemolysis (repeat blood grouping, compatibility testing, direct and indirect antiglobulin test) was negative. The sample from the blood bags was centrifuged and showed no evidence of haemolysis. RCA revealed the possibility of mechanical red cell lysis that occurred in the cardiopulmonary bypass (CPB) circuit as the three patients underwent cardiac surgery under CPB. Two patients underwent coronary artery bypass surgery and the other patient was a one year old child who underwent elective surgery for ventricular septal defect. Conclusions: The use of the CPB circuit is associated with an increase in plasma haemoglobin and a decrease in haptoglobin levels indicating mechanical red cell destruction. However, most of the red cell destruction that occurs with CPB often remains within the capacity of endogenous clearance mechanisms and will only be evident when it passes the threshold of clearance by the reticuloendothelial system, showing features of AHTR that need immediate attention and transfusion reaction workup. Haemolysis that can occur during CPB is a well-recognised complication and transfusion medicine specialists should be aware of this possible complication when an AHTR has been reported with on-pump surgeries. Immediate management of the patient like any other AHTR is also warranted in these situations.

Sunistha Bhattacharjee, Jyoti Shaw, Anjumana Khatun, Maitreyee Bhattacharyya Introduction: Beta thalassemia is one of the most common autosomal recessive disorders worldwide. Sequencing for beta mutations done where phenotype-HPLC discrepancies exist, often leads to discovery of rare or novel mutations. Aims & Objectives: The aim of this study was to investigate the molecular defect of patients whose clinical phenotypes remains unexplained by routine hematological investigation. Materials & Methods: Patients visiting at thalassemia OPD whose clinical phenotypes remains unexplained by HPLC and routine molecular investigation and carrying one mutation in beta globin gene or no mutation in alpha gene cluster were included in this study. Complete Hemogram analysis (Sysmex KX-21), HPLC analysis (Bio-Rad Variant II, Beta Thal Short Program) and Serum Ferritin estimation (EIiSA) was performed. ARMS PCR was done to detect common beta mutations. Alpha globin gene triplication or deletion analysis was done by GAP PCR (Liu et al.) . The patients who were normal for alpha triplication/deletion with above mentioned phenotypes were subjected to DNA Sequencing Analysis (ABI 3500 Genetic Analyzer) to identify the presence of rare mutation in beta globin gene. Result: A child with HbE trait in HPLC, having low hemoglobin and jaundice required blood transfusion was detected to have CD26 mutation in heterozygous state as common mutation. A 14 years old boy showing Sickle beta in HPLC having low hemoglobin, low MCV, was detected to have homozygous CD6 in ARMS PCR. Third patient was also transfusion dependent with history of jaundice and splenomegaly was detected to have IVS-I-5 mutation in heterozygous state as common mutation. A 18 years old patient having low hemoglobin with jaundice, once required blood transfusion was detected to have E disease in ARMS. Last patient was beta carrier having high HBA2 value having jaundice, pallor and splenomegaly was found to be normal for 3.7 alpha triplication. All five patients have a rare mutation i.e. IVS-II-850(G [ C) located at splice junction of intron 2 and exon 3 region of beta globin gene. Conclusions: IVS-II-850(G [ C) have been reported previously in a Yugoslavian family. This mutation is located on a splice junction in beta globin gene and the G-[ C change in the AG dinucleotide, which is required for normal splicing, abolishes this process, and assumed to affect transcription. Introduction: The effect of COVID-19 infection and its vaccines on the immune system is still a subject of much research and debate. Unusual findings due to COVID-19 infection or COVID-19 vaccination are increasingly being reported. However, caution is warranted to rule out known entities before considering these possibilities. Aims & Objectives: We report a case of incidentally detected ABO discrepancy attributed to complications of COVID-19 vaccination but diagnosed ultimately as multiple myeloma. Materials & Methods: Case Report: A 52-year-old male presented with weakness, easy fatigability and chest pain following the second dose of the COVID-19 vaccine. His hemoglobin fell progressively and he was advised blood transfusion. Result: Blood grouping revealed ABO discrepancy in forward and reverse grouping. Routine peripheral blood smear examination showed rouleaux formation and background blue-tinging. The patient also had raised ESR. The patient was suspected to have a plasma cell dyscrasia, which was confirmed on serum electrophoresis and this explained the ABO discrepancy. Conclusions: M protein in plasma cell myeloma is known to cause group III ABO discrepancy due to rouleaux formation which can be interpreted as pseudo-agglutination and can be a presenting feature. Though vaccine-induced blood group discrepancies have also been reported in the literature, a detailed workup with a good interpretation of peripheral smear findings is necessary so as not to miss the primary underlying disease.

Vijay Anand V, Amit Sharma Introduction: Safe storage of blood is an integral component for blood safety and it should be stored in an equipment that meets defined standards of performance and by staff who follow established procedures at all times. The blood bank refrigerator is the basic requirement for any blood bank. Whole blood and packed red cells are stored in a Blood Bank Refrigerator (BBR) at temperature between 2 and 6°C with set temperature of 4°C.Temperature recording device such as thermograph and temperature monitor chart are used for constant monitoring of temperature.

This was a prospective study done over a period of 18 months (Jan 2020-July 2021). Buffy coat pooled platelet concentrates (BC-PPCs) were prepared from four buffy coats as per institute protocol using quadruple top and bottom blood bag system (LQT, Macopharma, France) and a dedicated platelet pooling set (TRV, Macopharma, France). Single donor platelets (SDPs) were prepared as per institute protocol. The platelet concentrates were issued to patients admitted in Hematology ward. Corrected count increment (CCI) within 24 h of transfusion was calculated to assess response to platelet transfusion. Statistical analysis was done using SPSS software (version 23.0, IBM Corporation, USA). Result: A total of 57 units of BC-PC and 140 SDPs were transfused to hematology patients. The clinical details of patients and outcome of platelet transfusions are shown in Table 1 . Conclusions: Clinical efficacy of BC-PCC in the form of corrected count increment was comparable to SDP in the study population. BC-PCs seem to be a good alternative to apheresis platelets in settings with limited resources.

Bharat Singh, Jyoti Kala Bharati, Rajendra Chaudhary, Preeti Elhence Introduction: Direct antiglobulin test (DAT) demonstrates in-vivo sensitization of red cells with immunoglobulin or complement. DAT positivity is reported in 0.008% of healthy blood donors. Mostly, donors with a positive DAT appear to be perfectly healthy and have no obvious signs of hemolysis. However, a careful evaluation may show evidence of increased red cell destruction.

Aims & Objectives: To study the serological characteristics and evidence of hemolysis in DAT positive healthy donors. Materials & Methods: This was a prospective analysis of DAT positive blood donors, identified during cross match incompatibility work up. Donor DAT was performed initially by column agglutination technique followed by conventional tube technique (CTT). DAT positivity was further evaluated in detail by performing monospecific DAT, IgG subclassing, Antibody screening and elution study. Various clinical and laboratory parameters indicating hemolysis in donors were also assessed. Result: During routine AHG cross-matching, 14 units were found to be incompatible with patient sera. Donor DAT positivity was found to be responsible for incompatibility. DAT strength was moderate in all cases. Out of these 14 donors, only 3 were positive when DAT was repeated by CTT. Monospecific DAT demonstrated IgG alone in 12 cases and C3d in rest two cases. On subclassing, IgG1 was demonstrated in 3 cases while rest 11 were negative for IgG1 and IgG3. Antibody screening was negative in all donors. Red cell eluate showed panreactivity in 4, specific pattern in 3 donors while rest 7 were negative. On resolution of 2 cases with specific pattern, anti-E and anti-M were identified. We could not find any laboratory or clinical evidence of hemolysis in any donor. There was no history of blood transfusion or medication in recent past. Units were not used for transfusion and discarded. Conclusions: In the paucity of guidelines regarding safety of such units, the units may continue to be discarded. A prudent approach would be to defer, notify and refer these donors to physician for further counselling and follow up. Reinstatement of such donors could occur if the DAT becomes negative at a predetermined interval but further studies are required.

Feasibility of High Yield Plateletpheresis in Routine Practice: Experience from Tertiary Health Centre from South India Dibyajyoti Sahoo, Shahida Noushad Introduction: Introduction: High Yield Plateletpheresis donations can reduce donor exposure and be economically beneficial as well. However, obtaining a High Yield Plateletpheresis from a maximum number of donors with low basal platelet count and its effect on postdonation platelet count of donors undergoing High Yield Plateletpheresis has been a matter of concern. Aims & Objectives: Aims & Objectives: This study aimed to assess the feasibility of making high yield platelet donation as a routine practice. Materials & Methods: Methods: It was a retrospective observational study to determine the effect of High Yield Plateletpheresis on donor reactions, efficacy, and quality parameters. It was conducted from 1st Jan 2019 to 30th June 2021 at the Department of Transfusion Medicine in a tertiary care hospital of South India. Result: Out of the 669 procedures, 564 (84.3%) of the collection had a platelet yield of had C 5 9 10 11 , 468 (70%) of the collection had a platelet yield of 5.5 9 10 11 , whereas 284 (42.5%) met the target of 6 9 10 11 . The mean drops in platelet count were 95 ± 16 9 10 3 /ll (77,600 to 113,000/ll), mean platelet recruitment was 1.31 ± 0.51. The mean collection efficiency of the procedure for the 669 cases was shown to be 80.21 ± 15.34, and the mean collection rate was 0.07 9 1011 ± 0.02 per minute. Only forty donors (5.5%) experienced adverse donor reactions. Conclusions: High yield Plateletpheresis with 5.5 9 10 11 yield can be done safely in routine practice even with a pre-platelet count of 220 9 10 3 /ll by increasing procedure time. These donations can reduce donor exposure further as well as add economic benefits to the patients. We hope that our data can guide in performing High yield Plateletpheresis using high-end machines.

DR AKSHAY JOSHI, S.K.Shere, S.N.Gawai, A.R.Joshi

Introduction: Blood transfusion services are an important part of the health care system. Covid 19 pandemic has severely affected health care system along with blood transfusion services. Severe fall in number of donors with arrival of pandemic due to public fear resulted in disproportionate decrease in demand and supply with net effect of shortage of blood units.

1. To study overall effect of covid 19 on blood transfusion services. 2. To formulate corrective and preventive measures.

A retrospective study was conducted at Regional blood centre. In this study 1 year data of precovid era is compared with 1 year data during covid 19 pandemic. Data is obtained from SBTC software, master stock register, camp record register, donor register and blood issue register. Result: During covid 19 pandemic there is significant fall in total number of donors, Decrease in number of blood donation camps along with no change in emergency requirement. Although pandemic reduced the elective procedure related blood transfusion. Conclusions: Covid 19 showed negative effect on blood transfusion services. We need to reduce fear and anxiety among donors and ensure safety. Plan small and consistent flow of donors rather than being dependent on mega donation camps. This can be achieved by supporting the intraoperative transfusion strategy in patients with cancer.

Aims & Objectives: The aim of this study was to review and identify the blood transfusion indicators of four major surgical oncology subspecialty divisions. The primary end point in the study was to identify factors responsible for intraoperative blood transfusion.

The present retrospective analysis was conducted in the Department of Transfusion Medicine from December 2020 to April 2021. The surgical procedures were categorized as Major Invasive (MaI) and Minor Invasive (MI). The volume of intraoperative blood loss was also further categorized as [ 500 ml and \ 500 ml. Chi-Square test and Fisher Exact were used for univariate analysis. Logistic regression was used to identify factors predicting blood transfusion. Result: The analysis comprised 470 patients that underwent oncologic surgeries constituting 374 (79%) as MaI and 96 (20.4%) as MI surgery respectively. Among 470 patients, only 66 (14%) patients received intraoperative blood transfusions. Univariate analysis showed that Sex, Pre-Operative Hemoglobin, and blood loss during the operative procedures were significantly associated with blood transfusion. Multivariate logistic regression demonstrated that Pre-Operative Hemoglobin (p \ 0.001) and Amount of blood lost in ml (p \ 0.001) as independent factors predicting blood transfusion. The number of blood transfusions was significantly higher in 36 (76%) MaI with blood loss [ 500 ml (p \ 0.05). A reduced Median preoperative Hb of 10.1(Range-7.9 to11.5) was associated with more intraoperative transfusions in 54 (81%) patients (p \ 0.05). Conclusions: The factors responsible for intraoperative blood transfusion should be assessed for each surgical oncology patient during the pre-operative planning as a part of blood conservation strategy.

A Case of ABO Discrepancy in Primigravidae Antenatal Patient UTKARSH VIRESH AGRAWAL, Dimple Darad, Mayuree Modi Introduction: ABO Discrepancy is the disagreement between the results of red cell grouping (or forward grouping) and serum grouping (or reverse grouping). It is classified into 4 types based on the cause-Group 1 (problem with serum grouping).

Group 2 (problem with cell grouping) Group 3 (plasma/ protein abnormalities) Group 4 (Miscellaneous)

Aims & Objectives: To study and resolve ABO discrepancy in a case of 19 yr old primigravidae patient and correlate it clinically and with relevant findings of other investigations. Materials & Methods: EDTA and Plain blood sample of patient was received in blood centre. Forward and reverse grouping was done by tube method. Forward group shows B Positive with presence of weak A antigen of other than A1 subgroup and reverse group shows B group with weak O antibodies. All possible technical causes related to clerical, procedural and reagents were ruled out. Repeat sample was asked for. Direct Antiglobulin test and autogglutination test was carried out to classify and confirm type of ABO discrepancy. Both the tests turned out to be positive. After incubation at 37 deg C for 30 min O antibodies became negative. Further investigations were advised for. Result: It is a case of Group IV ABO Discrepancy with autoagglutination due to Autoimmune haemolytic anemia secondary to Systemic Lupus Erythematosus. Hence the reporting of blood centre correlated well with all clinical and laboratory findings. Conclusions: Correct blood typing, labelling and extensive workup of an autoimmune disease suspected individual is essential to classify type of ABO Discrepancy, especially in cases having history of previous blood transfusion so as to recognize discrepant results and to resolve them. Besides these must be investigated further to avoid and minimize chances of transfusion reaction.

Healthy Blood Donors in Delhi-National Capital Region Alexandra Kristin Mawlong, Priyanka Gogoi, Preeti Diwaker, Mrinalini Kotru

Introduction: A novel Coronavirus (2019-nCoV) was first reported from Wuhan, China, in December 2019. This 2019-nCoV was found to be an enveloped RNA beta coronavirus which contains four structural proteins: spike (S), envelope (E), membrane (M) and nucleocapsid (N). During infections, neutralizing antibodies are mainly targeted against the spike protein, which has been the main focus of vaccine development. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is disease implicated in the infection by this novel pathogen. The actual percentage of asymptomatic cases is unclear and how long they continue to be carriers is unknown. Sero-prevalence data can therefore throw light on the exposure, immune status and disease severity in a population.

To determine the sero-positivity of SARS-CoV-2 Antibodies among healthy blood donors attending a tertiary care hospital and voluntary blood donor camps, in Delhi-National Capital Region.

Analysis of Post Transfusion Platelet Increment in Acute Leukemia Patients-A Tertiary Cancer Centre Experience Neelesh Jain, Dibyendu De, Ruchi Aujla Introduction: Acute leukemia patients require multiple transfusions for a prolonged period of time. Patients undergoing induction and/or consolidation chemotherapy often require platelet transfusion at least every 3 days. Normal platelet survival is approximately 5-7 days. Long-term platelet supportive care may be complicated by the development of a state of refractoriness, resulting in inadequate recovery of platelets. The Platelet transfusion refractoriness occurs when there is an inadequate change in the desired level of platelets in the recipient's blood following a platelet transfusion. Platelet refractoriness occurs in approximately 30-70% of patients who receive multiple transfusions. Aims & Objectives: To Study Platelet Transfusion efficacy in acute leukemia patients. To study platelet transfusion threshold.

To study adequate dosing of platelet concentrate transfused. Materials & Methods: This is a 1 year (Jan to Dec-2020) prospective observational study undertaken in Centre at Raipur, Chhattisgarh. The study population included acute leukemia patients who had been transfused with platelet concentrates (i.e. Random Donor Platelet or RDP). Threshold for platelet transfusion was kept at 10,000/microliter or active bleeding irrespective of platelet count. The study group included patients of both sexes and of all age groups. Result: A total of 52 patients received 785 Platelet concentrate units (RDP) at 211 occasions with a median of 10.5 units RDP given to each patient in the median of 3 episodes of transfusion. The mean value of 24 h post transfusion platelet increment (PPI) was 9655/ll. Seventeen (32.6%) patients showed 24 h PPI value \ 4500/ll. Overall 31 (59.6%) patients developed blood and/or urine culture positive sepsis during the course of treatment, of which nine (52.9%) patients belongs to the category whose PPI value was \ 4500/ll. All patients received across the ABO group platelet transfusion at least at one occasion. Males (53%) showed high post transfusion platelet increment then females (47%) (i.e. 10,420 v/s 8890). Dose adequacy was noticed in 66.82% of events of transfusion with 67.40% of response adequacy. AML patients showed better post transfusion platelet response then ALL. Mean platelet count per RDP unit was 6.45 9 1010. Conclusions: Two third of our study population received adequate platelet transfusion with 67.4% showed adequate platelet recovery after 24 h of transfusion. Interestingly we found that AML and male patients' 24 h PPI value was better than female and ALL patients. Further studies needs to be conducted to determine the causal associations for these findings.

A Case Series in a Tertiary Care Centre from Western India Para Trivedi, Farzana Kothari Introduction: Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that selectively affects the optic nerves and spinal cord and generally follows a relapsing course. As per American Society for Apheresis (ASFA) guidelines, Therapeutic Plasma Exchange (TPE) is considered as a second-line treatment for acute episodes of NMO. Aims & Objectives: It is a retrospective review of the use of TPE in the treatment of an acute attack of NMO in 6 patients.

The effect of TPE on the degree of recovery from NMO was evaluated by performing a single volume plasma exchange with intermittent and continuous flow cell separator by femoral or central line access and scheduled preferably on alternate day intervals over 8-10 days. Clinical outcome in response to TPE with patient characteristics and procedural parameters were noted. Result: All patients were severely disabled before the initiation of TPE and out of them 3 were female and 3 were male; with the mean age of these patients was 41.67 years (range = 30-62 years), and the median duration of disease was few days to weeks. Out of 6 patients, 4 had a history of bilateral optic neuritis, and all patients were anti aquaporin-4 antibody positive with MRI showing features of NMO. Totally 32 TPE procedures were performed on 6 patients, the mean time of start of TPE in the acute attack was 3.5 days. Patients were severely disabled at the initiation of TPE, and improvement was observed early in the course of TPE treatment in most patients. Mean volume processed was 4145.97 ml with mean plasma volume removed was 2239.17 ml and mean ACD used was 232.16 ml. One patient developed relapse after 6 months following discontinuation of treatment.

The present study provides clinical support for the importance of TPE in acute attack in NMO. TPE has been shown to be beneficial in the management of acute episodes of NMO/NMOSD (ASFA category II) as it also removed the antibodies. TPE improved the clinical status of the patients. TPE was well-tolerated and had a low severe adverse event profile.

A Case Series in a Tertiary Care Centre from Western India Para Trivedi, Farzana Kothari Introduction: Neuromyelitis optica (NMO) is an inflammatory demyelinating disease that selectively affects the optic nerves and spinal cord and generally follows a relapsing course. As per American Society for Apheresis (ASFA) guidelines, therapeutic plasma exchange (TPE) is considered as a second-line treatment for acute episodes of NMO. Aims & Objectives: It is a retrospective review of the use of TPE in the treatment of an acute attack of NMO in 6 patients.

The effect of TPE on the degree of recovery from NMO was evaluated by performing a single volume plasma exchange with intermittent and continuous flow cell separator by femoral or central line access and scheduled preferably on alternate day intervals over 8-10 days. Clinical outcome in response to TPE with patient characteristics and procedural parameters were noted. Result: All patients were severely disabled before the initiation of TPE and out of them 3 were female and 3 were male; with the mean age of these patients was 41.67 years (range = 30-62 years), and the median duration of disease was few days to weeks. Out of 6 patients, 4 had a history of bilateral optic neuritis, and all patients were anti aquaporin-4 antibody positive with MRI showing features of NMO. Totally 32 TPE procedures were performed on 6 patients, the mean time of start of TPE in the acute attack was 3.5 days. Patients were severely disabled at the initiation of TPE, and improvement was observed early in the course of TPE treatment in most patients. Mean volume processed was 4145.97 ml with mean plasma volume removed was 2239.17 ml and mean ACD used was 232.16 ml. One patient developed relapse after 6 months following discontinuation of treatment.

The present study provides clinical support for the importance of TPE in acute attack in NMO. TPE has been shown to be beneficial in the management of acute episodes of NMO/NMOSD (ASFA category II) as it also removed the antibodies. TPE improved the clinical status of the patients. TPE was well-tolerated and had a low severe adverse event profile.

Vidhi Jain, Farzana Kothari Introduction: Hemovigilance like quality systems and audits have become an integral part of Blood Transfusion Services in the developed countries and have contributed greatly to its development. Hemovigilance begins with donors and must enable the collection of information on reactions occurring during the donation of blood, selections of donors and to prevent such incidents. Aims & Objectives: The aim of study was to help identify the trends of adverse events, occurring in blood donors at a tertiary-care hospital, to recommend best practices to improve donor care and safety. Materials & Methods: This record-based study was conducted on all adverse events related to allogenic whole blood donations performed over 08 months. Prior informed consent was obtain and donor confidentiality was maintained. The donor was observed before and after for any adverse event. For delayed reactions, donors were requested to contact the blood center or any designated departmental staff. Data was collected in case record form. All whole blood donations were analyzed. All adverse events occurring during or at the end of the donation were noted using a standardized format and analysed. Result: Overall rate was 0.3% with vasovagal reactions constituting 82%, and 18% mild syncopal reactions (p \ 0 [). Conclusions: In order to have a well organized hemovigilance system in developing countries like India, a comprehensive approach is required. A streamlined mechanism for data collection using standardized tools at hospital level and good coordination at national level can bring up effective hemovigilance system in a country. There is need to strengthen and to bring uniformity in the hemovigilance system globally. Introduction: Blood transfusion plays a vital role in patient management (both medical & surgical cases) in modern medicine. As Blood is a valuable resource, blood wastage can have negative impact on blood transfusion services. The rate of discarded blood components (Wastage rate) is one of the quality indicators in blood banks, recommended by NABH. Many factors lead to the wastage of blood products such as broken bag, broken seal, expired units, serology positive units, broken cold chain, clotted blood, or most importantly due to lack of proper knowledge, training, and awareness. Aims & Objectives: Aim of this study is to determine rate of discard (wastage rate) of blood & blood components, and to evaluate the reasons for discard of blood components.

The study of analysis of data was carried out retrospectively from Jan 2016 to Dec 2020 (5 year period) from NIMS blood center. All the data of discarded blood components and the reasons for discard, from this 5 year period is collected from documented registers and computer saved data.

Result: In 5 year study period, total 84,952 donors donated at NIMS blood center and 2,23,064 components were prepared. 8,659 components were discarded. Wastage rate of blood and components is 4.66%. Highest percent of wastage is due to TTI positivity of donors, that is 51% of total discarded blood components, followed by expiry 25%, Phlebotomy 13% and under-collection 9%. Conclusions: Blood being an irreplaceable resource, it needs to be properly utilized and to minimize wastage of blood there should be proper implementation of blood bank policies. Strict adherence to donor selection criteria, proper pre-donation history taking, counseling and software to identify TTI positive donors and suspected professional donors who have been screened previously can reduce the seropositivity. Continued medical education for technical staff to maintain self-audit, follow quality standards of processing and preparation of blood components could minimize the wastage rate of blood components. Introduction: There are more than 38 blood group systems with over 300 antigens defined till date, but while transfusion, only ABO and RhD status is selected for cross match. Presence of red cell alloantibodies against these antigens may cause transfusion reactions in multiple, chronically transfused patients and also have the risk of haemolytic disease of newborn. Typing of blood group antigens helps in developing antigen-negative inventories and may also identify rare donors.

Aims & Objectives: The aim of this article is to analyze the need of Rhesus extended phenotyping in different case scenarios and also to know the distribution of major Rh antigens, their phenotypes and genotypes in the population. Materials & Methods: This is a retrospective study done in NIZAM's institute of medical sciences in the department of immunohematology and blood transfusion. All the data has been consolidated from the registries maintained in our department from year Jan 2020 to Sept 2021. Samples were collected from donors and recipients and tested for ABO, Rhesus and Kell antigens in tube agglutination method and/or gel cards technology. Result: A total of 178 samples were tested for phenotyping including 7 cases of thalassemia, 3 cases of HDNB and 1 patient had Von Willebrand's disease, of these 159 (89.4%) tested for RhD positive status and only 19 samples (10.6%) were detected as RhD negative. Among other Rhesus antigens the most common antigen in this population was e (39.6%), C (34.07%), c (19.3%) and E (6.9%). The most common phenotype was found to be DCe in RhD positive units and dce in RhD negative units. Introduction: About 1.5% global populations (80-90 million) are carriers and approximately 4.4 out of every 10,000 live births are affected throughout the world of which 60,000 symptomatic individuals born annually. India has burden of estimated 100,000 patients Indian J Hematol Blood Transfus with a b thalassemia with average prevalence of b thalassemia carriers of 3-4%(Sensus of India2011). Transfusion dependent infections again surmount the ongoing major health issues in these patients, mainly including HCV/HBV and HIV infection.Hepatitis B and C infections are prevalent in India and carrier rate is about 1-5% and 1%, respectively. Post transfusion hepatitis B/C and HIV is a major challenge in India (about 10%) due to low viremia, undetectable mutant strains and long window period (Chowdary.et.al). Our study was designed to determine the prevalence of HBV/HCV/HIV in multiply transfused thalassemia patients by standard laboratory tests. The factors affecting were studied and analyzed. Aims & Objectives: To determine the prevalence of Hepatitis C, Hepatitis B & Human immunodeficiency virus (HIV) in transfusion dependent b-thalassemia major (TM) patients and to determine the factors i.e. chronicity; frequency of transfusions; multi institutes/donor provided transfusions with frequent lost to fallow up secondary to covid lock-down affecting them. And to correlate Liver function tests and Ferritin levels among these positive children to those who are not. Materials & Methods: This is a retrospective cross-sectional study conducted from January 1st 2020 till September 30, 2021. A total 134 patients were enrolled from thalassemia unit of tertiary care hospital of western Maharashtra ageing from 1 to 13 years. Statistical analysis was done by using SPSS 17.0 software using T test and chi square test.

Result: Among them, infected cases with HCV, HBV and HIV were 27.61%, 0.75% and 2.24% respectively. Moreover, of the patients were found to be co-infected with both HBV and HCV. The percentage of infections in the patients with frequent transfusion interval (B 30 days) was significantly higher (p \ 0 [ 30 days) so was the patients who received transfusions long time. Ferritin, SGPT and SGOT were significantly raised in infected patients. The rate of infection for HIV, HBV &HCV was significantly high in patients who were diagnosed early for thalassemia, who lost follow up & transfused from multiple institutes due to COVID lockdown due to lack of transportation facilities. Conclusions: To ensure the frequently transfused patients, a good quality of life from the preventable HBV/HCV/ HIV related complications. Efficient screening methods for proper donor selection should be adopted and awareness should be built to ascertain a safe transfusion.

Transfusion Support in a Sickle Beta Thalassemia Antenatal Patient with Red Cell Alloimmunization-Double Trouble G. Saranya, V. Shanthini Gilda, A. Ruth Jenila, M. Sintha Introduction: Unexpected antibodies in the patient pose a challenge to find compatible units, higher when multiple allo-antibodies are present. We hereby present a case of Pregnant female with multiple allo-antibodies. Aims & Objectives: To highlight effective management of an antenatal case of Sickle b Thalassemia with multiple alloantibodies. Materials & Methods: A 28 years old pregnant female, G4P2L1A1D1, with two previous caesarean section, diagnosed with Sickle b Thalassemia, presented at 20 weeks of gestation with severe dyspnoea and anemia. Past history of 10 unit packed cell transfusion during previous deliveries was present. History of packed cell transfusion 20 days back, but there was significant drop in hemoglobin after transfusion. Hemoglobin on admission was 3.8 g. Requisition for packed red cells was received in blood bank. Result: Patient was typed as O RhD positive. Direct antiglobulin test and auto-control was negative.Indirect antiglobulin test was positive. Antibody screening and identification with 3 and 11 cell panel identified multiple alloantibodies. Plasma was incompatible with random O RhD positive units.Patient was started on injection methylprednisolone intravenously.Following steroids, 3 units of Coombs cross matched packed cells were transfused. Coombs cross matching was tough and tedious. 20-30 units were cross matched to find one compatible unit of packed cells.Post transfusion increment in hemoglobin was 5.6 g. Patient was monitored for hemoglobin rise and serum indirect bilirubin.Intravenous steroids changed to oral prednisolone. The peak systolic velocity of middle cerebral artery was increased in Foetal Doppler.Patient was taken for hysterotomy on a quasi-emergency basis as patient was dyspnoeic with severe anaemia and transfused 2 units packed cells and platelets intraoperatively.Postoperative period uneventful. Patient was discharged with tapering dose of steroids and azathioprine.Patient was reviewed after 10 days with hemoglobin 5.3 g. Conclusions: Aggressive management of Sickle b Thalassemia patient with multiple alloantibodies saves the life of the patient. The combined teamwork of physicians, obstetricians, haematologists and transfusionist helped in the treatment and prevented a fatal outcome. Our country needs cryopreservation of red blood cells as a part of rare donor program.

Extracorporeal Photopheresis in the Management of Graft Versus Host Disease in Children-Single Centre Experience from India Harika Varla, Satish Kumar Meena, Rumesh Chandar, Venkateswaran Vellaichamy Swaminathan, Ramya Uppuluri, Indira Jayakumar, Revathi Raj Introduction: Extracorporeal photopheresis (ECP) is an immunomodulatory therapy with established outcomes in the management of steroid refractory acute and chronic graft versus host disease (GVHD). We describe our experience with ECP in middle income countries in the Ruxolitinib era. Aims & Objectives: We aimed to analyze the effectiveness of ECP in the management of GVHD.

We performed a retrospective analysis of data from children who underwent ECP for the management of steroid refractory acute and chronic GVHD between January 2016 and December 2020. In addition to calcineurin inhibitors, GVHD was treated as per standard guidelines using 2 mg/kg/day of methylprednisolone. Mononuclear cells were harvested using Cobe-Spectra cell separator and 8-methoxy psoralen was injected at a dose of 20mcg/ml. Children less than 40 kg had blood priming of the circuit during the donor lymphocyte collection. The collected product was subjected to UV-A exposure utilizing MACOGENIC-2 device and infused back into the patient. Result: Seventeen patients underwent ECP with a median age of 9 years (2-34 years). The indications for HSCT were benign haematological disorder in 9 children and malignancy in 8 children. Among the 7 children who underwent ECP for acute GVHD, all had grade IV skin and gastrointestinal tract (GUT) GVHD. All the 10 children with chronic GVHD in addition to skin, had involvement of musculoskeletal system (n = 6), GUT (n = 1) and mouth (n = 2). The median follow-up period was 21 months (3-79 months) . Five children had ECP as second line agent (acute GVHD (n = 1), chronic GVHD (n = 4). ECP was used after ruxolitinib in 1 child with acute GVHD and 6 with chronic GVHD. The total number of sessions performed were 58. Children with chronic GVHD on ruxolitinib underwent ECP cycles once in two weeks while those not on ruxolitinib required weekly ECP cycles. Two children had hypotension during ECP and responded to fluid resuscitation. Mortality was related to GVHD in 4 children and infection in 3 children. The overall response rate was 82%.

Saina Abdul Salam, Shaiji PS, Safdar Basheer Introduction: The platelet rich plasma (PRP) is an endogenous therapeutic technology that has immense scope in regenerative medicine due to its potential to stimulate and accelerate tissue healing, attributable to their hemostatic potential and presence of multiple growth factors and cytokines.Quality of the PRP prepared is one of the important factor affecting the result.Literature is sparse regarding factors affecting quality and Standardization of procedure in refrigerated centrifuge EPPENDORF 5810 R. Aims & Objectives: To analyse the effect of various parameters (centrifugation time, speed, acceleration, decceleration) during standardization of PRP preparation by double centrifugation technique in swing bucket,which would aid in maximum PRP yield.The final quality control criteria was the platelet count of final concentrate and yield compared to initial count.Variables tested were quantity of whole blood, type of anticoagulant, the speed/duration of centrifugation, platelet agitation favourability and various pellet extraction methods. Materials & Methods: 14 ml of whole blood was collected in conical falcon tubes (15 ml) from 40 donors who consented for autologous PRP preparation.Only donors with normal initial blood count including Hb, TC, DC and platelet count was selected. Double centrifugation of all the samples were done using different permutations of parameters-centrifugation time, speed, amount of whole blood, various anticoagulants in swing bucket rotor of EPENDORF-5810R.The volume and the platelet count was assessed after each centrifugation as part of quality control. Target platelet count was 3 times baseline/ [ 10Lakhs/microliter. Result: Maximum yield (3 times baseline) was obtained with a low spin of 1600 rpm 9 15 min with acceleration of 9 and deceleration of 4, and a high spin of 3200 rpm 9 8 min with acceleration of 9 and deceleration of 4. Platelet agitation and incubation of final Platelet concentrate for 1 h (than 2 h)yielded much better platelet count than without agitated.14 ml whole blood in CPD (than ACD) was adequate for a preparation of 2 ml PRP. Homogenising of the platelet pellets in final platelet concentrate yielded low platelet count compared to platelet extraction to concentrate. No red cell contamination associated with these centrifugation parameters.

Bone marrow failure and MDS (Clinical)

Bone Marrow Failure and MDS (Laboratory)

Lymphoma and Myeloma (Laboratory)

Skin toxicities in 4(40%) patients (Eczema Grade I to II, Bullous dermatitis Grade II to III) and urinary bladder toxicities in 1(10%) patient. Sinusoidal obstruction syndrome (SOS) was not seen in any patients. Conclusions: TTF based conditioning regimen achieved good graft function, was well tolerated with low incidences of acute and/or chronic GVHD with no incidence of SOS in a heterogenous cohort of high-risk patients undergoing allogeneic HSCT including alternate donor haploidentical transplants. related (n = 3), unrelated (n = 1) and haploidentical donors (n = 2). level of 10.7-16.8 mg/dl requiring corticosteroids, forced diuresis, calcitonin and bisphosphonates. Duration of hyperand well. Causes of death after HSCT were sepsis (n = 1), GVHD (n = 1) and cardiac failure (n = 1)

Hematopoietic Stem Cell Transplantion in Transfusion Dependent Thalassemia (TDT)-A Comparative Analysis of Busulfan-Cyclophosphamide (BU-CY) and Fludarabine-Thiotepa-Treosulfan (FTT) Conditioning Regimen

Hematopoietic Stem Cell Transplantation (HSCT) is currently the only curative option present for this condition in developing countries like India

Aims & Objectives: (1) To describe the outcome of TDT patients undergoing HSCT. (2) To compare outcomes and toxicity profile with Bu-Cy ± Antithymocyte Globulin (ATG) and FTT ± ATG as conditioning regimen

FTT ± ATG in 28 (50%) patients, one patient in FFT group was retransplanted using Fludarabine-Cyclophosphamide for graft rejection. The FTT group had higher median age (11 vs 5 yrs) at transplant and more pesaro class III patients (11 vs. 2 patients). BM was the predominant graft source (85%) in Bu-Cy regimens as compared to PBSC (97%) in FTT regimens. GVHD prophylaxis was cyclosporine-methotrexate in 95% of transplants

Grade II-IV acute GVHD and chronic GVHD were similar in Bu-Cy and FTT group (30% vs 34.5%, p = 0.77 for aGVHD, 15% vs 20.6%, p = 0.73 for cGVHD)

Previous GWAS studies have demonstrated role of various SNPs in genes of pro-coagulants, coagulation factors and inflammation, in VTE prognosis, including cyclo-oxygenase or prostaglandin oxidase and coagulation F11 gene variants. COX enzyme plays a key role in arachidonic acid metabolism of prostaglandins (PGs) and thromboxane A2 (TXA2) which are involved in the process of inflammation and platelet aggregation respectively. FXI is an integral component of intrinsic coagulation pathway and a cofactor for factor IX. Thus increase in levels of both COX2 and FXI facilitates thrombus formation duing VTE. Aims & Objectives: Present study evaluates association of four common single nucleotide polymorphisms (SNP) in Factor XI (FXI) and Cyclooxygenase-2 gene (COX-2) with the risk of venous thromboembolism (VTE) in Indian population. Materials & Methods: Study participants were Indian Army personnel who were recruited for study after obtaining written consent from them. Volunteers were divided into two study groups: VTE patients (n = 103) and healthy controls (n = 160). Peripheral blood was collected in EDTA tubes and high molecular weight DNA was extracted using Qiagen DNA isolation kit. Quantitative and qualitative check of DNA samples were performed. Four SNPs, two in each gene, were studied using PCR-RFLP method. For FXI

Result: FXI c.403G [ T SNP variant showed statistically significant difference between VTE patients and healthy controls (v 2 = 58.26, p = 0.0001). FXI c.901 T [ C and COX2 C/G showed similar monomorphic profile in both study groups. COX2 G/A SNP showed insignificant diffenece between VTE patients and controls. Conclusions: FXI, c.403G [ T (p.Glu135*type II mutation) is significantly associated with VTE susceptibility in Indian population. Evaluating COVID-19 Associated Coagulopathy with Thromboelastogram-Experience from South India Ganesh Mohan, Bemma Paonam, Ashwinkumar Vaidya, Shamee Shastry, William Wilson, Prithvishree, Jayaraj MB Indian J Hematol Blood Transfus COVID-19 Related Extensive Thrombosis Shivampatel, Madhukar Rai Introduction: While the COVID-19 syndrome triggered by SARS CoV-2 was initially seen predominantly as a pulmonary disease, the number of vascular complications has recently increased. These include venous and arterial thromboembolic events as well as local thromboses, which can form directly on the endothelium at the site of cytokine release

Result: All the tests for evaluation of common causes of extensive thrombosis were ruled out. Even covidrtpcr was negative, but SARSlike giddiness, sweating, vomiting and nausea. Only trend in ADR

The vasovagal reaction was managed by lowering the head end, loosening the tight clothing's thus maintaining adequate airway and elevating the legs. Conclusions: Vasovagal reactions were the most common adverse reaction. These adverse reactions are higher in first time donors, young age

Seroprevalence of Transfusion Transmitted Infections Among Blood Donors Parimala Puttaiah, Seemang Boro, Sitalakshmi S Introduction: Risk of transfusion transmitted infections (TTI)

Aims & Objectives: To study the prevalence of HIV, Hepatitis B, Hepatitis C,syphilis,malaria among blood donors in a tertiary care centre

After obtaining informed consent and analysed for HBsAg, anti-HCV and Anti-HIV1&2 Malaria and Syphilis. Result: Of the total number of 96,114 blood donors

1842 donors (1.9%) were reactive for TTI. Prevalence of HIV, HBsAg, HCV, syphilis and malaria in our

Co-infection was seen in 6 donors (0.008%). Co-infectivity for Hepatitis B and Hepatitis C was highest which is 0.005%, whereas HIV seropositivity along with Hepatitis B and HIV seropositivity with Hepatitis C was 0.001%. Out of 96,114 donors, 33,506 donors tested by ELISA method from year

All 24 females who have antibodies in their serum were having significant history of blood transfusion and were multigravida

Only 3 females were primigravida, who had alloantibodies out of 24 high risk females

Most common antibody was anti-D 50%

Conclusions: ARMS PCR is routinely used for the screening of 22 common beta globin gene mutations. These also include the five most common variant found in Indian populations. The success of the ARMS PCR depends on the proper annealing of the allele specific primer which has a mismatch of a single base at the 5' end. If the primer fails to anneal, then PCR fails to give result. This limitation is overcome in the DNA sequencing method. Moreover

Warm Autoantibody with Underlying Anti-E Alloantibody in a Thalassemia Patient: A Diagnostic Challenge and its Implications Kusha Sharma, Sangeeta Pahuja Sindhwani, Deeksha Singh, Shruti Chauhan, Manisha, Ramvilas formulating strict guidelines and implementing them which can prevent such crisis in future

Materials & Methods: A mixed cohort study; plasma (PL) and/or platelet transfusions (PLT) to children B 2 years were observed (n = 127). Patient's classified as: I

Low birth weight/pre-term (LBW/ PT) children (n = 28) and IV. Other diagnoses (OD) (n = 43). PL and PLT thresholds were observed for survival INR

Hb g/dl (0-9 g/dl; 10-12 g/dl and [ 12 g/dl) respectively. Patients were also analysed for survival with PL only; PL and PLT or PL, PLT with RBC transfusions for best practice recommendation. Result: A single centre cohort study (n = 127)

Intra Operative Transfusion Indicators in Surgical Oncology Patients in a Tertiary Care Oncology Centre Suryatapa Saha, Bhakti, Sashank Ojha, Dr Minal, Sumathi, Arun, Nagaraju Introduction: Intraoperative blood loss is a major cause of anemia in surgical oncology patients

Blood Transfus • After obtaining written informed consent, 2 ml of venous blood was collected in plain sterile vials, during phlebotomy of the voluntary blood donors. Separated serum samples were used for testing

• Serum samples were tested for the presence of IgG antibodies against COVID-19 using a commercially available ELISA kit

• ErbaLisa COVID-19 IgG, developed and manufactured by Calbiotech. Inc USA will be used

• Statistical analysis: Prevalence of healthy blood donors positive for SARS-CoV-2 IgG Antibodies is expressed as a percentage

Percentage of healthy blood donors positive for SARS-CoV-2 IgG Antibodies in Delhi-National Capital Region. Results: • 119/182 (65.38%) of healthy blood donors were positive for Spike protein of SARS-CoV-2 IgG antibodies

• Blood group wise percentage of sero-positivity was as follows: A?: 64.28% (27/42

Other 3 samples (HIV-1, HBsAg-1, HCV-1) were retested by CMIA, CLIA and ELFA which were concordant with ECLIA, but discordant with ELISA. Conclusions: ELISA and ECLIA observed highest similar performance for HBsAg followed by HCV whereas ELISA and Rapid test showed highest similar for HBsAg and moderate for HIV and HCV. According to this study, both methods; ELISA and ECLIA were comparable for TTD screening. Assessment of Quality Parameters in Peripheral Stem Cell Collection: A One-Year Audit Rizwan Javed, Mita RoyChowdhury

Aims & Objectives: To conduct an audit of the apheresis service and develop quality indicators for PBSC in conformance with International quality standards

Patient selection: All patients/ donors for PBSC collections underwent medical examination and investigations as per the Institutional protocol. Mobilisation Regime: All patients/donors received G-CSF subcutaneously daily (10ug/kg/day) single dose for pediatrics and split dosing for adults for 5 days, followed by harvest on the fifth day. In autologous collections, prelixafor 0.24 mg/Kg was administered 12 h prior to collection, if peripheral CD34 ? count was less than 30 cells/ ll in the morning of day 4 G-CSF administration

No procedure-related adverse reaction (Grade 3 and 4) was observed. Microbiological culture positivity in HPC product was 3.5%. Conclusions: Mobilization related adverse reactions in 54% of the patients. As a corrective action prophylactic analgesics were added to alleviate the pain. Hence, quality indicators are useful for objective assessment, analysis and corrective action in PBSC collection. of outcome of platelet transfusion was assessed by corrected count increment (CCI), percent recovery of platelets (PPR) and transfusion interval (TI). Patients were divided into refractory and non-refractory categories based on their 24-h CCI. Those having two-consecutive-24-h-CCIs less than 4500 were classified as refractory. Ethical clearance was duly taken from the Institutional Bioethical Committee. Result: A total of 273 prophylactic platelet transfusion episodes were recorded for 35 patients. The median 24-h-CCI and PPR were 2908 and 6.43% for refractory patients; 6027 and 12.9% for non-refractory patients, respectively. The mean number of platelet transfusion episodes were 10.3 per refractory patient and 5.8 per non-refractory. Presence of splenomegaly and use of Amphotericin-B had a statistically significant contribution towards refractoriness. Fever, sepsis, and other observed drugs were not found to be statistically significant factors amongst the two groups of patients. The median transfusion interval was 1 day for refractory patients and 2 days for non-refractory patients. Conclusions: It was noticed that some patients failed to attain the expected post-transfusion platelet increment. This may be caused by refractoriness to platelet transfusion due to patient factors such as splenomegaly and use of antifungal drugs like Amphotericin-B. The 24-h-CCI was significantly lower in refractory patients. Prevalence of Adverse Transfusion Reactions: 15 Years Analysis in Tertiary Care Oncology Centre Vidya Sandip Patil

They were further categorised as per HvPI and International Haemovigilance Network (IHN) standards. Statistical analysis was done by using the Chi-square test. Result: In 15 years period 54,757 units of blood and blood components were transfused. Total 104(0.19%) ATRs were reported. Total ATRs were noticed as higher in Males (69%) compared with Females (31%) and highest ATR rate was observed in Haematopoietic Stem Cell Transplant patients (38%) followed by Gastro intestinal cancer patients (17%)

Total ATRs reported were comparable between before (0.11%) & after (0.23%) HvPI. Conclusions: Hemovigilance programme helps a lot to categorise the transfusion reactions. Complete Hemovigilance reporting and awareness among clinicians can minimize the risk of transfusion reaction and increases blood transfusion quality and safety

data of 120 cases were collected. Because of incomplete clinical data 10 cases were excluded from this study. Age group of our study population was in between 3 months to 11 years. Male female ratio was 3.76:1. Fever was the most common presenting symptom. Pallor, hepatomegaly, splenomegaly and bone deformities were the most common signs among cases. Our study result showed that 74% patients were found to be underweight, 21.73% were short stature, 39.68% were hypocalcaemia, 54.5% had low serum alkaline phosphatase. Level of Hb, RBC, MCH, MCHC was found to be low as compared to control groups. Mean Hb F levels was 92.44 ± 4.76%. Whereas Mean Hb A0 and A2 were 20.12 and 1.2 respectively. Our study also found that level of serum ferritin was significantly high among in this cases (3996.84 ± 2695.9 ng/ml). Conclusion: The study showed that children with beta thalassemia major are anaemic

Materials & Methods: Bone marrow aspiration alongside bone marrow biopsy was done following a complete blood count of the patient followed up with cytogenetic studies. Result:1. Bone marrow aspiration showed hypercellular marrow with trilineage hyperplasia and disorganised hematopoeisis affecting all three series suggestive of chronic myeloproliferative disease/ myeloproliferative neoplasm. 2. Cytogenetic study was positive for JAK2 STAT mutation.Conclusions: The diagnosis of individual patients with a myeloproliferative disorder can be difficult. The integration of clinical features, laboratory findings, bone marrow features, and molecular analysis have become the standard approach to the MPN diagnostic evaluation. In the above case, laboratory findings of polycythemia, neutrophilia and thrombocytosis and bone marrow findings of erythroid hyperplasia and subtle megakaryocytic atypia and/or clustering together with cytogenetic studies revealing JAK2 STAT mutation points to a diagnosis of Polycythemia Vera. This diagnosis will help the physician in choosing the correct treatment modality.A Study of the Expression of GATA1 Protein by Immunohistochemistry in BCR ABL1 Negative Myeloproliferative Neoplasms Prerna Arora, SeemaTyagi, Tulika Seth, ManoranjanMahapatraIntroduction: BCR/ABL1-negative MPNs include polycythaemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF) and are characterized by mutations in JAK2, CALR, or MPL, however, none of the these mutations are specific. Clinical and morphological features can also be overlapping. It is imperative to discriminate between them as the clinical outcome is considerably different. GATA1 is a DNA and protein-binding transcription factor essential for differentiation within the erythroid & megakaryocytic compartments & may have utility as a diagnostic marker in BCRABL1 negative MPNs. In this study, we will study the expression of GATA-1 in BCR/ABL1-negative MPNs. Aims & Objectives: To assess the expression of GATA1 by IHC on newly diagnosed &followup cases of ET, PV, PMF with progression to fibrosis or leukemic transformation. Materials & Methods: 45 cases of BCRABL1 negative MPN were studied over a period of 1 year (June2020-June 2021) presenting in Department of Haematology. The clinical data was retrieved from the records. Complete hemogram, peripheral smear, bone marrow aspirate & biopsy (BMA & BMB) were evaluated. All cases were classified as per WHO 2017 classification of MPN. IHC was done on BMB for GATA 1 (D52H6)XP Rabbit monoclonal antibody in 1:100 dilution. GATA score was evaluated semi-quantitatively by multiplying the intensity score and positive cell percentage. Result: There were 20 cases of fibrotic PMF (44%), 10 cases of PV (22%), 6 cases of prefibrotic MF (13%),5 cases of ET (11%) and 4 cases of ?PrePMF ? ET (8%). 3 cases of fibrotic MF progressed to accelaeratedphase, 1 case each of PV progressed to acute leukemia and fibrosis, while 1 case of PrePMF progressed to acute leukemia. Median GATA score of control was 6, while the lowest GATA score of 2 was found in ET, followed by 3.5 in Prefibrotic PMF, 5 in fibrotic PMF and PV, while equivocal score of 6 in ?PrePMF ? ET. GATA score decreased with progression to acute leukemia or fibrosis in PV and remain unchanged with progression to accelerated phase in PMF. Conclusions: GATA score can give an early insight into progression to fibrosis in BCRABL1 negative MPNs and can suggest alternative diagnosis particularly in cases with morphological diagnostic dilemma in ET VS prePMF. Moreover, new insights are underway to increase GATA1 expression as a measure to correct megakaryocyte defect and hence cause early reversal of fibrosis.

Rashmi Rajora, Deepika Gupta, Adhiraj Singh, Gopal Krishana Bohra, Abhishek Purohit Introduction: Essential thrombocythaemia (ET) is a type of chronic myeloproliferative neoplasm involving the megakaryocytic lineage. Usually seen in 5th decade of life with slight female predilection. It is characterized by peripheral blood thrombocytosis (platelet count C 450 9 109/L) and proliferation of mainly megakaryocytic lineage with increased number of enlarged mature megakaryocytes with hyperlobulated nuclei in bone marrow. Driver mutations associated are JAK2V617F(*50-60%), CALR(*30%) or MPL(*03%) and about 12.Aims & Objectives: The aim of the present case presentation is to highlight one uncommon presentation of myeloproliferative neoplasm.

A 65-year-old female, known case of hypertension and diabetes mellitus type2, presented with history of dry gangrene and severe pain in right great toe. On examination, the patient had pallor, splenomegaly and blackish discoloration of right great toe. Computed tomomography angiography revealed thrombus in aorta, portal vein and right post tibial artery along with splenomegaly. Haematological investigations including complete haemogram, bone marrow examination and molecular studies were performed. Biopsy was processed and stained using haematoxylin and eosin. Reticulin stain was performed on bone marrow biopsy to look for degree of myelofibrosis. Result: CBC revealed anaemia (Haemoglobin-10.8 g/dL), neutrophilic leucocytosis (TLC-29,500/ll) and marked thrombocytosis (Platelet count-13,30,000/ll). Reactive causes of thrombocytosis were ruled out. Cellular bone marrow aspirate smears showed marked prominence of megakaryocytes, showing few large forms with hyper lobulated or stag-horn like nuclei. Normocellular bone marrow biopsy showed marked megakaryocytic prominence with focal loose clusters and predominance of large forms displaying abundant cytoplasm and hypersegmented nuclei. Reticulin stain revealed loose network of reticulin fibres with no intersection (WHO grade, MF-1). Molecular studies were performed. bcr-abl1 mutation was not detected and JAK2617F mutation was detected. Patient was diagnosed as essential thrombocythemia and is on aspirin, dabigatran and hydroxyurea and is being followed-up in haematology clinic. Conclusions: Although digital gangrene is a rare manifestation of ET, it should always be suspected in a patient presenting with microvascular occlusion as use of cytoreductive therapies prevents disease progression to a significant extent.A Rare Case of Extramedullary Blastic Transformation (Myeloid Sarcoma-Megakaryoblastic) in a Patient with Primary Myelofibrosis Rincy Thomas, Boben Thomas, Bindu TG, Shabnam Introduction: Myeloid sarcoma is a tumour composed of myeloid blasts, with or without maturation ocurring at extramedullary sites. Myeloid sarcoma with megakaryoblastic transformation in chronic myelofibrosis is very rare. Only a few cases have been reported till date.Introduction: Mobilization of peripheral blood stem cell (PBSCs) for autologous stem cell transplantation (ASCT) is usually achieved using cytokines namely granulocyte colony-stimulating factor (G-CSF). Plerixafor is a novel mobilization agent that is absorbed quickly after subcutaneous injection and provides a sustained increase in circulating CD34? cells for 10-18 h. Aims & Objectives: To compare the efficacy of plerixafor in enhancing hematopoietic stem-cell mobilization and collection before ASCT in patients where G-CSF failed to achieve adequate mobilization in the first harvest.

The study included paired 178 PBSC harvest samples evaluated by flow cytometry for CD34 enumeration between March 2015 and August 2021. PBSCs were mobilized with G-CSF on day 1 in all patients while day 2 mobilization was done using either G-CSF (group 1) or G-CSF ? plerixafor (group 2). Single platform CD34 enumeration was performed using BD stem cell enumeration kit and BD Trucount tubes by lyse no wash method in BD FACS Canto. Total number of 100,000 events or above and 50 or more CD34 events were acquired in each sample and analysis was done in BD FACS Diva software. The percentage of viable CD34? cells and CD34 doses were calculated. Result: Among 178 patients included in the analysis, 117 patients were in group 1 while 61 patients were in group 2. When G-CSF alone is used on both the days, the median CD34 dose was 2.95 9 10 6 /kg (0.25-8.4) on day 1 and 2.06 9 10 6 /kg (0.48-8.7) on day 2 harvests respectively. When plerixafor was added with G-CSF for the day 2 mobilization, there was a significant increase in the day 2 median CD34 dose [(3.74 9 10 6 /kg (0.55-11.06)] when compared to the day 1 [median CD34 dose:1.69 9 10 6 /kg (0.25-7.9)] where G-CSF alone was used for mobilization (p = \ 0.0001).

The retrospective single center study shows that in patients who failed to achieve adequate mobilization with G-CSF alone, adding plerixafor can maximize stem-cell collection and improve the CD34 dose. A follow up prospective study can help in forming recommendations regarding the use of plerixafor for mobilization of PBSCs for ASCT.

1. To assess the clinical course of TTP in our institution and monitor the outcome, both immediate and long term. 2. To review the different practical issues involved in management.

The records of all TTP patients diagnosed from January 2019 till June 2021 were analyzed including clinical manifestations, diagnostic challenges, response to treatment and outcomes. The ISTH diagnostic criteria were used to aid in diagnosis, however, ADAMTS 13 testing (ADAMTS 13 activity or Anti ADAMTS 13 IgG) could not be done in any of the cases due to financial and logistic issues. The PLASMIC score was also used to aid in diagnosis and for guiding further management. Result: In this 2 1/2 year period 7 cases of TTP were diagnosed. There was female predominance (M:F = 6:1). Only one patient (14.3%) was below 20 years of age and rest (85.7%) were C 40 years age. Patients presented most commonly with neurological symptoms (n = 6) with stroke being the commonest among them (3 cases). Laboratory investigations showed microangiopathichemolyticanemia in all cases (100%), whereas renal failure was also seen in one case at the time of presentation (14.7%). Autoimmune cause could be detected in two cases (28%) whereas in rest of the cases (72%) no primary cause could be established. All patients underwent therapeutic plasma exchange (3-5 sessions, median 3) and recovered. All patients are now on follow up and none of them have relapsed.

1. Classical pentad is no longer needed or mandatory to diagnose TTP. 2. Unavailability of ADMATS 13 activity does not affect the diagnosis or treatment if low threshold for clinical suspicion is kept. 3. LDH and Reticulocyte count at presentation is more representative of the clinical scenario than at the end of PEX. 4. 4. LDH and reticulocyte count are usually high at presentation but with exceptions. 5. After each session of PEX, LDH may show an immediate improvement but the reticulocyte count may still remain high and may take longer time to normalize. So, the LDH may help in response assessment but not the reticulocyte count.

Nilanjana Ghosh, Vinay Kumar, Anju A. Hembrom, BabitaKumari, Lilly Ganju, Rajeev Varshney, Swati Srivastava, Iti Garg* Introduction: Mitochondrial engagement has been documented in numerous diseases pathlogies. The shift of influence is expanding day by day with new connection and cellular networks of mitochondria with several biochemical pathways and metabolites in human physiology. Cardiovascular diseases (CVD) being one of the reasons of high mortality rates worldwide, has mitochondria controlling some of its important strings leading to the causes of Diabetes mellitus, obesity, strokes, MI, etc. Venous thromboembolism (VTE) being the third common CVD, responsible for several deaths throughout the world every year. Mitochondrial signatures have also been found to be associated with theses diseases as well as mitochondrial functioning is signficantly affected by hypoxia exposure. Increase in timing of hypoxia exposure leads to damaged mitochondria which in turn effectuate formation of dysfunctional mitochondria. Hence, a network analysis was performed to find a connection of Mitochondrial genome, Hypoxia inducible factors (HIF) and coagulation associated genes.Aims & Objectives: In-sillico investigation to ascertain the association of mitochondrial genome, coagulation pathway and Hypoxia inducible factors in the pathogenesis of VTE.

Based on earlier studies, potential genes associated with coagulation associated genes, hypoxia induced factors and mitochondrial genome taken together and analysed in-sillico for Network analysis The gene IDs of each and every genes were taken from NCBI database and Genemania software was used to perform the network analysis among the three groups i.e. inter, intra and collectively in all groups together.Result: Network analysis results depict availability of 4 networks (hypoxia induced factors and mitochondrial genome), 3 networks (coagulation associated gene and mitochondrial genome), 3 networks (coagulation associated genes hypoxia inducible factors and mitochondrial genome individually). Network analysis of three groups together eventually pointed out towards involvement of two important mitochondrial genes i.e., MT-ND6 and MT-CO2 which are connected with all groups.Conclusions: These results demonstrate that mitochondrial genome actively play a potential role in hypoxia induced venous thromboembolism and could be explored further to get deep understanding of the mechanism.14. Transfusion Medicine

Adil Salmani, Aparna Bhardwaj, Seema AcharyaIntroduction: Hemolytic disease of newborn due to Rh isoimmunization is a serious and potentially fatal condition. Anti D causes the most severe form of hemolytic disease of newborn and happens to be the leading causes of fetal death. Sensitization to antigens other than D in C E system is not uncommon. Anti c is clinically the most important Rh antigen after anti D and often causes severe HDN.Result: Here in we present a case of term male baby Rh positive, born extramurally and admitted in NICU within 34 h of life with complain of respiratory distress, anemia and severe hyperbilirubinemia. PRBC transfusion could not be done due to incompatible X match even with O negative blood and direct coombs test positive. On detailed Antibody screening and identification anti-c antibody was positive.Conclusions: Anti-c is a major cause of hemolytic disease of new born, the practitioners must be vigilant and manage anti-c isoimmunization in a manner similar to anti D. Introduction: Antibodies against 25-28 blood group antigens are known to cause hemolytic transfusion reactions (HTRs), and red cell antibody screening by commercial cell should detect such clinically significant antibodies. It will increase sensitivity of testing and help to identify irregular antibody missed by pooled cell testing. Timely identification of antibody will help in timely transfusion without any risk to patient.

Aims & Objectives: The aim of this study was to find out utility and sensitivity of Antibody screening by 3 cell panel on column agglutination testing (CAT) for the first time patient in pre-transfusion testing.

We had done 1161 Antibody screening by commercial cell and pooled O cell. An antibody screen was carried out in all the patients using the ortho diagnostics surgiscreen I ? II ? III. The results were compared to see irregular antibody identified by 3 cell panel which may get missed by O pooled cell and vice versa.Result: Out of 1161 patient tested 26 were antibody screen positive by 3 cell panel and only 7 were positive by pooled cell. 4 patients were negative with pooled cell and were crossmatch incompatible on AHG phase. Not a single case was found where the antibody screen was negative and AHG crossmatch showed incompatibility.Conclusions: Antibody screening of patient by commercial 3 cell panel is sensitive due to presence of homozygous expression of antigen on cells. It will help in better detection of irregular antibody in patient before crossmatch and give time to arrange compatible blood in advance. It will also help in Identification of irregular antibody by identification panel, further decrease the turnaround time for arrangement of blood unit. It will further help in immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients. Identification of antibody helps in prevention of Allo-immunization by transfusion of phenotype matched blood. Introduction: Cold agglutinin disease (CAD) is a complement mediated immune hemolytic disease, characterized by haemolysis and red cell destruction in the reticuloendothelial system, predominantly in the liver, or by agglutination of red cells in peripheral cold-exposed vessels leading to vaso-occlusion.Aims & Objectives: To report a case of cold agglutination disease leading to early diagnosis of multiple myeloma. Materials & Methods: Study was conducted in Department of IHBT, in a tertiary care centre.Result: Blood requisition for 61 year old female with complaints of anemia and difficulty in breathing for Packed RBC was sent to the Blood centre. Visible spontaneous agglutinates were seen in blood samples. Blood group discrepancy was observed in cell and serum grouping by conventional tube technique. Screening antibody by 3 cell panel showed pan-agglutination. 11 cell panels were performed to rule out any underlying alloantibodies. A direct anti-globulin gel card test revealed Grade 3 ? positivity. The thermal amplitude test showed association with autoantibody to the I antigen present on adult RBCs. Subsequently Peripheral blood smear was ordered showed extensive red cell agglutination along with few plasmacytoid cells, raising suspicion of possible plasma cell dyscrasia. Bone marrow aspirate revealed a mixture of [ 30%plasma cell and plasma blast.Bone marrow biopsy subsequently revealed interstitial, focal and nodular pattern of involvement by Plasma cells.Conclusions: Blood group discrepancy may reveal underlying secondary CAD disorders as in our case.Careful communication between the transfusion services and clinicians can avoid unnecessary blood transfusions and early detection in such cases especially in clinically responding patients.

1. The study was conducted to monitor and analyze temperature deviations in storage of red cells in blood blank refrigerator (BBR). 2. To compare the temperature recording chart and thermograph in identifying deviations. 3. Steps to prevent the reoccurrence of temperature deviations.

This study was conducted in the Department of IHBTM, SMS Medical college, Jaipur from a time period of-January 2021 to June 2021.Thermograph and temperature chart were analyzed and deviations of over 5°C or less than 3°C from the standard temperature of 4°C in BBR were recorded into four quadrants based on the graphic representation in thermograph.1. 12:00 AM-6:00 AM (1st Quadrant) 2. 6:00 AM-12:00 Noon (2nd Quadrant) 3. 12:00 Noon-6:00 PM (3rd Quadrant) 4. 6:00 PM-12:00 AM (4th Quadrant)Result: The total number of deviations occurred were 56.There was an even distribution of the number of deviations in each month. Increase of temperature of over 5°C from 4°C were more common (42%) than the other deviations observed. Introduction: Granulocyte concentrates can be obtained using different cell separators from healthy donors, mobilized with granulocyte-colony-stimulating factor and steroids. To ensure that an adequate number of granulocytes are collected, the more efficient cell separator should be preferred. Granulocyte concentrates are administered to patients with severe neutropenia (ANC \ 500/ll) resistant to antibacterial and antifungal drugs.Aims & Objectives: To compare the granulocyte collection efficiency of Two Cell Separators COBE Spectra and COMTEC.Materials & Methods: Retrospective data was collected from granulocyte procedure sheets, maintained in the Department of Transfusion Medicine at a tertiary care oncology centre, between May 2016 to July 2020.Comparative analysis of total 82 granulocyte collection procedure were performed in two different Cell Separators, COBE Spectra (n = 40) and Fresenius COMTEC (n = 42). Collection efficiency related variables like pre procedure blood counts, total blood volume processed, anticoagulant used were also recorded. Statistical analysis was done by using SPSS software version 25. P value \ 0.05 was considered significant. Also, product quality and collection efficiency were analysed using Independent T test.Result: The quality control parameters of the granulocyte product were significant in COBE Spectra compared to COMTEC in terms of the higher granulocyte collection efficiency (CE2) (P = 0.02) and lesser platelet contamination (P = 0.00). COBE Spectra was observed to be more donor friendly compared to COMTEC, with significantly lesser separation time (P = 0.000), total blood volume processed (P = 0.01) and anticoagulant used (P = 0.00). Additional parameters like product yield, red cell contamination was better in COBE Spectra compared to COMTEC, however, not statistically significant. Conclusions: COBE Spectra has a better granulocyte collection efficiency (CE2) and lesser non targeted cell contamination in product.

Prakher Sharma, Amita MalikIntroduction: Liver iron overload measurement is an important predictor for the burden of blood transfusion and long term complications in transfusion-dependent patients. Use of MRI is becoming a standard for diagnosing and monitoring iron overload due to its noninvasiveness, easy availability and reliable Results.Aims & Objectives: To calculate liver iron content on 3T MRI using R2* method.

In this IRB approved study, ten (8 female, 2 male) transfusion dependent patients visited the Safdarjung hospital and were enrolled in a cross-sectional study. Median duration of transfusion was seven years. Each patient underwent MRI for liver iron overload quantification on 3T MRI. LIC calculated by the relaxometry method and graded according to the severity of iron overload.Result: The most common cause for transfusion dependence in our study was b-thalassemia (n = 4), followed by aplastic anaemia (n = 2). LIC calculated using 3 T MRI ranged from 97.32 to 704.9 lmol/g.Six patients had severe iron overload, three had moderate to severe and one had mild iron overload in the liver. Serum ferritin ranged from 350 to 3190 ng/ml. Compared with serum ferritin values, LIC calculated by the MRI showed a moderate positive correlation with p-value of 0.078. Splenic iron overload was also seen in 9 out of ten participants computed in the same sitting with mean value of 86.56 lmol/g. Conclusions: MRI of the liver is a reliable non-invasive investigation for quantification of iron overload, thus obviating the need of liver biopsy. It can also be used for monitoring of response to therapy. It also has the advantage of detecting Iron deposition in other organs like spleen, pancreas and heart in the same sitting. Conclusions: Results obtained from our study will be useful to gauge the current immunological status, which will allow further policymaking to be guided by more reliable evidence-based data. Conclusions: Study of adverse transfusion reactions is very much important to improve the safety aspects of blood transfusion. Close monitoring of each and every transfusion reaction case should be of utmost priority to detect onset of any reaction. There is scope for proactive and preventive actions to minimize occurrence of transfusion reactions. Moreover, accurate reporting of all transfusion reactions at the national haemovigilance system significantly improves execution of haemovigilance program in our country.

Mayank Dosi, Nidhi Soni, Sumit Prakash Rathor Introduction: The primary methodology for HIV testing has shifted to rapid diagnostic tests (RDTs) in recent years, especially in resource limited settings. Nucleic acid amplification test (NAAT) narrows the window period thereby increasing the blood safety. It becoming a standard method for detection of pathogens before the appearance of antibodies.

(1) To estimate the proportion of HIV infection among random blood donors by Rapid card test. (2) To find the sensitivity and specificity of rapid card test against Nucleic acid Amplification Test for screening of HIV infection among random blood donors. Introduction: Extracorporeal photopheresis (ECP) is an immunomodulatory therapy with established outcomes in the management of steroid refractory acute and chronic graft versus host disease (GVHD). We describe our experience with ECP in middle income countries in the Ruxolitinib era.Aims & Objectives: We aimed to analyze the effectiveness of ECP in the management of GVHD.

We performed a retrospective analysis of data from children who underwent ECP for the management of steroid refractory acute and chronic GVHD between January 2016 and December 2020. In addition to calcineurin inhibitors, GVHD was treated as per standard guidelines using 2 mg/kg/day of methylprednisolone. Mononuclear cells were harvested using Cobe-Spectra cell separator and 8-methoxy psoralen was injected at a dose of 20mcg/ml. Children less than 40 kg had blood priming of the circuit during the donor lymphocyte collection. The collected product was subjected to UV-A exposure utilizing MACOGENIC-2 device and infused back into the patient.Result: Seventeen patients underwent ECP with a median age of 9 years (2-34 years) . The indications for HSCT were benign haematological disorder in 9 children and malignancy in 8 children. Among the 7 children who underwent ECP for acute GVHD, all had grade IV skin and gastrointestinal tract (GUT) GVHD. All the 10 children with chronic GVHD in addition to skin, had involvement of musculoskeletal system (n = 6), GUT (n = 1) and mouth (n = 2). The median follow-up period was 21 months (3-79 months) . Five children had ECP as second line agent acute GVHD (n = 1), chronic GVHD (n = 4). ECP was used after ruxolitinib in 1 child with acute GVHD and 6 with chronic GVHD. The total number of sessions performed were 58. Children with chronic GVHD on ruxolitinib underwent ECP cycles once in two weeks while those not on ruxolitinib required weekly ECP cycles. Two children had hypotension during ECP and responded to fluid resuscitation. Mortality was related to GVHD in 4 children and infection in 3 children. The overall response rate was 82%.Conclusions: ECP is a safe and effective second line agent in children with acute GVHD as it reduces risk of viral reactivation associated with immunosuppressive therapies. Ruxolitinib along with ECP in chronic GVHD results in effective symptom relief with a minimum number of ECP sessions. Introduction: Anti D differentiation is of paramount clinical importance in alloimmunized pregnant females with apparent anti D and anti C reactivity pattern in antibody identification panels. Anti-G can mimic Anti-D/anti-C reactivity pattern. The patients who develop anti-G are D-negative with rr genotype and exposed to D positive or r'r red cells during pregnancy.

Aims & Objectives: To demonstrate unequivocally the presence of anti-D in antenatal cases presumed to have anti-D and anti-C antibody specificity to guide the further management of pregnancy for RhIG immunoprophylaxis.Materials & Methods: ABO/Rh blood grouping and Rh-Kell antigen typing was done in the patient by gel card method.The antibody screening and antibody identification by indirect antiglobulin test (IAT) was performed using commercially available 3-cell and 11-cell panel respectively. For anti-D differentiation in the serum (1) Parallel and differential adsorption was done with r'r and R2R2 group O packed RBC (2) IAT of the adsorbed serum (3) Titers of the adsorbed serum were done by tube and gel card method. Result: We hereby report 3 cases of antenatal females, which showedanti-C ? anti-D reactivity pattern in antibody identification panel. Case1 was 19 year old G2L1P1, 36 weeks gestation, case 2 was 29 year old G4P2L2, term pregnancy and case 3 was 29 year old G4P3L3, 33 weeks gestation.Blood group of all the above cases was A negative.However, there was blood-grouping discrepancy in case1. Adsorption studies with group O, D-C ? red cells confirmed the presence of anti-D alloantibody in the adsorbed sera in case 1 and 2.Whereas in case 3 adsorption studies with group O, D-C ? and C ? D-red cells confirmed the presence of anti-C ? G alloantibody. The titers of anti-D antibody done by tube method were 128 and 32and by gel card method were 256 and 64 in case1 and case 2 respectively. In case 3 titers of anti-C done by gel card method was 32.Conclusions: It is therefore of clinical importance to confirm the presence of anti-D in D negative woman with anti-C ? anti-D reactivity pattern by a simpler and less-time consuming strategy. Also it ensures timely availability of antigen negative blood for IUT and exchange transfusion if needed.

Shanthini Gilda V., G. Saranya, A. Ruth Jenila, M. Sintha Introduction: Hemolytic disease of the fetus and newborn is the destruction of fetus and newborn red cell by maternal red cell alloantibodies that are specific for inherited paternal red cell alloantigens. Antibodies targeted to blood group antigens in addition to RhD can cause HDFN.The most common of these antigens are K and c.Other antibodies that have been less commonly reported to cause moderate or severe disease include E,k,Kpa,Kpb,Jsa,Jsb,Jka,-Fya,Fyb,S,s and U.The rate of hemolysis and severity of disease are determined by the IgG subclass,amount of antibody and number of antigenic sites on the red cells.During the first prenatal visit,maternal ABO and Rh should be typed and an antibody screen should be performed. During the first day after birth, close monitoring of the bilirubin level is necessary because of the threat of kernictus, especially in premature neonates.The infant may require blue-green light theraphy, in addition intravenous immunoglobulin,in neonates who are nonresponsive, a double-volume-exchange transfusion.Because of the use of Rh Immunoglobulin,ABO incompatibility is now the most common cause of hemolytic disease of fetus and newborn.Aims & Objectives: To enlighten rare case of hemolytic disease of fetus and newborn due to alloantibodies anti-E and anti-c in an RH(D) positive mother.Materials & Methods: A G2P1L1 B RhD positive mother delivered an alive,term, male baby O RhD positive by LSCS at a peripheral secondary care hospital 14 days back with newborn parameter Hb-15.7 g/dl and serum bilirubin-23.2 mg/dl.Baby had respiratory distress and jaundice on day 1 of life.Serum bilirubin of baby 33 mg/dl and direct coombs test positive on day 4 of life.Exchange transfusion done at peripheral secondary care hospital with O RhD positive blood.Baby referred to our teritory care centre on day 14 of life for respiratory distress and anemia Hb-7.9 g/dl with serum bilirubin-9 mg/dl on day 13 of life.H/O blood transfusion in mother 3 years back in postnatal period. Repeat direct coombs test done for baby in our institution using tube method.Indirect coombs test done for mother using tube method.Antibody screening done using 3 cell panel,antibody identification done using 11 cell panel and autocontrol was done.Baby transfused with coombs cross matched O RhD positive packed cell on day 15 of life.Result: Repeat direct coombs test of baby was positive.Indirect coombs test of mother was positive.Antibody screening was positive.Antibody identification confirm the presence of anti-E and anti-c and autocontrol were negative.Repeat Hb improved to 11.2 g/dl and serum bilirubin reduced to 8.4 mg/dl on day 17 of life.Conclusions: To confirm RH(D) positive rare hemolytic disease of fetus and newborn.Identify early and prevent sequele by doing antibody screening in all pregnant women and not restricted to RH(D) negative mother or those with past history of hemolytic disease of fetus and newborn.This strengthen the concept of antibody screening in all antenatal cases.so that hemolytic disease of fetus and newborn and neonatal mortality prevented.